id	sid	tid	token	lemma	pos
aji-158	1	1	_	_	PUNCT
aji-158	2	1	_	_	PUNCT
aji-158	3	1	_	_	PUNCT
aji-158	4	1	_	_	PUNCT
aji-158	5	1	_	_	PUNCT
aji-158	6	1	_	_	PUNCT
aji-158	7	1	_	_	PUNCT
aji-158	8	1	_	_	PUNCT
aji-158	9	1	_	_	PUNCT
aji-158	10	1	_	_	PUNCT
aji-158	11	1	_	_	PUNCT
aji-158	12	1	_	_	PUNCT
aji-158	13	1	_	_	PUNCT
aji-158	14	1	_	_	PUNCT
aji-158	15	1	_	_	PUNCT
aji-158	16	1	_	_	PUNCT
aji-158	17	1	_	_	PUNCT
aji-158	18	1	_	_	PUNCT
aji-158	19	1	_	_	PUNCT
aji-158	20	1	_	_	PUNCT
aji-158	21	1	_	_	PUNCT
aji-158	22	1	_	_	PUNCT
aji-158	23	1	_	_	PUNCT
aji-158	24	1	_	_	PUNCT
aji-158	25	1	_	_	PUNCT
aji-158	26	1	_	_	PUNCT
aji-158	27	1	_	_	PUNCT
aji-158	28	1	_	_	PUNCT
aji-158	29	1	_	_	PUNCT
aji-158	30	1	_	_	PUNCT
aji-158	31	1	_	_	PUNCT
aji-158	32	1	_	_	PUNCT
aji-158	33	1	_	_	PUNCT
aji-158	34	1	_	_	PUNCT
aji-158	35	1	_	_	PUNCT
aji-158	36	1	_	_	PUNCT
aji-158	37	1	_	_	PUNCT
aji-158	38	1	_	_	PUNCT
aji-158	39	1	_	_	PUNCT
aji-158	40	1	_	_	PUNCT
aji-158	41	1	_	_	PUNCT
aji-158	42	1	_	_	PUNCT
aji-158	43	1	_	_	PUNCT
aji-158	44	1	_	_	PUNCT
aji-158	45	1	_	_	PUNCT
aji-158	46	1	_	_	PUNCT
aji-158	47	1	_	_	PUNCT
aji-158	48	1	_	_	PUNCT
aji-158	49	1	_	_	PUNCT
aji-158	50	1	_	_	PUNCT
aji-158	51	1	_	_	PUNCT
aji-158	52	1	_	_	PUNCT
aji-158	53	1	_	_	PUNCT
aji-158	54	1	_	_	PUNCT
aji-158	55	1	_	_	PUNCT
aji-158	56	1	_	_	PUNCT
aji-158	57	1	_	_	PUNCT
aji-158	58	1	_	_	PUNCT
aji-158	59	1	_	_	PUNCT
aji-158	60	1	_	_	PUNCT
aji-158	61	1	_	_	PUNCT
aji-158	62	1	_	_	PUNCT
aji-158	63	1	_	_	PUNCT
aji-158	64	1	_	_	PUNCT
aji-158	65	1	_	_	PUNCT
aji-158	66	1	_	_	PUNCT
aji-158	67	1	_	_	PUNCT
aji-158	68	1	_	_	PUNCT
aji-158	69	1	_	_	PUNCT
aji-158	70	1	_	_	PUNCT
aji-158	71	1	_	_	PUNCT
aji-158	72	1	_	_	PUNCT
aji-158	73	1	_	_	PUNCT
aji-158	74	1	_	_	PUNCT
aji-158	75	1	_	_	PUNCT
aji-158	76	1	_	_	PUNCT
aji-158	77	1	_	_	PUNCT
aji-158	78	1	_	_	PUNCT
aji-158	79	1	_	_	PUNCT
aji-158	80	1	_	_	PUNCT
aji-158	81	1	_	_	PUNCT
aji-158	82	1	_	_	PUNCT
aji-158	83	1	_	_	PUNCT
aji-158	84	1	_	_	PUNCT
aji-158	85	1	_	_	PUNCT
aji-158	86	1	_	_	PUNCT
aji-158	87	1	_	_	PUNCT
aji-158	88	1	_	_	PUNCT
aji-158	89	1	_	_	PUNCT
aji-158	90	1	_	_	PUNCT
aji-158	91	1	_	_	PUNCT
aji-158	92	1	_	_	PUNCT
aji-158	93	1	_	_	PUNCT
aji-158	94	1	_	_	PUNCT
aji-158	95	1	_	_	PUNCT
aji-158	96	1	_	_	PUNCT
aji-158	97	1	_	_	PUNCT
aji-158	98	1	_	_	PUNCT
aji-158	99	1	_	_	PUNCT
aji-158	100	1	_	_	PUNCT
aji-158	101	1	_	_	PUNCT
aji-158	102	1	*	*	PUNCT
aji-158	102	2	corresponding	correspond	VERB
aji-158	102	3	author	author	NOUN
aji-158	102	4	:	:	PUNCT
aji-158	102	5	e	e	NOUN
aji-158	102	6	-	-	NOUN
aji-158	102	7	mail	mail	NOUN
aji-158	102	8	:	:	PUNCT
aji-158	102	9	celso@alergoimuno.med.br	celso@alergoimuno.med.br	ADJ
aji-158	102	10	;	;	PUNCT
aji-158	102	11	cite	cite	VERB
aji-158	102	12	as	as	ADP
aji-158	102	13	:	:	PUNCT
aji-158	102	14	olivier	olivier	PROPN
aji-158	102	15	,	,	PUNCT
aji-158	102	16	celso	celso	PROPN
aji-158	102	17	eduardo	eduardo	PROPN
aji-158	102	18	,	,	PUNCT
aji-158	102	19	daiana	daiana	PROPN
aji-158	102	20	guedes	guedes	PROPN
aji-158	102	21	pinto	pinto	PROPN
aji-158	102	22	,	,	PUNCT
aji-158	102	23	ana	ana	PROPN
aji-158	102	24	paula	paula	PROPN
aji-158	102	25	monezzi	monezzi	PROPN
aji-158	102	26	teixeira	teixeira	PROPN
aji-158	102	27	,	,	PUNCT
aji-158	102	28	cibele	cibele	PROPN
aji-158	102	29	silva	silva	PROPN
aji-158	102	30	miguel	miguel	PROPN
aji-158	102	31	,	,	PUNCT
aji-158	102	32	jhéssica	jhéssica	PROPN
aji-158	102	33	letícia	letícia	PROPN
aji-158	102	34	santos	santos	PROPN
aji-158	102	35	santana	santana	PROPN
aji-158	102	36	,	,	PUNCT
aji-158	102	37	regiane	regiane	VERB
aji-158	102	38	patussi	patussi	PROPN
aji-158	102	39	santos	santos	PROPN
aji-158	102	40	lima	lima	PROPN
aji-158	102	41	,	,	PUNCT
aji-158	102	42	nicole	nicole	PROPN
aji-158	102	43	sartoreto	sartoreto	PROPN
aji-158	102	44	rocha	rocha	PROPN
aji-158	102	45	,	,	PUNCT
aji-158	102	46	and	and	CCONJ
aji-158	102	47	raquel	raquel	NOUN
aji-158	102	48	acácia	acácia	PROPN
aji-158	102	49	pereira	pereira	PROPN
aji-158	102	50	gonçalves	gonçalves	PROPN
aji-158	102	51	santos	santos	PROPN
aji-158	102	52	.	.	PUNCT
aji-158	103	1	2025	2025	NUM
aji-158	103	2	.	.	PUNCT
aji-158	104	1	“	"	PUNCT
aji-158	104	2	immunoreactivity	immunoreactivity	NOUN
aji-158	104	3	to	to	ADP
aji-158	104	4	cocoa	cocoa	NOUN
aji-158	104	5	and	and	CCONJ
aji-158	104	6	nickel	nickel	NOUN
aji-158	104	7	in	in	ADP
aji-158	104	8	atopic	atopic	NOUN
aji-158	104	9	and	and	CCONJ
aji-158	104	10	allergic	allergic	ADJ
aji-158	104	11	contact	contact	NOUN
aji-158	104	12	dermatitis	dermatitis	NOUN
aji-158	104	13	”	"	PUNCT
aji-158	104	14	.	.	PUNCT
aji-158	105	1	asian	asian	ADJ
aji-158	105	2	journal	journal	NOUN
aji-158	105	3	of	of	ADP
aji-158	105	4	immunology	immunology	NOUN
aji-158	105	5	8	8	NUM
aji-158	105	6	(	(	PUNCT
aji-158	105	7	1):35	1):35	NUM
aji-158	105	8	-	-	SYM
aji-158	105	9	49	49	NUM
aji-158	105	10	.	.	PUNCT
aji-158	106	1	https://doi.org/10.9734/aji/2025/v8i1158	https://doi.org/10.9734/aji/2025/v8i1158	PROPN
aji-158	106	2	.	.	PUNCT
aji-158	107	1	asian	asian	ADJ
aji-158	107	2	journal	journal	PROPN
aji-158	107	3	of	of	ADP
aji-158	107	4	immunology	immunology	NOUN
aji-158	107	5	volume	volume	NOUN
aji-158	107	6	8	8	NUM
aji-158	107	7	,	,	PUNCT
aji-158	107	8	issue	issue	NOUN
aji-158	107	9	1	1	NUM
aji-158	107	10	,	,	PUNCT
aji-158	107	11	page	page	NOUN
aji-158	107	12	35	35	NUM
aji-158	107	13	-	-	SYM
aji-158	107	14	49	49	NUM
aji-158	107	15	,	,	PUNCT
aji-158	107	16	2025	2025	NUM
aji-158	107	17	;	;	PUNCT
aji-158	107	18	article	article	NOUN
aji-158	107	19	no.aji.133582	no.aji.133582	PROPN
aji-158	107	20	immunoreactivity	immunoreactivity	NOUN
aji-158	107	21	to	to	ADP
aji-158	107	22	cocoa	cocoa	NOUN
aji-158	107	23	and	and	CCONJ
aji-158	107	24	nickel	nickel	NOUN
aji-158	107	25	in	in	ADP
aji-158	107	26	atopic	atopic	NOUN
aji-158	107	27	and	and	CCONJ
aji-158	107	28	allergic	allergic	ADJ
aji-158	107	29	contact	contact	NOUN
aji-158	107	30	dermatitis	dermatitis	PROPN
aji-158	107	31	celso	celso	PROPN
aji-158	107	32	eduardo	eduardo	PROPN
aji-158	107	33	olivier	olivier	PROPN
aji-158	107	34	a	a	PROPN
aji-158	107	35	*	*	PROPN
aji-158	107	36	,	,	PUNCT
aji-158	107	37	daiana	daiana	PROPN
aji-158	107	38	guedes	guede	VERB
aji-158	107	39	pinto	pinto	NOUN
aji-158	107	40	a	a	PRON
aji-158	107	41	,	,	PUNCT
aji-158	107	42	ana	ana	PROPN
aji-158	107	43	paula	paula	PROPN
aji-158	107	44	monezzi	monezzi	PROPN
aji-158	107	45	teixeira	teixeira	PROPN
aji-158	107	46	a	a	PROPN
aji-158	107	47	,	,	PUNCT
aji-158	107	48	cibele	cibele	PROPN
aji-158	107	49	silva	silva	PROPN
aji-158	107	50	miguel	miguel	PROPN
aji-158	107	51	a	a	PROPN
aji-158	107	52	,	,	PUNCT
aji-158	107	53	jhéssica	jhéssica	PROPN
aji-158	107	54	letícia	letícia	PROPN
aji-158	107	55	santos	santo	VERB
aji-158	107	56	santana	santana	PROPN
aji-158	107	57	b	b	PROPN
aji-158	107	58	,	,	PUNCT
aji-158	107	59	regiane	regiane	VERB
aji-158	107	60	patussi	patussi	PROPN
aji-158	107	61	santos	santos	PROPN
aji-158	107	62	lima	lima	PROPN
aji-158	107	63	c	c	PROPN
aji-158	107	64	,	,	PUNCT
aji-158	107	65	nicole	nicole	PROPN
aji-158	107	66	sartoreto	sartoreto	PROPN
aji-158	107	67	rocha	rocha	PROPN
aji-158	107	68	d	d	PROPN
aji-158	107	69	and	and	CCONJ
aji-158	107	70	raquel	raquel	PROPN
aji-158	107	71	acácia	acácia	PROPN
aji-158	107	72	pereira	pereira	PROPN
aji-158	107	73	gonçalves	gonçalves	PROPN
aji-158	107	74	santos	santo	VERB
aji-158	107	75	a	a	DET
aji-158	107	76	a	a	DET
aji-158	107	77	instituto	instituto	PROPN
aji-158	107	78	alergoimuno	alergoimuno	PROPN
aji-158	107	79	de	de	X
aji-158	107	80	americana	americana	PROPN
aji-158	107	81	,	,	PUNCT
aji-158	107	82	brazil	brazil	PROPN
aji-158	107	83	.	.	PUNCT
aji-158	108	1	b	b	PROPN
aji-158	108	2	instituto	instituto	PROPN
aji-158	108	3	de	de	PROPN
aji-158	108	4	ensino	ensino	PROPN
aji-158	108	5	e	e	PROPN
aji-158	108	6	pesquisa	pesquisa	NOUN
aji-158	108	7	do	do	VERB
aji-158	108	8	hospital	hospital	NOUN
aji-158	108	9	de	de	X
aji-158	108	10	amor	amor	PROPN
aji-158	108	11	de	de	X
aji-158	108	12	barretos	barretos	PROPN
aji-158	108	13	,	,	PUNCT
aji-158	108	14	brazil	brazil	PROPN
aji-158	108	15	.	.	PUNCT
aji-158	109	1	c	c	PROPN
aji-158	109	2	lavoisier	lavoisier	PROPN
aji-158	109	3	laboratórios	laboratórios	PROPN
aji-158	109	4	,	,	PUNCT
aji-158	109	5	são	são	PROPN
aji-158	109	6	paulo	paulo	PROPN
aji-158	109	7	,	,	PUNCT
aji-158	109	8	brazil	brazil	PROPN
aji-158	109	9	.	.	PUNCT
aji-158	110	1	d	d	PROPN
aji-158	110	2	faculdade	faculdade	PROPN
aji-158	110	3	de	de	X
aji-158	110	4	americana	americana	PROPN
aji-158	110	5	,	,	PUNCT
aji-158	110	6	são	são	PROPN
aji-158	110	7	paulo	paulo	PROPN
aji-158	110	8	,	,	PUNCT
aji-158	110	9	brazil	brazil	PROPN
aji-158	110	10	.	.	PUNCT
aji-158	111	1	authors	author	NOUN
aji-158	111	2	’	’	PART
aji-158	111	3	contributions	contribution	NOUN
aji-158	111	4	this	this	DET
aji-158	111	5	work	work	NOUN
aji-158	111	6	was	be	AUX
aji-158	111	7	carried	carry	VERB
aji-158	111	8	out	out	ADP
aji-158	111	9	in	in	ADP
aji-158	111	10	collaboration	collaboration	NOUN
aji-158	111	11	among	among	ADP
aji-158	111	12	all	all	DET
aji-158	111	13	authors	author	NOUN
aji-158	111	14	.	.	PUNCT
aji-158	112	1	the	the	DET
aji-158	112	2	author	author	NOUN
aji-158	112	3	ceo	ceo	NOUN
aji-158	112	4	did	do	VERB
aji-158	112	5	conceptualization	conceptualization	NOUN
aji-158	112	6	,	,	PUNCT
aji-158	112	7	data	data	NOUN
aji-158	112	8	curation	curation	NOUN
aji-158	112	9	,	,	PUNCT
aji-158	112	10	formal	formal	ADJ
aji-158	112	11	analysis	analysis	NOUN
aji-158	112	12	,	,	PUNCT
aji-158	112	13	literature	literature	NOUN
aji-158	112	14	review	review	NOUN
aji-158	112	15	,	,	PUNCT
aji-158	112	16	and	and	CCONJ
aji-158	112	17	writing	write	VERB
aji-158	112	18	the	the	DET
aji-158	112	19	original	original	ADJ
aji-158	112	20	draft	draft	NOUN
aji-158	112	21	.	.	PUNCT
aji-158	113	1	authors	author	NOUN
aji-158	113	2	dgp	dgp	PROPN
aji-158	113	3	,	,	PUNCT
aji-158	113	4	apmt	apmt	PROPN
aji-158	113	5	,	,	PUNCT
aji-158	113	6	csm	csm	NOUN
aji-158	113	7	,	,	PUNCT
aji-158	113	8	jlss	jlss	ADJ
aji-158	113	9	,	,	PUNCT
aji-158	113	10	rpsl	rpsl	NOUN
aji-158	113	11	and	and	CCONJ
aji-158	113	12	nsr	nsr	PROPN
aji-158	113	13	performed	perform	VERB
aji-158	113	14	laboratory	laboratory	NOUN
aji-158	113	15	procedures	procedure	NOUN
aji-158	113	16	.	.	PUNCT
aji-158	114	1	author	author	NOUN
aji-158	114	2	rapgs	rapgs	PROPN
aji-158	114	3	performed	perform	VERB
aji-158	114	4	cutaneous	cutaneous	ADJ
aji-158	114	5	tests	test	NOUN
aji-158	114	6	.	.	PUNCT
aji-158	115	1	all	all	DET
aji-158	115	2	authors	author	NOUN
aji-158	115	3	read	read	VERB
aji-158	115	4	and	and	CCONJ
aji-158	115	5	approved	approve	VERB
aji-158	115	6	of	of	ADP
aji-158	115	7	the	the	DET
aji-158	115	8	final	final	ADJ
aji-158	115	9	manuscript	manuscript	NOUN
aji-158	115	10	.	.	PUNCT
aji-158	116	1	article	article	NOUN
aji-158	116	2	information	information	PROPN
aji-158	116	3	doi	doi	PROPN
aji-158	116	4	:	:	PUNCT
aji-158	116	5	https://doi.org/10.9734/aji/2025/v8i1158	https://doi.org/10.9734/aji/2025/v8i1158	PROPN
aji-158	116	6	open	open	ADJ
aji-158	116	7	peer	peer	NOUN
aji-158	116	8	review	review	NOUN
aji-158	116	9	history	history	NOUN
aji-158	116	10	:	:	PUNCT
aji-158	116	11	this	this	DET
aji-158	116	12	journal	journal	NOUN
aji-158	116	13	follows	follow	VERB
aji-158	116	14	the	the	DET
aji-158	116	15	advanced	advance	VERB
aji-158	116	16	open	open	ADJ
aji-158	116	17	peer	peer	NOUN
aji-158	116	18	review	review	NOUN
aji-158	116	19	policy	policy	NOUN
aji-158	116	20	.	.	PUNCT
aji-158	117	1	identity	identity	NOUN
aji-158	117	2	of	of	ADP
aji-158	117	3	the	the	DET
aji-158	117	4	reviewers	reviewer	NOUN
aji-158	117	5	,	,	PUNCT
aji-158	117	6	editor(s	editor(s	NOUN
aji-158	117	7	)	)	PUNCT
aji-158	117	8	and	and	CCONJ
aji-158	117	9	additional	additional	ADJ
aji-158	117	10	reviewers	reviewer	NOUN
aji-158	117	11	,	,	PUNCT
aji-158	117	12	peer	peer	NOUN
aji-158	117	13	review	review	NOUN
aji-158	117	14	comments	comment	NOUN
aji-158	117	15	,	,	PUNCT
aji-158	117	16	different	different	ADJ
aji-158	117	17	versions	version	NOUN
aji-158	117	18	of	of	ADP
aji-158	117	19	the	the	DET
aji-158	117	20	manuscript	manuscript	NOUN
aji-158	117	21	,	,	PUNCT
aji-158	117	22	comments	comment	NOUN
aji-158	117	23	of	of	ADP
aji-158	117	24	the	the	DET
aji-158	117	25	editors	editor	NOUN
aji-158	117	26	,	,	PUNCT
aji-158	117	27	etc	etc	X
aji-158	117	28	are	be	AUX
aji-158	117	29	available	available	ADJ
aji-158	117	30	here	here	ADV
aji-158	117	31	:	:	PUNCT
aji-158	117	32	https://pr.sdiarticle5.com/review-history/133582	https://pr.sdiarticle5.com/review-history/133582	NOUN
aji-158	117	33	received	receive	VERB
aji-158	117	34	:	:	PUNCT
aji-158	117	35	01/02/2025	01/02/2025	NUM
aji-158	117	36	published	publish	VERB
aji-158	117	37	:	:	PUNCT
aji-158	117	38	05/04/2025	05/04/2025	NUM
aji-158	117	39	original	original	ADJ
aji-158	117	40	research	research	NOUN
aji-158	117	41	article	article	NOUN
aji-158	117	42	https://doi.org/10.9734/aji/2025/v8i1158	https://doi.org/10.9734/aji/2025/v8i1158	PROPN
aji-158	117	43	https://pr.sdiarticle5.com/review-history/133582	https://pr.sdiarticle5.com/review-history/133582	PROPN
aji-158	117	44	olivier	olivier	PROPN
aji-158	117	45	et	et	PROPN
aji-158	117	46	al	al	PROPN
aji-158	117	47	.	.	PROPN
aji-158	117	48	;	;	PUNCT
aji-158	117	49	asian	asian	PROPN
aji-158	117	50	j.	j.	PROPN
aji-158	117	51	immunol	immunol	PROPN
aji-158	117	52	.	.	PROPN
aji-158	117	53	,	,	PUNCT
aji-158	117	54	vol	vol	NOUN
aji-158	117	55	.	.	PROPN
aji-158	117	56	8	8	NUM
aji-158	117	57	,	,	PUNCT
aji-158	117	58	no	no	INTJ
aji-158	117	59	.	.	NOUN
aji-158	117	60	1	1	NUM
aji-158	117	61	,	,	PUNCT
aji-158	117	62	pp	pp	ADJ
aji-158	117	63	.	.	PUNCT
aji-158	118	1	35	35	NUM
aji-158	118	2	-	-	SYM
aji-158	118	3	49	49	NUM
aji-158	118	4	,	,	PUNCT
aji-158	118	5	2025	2025	NUM
aji-158	118	6	;	;	PUNCT
aji-158	118	7	article	article	NOUN
aji-158	118	8	no.aji.133582	no.aji.133582	NOUN
aji-158	118	9	36	36	NUM
aji-158	118	10	abstract	abstract	ADJ
aji-158	118	11	background	background	NOUN
aji-158	118	12	:	:	PUNCT
aji-158	118	13	cocoa	cocoa	NOUN
aji-158	118	14	is	be	AUX
aji-158	118	15	one	one	NUM
aji-158	118	16	of	of	ADP
aji-158	118	17	the	the	DET
aji-158	118	18	foods	food	NOUN
aji-158	118	19	more	more	ADV
aji-158	118	20	consistently	consistently	ADV
aji-158	118	21	associated	associate	VERB
aji-158	118	22	with	with	ADP
aji-158	118	23	high	high	ADJ
aji-158	118	24	nickel	nickel	NOUN
aji-158	118	25	content	content	NOUN
aji-158	118	26	,	,	PUNCT
aji-158	118	27	a	a	DET
aji-158	118	28	metal	metal	NOUN
aji-158	118	29	that	that	PRON
aji-158	118	30	functions	function	NOUN
aji-158	118	31	as	as	ADP
aji-158	118	32	a	a	DET
aji-158	118	33	hapten	hapten	NOUN
aji-158	118	34	responsible	responsible	ADJ
aji-158	118	35	for	for	ADP
aji-158	118	36	various	various	ADJ
aji-158	118	37	non	non	ADJ
aji-158	118	38	–	–	PUNCT
aji-158	118	39	ige	ige	ADJ
aji-158	118	40	-	-	PUNCT
aji-158	118	41	mediated	mediate	VERB
aji-158	118	42	symptomatic	symptomatic	ADJ
aji-158	118	43	hypersensitivities	hypersensitivity	NOUN
aji-158	118	44	.	.	PUNCT
aji-158	119	1	aim	aim	VERB
aji-158	119	2	:	:	PUNCT
aji-158	119	3	the	the	DET
aji-158	119	4	present	present	ADJ
aji-158	119	5	study	study	NOUN
aji-158	119	6	is	be	AUX
aji-158	119	7	a	a	DET
aji-158	119	8	proof	proof	NOUN
aji-158	119	9	-	-	PUNCT
aji-158	119	10	of	of	ADP
aji-158	119	11	-	-	PUNCT
aji-158	119	12	concept	concept	NOUN
aji-158	119	13	that	that	PRON
aji-158	119	14	hypothesizes	hypothesize	VERB
aji-158	119	15	that	that	DET
aji-158	119	16	lait	lait	NOUN
aji-158	119	17	and	and	CCONJ
aji-158	119	18	the	the	DET
aji-158	119	19	ttp	ttp	NOUN
aji-158	119	20	may	may	AUX
aji-158	119	21	differentiate	differentiate	VERB
aji-158	119	22	diverse	diverse	ADJ
aji-158	119	23	degrees	degree	NOUN
aji-158	119	24	of	of	ADP
aji-158	119	25	cellular	cellular	ADJ
aji-158	119	26	and	and	CCONJ
aji-158	119	27	humoral	humoral	ADJ
aji-158	119	28	immunoreactivity	immunoreactivity	NOUN
aji-158	119	29	against	against	ADP
aji-158	119	30	cocoa	cocoa	NOUN
aji-158	119	31	extract	extract	NOUN
aji-158	119	32	and	and	CCONJ
aji-158	119	33	a	a	DET
aji-158	119	34	nickel	nickel	NOUN
aji-158	119	35	solution	solution	NOUN
aji-158	119	36	,	,	PUNCT
aji-158	119	37	as	as	ADV
aji-158	119	38	well	well	ADV
aji-158	119	39	to	to	PART
aji-158	119	40	verify	verify	VERB
aji-158	119	41	some	some	DET
aji-158	119	42	sort	sort	NOUN
aji-158	119	43	of	of	ADP
aji-158	119	44	cross	cross	NOUN
aji-158	119	45	-	-	NOUN
aji-158	119	46	reactivity	reactivity	NOUN
aji-158	119	47	between	between	ADP
aji-158	119	48	them	they	PRON
aji-158	119	49	in	in	ADP
aji-158	119	50	patients	patient	NOUN
aji-158	119	51	suffering	suffer	VERB
aji-158	119	52	from	from	ADP
aji-158	119	53	non	non	ADJ
aji-158	119	54	–	–	PUNCT
aji-158	119	55	ige	ige	ADJ
aji-158	119	56	-	-	PUNCT
aji-158	119	57	mediated	mediate	VERB
aji-158	119	58	atopic	atopic	NOUN
aji-158	119	59	and	and	CCONJ
aji-158	119	60	allergic	allergic	ADJ
aji-158	119	61	contact	contact	NOUN
aji-158	119	62	dermatitis	dermatitis	NOUN
aji-158	119	63	.	.	PUNCT
aji-158	120	1	methodology	methodology	NOUN
aji-158	120	2	:	:	PUNCT
aji-158	121	1	we	we	PRON
aji-158	121	2	examined	examine	VERB
aji-158	121	3	the	the	DET
aji-158	121	4	medical	medical	ADJ
aji-158	121	5	charts	chart	NOUN
aji-158	121	6	of	of	ADP
aji-158	121	7	two	two	NUM
aji-158	121	8	cohorts	cohort	NOUN
aji-158	121	9	of	of	ADP
aji-158	121	10	patients	patient	NOUN
aji-158	121	11	clinically	clinically	ADV
aji-158	121	12	diagnosed	diagnose	VERB
aji-158	121	13	with	with	ADP
aji-158	121	14	intrinsic	intrinsic	ADJ
aji-158	121	15	atopic	atopic	NOUN
aji-158	121	16	dermatitis	dermatitis	NOUN
aji-158	121	17	and	and	CCONJ
aji-158	121	18	allergic	allergic	ADJ
aji-158	121	19	contact	contact	NOUN
aji-158	121	20	dermatitis	dermatitis	PROPN
aji-158	121	21	,	,	PUNCT
aji-158	121	22	who	who	PRON
aji-158	121	23	were	be	AUX
aji-158	121	24	simultaneously	simultaneously	ADV
aji-158	121	25	investigated	investigate	VERB
aji-158	121	26	with	with	ADP
aji-158	121	27	cocoa	cocoa	NOUN
aji-158	121	28	extract	extract	NOUN
aji-158	121	29	and	and	CCONJ
aji-158	121	30	nickel	nickel	NOUN
aji-158	121	31	solution	solution	NOUN
aji-158	121	32	with	with	ADP
aji-158	121	33	the	the	DET
aji-158	121	34	help	help	NOUN
aji-158	121	35	of	of	ADP
aji-158	121	36	ttp	ttp	PROPN
aji-158	121	37	or	or	CCONJ
aji-158	121	38	lait	lait	NOUN
aji-158	121	39	.	.	PUNCT
aji-158	122	1	the	the	DET
aji-158	122	2	registered	register	VERB
aji-158	122	3	results	result	NOUN
aji-158	122	4	of	of	ADP
aji-158	122	5	the	the	DET
aji-158	122	6	semi	semi	ADJ
aji-158	122	7	-	-	ADJ
aji-158	122	8	quantitative	quantitative	ADJ
aji-158	122	9	serum	serum	NOUN
aji-158	122	10	ttp	ttp	X
aji-158	122	11	against	against	ADP
aji-158	122	12	cocoa	cocoa	NOUN
aji-158	122	13	extract	extract	NOUN
aji-158	122	14	and	and	CCONJ
aji-158	122	15	nickel	nickel	NOUN
aji-158	122	16	solution	solution	NOUN
aji-158	122	17	,	,	PUNCT
aji-158	122	18	as	as	ADV
aji-158	122	19	well	well	ADV
aji-158	122	20	as	as	ADP
aji-158	122	21	the	the	DET
aji-158	122	22	registered	register	VERB
aji-158	122	23	results	result	NOUN
aji-158	122	24	of	of	ADP
aji-158	122	25	the	the	DET
aji-158	122	26	leukocyte	leukocyte	NOUN
aji-158	122	27	adherence	adherence	NOUN
aji-158	122	28	inhibition	inhibition	NOUN
aji-158	122	29	(	(	PUNCT
aji-158	122	30	lai	lai	NOUN
aji-158	122	31	)	)	PUNCT
aji-158	122	32	percentage	percentage	NOUN
aji-158	122	33	promoted	promote	VERB
aji-158	122	34	by	by	ADP
aji-158	122	35	the	the	DET
aji-158	122	36	ex	ex	ADJ
aji-158	122	37	vivo	vivo	ADJ
aji-158	122	38	challenges	challenge	NOUN
aji-158	122	39	against	against	ADP
aji-158	122	40	a	a	DET
aji-158	122	41	cocoa	cocoa	NOUN
aji-158	122	42	extract	extract	NOUN
aji-158	122	43	and	and	CCONJ
aji-158	122	44	a	a	DET
aji-158	122	45	nickel	nickel	NOUN
aji-158	122	46	solution	solution	NOUN
aji-158	122	47	,	,	PUNCT
aji-158	122	48	were	be	AUX
aji-158	122	49	distributed	distribute	VERB
aji-158	122	50	in	in	ADP
aji-158	122	51	ranges	range	NOUN
aji-158	122	52	through	through	ADP
aji-158	122	53	a	a	DET
aji-158	122	54	cascade	cascade	NOUN
aji-158	122	55	distribution	distribution	NOUN
aji-158	122	56	chart	chart	NOUN
aji-158	122	57	to	to	PART
aji-158	122	58	outline	outline	VERB
aji-158	122	59	the	the	DET
aji-158	122	60	variability	variability	NOUN
aji-158	122	61	of	of	ADP
aji-158	122	62	the	the	DET
aji-158	122	63	results	result	NOUN
aji-158	122	64	inside	inside	ADP
aji-158	122	65	the	the	DET
aji-158	122	66	cohorts	cohort	NOUN
aji-158	122	67	.	.	PUNCT
aji-158	123	1	results	result	NOUN
aji-158	123	2	:	:	PUNCT
aji-158	123	3	the	the	DET
aji-158	123	4	mean	mean	NOUN
aji-158	123	5	for	for	ADP
aji-158	123	6	the	the	DET
aji-158	123	7	ttp	ttp	NOUN
aji-158	123	8	for	for	ADP
aji-158	123	9	the	the	DET
aji-158	123	10	cocoa	cocoa	NOUN
aji-158	123	11	extract	extract	NOUN
aji-158	123	12	was	be	AUX
aji-158	123	13	estimated	estimate	VERB
aji-158	123	14	at	at	ADP
aji-158	123	15	1:385	1:385	NUM
aji-158	123	16	;	;	PUNCT
aji-158	123	17	the	the	DET
aji-158	123	18	median	median	NOUN
aji-158	123	19	at	at	ADP
aji-158	123	20	1:512	1:512	NUM
aji-158	123	21	;	;	PUNCT
aji-158	123	22	and	and	CCONJ
aji-158	123	23	the	the	DET
aji-158	123	24	sd	sd	NOUN
aji-158	123	25	at	at	ADP
aji-158	123	26	1:180	1:180	NUM
aji-158	123	27	.	.	PUNCT
aji-158	124	1	the	the	DET
aji-158	124	2	mean	mean	NOUN
aji-158	124	3	or	or	CCONJ
aji-158	124	4	the	the	DET
aji-158	124	5	ttp	ttp	NOUN
aji-158	124	6	for	for	ADP
aji-158	124	7	the	the	DET
aji-158	124	8	nickel	nickel	NOUN
aji-158	124	9	was	be	AUX
aji-158	124	10	estimated	estimate	VERB
aji-158	124	11	at	at	ADP
aji-158	124	12	1:309	1:309	NUM
aji-158	124	13	;	;	PUNCT
aji-158	124	14	the	the	DET
aji-158	124	15	median	median	NOUN
aji-158	124	16	was	be	AUX
aji-158	124	17	1:256	1:256	NUM
aji-158	124	18	;	;	PUNCT
aji-158	124	19	the	the	DET
aji-158	124	20	sd	sd	NOUN
aji-158	124	21	was	be	AUX
aji-158	124	22	estimated	estimate	VERB
aji-158	124	23	at	at	ADP
aji-158	124	24	1:199	1:199	NUM
aji-158	124	25	.	.	PUNCT
aji-158	125	1	the	the	DET
aji-158	125	2	mean	mean	NOUN
aji-158	125	3	for	for	ADP
aji-158	125	4	for	for	ADP
aji-158	125	5	the	the	DET
aji-158	125	6	leukocyte	leukocyte	NOUN
aji-158	125	7	adherence	adherence	NOUN
aji-158	125	8	inhibition	inhibition	NOUN
aji-158	125	9	(	(	PUNCT
aji-158	125	10	lai	lai	PROPN
aji-158	125	11	)	)	PUNCT
aji-158	125	12	the	the	DET
aji-158	125	13	cocoa	cocoa	NOUN
aji-158	125	14	extract	extract	NOUN
aji-158	125	15	was	be	AUX
aji-158	125	16	51.9	51.9	NUM
aji-158	125	17	%	%	NOUN
aji-158	125	18	;	;	PUNCT
aji-158	125	19	the	the	DET
aji-158	125	20	median	median	NOUN
aji-158	125	21	was	be	AUX
aji-158	125	22	56	56	NUM
aji-158	125	23	%	%	NOUN
aji-158	125	24	;	;	PUNCT
aji-158	125	25	the	the	DET
aji-158	125	26	sd	sd	NOUN
aji-158	125	27	was	be	AUX
aji-158	125	28	26.3	26.3	NUM
aji-158	125	29	%	%	NOUN
aji-158	125	30	.	.	PUNCT
aji-158	126	1	the	the	DET
aji-158	126	2	mean	mean	NOUN
aji-158	126	3	for	for	ADP
aji-158	126	4	the	the	DET
aji-158	126	5	lai	lai	PROPN
aji-158	126	6	for	for	ADP
aji-158	126	7	nickel	nickel	NOUN
aji-158	126	8	solution	solution	NOUN
aji-158	126	9	was	be	AUX
aji-158	126	10	33	33	NUM
aji-158	126	11	%	%	NOUN
aji-158	126	12	;	;	PUNCT
aji-158	126	13	the	the	DET
aji-158	126	14	median	median	NOUN
aji-158	126	15	was	be	AUX
aji-158	126	16	33	33	NUM
aji-158	126	17	%	%	NOUN
aji-158	126	18	;	;	PUNCT
aji-158	126	19	the	the	DET
aji-158	126	20	sd	sd	NOUN
aji-158	126	21	was	be	AUX
aji-158	126	22	26,6	26,6	NOUN
aji-158	126	23	%	%	NOUN
aji-158	126	24	.	.	PUNCT
aji-158	127	1	the	the	DET
aji-158	127	2	pearson	pearson	PROPN
aji-158	127	3	correlation	correlation	NOUN
aji-158	127	4	indicated	indicate	VERB
aji-158	127	5	that	that	SCONJ
aji-158	127	6	there	there	PRON
aji-158	127	7	is	be	VERB
aji-158	127	8	a	a	DET
aji-158	127	9	significant	significant	ADJ
aji-158	127	10	medium	medium	ADJ
aji-158	127	11	positive	positive	ADJ
aji-158	127	12	relationship	relationship	NOUN
aji-158	127	13	between	between	ADP
aji-158	127	14	ttp	ttp	PROPN
aji-158	127	15	results	result	NOUN
aji-158	127	16	between	between	ADP
aji-158	127	17	cocoa	cocoa	NOUN
aji-158	127	18	(	(	PUNCT
aji-158	127	19	x	x	NOUN
aji-158	127	20	-	-	NOUN
aji-158	127	21	axis	axis	ADJ
aji-158	127	22	)	)	PUNCT
aji-158	127	23	and	and	CCONJ
aji-158	127	24	nickel	nickel	NOUN
aji-158	127	25	(	(	PUNCT
aji-158	127	26	y	y	NOUN
aji-158	127	27	-	-	PUNCT
aji-158	127	28	axis	axis	NOUN
aji-158	127	29	)	)	PUNCT
aji-158	127	30	,	,	PUNCT
aji-158	127	31	r(98	r(98	PROPN
aji-158	127	32	)	)	PUNCT
aji-158	128	1	=	=	PUNCT
aji-158	128	2	.335	.335	NUM
aji-158	128	3	;	;	PUNCT
aji-158	128	4	p	p	X
aji-158	128	5	<	<	X
aji-158	128	6	.001	.001	NUM
aji-158	128	7	.	.	PUNCT
aji-158	129	1	the	the	DET
aji-158	129	2	pearson	pearson	PROPN
aji-158	129	3	correlation	correlation	NOUN
aji-158	129	4	indicated	indicate	VERB
aji-158	129	5	that	that	SCONJ
aji-158	129	6	there	there	PRON
aji-158	129	7	is	be	VERB
aji-158	129	8	a	a	DET
aji-158	129	9	significant	significant	ADJ
aji-158	129	10	medium	medium	ADJ
aji-158	129	11	positive	positive	ADJ
aji-158	129	12	relationship	relationship	NOUN
aji-158	129	13	between	between	ADP
aji-158	129	14	lait	lait	NOUN
aji-158	129	15	results	result	NOUN
aji-158	129	16	between	between	ADP
aji-158	129	17	cocoa	cocoa	NOUN
aji-158	129	18	(	(	PUNCT
aji-158	129	19	x	x	NOUN
aji-158	129	20	-	-	NOUN
aji-158	129	21	axis	axis	ADJ
aji-158	129	22	)	)	PUNCT
aji-158	129	23	and	and	CCONJ
aji-158	129	24	nickel	nickel	NOUN
aji-158	129	25	(	(	PUNCT
aji-158	129	26	y	y	NOUN
aji-158	129	27	-	-	PUNCT
aji-158	129	28	axis	axis	NOUN
aji-158	129	29	)	)	PUNCT
aji-158	129	30	,	,	PUNCT
aji-158	129	31	r(98	r(98	PROPN
aji-158	129	32	)	)	PUNCT
aji-158	129	33	=	=	PUNCT
aji-158	130	1	.425	.425	NUM
aji-158	130	2	;	;	PUNCT
aji-158	130	3	p	p	X
aji-158	130	4	<	<	X
aji-158	130	5	.001	.001	NUM
aji-158	130	6	.	.	PUNCT
aji-158	131	1	conclusion	conclusion	NOUN
aji-158	131	2	:	:	PUNCT
aji-158	131	3	the	the	DET
aji-158	131	4	results	result	NOUN
aji-158	131	5	demonstrated	demonstrate	VERB
aji-158	131	6	a	a	DET
aji-158	131	7	more	more	ADV
aji-158	131	8	significant	significant	ADJ
aji-158	131	9	immunoreactivity	immunoreactivity	NOUN
aji-158	131	10	from	from	ADP
aji-158	131	11	the	the	DET
aji-158	131	12	tests	test	NOUN
aji-158	131	13	performed	perform	VERB
aji-158	131	14	with	with	ADP
aji-158	131	15	cocoa	cocoa	NOUN
aji-158	131	16	extract	extract	NOUN
aji-158	131	17	than	than	SCONJ
aji-158	131	18	obtained	obtain	VERB
aji-158	131	19	with	with	ADP
aji-158	131	20	the	the	DET
aji-158	131	21	nickel	nickel	NOUN
aji-158	131	22	solution	solution	NOUN
aji-158	131	23	.	.	PUNCT
aji-158	132	1	these	these	DET
aji-158	132	2	findings	finding	VERB
aji-158	132	3	state	state	NOUN
aji-158	132	4	that	that	SCONJ
aji-158	132	5	cocoa	cocoa	NOUN
aji-158	132	6	possesses	possess	VERB
aji-158	132	7	other	other	ADJ
aji-158	132	8	allergens	allergen	NOUN
aji-158	132	9	responsible	responsible	ADJ
aji-158	132	10	for	for	ADP
aji-158	132	11	cellular	cellular	ADJ
aji-158	132	12	immunoreactivity	immunoreactivity	NOUN
aji-158	132	13	besides	besides	SCONJ
aji-158	132	14	nickel	nickel	NOUN
aji-158	132	15	.	.	PUNCT
aji-158	133	1	this	this	PRON
aji-158	133	2	means	mean	VERB
aji-158	133	3	that	that	SCONJ
aji-158	133	4	if	if	SCONJ
aji-158	133	5	a	a	DET
aji-158	133	6	patient	patient	NOUN
aji-158	133	7	presents	present	VERB
aji-158	133	8	cellular	cellular	ADJ
aji-158	133	9	immunoreactivity	immunoreactivity	NOUN
aji-158	133	10	against	against	ADP
aji-158	133	11	cocoa	cocoa	NOUN
aji-158	133	12	,	,	PUNCT
aji-158	133	13	he	he	PRON
aji-158	133	14	/	/	SYM
aji-158	133	15	she	she	PRON
aji-158	133	16	will	will	AUX
aji-158	133	17	not	not	PART
aji-158	133	18	necessarily	necessarily	ADV
aji-158	133	19	present	present	VERB
aji-158	133	20	immunoreactivity	immunoreactivity	NOUN
aji-158	133	21	against	against	ADP
aji-158	133	22	nickel	nickel	NOUN
aji-158	133	23	;	;	PUNCT
aji-158	133	24	however	however	ADV
aji-158	133	25	,	,	PUNCT
aji-158	133	26	reciprocation	reciprocation	NOUN
aji-158	133	27	is	be	AUX
aji-158	133	28	less	less	ADV
aji-158	133	29	probable	probable	ADJ
aji-158	133	30	.	.	PUNCT
aji-158	134	1	keywords	keyword	NOUN
aji-158	134	2	:	:	PUNCT
aji-158	134	3	cocoa	cocoa	NOUN
aji-158	134	4	,	,	PUNCT
aji-158	134	5	dermatitis	dermatitis	NOUN
aji-158	134	6	,	,	PUNCT
aji-158	134	7	endotype	endotype	NOUN
aji-158	134	8	;	;	PUNCT
aji-158	134	9	hypersensitivity	hypersensitivity	NOUN
aji-158	134	10	;	;	PUNCT
aji-158	134	11	leukocyte	leukocyte	ADJ
aji-158	134	12	adherence	adherence	NOUN
aji-158	134	13	inhibition	inhibition	NOUN
aji-158	134	14	test	test	NOUN
aji-158	134	15	;	;	PUNCT
aji-158	134	16	nickel	nickel	NOUN
aji-158	134	17	;	;	PUNCT
aji-158	134	18	non	non	ADJ
aji-158	134	19	–	–	PUNCT
aji-158	134	20	ige	ige	ADJ
aji-158	134	21	-	-	PUNCT
aji-158	134	22	mediated	mediate	VERB
aji-158	134	23	immunoreactivity	immunoreactivity	NOUN
aji-158	134	24	;	;	PUNCT
aji-158	134	25	precipitins	precipitin	NOUN
aji-158	134	26	.	.	PUNCT
aji-158	135	1	abbreviations	abbreviation	NOUN
aji-158	135	2	lai	lai	NOUN
aji-158	135	3	:	:	PUNCT
aji-158	135	4	leukocyte	leukocyte	NOUN
aji-158	135	5	adherence	adherence	NOUN
aji-158	135	6	inhibition	inhibition	NOUN
aji-158	135	7	lait	lait	NOUN
aji-158	135	8	:	:	PUNCT
aji-158	135	9	leukocyte	leukocyte	ADJ
aji-158	135	10	adherence	adherence	NOUN
aji-158	135	11	inhibition	inhibition	NOUN
aji-158	135	12	test	test	NOUN
aji-158	135	13	ttp	ttp	NOUN
aji-158	135	14	:	:	PUNCT
aji-158	135	15	tube	tube	NOUN
aji-158	135	16	titration	titration	NOUN
aji-158	135	17	of	of	ADP
aji-158	135	18	precipitins	precipitin	NOUN
aji-158	135	19	1	1	NUM
aji-158	135	20	.	.	PUNCT
aji-158	135	21	introduction	introduction	NOUN
aji-158	135	22	self	self	NOUN
aji-158	135	23	-	-	PUNCT
aji-158	135	24	reported	report	VERB
aji-158	135	25	allergy	allergy	NOUN
aji-158	135	26	to	to	ADP
aji-158	135	27	chocolate	chocolate	NOUN
aji-158	135	28	is	be	AUX
aji-158	135	29	a	a	DET
aji-158	135	30	common	common	ADJ
aji-158	135	31	complaint	complaint	NOUN
aji-158	135	32	in	in	ADP
aji-158	135	33	the	the	DET
aji-158	135	34	clinical	clinical	ADJ
aji-158	135	35	practice	practice	NOUN
aji-158	135	36	of	of	ADP
aji-158	135	37	allergology	allergology	NOUN
aji-158	135	38	;	;	PUNCT
aji-158	135	39	however	however	ADV
aji-158	135	40	,	,	PUNCT
aji-158	135	41	ige	ige	NOUN
aji-158	135	42	-	-	PUNCT
aji-158	135	43	mediated	mediate	VERB
aji-158	135	44	cocoa	cocoa	NOUN
aji-158	135	45	hypersensitivity	hypersensitivity	NOUN
aji-158	135	46	is	be	AUX
aji-158	135	47	not	not	PART
aji-158	135	48	a	a	DET
aji-158	135	49	commonly	commonly	ADV
aji-158	135	50	demonstrable	demonstrable	ADJ
aji-158	135	51	endotype	endotype	NOUN
aji-158	135	52	responsible	responsible	ADJ
aji-158	135	53	for	for	ADP
aji-158	135	54	the	the	DET
aji-158	135	55	phenotypes	phenotype	NOUN
aji-158	135	56	described	describe	VERB
aji-158	135	57	as	as	ADP
aji-158	135	58	cocoa	cocoa	NOUN
aji-158	135	59	allergies	allergy	NOUN
aji-158	135	60	(	(	PUNCT
aji-158	135	61	nin	nin	NOUN
aji-158	135	62	-	-	PUNCT
aji-158	135	63	valencia	valencia	PROPN
aji-158	135	64	et	et	PROPN
aji-158	135	65	al	al	PROPN
aji-158	135	66	.	.	PROPN
aji-158	135	67	2024	2024	NUM
aji-158	135	68	;	;	PUNCT
aji-158	135	69	sloan	sloan	PROPN
aji-158	135	70	&	&	CCONJ
aji-158	135	71	powers	power	NOUN
aji-158	135	72	1986	1986	NUM
aji-158	135	73	)	)	PUNCT
aji-158	135	74	.	.	PUNCT
aji-158	136	1	when	when	SCONJ
aji-158	136	2	thoroughly	thoroughly	ADV
aji-158	136	3	investigated	investigate	VERB
aji-158	136	4	,	,	PUNCT
aji-158	136	5	ige	ige	NOUN
aji-158	136	6	-	-	PUNCT
aji-158	136	7	mediated	mediate	VERB
aji-158	136	8	reactions	reaction	NOUN
aji-158	136	9	to	to	ADP
aji-158	136	10	chocolate	chocolate	NOUN
aji-158	136	11	are	be	AUX
aji-158	136	12	usually	usually	ADV
aji-158	136	13	due	due	ADJ
aji-158	136	14	to	to	ADP
aji-158	136	15	cow	cow	PROPN
aji-158	136	16	's	's	PART
aji-158	136	17	milk	milk	NOUN
aji-158	136	18	,	,	PUNCT
aji-158	136	19	hen	hen	NOUN
aji-158	136	20	's	's	PART
aji-158	136	21	egg	egg	NOUN
aji-158	136	22	,	,	PUNCT
aji-158	136	23	peanut	peanut	NOUN
aji-158	136	24	,	,	PUNCT
aji-158	136	25	soybean	soybean	NOUN
aji-158	136	26	,	,	PUNCT
aji-158	136	27	hazelnut	hazelnut	NOUN
aji-158	136	28	,	,	PUNCT
aji-158	136	29	almond	almond	NOUN
aji-158	136	30	,	,	PUNCT
aji-158	136	31	and	and	CCONJ
aji-158	136	32	other	other	ADJ
aji-158	136	33	ingredients	ingredient	NOUN
aji-158	136	34	and	and	CCONJ
aji-158	136	35	contaminants	contaminant	NOUN
aji-158	136	36	added	add	VERB
aji-158	136	37	to	to	ADP
aji-158	136	38	cocoa	cocoa	NOUN
aji-158	136	39	to	to	PART
aji-158	136	40	make	make	VERB
aji-158	136	41	sweet	sweet	ADJ
aji-158	136	42	chocolate	chocolate	NOUN
aji-158	136	43	(	(	PUNCT
aji-158	136	44	lopes	lope	NOUN
aji-158	136	45	et	et	PROPN
aji-158	136	46	al	al	PROPN
aji-158	136	47	.	.	PROPN
aji-158	136	48	2019	2019	NUM
aji-158	136	49	,	,	PUNCT
aji-158	136	50	pilolli	pilolli	NOUN
aji-158	136	51	et	et	PROPN
aji-158	136	52	al	al	PROPN
aji-158	136	53	.	.	PROPN
aji-158	136	54	2024	2024	NUM
aji-158	136	55	)	)	PUNCT
aji-158	136	56	.	.	PUNCT
aji-158	137	1	“	"	PUNCT
aji-158	137	2	the	the	DET
aji-158	137	3	allergen	allergen	NOUN
aji-158	137	4	nomenclature	nomenclature	ADJ
aji-158	137	5	sub	sub	NOUN
aji-158	137	6	-	-	NOUN
aji-158	137	7	committee	committee	NOUN
aji-158	137	8	of	of	ADP
aji-158	137	9	the	the	DET
aji-158	137	10	world	world	PROPN
aji-158	137	11	health	health	PROPN
aji-158	137	12	organization	organization	NOUN
aji-158	137	13	and	and	CCONJ
aji-158	137	14	international	international	ADJ
aji-158	137	15	union	union	NOUN
aji-158	137	16	of	of	ADP
aji-158	137	17	immunological	immunological	ADJ
aji-158	137	18	societies	society	NOUN
aji-158	137	19	(	(	PUNCT
aji-158	137	20	who	who	PRON
aji-158	137	21	/	/	SYM
aji-158	137	22	iuis	iuis	NOUN
aji-158	137	23	)	)	PUNCT
aji-158	137	24	do	do	AUX
aji-158	137	25	not	not	PART
aji-158	137	26	recognize	recognize	VERB
aji-158	137	27	any	any	DET
aji-158	137	28	protein	protein	NOUN
aji-158	137	29	derived	derive	VERB
aji-158	137	30	from	from	ADP
aji-158	137	31	theobroma	theobroma	NOUN
aji-158	137	32	cacao	cacao	NOUN
aji-158	137	33	that	that	PRON
aji-158	137	34	could	could	AUX
aji-158	137	35	officially	officially	ADV
aji-158	137	36	be	be	AUX
aji-158	137	37	stated	state	VERB
aji-158	137	38	as	as	ADP
aji-158	137	39	a	a	DET
aji-158	137	40	major	major	ADJ
aji-158	137	41	(	(	PUNCT
aji-158	137	42	or	or	CCONJ
aji-158	137	43	a	a	DET
aji-158	137	44	minor	minor	ADJ
aji-158	137	45	)	)	PUNCT
aji-158	137	46	ige	ige	NOUN
aji-158	137	47	-	-	PUNCT
aji-158	137	48	mediated	mediate	VERB
aji-158	137	49	allergen	allergen	NOUN
aji-158	137	50	.	.	PUNCT
aji-158	138	1	a	a	DET
aji-158	138	2	candidate	candidate	NOUN
aji-158	138	3	to	to	PART
aji-158	138	4	be	be	AUX
aji-158	138	5	recognized	recognize	VERB
aji-158	138	6	as	as	ADP
aji-158	138	7	a	a	DET
aji-158	138	8	significant	significant	ADJ
aji-158	138	9	igemediated	igemediate	VERB
aji-158	138	10	cocoa	cocoa	NOUN
aji-158	138	11	allergen	allergen	NOUN
aji-158	138	12	is	be	AUX
aji-158	138	13	the	the	DET
aji-158	138	14	pathogenesisrelated	pathogenesisrelate	VERB
aji-158	138	15	protein	protein	NOUN
aji-158	138	16	pr10	pr10	PROPN
aji-158	138	17	(	(	PUNCT
aji-158	138	18	tcpr-10	tcpr-10	PROPN
aji-158	138	19	)	)	PUNCT
aji-158	138	20	,	,	PUNCT
aji-158	138	21	a	a	DET
aji-158	138	22	protein	protein	NOUN
aji-158	138	23	with	with	ADP
aji-158	138	24	homology	homology	NOUN
aji-158	138	25	to	to	PART
aji-158	138	26	pollen	pollen	VERB
aji-158	138	27	and	and	CCONJ
aji-158	138	28	food	food	NOUN
aji-158	138	29	allergens	allergen	NOUN
aji-158	138	30	derived	derive	VERB
aji-158	138	31	from	from	ADP
aji-158	138	32	the	the	DET
aji-158	138	33	birch	birch	NOUN
aji-158	138	34	(	(	PUNCT
aji-158	138	35	betula	betula	PROPN
aji-158	138	36	verrucosa	verrucosa	PROPN
aji-158	138	37	)	)	PUNCT
aji-158	138	38	,	,	PUNCT
aji-158	138	39	the	the	DET
aji-158	138	40	pear	pear	NOUN
aji-158	138	41	(	(	PUNCT
aji-158	138	42	prunus	prunus	NOUN
aji-158	138	43	persica	persica	NOUN
aji-158	138	44	)	)	PUNCT
aji-158	138	45	,	,	PUNCT
aji-158	138	46	the	the	DET
aji-158	138	47	apple	apple	NOUN
aji-158	138	48	(	(	PUNCT
aji-158	138	49	malus	malus	PROPN
aji-158	138	50	domestica	domestica	PROPN
aji-158	138	51	)	)	PUNCT
aji-158	138	52	,	,	PUNCT
aji-158	138	53	the	the	DET
aji-158	138	54	cherry	cherry	NOUN
aji-158	138	55	(	(	PUNCT
aji-158	138	56	prunus	prunus	NOUN
aji-158	138	57	avium	avium	NOUN
aji-158	138	58	)	)	PUNCT
aji-158	138	59	and	and	CCONJ
aji-158	138	60	the	the	DET
aji-158	138	61	carrot	carrot	NOUN
aji-158	138	62	(	(	PUNCT
aji-158	138	63	daucus	daucus	NOUN
aji-158	138	64	carota	carota	NOUN
aji-158	138	65	)	)	PUNCT
aji-158	138	66	”	"	PUNCT
aji-158	138	67	(	(	PUNCT
aji-158	138	68	menezes	meneze	NOUN
aji-158	138	69	et	et	PROPN
aji-158	138	70	al	al	PROPN
aji-158	138	71	.	.	PROPN
aji-158	138	72	2012	2012	NUM
aji-158	138	73	)	)	PUNCT
aji-158	138	74	.	.	PUNCT
aji-158	139	1	however	however	ADV
aji-158	139	2	,	,	PUNCT
aji-158	139	3	cocoa	cocoa	NOUN
aji-158	139	4	is	be	AUX
aji-158	139	5	one	one	NUM
aji-158	139	6	of	of	ADP
aji-158	139	7	the	the	DET
aji-158	139	8	foods	food	NOUN
aji-158	139	9	more	more	ADV
aji-158	139	10	consistently	consistently	ADV
aji-158	139	11	associated	associate	VERB
aji-158	139	12	with	with	ADP
aji-158	139	13	high	high	ADJ
aji-158	139	14	nickel	nickel	NOUN
aji-158	139	15	content	content	NOUN
aji-158	139	16	,	,	PUNCT
aji-158	139	17	a	a	DET
aji-158	139	18	metal	metal	NOUN
aji-158	139	19	that	that	PRON
aji-158	139	20	functions	function	NOUN
aji-158	139	21	as	as	ADP
aji-158	139	22	a	a	DET
aji-158	139	23	hapten	hapten	NOUN
aji-158	139	24	responsible	responsible	ADJ
aji-158	139	25	for	for	ADP
aji-158	139	26	various	various	ADJ
aji-158	139	27	non	non	ADJ
aji-158	139	28	–	–	PUNCT
aji-158	139	29	ige	ige	ADJ
aji-158	139	30	-	-	PUNCT
aji-158	139	31	mediated	mediate	VERB
aji-158	139	32	symptomatic	symptomatic	ADJ
aji-158	139	33	hypersensitivities	hypersensitivity	NOUN
aji-158	139	34	associated	associate	VERB
aji-158	139	35	with	with	ADP
aji-158	139	36	several	several	ADJ
aji-158	139	37	toxic	toxic	ADJ
aji-158	139	38	and	and	CCONJ
aji-158	139	39	allergic	allergic	ADJ
aji-158	139	40	diseases	disease	NOUN
aji-158	139	41	(	(	PUNCT
aji-158	139	42	cubadda	cubadda	NOUN
aji-158	139	43	et	et	PROPN
aji-158	139	44	al	al	PROPN
aji-158	139	45	.	.	PROPN
aji-158	139	46	2020	2020	NUM
aji-158	139	47	)	)	PUNCT
aji-158	139	48	.	.	PUNCT
aji-158	140	1	nickel	nickel	NOUN
aji-158	140	2	is	be	AUX
aji-158	140	3	the	the	DET
aji-158	140	4	fifth	fifth	ADJ
aji-158	140	5	most	most	ADV
aji-158	140	6	abundant	abundant	ADJ
aji-158	140	7	metal	metal	NOUN
aji-158	140	8	in	in	ADP
aji-158	140	9	the	the	DET
aji-158	140	10	earth	earth	NOUN
aji-158	140	11	's	's	PART
aji-158	140	12	crust	crust	NOUN
aji-158	140	13	.	.	PUNCT
aji-158	141	1	it	it	PRON
aji-158	141	2	is	be	AUX
aji-158	141	3	found	find	VERB
aji-158	141	4	in	in	ADP
aji-158	141	5	soil	soil	NOUN
aji-158	141	6	,	,	PUNCT
aji-158	141	7	absorbed	absorb	VERB
aji-158	141	8	by	by	ADP
aji-158	141	9	cocoa	cocoa	NOUN
aji-158	141	10	roots	root	NOUN
aji-158	141	11	,	,	PUNCT
aji-158	141	12	and	and	CCONJ
aji-158	141	13	transported	transport	VERB
aji-158	141	14	upright	upright	ADJ
aji-158	141	15	to	to	PART
aji-158	141	16	accumulate	accumulate	VERB
aji-158	141	17	in	in	ADP
aji-158	141	18	cocoa	cocoa	NOUN
aji-158	141	19	beans	bean	NOUN
aji-158	141	20	(	(	PUNCT
aji-158	141	21	mostafa	mostafa	PROPN
aji-158	141	22	et	et	PROPN
aji-158	141	23	al	al	PROPN
aji-158	141	24	.	.	PROPN
aji-158	141	25	,	,	PUNCT
aji-158	141	26	2024	2024	NUM
aji-158	141	27	)	)	PUNCT
aji-158	141	28	.	.	PUNCT
aji-158	142	1	olivier	olivier	PROPN
aji-158	142	2	et	et	PROPN
aji-158	142	3	al	al	PROPN
aji-158	142	4	.	.	PROPN
aji-158	142	5	;	;	PUNCT
aji-158	142	6	asian	asian	PROPN
aji-158	142	7	j.	j.	PROPN
aji-158	142	8	immunol	immunol	PROPN
aji-158	142	9	.	.	PROPN
aji-158	142	10	,	,	PUNCT
aji-158	142	11	vol	vol	NOUN
aji-158	142	12	.	.	PROPN
aji-158	142	13	8	8	NUM
aji-158	142	14	,	,	PUNCT
aji-158	142	15	no	no	INTJ
aji-158	142	16	.	.	NOUN
aji-158	142	17	1	1	NUM
aji-158	142	18	,	,	PUNCT
aji-158	142	19	pp	pp	ADJ
aji-158	142	20	.	.	PUNCT
aji-158	143	1	35	35	NUM
aji-158	143	2	-	-	SYM
aji-158	143	3	49	49	NUM
aji-158	143	4	,	,	PUNCT
aji-158	143	5	2025	2025	NUM
aji-158	143	6	;	;	PUNCT
aji-158	143	7	article	article	NOUN
aji-158	143	8	no.aji.133582	no.aji.133582	PROPN
aji-158	143	9	37	37	NUM
aji-158	143	10	besides	besides	SCONJ
aji-158	143	11	nickel	nickel	NOUN
aji-158	143	12	,	,	PUNCT
aji-158	143	13	cocoa	cocoa	NOUN
aji-158	143	14	beans	bean	NOUN
aji-158	143	15	may	may	AUX
aji-158	143	16	present	present	VERB
aji-158	143	17	several	several	ADJ
aji-158	143	18	toxic	toxic	ADJ
aji-158	143	19	metals	metal	NOUN
aji-158	143	20	absorbed	absorb	VERB
aji-158	143	21	from	from	ADP
aji-158	143	22	the	the	DET
aji-158	143	23	soil	soil	NOUN
aji-158	143	24	,	,	PUNCT
aji-158	143	25	posing	pose	VERB
aji-158	143	26	human	human	ADJ
aji-158	143	27	health	health	NOUN
aji-158	143	28	risks	risk	NOUN
aji-158	143	29	(	(	PUNCT
aji-158	143	30	frimpong	frimpong	PROPN
aji-158	143	31	et	et	PROPN
aji-158	143	32	al	al	PROPN
aji-158	143	33	.	.	PROPN
aji-158	143	34	,	,	PUNCT
aji-158	143	35	2024	2024	NUM
aji-158	143	36	)	)	PUNCT
aji-158	143	37	.	.	PUNCT
aji-158	144	1	besides	besides	SCONJ
aji-158	144	2	cocoa	cocoa	NOUN
aji-158	144	3	,	,	PUNCT
aji-158	144	4	nickel	nickel	NOUN
aji-158	144	5	may	may	AUX
aji-158	144	6	be	be	AUX
aji-158	144	7	present	present	ADJ
aji-158	144	8	in	in	ADP
aji-158	144	9	licorice	licorice	NOUN
aji-158	144	10	,	,	PUNCT
aji-158	144	11	lettuce	lettuce	NOUN
aji-158	144	12	,	,	PUNCT
aji-158	144	13	soybeans	soybean	NOUN
aji-158	144	14	,	,	PUNCT
aji-158	144	15	oatmeal	oatmeal	NOUN
aji-158	144	16	,	,	PUNCT
aji-158	144	17	nuts	nut	NOUN
aji-158	144	18	,	,	PUNCT
aji-158	144	19	almonds	almond	NOUN
aji-158	144	20	,	,	PUNCT
aji-158	144	21	legumes	legume	NOUN
aji-158	144	22	,	,	PUNCT
aji-158	144	23	peanuts	peanut	NOUN
aji-158	144	24	,	,	PUNCT
aji-158	144	25	oats	oats	NOUN
aji-158	144	26	,	,	PUNCT
aji-158	144	27	grains	grain	NOUN
aji-158	144	28	,	,	PUNCT
aji-158	144	29	whole	whole	ADJ
aji-158	144	30	wheat	wheat	NOUN
aji-158	144	31	(	(	PUNCT
aji-158	144	32	and	and	CCONJ
aji-158	144	33	whole	whole	ADJ
aji-158	144	34	meal	meal	NOUN
aji-158	144	35	flours	flour	NOUN
aji-158	144	36	)	)	PUNCT
aji-158	144	37	,	,	PUNCT
aji-158	144	38	and	and	CCONJ
aji-158	144	39	mainly	mainly	ADV
aji-158	144	40	in	in	ADP
aji-158	144	41	canned	canned	ADJ
aji-158	144	42	food	food	NOUN
aji-158	144	43	with	with	ADP
aji-158	144	44	high	high	ADJ
aji-158	144	45	nickel	nickel	NOUN
aji-158	144	46	contents	content	NOUN
aji-158	144	47	,	,	PUNCT
aji-158	144	48	liberated	liberate	VERB
aji-158	144	49	from	from	ADP
aji-158	144	50	a	a	DET
aji-158	144	51	nickel	nickel	NOUN
aji-158	144	52	-	-	PUNCT
aji-158	144	53	plated	plate	VERB
aji-158	144	54	tin	tin	NOUN
aji-158	144	55	alloy	alloy	NOUN
aji-158	144	56	(	(	PUNCT
aji-158	144	57	sharma	sharma	PROPN
aji-158	144	58	2013	2013	NUM
aji-158	144	59	,	,	PUNCT
aji-158	144	60	abeck	abeck	PROPN
aji-158	144	61	et	et	PROPN
aji-158	144	62	al	al	PROPN
aji-158	144	63	.	.	PROPN
aji-158	144	64	,	,	PUNCT
aji-158	144	65	1993	1993	NUM
aji-158	144	66	;	;	PUNCT
aji-158	144	67	veien	veien	PROPN
aji-158	144	68	&	&	CCONJ
aji-158	144	69	menné	menné	NOUN
aji-158	144	70	,	,	PUNCT
aji-158	144	71	1990	1990	NUM
aji-158	144	72	;	;	PUNCT
aji-158	144	73	veien	veien	PROPN
aji-158	144	74	et	et	PROPN
aji-158	144	75	al	al	PROPN
aji-158	144	76	.	.	PROPN
aji-158	144	77	,	,	PUNCT
aji-158	144	78	1985	1985	NUM
aji-158	144	79	)	)	PUNCT
aji-158	144	80	.	.	PUNCT
aji-158	145	1	nickel	nickel	NOUN
aji-158	145	2	is	be	AUX
aji-158	145	3	one	one	NUM
aji-158	145	4	of	of	ADP
aji-158	145	5	the	the	DET
aji-158	145	6	leading	lead	VERB
aji-158	145	7	causes	cause	NOUN
aji-158	145	8	of	of	ADP
aji-158	145	9	allergic	allergic	ADJ
aji-158	145	10	contact	contact	NOUN
aji-158	145	11	dermatitis	dermatitis	NOUN
aji-158	145	12	,	,	PUNCT
aji-158	145	13	which	which	PRON
aji-158	145	14	is	be	AUX
aji-158	145	15	diagnosed	diagnose	VERB
aji-158	145	16	by	by	ADP
aji-158	145	17	patch	patch	NOUN
aji-158	145	18	tests	test	NOUN
aji-158	145	19	(	(	PUNCT
aji-158	145	20	isufi	isufi	NOUN
aji-158	145	21	et	et	PROPN
aji-158	145	22	al	al	PROPN
aji-158	145	23	.	.	PROPN
aji-158	145	24	,	,	PUNCT
aji-158	145	25	2025	2025	NUM
aji-158	145	26	)	)	PUNCT
aji-158	145	27	.	.	PUNCT
aji-158	146	1	nickel	nickel	NOUN
aji-158	146	2	is	be	AUX
aji-158	146	3	a	a	DET
aji-158	146	4	hapten	hapten	NOUN
aji-158	146	5	collected	collect	VERB
aji-158	146	6	by	by	ADP
aji-158	146	7	dendritic	dendritic	ADJ
aji-158	146	8	cells	cell	NOUN
aji-158	146	9	through	through	ADP
aji-158	146	10	the	the	DET
aji-158	146	11	toll	toll	NOUN
aji-158	146	12	-	-	PUNCT
aji-158	146	13	like	like	ADJ
aji-158	146	14	receptor	receptor	NOUN
aji-158	146	15	4	4	NUM
aji-158	146	16	and	and	CCONJ
aji-158	146	17	presented	present	VERB
aji-158	146	18	to	to	ADP
aji-158	146	19	naïve	naïve	ADJ
aji-158	146	20	t	t	NOUN
aji-158	146	21	cells	cell	NOUN
aji-158	146	22	in	in	ADP
aji-158	146	23	regional	regional	ADJ
aji-158	146	24	lymph	lymph	NOUN
aji-158	146	25	nodes	node	NOUN
aji-158	146	26	(	(	PUNCT
aji-158	146	27	schmidt	schmidt	PROPN
aji-158	146	28	et	et	PROPN
aji-158	146	29	al	al	PROPN
aji-158	146	30	.	.	PROPN
aji-158	146	31	,	,	PUNCT
aji-158	146	32	2010	2010	NUM
aji-158	146	33	,	,	PUNCT
aji-158	146	34	roediger	roediger	NOUN
aji-158	146	35	&	&	CCONJ
aji-158	146	36	weninger	weninger	NOUN
aji-158	146	37	,	,	PUNCT
aji-158	146	38	2011	2011	NUM
aji-158	146	39	)	)	PUNCT
aji-158	146	40	.	.	PUNCT
aji-158	147	1	“	"	PUNCT
aji-158	147	2	nickel	nickel	NOUN
aji-158	147	3	hypersensitivity	hypersensitivity	NOUN
aji-158	147	4	may	may	AUX
aji-158	147	5	be	be	AUX
aji-158	147	6	responsible	responsible	ADJ
aji-158	147	7	for	for	ADP
aji-158	147	8	allergic	allergic	ADJ
aji-158	147	9	contact	contact	NOUN
aji-158	147	10	dermatitis	dermatitis	NOUN
aji-158	147	11	,	,	PUNCT
aji-158	147	12	allergic	allergic	ADJ
aji-158	147	13	contact	contact	NOUN
aji-158	147	14	mucositis	mucositis	PROPN
aji-158	147	15	,	,	PUNCT
aji-158	147	16	and	and	CCONJ
aji-158	147	17	systemic	systemic	ADJ
aji-158	147	18	nickel	nickel	NOUN
aji-158	147	19	allergy	allergy	NOUN
aji-158	147	20	syndrome	syndrome	NOUN
aji-158	147	21	(	(	PUNCT
aji-158	147	22	schäfer	schäfer	NOUN
aji-158	147	23	et	et	PROPN
aji-158	147	24	al	al	PROPN
aji-158	147	25	.	.	PROPN
aji-158	147	26	,	,	PUNCT
aji-158	147	27	2001	2001	NUM
aji-158	147	28	;	;	PUNCT
aji-158	147	29	ahlström	ahlström	NOUN
aji-158	147	30	et	et	PROPN
aji-158	147	31	al	al	PROPN
aji-158	147	32	.	.	PROPN
aji-158	147	33	,	,	PUNCT
aji-158	147	34	2019	2019	NUM
aji-158	147	35	;	;	PUNCT
aji-158	147	36	greco	greco	PROPN
aji-158	147	37	et	et	PROPN
aji-158	147	38	al	al	PROPN
aji-158	147	39	.	.	PROPN
aji-158	147	40	,	,	PUNCT
aji-158	147	41	2023	2023	NUM
aji-158	147	42	;	;	PUNCT
aji-158	147	43	ricciardi	ricciardi	NOUN
aji-158	147	44	et	et	PROPN
aji-158	147	45	al	al	PROPN
aji-158	147	46	.	.	PROPN
aji-158	147	47	,	,	PUNCT
aji-158	147	48	2014	2014	NUM
aji-158	147	49	)	)	PUNCT
aji-158	147	50	.	.	PUNCT
aji-158	148	1	systemic	systemic	ADJ
aji-158	148	2	nickel	nickel	NOUN
aji-158	148	3	allergy	allergy	NOUN
aji-158	148	4	is	be	AUX
aji-158	148	5	a	a	DET
aji-158	148	6	term	term	NOUN
aji-158	148	7	commonly	commonly	ADV
aji-158	148	8	used	use	VERB
aji-158	148	9	to	to	PART
aji-158	148	10	describe	describe	VERB
aji-158	148	11	clinical	clinical	ADJ
aji-158	148	12	manifestations	manifestation	NOUN
aji-158	148	13	of	of	ADP
aji-158	148	14	the	the	DET
aji-158	148	15	systemic	systemic	ADJ
aji-158	148	16	provocation	provocation	NOUN
aji-158	148	17	by	by	ADP
aji-158	148	18	haptens	hapten	NOUN
aji-158	148	19	associated	associate	VERB
aji-158	148	20	with	with	ADP
aji-158	148	21	atopic	atopic	NOUN
aji-158	148	22	dermatitis	dermatitis	NOUN
aji-158	148	23	,	,	PUNCT
aji-158	148	24	psoriasis	psoriasis	NOUN
aji-158	148	25	,	,	PUNCT
aji-158	148	26	urticaria	urticaria	NOUN
aji-158	148	27	,	,	PUNCT
aji-158	148	28	angioedema	angioedema	VERB
aji-158	148	29	,	,	PUNCT
aji-158	148	30	rhinitis	rhinitis	ADJ
aji-158	148	31	,	,	PUNCT
aji-158	148	32	asthma	asthma	NOUN
aji-158	148	33	,	,	PUNCT
aji-158	148	34	headache	headache	NOUN
aji-158	148	35	,	,	PUNCT
aji-158	148	36	chronic	chronic	ADJ
aji-158	148	37	fatigue	fatigue	NOUN
aji-158	148	38	,	,	PUNCT
aji-158	148	39	postprandial	postprandial	ADJ
aji-158	148	40	dyspnea	dyspnea	NOUN
aji-158	148	41	,	,	PUNCT
aji-158	148	42	cystitis	cystitis	NOUN
aji-158	148	43	,	,	PUNCT
aji-158	148	44	vulvovaginitis	vulvovaginiti	NOUN
aji-158	148	45	,	,	PUNCT
aji-158	148	46	acne	acne	NOUN
aji-158	148	47	,	,	PUNCT
aji-158	148	48	and	and	CCONJ
aji-158	148	49	iron	iron	NOUN
aji-158	148	50	deficiency	deficiency	NOUN
aji-158	148	51	anemia	anemia	NOUN
aji-158	148	52	(	(	PUNCT
aji-158	148	53	nijhawan	nijhawan	PROPN
aji-158	148	54	et	et	PROPN
aji-158	148	55	al	al	PROPN
aji-158	148	56	.	.	PROPN
aji-158	148	57	,	,	PUNCT
aji-158	148	58	2009	2009	NUM
aji-158	148	59	;	;	PUNCT
aji-158	148	60	veien	veien	PROPN
aji-158	148	61	,	,	PUNCT
aji-158	148	62	2011	2011	NUM
aji-158	148	63	;	;	PUNCT
aji-158	148	64	akiba	akiba	PROPN
aji-158	148	65	et	et	PROPN
aji-158	148	66	al	al	PROPN
aji-158	148	67	.	.	PROPN
aji-158	148	68	,	,	PUNCT
aji-158	148	69	2025	2025	NUM
aji-158	148	70	)	)	PUNCT
aji-158	148	71	.	.	PUNCT
aji-158	149	1	“	"	PUNCT
aji-158	149	2	sometimes	sometimes	ADV
aji-158	149	3	,	,	PUNCT
aji-158	149	4	the	the	DET
aji-158	149	5	exposition	exposition	NOUN
aji-158	149	6	through	through	ADP
aji-158	149	7	a	a	DET
aji-158	149	8	systemic	systemic	ADJ
aji-158	149	9	route	route	NOUN
aji-158	149	10	of	of	ADP
aji-158	149	11	immunoreactive	immunoreactive	ADJ
aji-158	149	12	haptens	hapten	NOUN
aji-158	149	13	may	may	AUX
aji-158	149	14	produce	produce	VERB
aji-158	149	15	localized	localized	ADJ
aji-158	149	16	cutaneous	cutaneous	ADJ
aji-158	149	17	hypersensitivity	hypersensitivity	NOUN
aji-158	149	18	phenotypes	phenotype	NOUN
aji-158	149	19	such	such	ADJ
aji-158	149	20	as	as	ADP
aji-158	149	21	dyshidrotic	dyshidrotic	ADJ
aji-158	149	22	eczema	eczema	NOUN
aji-158	149	23	(	(	PUNCT
aji-158	149	24	pompholyx	pompholyx	PROPN
aji-158	149	25	)	)	PUNCT
aji-158	149	26	,	,	PUNCT
aji-158	149	27	toxicoderma	toxicoderma	NOUN
aji-158	149	28	-	-	PUNCT
aji-158	149	29	like	like	ADJ
aji-158	149	30	rash	rash	NOUN
aji-158	149	31	,	,	PUNCT
aji-158	149	32	chronic	chronic	ADJ
aji-158	149	33	pruritus	pruritus	NOUN
aji-158	149	34	,	,	PUNCT
aji-158	149	35	maculopapular	maculopapular	ADJ
aji-158	149	36	rash	rash	NOUN
aji-158	149	37	,	,	PUNCT
aji-158	149	38	vasculitis	vasculitis	NOUN
aji-158	149	39	-	-	PUNCT
aji-158	149	40	like	like	ADJ
aji-158	149	41	lesions	lesion	NOUN
aji-158	149	42	,	,	PUNCT
aji-158	149	43	flexural	flexural	ADJ
aji-158	149	44	dermatitis	dermatitis	NOUN
aji-158	149	45	,	,	PUNCT
aji-158	149	46	papuloerythrodermalike	papuloerythrodermalike	ADJ
aji-158	149	47	eruptions	eruption	NOUN
aji-158	149	48	,	,	PUNCT
aji-158	149	49	and	and	CCONJ
aji-158	149	50	baboon	baboon	PROPN
aji-158	149	51	syndrome	syndrome	PROPN
aji-158	149	52	”	"	PUNCT
aji-158	149	53	(	(	PUNCT
aji-158	149	54	antico	antico	PROPN
aji-158	149	55	&	&	CCONJ
aji-158	149	56	soana	soana	PROPN
aji-158	149	57	,	,	PUNCT
aji-158	149	58	2015	2015	NUM
aji-158	149	59	)	)	PUNCT
aji-158	149	60	.	.	PUNCT
aji-158	150	1	nickel	nickel	NOUN
aji-158	150	2	hypersensitivity	hypersensitivity	NOUN
aji-158	150	3	may	may	AUX
aji-158	150	4	be	be	AUX
aji-158	150	5	successfully	successfully	ADV
aji-158	150	6	treated	treat	VERB
aji-158	150	7	with	with	ADP
aji-158	150	8	sublingual	sublingual	ADJ
aji-158	150	9	desensitization	desensitization	NOUN
aji-158	150	10	and	and	CCONJ
aji-158	150	11	a	a	DET
aji-158	150	12	lownickel	lownickel	ADJ
aji-158	150	13	diet	diet	NOUN
aji-158	150	14	.	.	PUNCT
aji-158	151	1	(	(	PUNCT
aji-158	151	2	filatova	filatova	PROPN
aji-158	151	3	&	&	CCONJ
aji-158	151	4	cherpak	cherpak	PROPN
aji-158	151	5	,	,	PUNCT
aji-158	151	6	2020	2020	NUM
aji-158	151	7	;	;	PUNCT
aji-158	151	8	ricciardi	ricciardi	NOUN
aji-158	151	9	et	et	PROPN
aji-158	151	10	al	al	PROPN
aji-158	151	11	.	.	PROPN
aji-158	151	12	,	,	PUNCT
aji-158	151	13	2013	2013	NUM
aji-158	151	14	;	;	PUNCT
aji-158	151	15	morris	morris	PROPN
aji-158	151	16	,	,	PUNCT
aji-158	151	17	1998	1998	NUM
aji-158	151	18	)	)	PUNCT
aji-158	151	19	.	.	PUNCT
aji-158	152	1	nickel	nickel	NOUN
aji-158	152	2	allergy	allergy	NOUN
aji-158	152	3	can	can	AUX
aji-158	152	4	be	be	AUX
aji-158	152	5	diagnosed	diagnose	VERB
aji-158	152	6	with	with	ADP
aji-158	152	7	cutaneous	cutaneous	ADJ
aji-158	152	8	and	and	CCONJ
aji-158	152	9	oral	oral	ADJ
aji-158	152	10	challenge	challenge	NOUN
aji-158	152	11	tests	test	NOUN
aji-158	152	12	(	(	PUNCT
aji-158	152	13	veien	veien	PROPN
aji-158	152	14	et	et	PROPN
aji-158	152	15	al	al	PROPN
aji-158	152	16	.	.	PROPN
aji-158	152	17	,	,	PUNCT
aji-158	152	18	1987	1987	NUM
aji-158	152	19	)	)	PUNCT
aji-158	152	20	.	.	PUNCT
aji-158	153	1	non	non	ADJ
aji-158	153	2	–	–	PUNCT
aji-158	153	3	ige	ige	ADJ
aji-158	153	4	-	-	PUNCT
aji-158	153	5	mediated	mediate	VERB
aji-158	153	6	symptomatic	symptomatic	ADJ
aji-158	153	7	nickel	nickel	NOUN
aji-158	153	8	hypersensitivity	hypersensitivity	NOUN
aji-158	153	9	may	may	AUX
aji-158	153	10	be	be	AUX
aji-158	153	11	differentiated	differentiate	VERB
aji-158	153	12	with	with	ADP
aji-158	153	13	the	the	DET
aji-158	153	14	help	help	NOUN
aji-158	153	15	of	of	ADP
aji-158	153	16	the	the	DET
aji-158	153	17	leukocyte	leukocyte	NOUN
aji-158	153	18	adherence	adherence	NOUN
aji-158	153	19	inhibition	inhibition	NOUN
aji-158	153	20	test	test	NOUN
aji-158	153	21	(	(	PUNCT
aji-158	153	22	olivier	olivier	PROPN
aji-158	153	23	et	et	PROPN
aji-158	153	24	al	al	PROPN
aji-158	153	25	.	.	PROPN
aji-158	153	26	,	,	PUNCT
aji-158	153	27	2023c	2023c	NUM
aji-158	153	28	)	)	PUNCT
aji-158	153	29	.	.	PUNCT
aji-158	154	1	“	"	PUNCT
aji-158	154	2	non	non	ADJ
aji-158	154	3	–	–	PUNCT
aji-158	154	4	ige	ige	ADJ
aji-158	154	5	-	-	PUNCT
aji-158	154	6	mediated	mediate	VERB
aji-158	154	7	cellular	cellular	ADJ
aji-158	154	8	immunoreactivity	immunoreactivity	NOUN
aji-158	154	9	against	against	ADP
aji-158	154	10	several	several	ADJ
aji-158	154	11	food	food	NOUN
aji-158	154	12	allergens	allergen	NOUN
aji-158	154	13	had	have	AUX
aji-158	154	14	already	already	ADV
aji-158	154	15	been	be	AUX
aji-158	154	16	reported	report	VERB
aji-158	154	17	by	by	ADP
aji-158	154	18	our	our	PRON
aji-158	154	19	group	group	NOUN
aji-158	154	20	with	with	ADP
aji-158	154	21	the	the	DET
aji-158	154	22	help	help	NOUN
aji-158	154	23	of	of	ADP
aji-158	154	24	the	the	DET
aji-158	154	25	leukocyte	leukocyte	NOUN
aji-158	154	26	adherence	adherence	NOUN
aji-158	154	27	inhibition	inhibition	NOUN
aji-158	154	28	test	test	NOUN
aji-158	154	29	(	(	PUNCT
aji-158	154	30	lait	lait	NOUN
aji-158	154	31	)	)	PUNCT
aji-158	154	32	(	(	PUNCT
aji-158	154	33	olivier	olivier	PROPN
aji-158	154	34	et	et	PROPN
aji-158	154	35	al	al	PROPN
aji-158	154	36	.	.	PROPN
aji-158	154	37	,	,	PUNCT
aji-158	154	38	2021d	2021d	NUM
aji-158	154	39	;	;	PUNCT
aji-158	154	40	olivier	olivier	PROPN
aji-158	154	41	et	et	PROPN
aji-158	154	42	al	al	PROPN
aji-158	154	43	.	.	PROPN
aji-158	154	44	,	,	PUNCT
aji-158	154	45	2022a	2022a	NUM
aji-158	154	46	;	;	PUNCT
aji-158	154	47	olivier	olivier	PROPN
aji-158	154	48	et	et	PROPN
aji-158	154	49	al	al	PROPN
aji-158	154	50	.	.	PROPN
aji-158	154	51	,	,	PUNCT
aji-158	154	52	2022c	2022c	NUM
aji-158	154	53	;	;	PUNCT
aji-158	154	54	olivier	olivier	PROPN
aji-158	154	55	et	et	PROPN
aji-158	154	56	al	al	PROPN
aji-158	154	57	.	.	PROPN
aji-158	154	58	,	,	PUNCT
aji-158	154	59	2024a	2024a	NUM
aji-158	154	60	)	)	PUNCT
aji-158	154	61	.	.	PUNCT
aji-158	155	1	the	the	DET
aji-158	155	2	humoral	humoral	ADJ
aji-158	155	3	immunoreactivity	immunoreactivity	NOUN
aji-158	155	4	against	against	ADP
aji-158	155	5	several	several	ADJ
aji-158	155	6	food	food	NOUN
aji-158	155	7	allergens	allergen	NOUN
aji-158	155	8	with	with	ADP
aji-158	155	9	the	the	DET
aji-158	155	10	help	help	NOUN
aji-158	155	11	of	of	ADP
aji-158	155	12	the	the	DET
aji-158	155	13	tube	tube	NOUN
aji-158	155	14	titration	titration	NOUN
aji-158	155	15	of	of	ADP
aji-158	155	16	precipitins	precipitin	NOUN
aji-158	155	17	(	(	PUNCT
aji-158	155	18	ttp	ttp	X
aji-158	155	19	)	)	PUNCT
aji-158	155	20	was	be	AUX
aji-158	155	21	also	also	ADV
aji-158	155	22	evaluated	evaluate	VERB
aji-158	155	23	”	"	PUNCT
aji-158	155	24	(	(	PUNCT
aji-158	155	25	olivier	olivier	PROPN
aji-158	155	26	et	et	PROPN
aji-158	155	27	al	al	PROPN
aji-158	155	28	.	.	PROPN
aji-158	155	29	,	,	PUNCT
aji-158	155	30	2024b	2024b	NUM
aji-158	155	31	;	;	PUNCT
aji-158	155	32	olivier	olivier	PROPN
aji-158	155	33	et	et	PROPN
aji-158	155	34	al	al	PROPN
aji-158	155	35	.	.	PROPN
aji-158	155	36	,	,	PUNCT
aji-158	155	37	2024c	2024c	NUM
aji-158	155	38	;	;	PUNCT
aji-158	155	39	olivier	olivier	PROPN
aji-158	155	40	et	et	PROPN
aji-158	155	41	al	al	PROPN
aji-158	155	42	.	.	PROPN
aji-158	155	43	,	,	PUNCT
aji-158	155	44	2025	2025	NUM
aji-158	155	45	)	)	PUNCT
aji-158	155	46	.	.	PUNCT
aji-158	156	1	“	"	PUNCT
aji-158	156	2	we	we	PRON
aji-158	156	3	routinely	routinely	ADV
aji-158	156	4	employ	employ	VERB
aji-158	156	5	the	the	DET
aji-158	156	6	lait	lait	NOUN
aji-158	156	7	and	and	CCONJ
aji-158	156	8	the	the	DET
aji-158	156	9	ttp	ttp	NOUN
aji-158	156	10	in	in	ADP
aji-158	156	11	our	our	PRON
aji-158	156	12	facilities	facility	NOUN
aji-158	156	13	as	as	ADP
aji-158	156	14	a	a	DET
aji-158	156	15	triage	triage	NOUN
aji-158	156	16	to	to	PART
aji-158	156	17	evaluate	evaluate	VERB
aji-158	156	18	non	non	ADJ
aji-158	156	19	–	–	VERB
aji-158	156	20	igemediated	igemediate	VERB
aji-158	156	21	immunoreactivity	immunoreactivity	NOUN
aji-158	156	22	against	against	ADP
aji-158	156	23	suspected	suspect	VERB
aji-158	156	24	allergens	allergen	NOUN
aji-158	156	25	before	before	ADP
aji-158	156	26	performing	perform	VERB
aji-158	156	27	more	more	ADV
aji-158	156	28	exhaustive	exhaustive	ADJ
aji-158	156	29	in	in	ADP
aji-158	156	30	vivo	vivo	ADJ
aji-158	156	31	provocation	provocation	NOUN
aji-158	156	32	tests	test	NOUN
aji-158	156	33	”	"	PUNCT
aji-158	156	34	(	(	PUNCT
aji-158	156	35	kuratsuji	kuratsuji	PROPN
aji-158	156	36	,	,	PUNCT
aji-158	156	37	1981	1981	NUM
aji-158	156	38	;	;	PUNCT
aji-158	156	39	olivier	olivier	PROPN
aji-158	156	40	et	et	PROPN
aji-158	156	41	al	al	PROPN
aji-158	156	42	.	.	PROPN
aji-158	156	43	,	,	PUNCT
aji-158	156	44	2023f	2023f	NUM
aji-158	156	45	;	;	PUNCT
aji-158	156	46	olivier	olivier	PROPN
aji-158	156	47	et	et	PROPN
aji-158	156	48	al	al	PROPN
aji-158	156	49	.	.	PROPN
aji-158	156	50	,	,	PUNCT
aji-158	156	51	2023h	2023h	NUM
aji-158	156	52	;	;	PUNCT
aji-158	156	53	olivier	olivier	PROPN
aji-158	156	54	et	et	PROPN
aji-158	156	55	al	al	PROPN
aji-158	156	56	.	.	PROPN
aji-158	156	57	,	,	PUNCT
aji-158	156	58	2023d	2023d	NUM
aji-158	156	59	)	)	PUNCT
aji-158	156	60	.	.	PUNCT
aji-158	157	1	to	to	PART
aji-158	157	2	evaluate	evaluate	VERB
aji-158	157	3	the	the	DET
aji-158	157	4	potential	potential	NOUN
aji-158	157	5	of	of	ADP
aji-158	157	6	the	the	DET
aji-158	157	7	lait	lait	NOUN
aji-158	157	8	and	and	CCONJ
aji-158	157	9	ttp	ttp	NOUN
aji-158	157	10	to	to	ADP
aji-158	157	11	endotyping	endotype	VERB
aji-158	157	12	non	non	ADJ
aji-158	157	13	–	–	PUNCT
aji-158	157	14	ige	ige	ADJ
aji-158	157	15	-	-	PUNCT
aji-158	157	16	mediated	mediate	VERB
aji-158	157	17	cellular	cellular	ADJ
aji-158	157	18	and	and	CCONJ
aji-158	157	19	humoral	humoral	ADJ
aji-158	157	20	immunoreactivity	immunoreactivity	NOUN
aji-158	157	21	against	against	ADP
aji-158	157	22	cocoa	cocoa	NOUN
aji-158	157	23	extract	extract	NOUN
aji-158	157	24	and	and	CCONJ
aji-158	157	25	nickel	nickel	NOUN
aji-158	157	26	solution	solution	NOUN
aji-158	157	27	,	,	PUNCT
aji-158	157	28	we	we	PRON
aji-158	157	29	retrospectively	retrospectively	ADV
aji-158	157	30	compiled	compile	VERB
aji-158	157	31	the	the	DET
aji-158	157	32	electronic	electronic	ADJ
aji-158	157	33	medical	medical	ADJ
aji-158	157	34	charts	chart	NOUN
aji-158	157	35	of	of	ADP
aji-158	157	36	patients	patient	NOUN
aji-158	157	37	diagnosed	diagnose	VERB
aji-158	157	38	with	with	ADP
aji-158	157	39	non	non	ADJ
aji-158	157	40	–	–	ADJ
aji-158	157	41	igemediated	igemediate	VERB
aji-158	157	42	hypersensitivity	hypersensitivity	NOUN
aji-158	157	43	who	who	PRON
aji-158	157	44	were	be	AUX
aji-158	157	45	investigated	investigate	VERB
aji-158	157	46	simultaneously	simultaneously	ADV
aji-158	157	47	for	for	ADP
aji-158	157	48	immunoreactivity	immunoreactivity	NOUN
aji-158	157	49	against	against	ADP
aji-158	157	50	these	these	DET
aji-158	157	51	two	two	NUM
aji-158	157	52	allergens	allergen	NOUN
aji-158	157	53	by	by	ADP
aji-158	157	54	one	one	NUM
aji-158	157	55	of	of	ADP
aji-158	157	56	these	these	DET
aji-158	157	57	assays	assay	NOUN
aji-158	157	58	(	(	PUNCT
aji-158	157	59	olivier	olivier	X
aji-158	157	60	et	et	PROPN
aji-158	157	61	al	al	PROPN
aji-158	157	62	.	.	PROPN
aji-158	157	63	,	,	PUNCT
aji-158	157	64	2023b	2023b	NUM
aji-158	157	65	;	;	PUNCT
aji-158	157	66	olivier	olivier	PROPN
aji-158	157	67	et	et	PROPN
aji-158	157	68	al	al	PROPN
aji-158	157	69	.	.	PROPN
aji-158	157	70	,	,	PUNCT
aji-158	157	71	2023e	2023e	NUM
aji-158	157	72	;	;	PUNCT
aji-158	157	73	olivier	olivier	PROPN
aji-158	157	74	et	et	PROPN
aji-158	157	75	al	al	PROPN
aji-158	157	76	.	.	PROPN
aji-158	157	77	,	,	PUNCT
aji-158	157	78	2024f	2024f	NUM
aji-158	157	79	)	)	PUNCT
aji-158	157	80	.	.	PUNCT
aji-158	158	1	the	the	DET
aji-158	158	2	present	present	ADJ
aji-158	158	3	study	study	NOUN
aji-158	158	4	is	be	AUX
aji-158	158	5	a	a	DET
aji-158	158	6	proof	proof	NOUN
aji-158	158	7	-	-	PUNCT
aji-158	158	8	of	of	ADP
aji-158	158	9	-	-	PUNCT
aji-158	158	10	concept	concept	NOUN
aji-158	158	11	that	that	PRON
aji-158	158	12	hypothesizes	hypothesize	VERB
aji-158	158	13	that	that	DET
aji-158	158	14	lait	lait	NOUN
aji-158	158	15	and	and	CCONJ
aji-158	158	16	the	the	DET
aji-158	158	17	ttp	ttp	NOUN
aji-158	158	18	may	may	AUX
aji-158	158	19	differentiate	differentiate	VERB
aji-158	158	20	diverse	diverse	ADJ
aji-158	158	21	degrees	degree	NOUN
aji-158	158	22	of	of	ADP
aji-158	158	23	cellular	cellular	ADJ
aji-158	158	24	and	and	CCONJ
aji-158	158	25	humoral	humoral	ADJ
aji-158	158	26	immunoreactivity	immunoreactivity	NOUN
aji-158	158	27	against	against	ADP
aji-158	158	28	cocoa	cocoa	NOUN
aji-158	158	29	extract	extract	NOUN
aji-158	158	30	and	and	CCONJ
aji-158	158	31	nickel	nickel	NOUN
aji-158	158	32	solution	solution	NOUN
aji-158	158	33	,	,	PUNCT
aji-158	158	34	as	as	ADV
aji-158	158	35	well	well	ADV
aji-158	158	36	to	to	PART
aji-158	158	37	verify	verify	VERB
aji-158	158	38	some	some	DET
aji-158	158	39	crossreactivity	crossreactivity	NOUN
aji-158	158	40	between	between	ADP
aji-158	158	41	them	they	PRON
aji-158	158	42	through	through	ADP
aji-158	158	43	the	the	DET
aji-158	158	44	calculation	calculation	NOUN
aji-158	158	45	of	of	ADP
aji-158	158	46	a	a	DET
aji-158	158	47	paired	pair	VERB
aji-158	158	48	t	t	NOUN
aji-158	158	49	-	-	PUNCT
aji-158	158	50	test	test	NOUN
aji-158	158	51	to	to	PART
aji-158	158	52	distinguish	distinguish	VERB
aji-158	158	53	some	some	DET
aji-158	158	54	order	order	NOUN
aji-158	158	55	of	of	ADP
aji-158	158	56	cross	cross	NOUN
aji-158	158	57	-	-	NOUN
aji-158	158	58	reactivity	reactivity	NOUN
aji-158	158	59	in	in	ADP
aji-158	158	60	patients	patient	NOUN
aji-158	158	61	suffering	suffer	VERB
aji-158	158	62	from	from	ADP
aji-158	158	63	non	non	ADJ
aji-158	158	64	–	–	PUNCT
aji-158	158	65	ige	ige	ADJ
aji-158	158	66	-	-	PUNCT
aji-158	158	67	mediated	mediate	VERB
aji-158	158	68	clinically	clinically	ADV
aji-158	158	69	diagnosed	diagnose	VERB
aji-158	158	70	allergies	allergy	NOUN
aji-158	158	71	.	.	PUNCT
aji-158	159	1	“	"	PUNCT
aji-158	159	2	as	as	SCONJ
aji-158	159	3	the	the	DET
aji-158	159	4	tests	test	NOUN
aji-158	159	5	were	be	AUX
aji-158	159	6	performed	perform	VERB
aji-158	159	7	simultaneously	simultaneously	ADV
aji-158	159	8	with	with	ADP
aji-158	159	9	the	the	DET
aji-158	159	10	same	same	ADJ
aji-158	159	11	venous	venous	ADJ
aji-158	159	12	sample	sample	NOUN
aji-158	159	13	for	for	ADP
aji-158	159	14	the	the	DET
aji-158	159	15	two	two	NUM
aji-158	159	16	allergens	allergen	NOUN
aji-158	159	17	,	,	PUNCT
aji-158	159	18	it	it	PRON
aji-158	159	19	is	be	AUX
aji-158	159	20	possible	possible	ADJ
aji-158	159	21	to	to	PART
aji-158	159	22	calculate	calculate	VERB
aji-158	159	23	a	a	DET
aji-158	159	24	paired	pair	VERB
aji-158	159	25	t	t	NOUN
aji-158	159	26	-	-	PUNCT
aji-158	159	27	test	test	NOUN
aji-158	159	28	between	between	ADP
aji-158	159	29	lait	lait	NOUN
aji-158	159	30	results	result	NOUN
aji-158	159	31	(	(	PUNCT
aji-158	159	32	since	since	SCONJ
aji-158	159	33	they	they	PRON
aji-158	159	34	refer	refer	VERB
aji-158	159	35	to	to	ADP
aji-158	159	36	the	the	DET
aji-158	159	37	same	same	ADJ
aji-158	159	38	quantitative	quantitative	ADJ
aji-158	159	39	variable	variable	NOUN
aji-158	159	40	)	)	PUNCT
aji-158	159	41	,	,	PUNCT
aji-158	159	42	as	as	ADV
aji-158	159	43	well	well	ADV
aji-158	159	44	as	as	ADP
aji-158	159	45	to	to	PART
aji-158	159	46	present	present	VERB
aji-158	159	47	a	a	DET
aji-158	159	48	dispersion	dispersion	NOUN
aji-158	159	49	graph	graph	NOUN
aji-158	159	50	between	between	ADP
aji-158	159	51	them	they	PRON
aji-158	159	52	to	to	PART
aji-158	159	53	distinguish	distinguish	VERB
aji-158	159	54	some	some	DET
aji-158	159	55	order	order	NOUN
aji-158	159	56	of	of	ADP
aji-158	159	57	correlation	correlation	NOUN
aji-158	159	58	suggesting	suggest	VERB
aji-158	159	59	(	(	PUNCT
aji-158	159	60	or	or	CCONJ
aji-158	159	61	not	not	PART
aji-158	159	62	)	)	PUNCT
aji-158	159	63	cross	cross	ADJ
aji-158	159	64	-	-	NOUN
aji-158	159	65	reactivity	reactivity	NOUN
aji-158	159	66	”	"	PUNCT
aji-158	159	67	(	(	PUNCT
aji-158	159	68	gosset	gosset	NOUN
aji-158	159	69	-	-	PUNCT
aji-158	159	70	student	student	NOUN
aji-158	159	71	1908	1908	NUM
aji-158	159	72	)	)	PUNCT
aji-158	159	73	.	.	PUNCT
aji-158	160	1	2	2	X
aji-158	160	2	.	.	X
aji-158	160	3	materials	material	NOUN
aji-158	160	4	and	and	CCONJ
aji-158	160	5	methods	method	NOUN
aji-158	160	6	2.1	2.1	NUM
aji-158	160	7	subjects	subject	NOUN
aji-158	160	8	after	after	ADP
aji-158	160	9	receiving	receive	VERB
aji-158	160	10	institutional	institutional	ADJ
aji-158	160	11	review	review	NOUN
aji-158	160	12	board	board	NOUN
aji-158	160	13	approval	approval	NOUN
aji-158	160	14	from	from	ADP
aji-158	160	15	the	the	DET
aji-158	160	16	instituto	instituto	PROPN
aji-158	160	17	alergoimuno	alergoimuno	PROPN
aji-158	160	18	de	de	X
aji-158	160	19	americana	americana	PROPN
aji-158	160	20	(	(	PUNCT
aji-158	160	21	brazil	brazil	PROPN
aji-158	160	22	;	;	PUNCT
aji-158	160	23	02/2025	02/2025	NUM
aji-158	160	24	)	)	PUNCT
aji-158	160	25	,	,	PUNCT
aji-158	160	26	we	we	PRON
aji-158	160	27	reviewed	review	VERB
aji-158	160	28	the	the	DET
aji-158	160	29	electronic	electronic	ADJ
aji-158	160	30	chart	chart	NOUN
aji-158	160	31	of	of	ADP
aji-158	160	32	10.170	10.170	NUM
aji-158	160	33	outpatients	outpatient	NOUN
aji-158	160	34	who	who	PRON
aji-158	160	35	attended	attend	VERB
aji-158	160	36	our	our	PRON
aji-158	160	37	facility	facility	NOUN
aji-158	160	38	from	from	ADP
aji-158	160	39	january	january	PROPN
aji-158	160	40	2018	2018	NUM
aji-158	160	41	to	to	ADP
aji-158	160	42	march	march	PROPN
aji-158	160	43	2025	2025	NUM
aji-158	160	44	.	.	PUNCT
aji-158	161	1	a	a	DET
aji-158	161	2	cohort	cohort	NOUN
aji-158	161	3	of	of	ADP
aji-158	161	4	100	100	NUM
aji-158	161	5	consecutive	consecutive	ADJ
aji-158	161	6	outside	outside	ADJ
aji-158	161	7	patients	patient	NOUN
aji-158	161	8	(	(	PUNCT
aji-158	161	9	ttp	ttp	X
aji-158	161	10	cohort	cohort	NOUN
aji-158	161	11	)	)	PUNCT
aji-158	161	12	had	have	AUX
aji-158	161	13	been	be	AUX
aji-158	161	14	simultaneously	simultaneously	ADV
aji-158	161	15	submitted	submit	VERB
aji-158	161	16	to	to	ADP
aji-158	161	17	ttp	ttp	PROPN
aji-158	161	18	with	with	ADP
aji-158	161	19	cocoa	cocoa	NOUN
aji-158	161	20	extract	extract	NOUN
aji-158	161	21	and	and	CCONJ
aji-158	161	22	nickel	nickel	NOUN
aji-158	161	23	solution	solution	NOUN
aji-158	161	24	for	for	ADP
aji-158	161	25	presenting	present	VERB
aji-158	161	26	non	non	ADJ
aji-158	161	27	–	–	PUNCT
aji-158	161	28	ige	ige	ADJ
aji-158	161	29	-	-	PUNCT
aji-158	161	30	mediated	mediate	VERB
aji-158	161	31	intrinsic	intrinsic	ADJ
aji-158	161	32	atopic	atopic	NOUN
aji-158	161	33	dermatitis	dermatitis	NOUN
aji-158	161	34	and	and	CCONJ
aji-158	161	35	contact	contact	NOUN
aji-158	161	36	dermatitis	dermatitis	NOUN
aji-158	161	37	.	.	PUNCT
aji-158	162	1	this	this	DET
aji-158	162	2	cohort	cohort	NOUN
aji-158	162	3	olivier	olivier	NOUN
aji-158	162	4	et	et	PROPN
aji-158	162	5	al	al	PROPN
aji-158	162	6	.	.	PROPN
aji-158	162	7	;	;	PUNCT
aji-158	162	8	asian	asian	PROPN
aji-158	162	9	j.	j.	PROPN
aji-158	162	10	immunol	immunol	PROPN
aji-158	162	11	.	.	PROPN
aji-158	162	12	,	,	PUNCT
aji-158	162	13	vol	vol	NOUN
aji-158	162	14	.	.	PROPN
aji-158	162	15	8	8	NUM
aji-158	162	16	,	,	PUNCT
aji-158	162	17	no	no	INTJ
aji-158	162	18	.	.	NOUN
aji-158	162	19	1	1	NUM
aji-158	162	20	,	,	PUNCT
aji-158	162	21	pp	pp	ADJ
aji-158	162	22	.	.	PUNCT
aji-158	163	1	35	35	NUM
aji-158	163	2	-	-	SYM
aji-158	163	3	49	49	NUM
aji-158	163	4	,	,	PUNCT
aji-158	163	5	2025	2025	NUM
aji-158	163	6	;	;	PUNCT
aji-158	163	7	article	article	NOUN
aji-158	163	8	no.aji.133582	no.aji.133582	PROPN
aji-158	163	9	38	38	NUM
aji-158	163	10	counted	count	VERB
aji-158	163	11	27	27	NUM
aji-158	163	12	males	male	NOUN
aji-158	163	13	;	;	PUNCT
aji-158	163	14	mean	mean	VERB
aji-158	163	15	age	age	NOUN
aji-158	163	16	38.6	38.6	NUM
aji-158	163	17	years	year	NOUN
aji-158	163	18	;	;	PUNCT
aji-158	163	19	sd	sd	ADP
aji-158	163	20	21.4	21.4	NUM
aji-158	163	21	years	year	NOUN
aji-158	163	22	;	;	PUNCT
aji-158	163	23	range	range	NOUN
aji-158	163	24	1	1	NUM
aji-158	163	25	to	to	ADP
aji-158	163	26	84	84	NUM
aji-158	163	27	years	year	NOUN
aji-158	163	28	;	;	PUNCT
aji-158	163	29	median	median	NOUN
aji-158	163	30	37.5	37.5	NUM
aji-158	163	31	years	year	NOUN
aji-158	163	32	;	;	PUNCT
aji-158	163	33	modes	mode	NOUN
aji-158	163	34	=	=	SYM
aji-158	163	35	4	4	NUM
aji-158	163	36	,	,	PUNCT
aji-158	163	37	7	7	NUM
aji-158	163	38	,	,	PUNCT
aji-158	163	39	27	27	NUM
aji-158	163	40	,	,	PUNCT
aji-158	163	41	30	30	NUM
aji-158	163	42	,	,	PUNCT
aji-158	163	43	32	32	NUM
aji-158	163	44	,	,	PUNCT
aji-158	163	45	33	33	NUM
aji-158	163	46	,	,	PUNCT
aji-158	163	47	41	41	NUM
aji-158	163	48	,	,	PUNCT
aji-158	163	49	45	45	NUM
aji-158	163	50	,	,	PUNCT
aji-158	163	51	46	46	NUM
aji-158	163	52	,	,	PUNCT
aji-158	163	53	50	50	NUM
aji-158	163	54	years	year	NOUN
aji-158	163	55	(	(	PUNCT
aji-158	163	56	each	each	PRON
aji-158	163	57	appeared	appear	VERB
aji-158	163	58	3	3	NUM
aji-158	163	59	times	time	NOUN
aji-158	163	60	)	)	PUNCT
aji-158	163	61	;	;	PUNCT
aji-158	163	62	geometric	geometric	ADJ
aji-158	163	63	mean	mean	NOUN
aji-158	163	64	=	=	NOUN
aji-158	163	65	29.9	29.9	NUM
aji-158	163	66	years	year	NOUN
aji-158	163	67	.	.	PUNCT
aji-158	164	1	a	a	DET
aji-158	164	2	cohort	cohort	NOUN
aji-158	164	3	of	of	ADP
aji-158	164	4	100	100	NUM
aji-158	164	5	consecutive	consecutive	ADJ
aji-158	164	6	outside	outside	ADJ
aji-158	164	7	patients	patient	NOUN
aji-158	164	8	(	(	PUNCT
aji-158	164	9	lait	lait	NOUN
aji-158	164	10	cohort	cohort	NOUN
aji-158	164	11	)	)	PUNCT
aji-158	164	12	had	have	AUX
aji-158	164	13	been	be	AUX
aji-158	164	14	simultaneously	simultaneously	ADV
aji-158	164	15	submitted	submit	VERB
aji-158	164	16	to	to	ADP
aji-158	164	17	tial	tial	NOUN
aji-158	164	18	with	with	ADP
aji-158	164	19	cocoa	cocoa	NOUN
aji-158	164	20	extract	extract	NOUN
aji-158	164	21	and	and	CCONJ
aji-158	164	22	nickel	nickel	NOUN
aji-158	164	23	solution	solution	NOUN
aji-158	164	24	for	for	ADP
aji-158	164	25	presenting	present	VERB
aji-158	164	26	non	non	ADJ
aji-158	164	27	–	–	PUNCT
aji-158	164	28	ige	ige	ADJ
aji-158	164	29	-	-	PUNCT
aji-158	164	30	mediated	mediate	VERB
aji-158	164	31	intrinsic	intrinsic	ADJ
aji-158	164	32	atopic	atopic	NOUN
aji-158	164	33	dermatitis	dermatitis	NOUN
aji-158	164	34	and	and	CCONJ
aji-158	164	35	contact	contact	NOUN
aji-158	164	36	dermatitis	dermatitis	NOUN
aji-158	164	37	.	.	PUNCT
aji-158	165	1	this	this	DET
aji-158	165	2	cohort	cohort	NOUN
aji-158	165	3	counted	count	VERB
aji-158	165	4	27	27	NUM
aji-158	165	5	males	male	NOUN
aji-158	165	6	;	;	PUNCT
aji-158	165	7	mean	mean	VERB
aji-158	165	8	age	age	NOUN
aji-158	165	9	43.3	43.3	NUM
aji-158	165	10	years	year	NOUN
aji-158	165	11	;	;	PUNCT
aji-158	165	12	sd	sd	ADP
aji-158	165	13	19.4	19.4	NUM
aji-158	165	14	years	year	NOUN
aji-158	165	15	;	;	PUNCT
aji-158	165	16	range	range	VERB
aji-158	165	17	10	10	NUM
aji-158	165	18	to	to	PART
aji-158	165	19	91	91	NUM
aji-158	165	20	years	year	NOUN
aji-158	165	21	;	;	PUNCT
aji-158	165	22	median	median	NOUN
aji-158	165	23	40	40	NUM
aji-158	165	24	years	year	NOUN
aji-158	165	25	;	;	PUNCT
aji-158	165	26	mode	mode	NOUN
aji-158	165	27	=	=	NOUN
aji-158	165	28	35	35	NUM
aji-158	165	29	years	year	NOUN
aji-158	165	30	(	(	PUNCT
aji-158	165	31	appeared	appear	VERB
aji-158	165	32	seven	seven	NUM
aji-158	165	33	times	time	NOUN
aji-158	165	34	)	)	PUNCT
aji-158	165	35	;	;	PUNCT
aji-158	165	36	geometric	geometric	ADJ
aji-158	165	37	mean	mean	NOUN
aji-158	165	38	=	=	SYM
aji-158	165	39	38.7	38.7	NUM
aji-158	165	40	years	year	NOUN
aji-158	165	41	.	.	PUNCT
aji-158	166	1	this	this	DET
aji-158	166	2	study	study	NOUN
aji-158	166	3	did	do	AUX
aji-158	166	4	not	not	PART
aji-158	166	5	include	include	VERB
aji-158	166	6	patients	patient	NOUN
aji-158	166	7	under	under	ADP
aji-158	166	8	biological	biological	ADJ
aji-158	166	9	and/or	and/or	CCONJ
aji-158	166	10	systemic	systemic	ADJ
aji-158	166	11	anti	anti	ADJ
aji-158	166	12	-	-	ADJ
aji-158	166	13	inflammatory	inflammatory	ADJ
aji-158	166	14	therapy	therapy	NOUN
aji-158	166	15	.	.	PUNCT
aji-158	167	1	these	these	DET
aji-158	167	2	procedures	procedure	NOUN
aji-158	167	3	were	be	AUX
aji-158	167	4	offered	offer	VERB
aji-158	167	5	to	to	ADP
aji-158	167	6	patients	patient	NOUN
aji-158	167	7	with	with	ADP
aji-158	167	8	clinical	clinical	ADJ
aji-158	167	9	suspicion	suspicion	NOUN
aji-158	167	10	of	of	ADP
aji-158	167	11	cocoa	cocoa	NOUN
aji-158	167	12	and/or	and/or	CCONJ
aji-158	167	13	nickel	nickel	NOUN
aji-158	167	14	hypersensitivity	hypersensitivity	NOUN
aji-158	167	15	who	who	PRON
aji-158	167	16	demonstrated	demonstrate	VERB
aji-158	167	17	an	an	DET
aji-158	167	18	undetectable	undetectable	ADJ
aji-158	167	19	specific	specific	ADJ
aji-158	167	20	ige	ige	NOUN
aji-158	167	21	against	against	ADP
aji-158	167	22	cocoa	cocoa	NOUN
aji-158	167	23	and	and	CCONJ
aji-158	167	24	nonreactive	nonreactive	ADJ
aji-158	167	25	or	or	CCONJ
aji-158	167	26	inconclusive	inconclusive	ADJ
aji-158	167	27	skin	skin	NOUN
aji-158	167	28	tests	test	NOUN
aji-158	167	29	against	against	ADP
aji-158	167	30	cocoa	cocoa	NOUN
aji-158	167	31	extract	extract	NOUN
aji-158	167	32	and	and	CCONJ
aji-158	167	33	nickel	nickel	NOUN
aji-158	167	34	solution	solution	NOUN
aji-158	167	35	(	(	PUNCT
aji-158	167	36	olivier	olivier	PROPN
aji-158	167	37	et	et	PROPN
aji-158	167	38	al	al	PROPN
aji-158	167	39	.	.	PROPN
aji-158	167	40	,	,	PUNCT
aji-158	167	41	2013	2013	NUM
aji-158	167	42	)	)	PUNCT
aji-158	167	43	.	.	PUNCT
aji-158	168	1	2.2	2.2	NUM
aji-158	168	2	extracts	extract	NOUN
aji-158	168	3	2.2.1	2.2.1	NUM
aji-158	168	4	cocoa	cocoa	NOUN
aji-158	168	5	extract	extract	VERB
aji-158	168	6	the	the	DET
aji-158	168	7	whole	whole	ADJ
aji-158	168	8	cocoa	cocoa	NOUN
aji-158	168	9	(	(	PUNCT
aji-158	168	10	pulp	pulp	NOUN
aji-158	168	11	,	,	PUNCT
aji-158	168	12	peel	peel	NOUN
aji-158	168	13	,	,	PUNCT
aji-158	168	14	and	and	CCONJ
aji-158	168	15	seeds	seed	NOUN
aji-158	168	16	)	)	PUNCT
aji-158	168	17	was	be	AUX
aji-158	168	18	crushed	crush	VERB
aji-158	168	19	,	,	PUNCT
aji-158	168	20	homogenized	homogenize	VERB
aji-158	168	21	,	,	PUNCT
aji-158	168	22	and	and	CCONJ
aji-158	168	23	then	then	ADV
aji-158	168	24	left	leave	VERB
aji-158	168	25	for	for	ADP
aji-158	168	26	48	48	NUM
aji-158	168	27	hours	hour	NOUN
aji-158	168	28	in	in	ADP
aji-158	168	29	a	a	DET
aji-158	168	30	coca	coca	NOUN
aji-158	168	31	-	-	PUNCT
aji-158	168	32	based	base	VERB
aji-158	168	33	extractor	extractor	NOUN
aji-158	168	34	solution	solution	NOUN
aji-158	168	35	(	(	PUNCT
aji-158	168	36	propylparaben	propylparaben	PROPN
aji-158	168	37	0.5	0.5	NUM
aji-158	168	38	g	g	NOUN
aji-158	168	39	,	,	PUNCT
aji-158	168	40	methylparaben	methylparaben	NOUN
aji-158	168	41	1	1	NUM
aji-158	168	42	g	g	NOUN
aji-158	168	43	,	,	PUNCT
aji-158	168	44	sorbitol	sorbitol	NOUN
aji-158	168	45	30	30	NUM
aji-158	168	46	g	g	NOUN
aji-158	168	47	,	,	PUNCT
aji-158	168	48	nacl	nacl	NOUN
aji-158	168	49	5	5	NUM
aji-158	168	50	g	g	NOUN
aji-158	168	51	,	,	PUNCT
aji-158	168	52	nahco3	nahco3	NOUN
aji-158	168	53	2.5	2.5	NUM
aji-158	168	54	g	g	NOUN
aji-158	168	55	,	,	PUNCT
aji-158	168	56	1,000ml	1,000ml	NUM
aji-158	168	57	h2o	h2o	PROPN
aji-158	168	58	)	)	PUNCT
aji-158	168	59	at	at	ADP
aji-158	168	60	4	4	NUM
aji-158	168	61	°	°	ADP
aji-158	168	62	c	c	NOUN
aji-158	168	63	for	for	ADP
aji-158	168	64	protein	protein	NOUN
aji-158	168	65	extraction	extraction	NOUN
aji-158	168	66	before	before	ADP
aji-158	168	67	centrifugation	centrifugation	NOUN
aji-158	168	68	and	and	CCONJ
aji-158	168	69	separation	separation	NOUN
aji-158	168	70	of	of	ADP
aji-158	168	71	the	the	DET
aji-158	168	72	water	water	NOUN
aji-158	168	73	-	-	PUNCT
aji-158	168	74	soluble	soluble	ADJ
aji-158	168	75	fraction	fraction	NOUN
aji-158	168	76	from	from	ADP
aji-158	168	77	solid	solid	ADJ
aji-158	168	78	particles	particle	NOUN
aji-158	168	79	and	and	CCONJ
aji-158	168	80	oily	oily	ADJ
aji-158	168	81	fraction	fraction	NOUN
aji-158	168	82	(	(	PUNCT
aji-158	168	83	coca	coca	NOUN
aji-158	168	84	,	,	PUNCT
aji-158	168	85	1922	1922	NUM
aji-158	168	86	)	)	PUNCT
aji-158	168	87	.	.	PUNCT
aji-158	169	1	the	the	DET
aji-158	169	2	protein	protein	NOUN
aji-158	169	3	quantification	quantification	NOUN
aji-158	169	4	of	of	ADP
aji-158	169	5	the	the	DET
aji-158	169	6	allergen	allergen	NOUN
aji-158	169	7	extracts	extract	NOUN
aji-158	169	8	was	be	AUX
aji-158	169	9	done	do	VERB
aji-158	169	10	according	accord	VERB
aji-158	169	11	to	to	ADP
aji-158	169	12	bradford	bradford	PROPN
aji-158	169	13	's	's	PART
aji-158	169	14	protein	protein	NOUN
aji-158	169	15	-	-	PUNCT
aji-158	169	16	dye	dye	NOUN
aji-158	169	17	binding	bind	VERB
aji-158	169	18	methodology	methodology	NOUN
aji-158	169	19	(	(	PUNCT
aji-158	169	20	bradford	bradford	NOUN
aji-158	169	21	,	,	PUNCT
aji-158	169	22	1976	1976	NUM
aji-158	169	23	)	)	PUNCT
aji-158	169	24	.	.	PUNCT
aji-158	170	1	the	the	DET
aji-158	170	2	solution	solution	NOUN
aji-158	170	3	was	be	AUX
aji-158	170	4	diluted	dilute	VERB
aji-158	170	5	in	in	ADP
aji-158	170	6	antigen	antigen	ADJ
aji-158	170	7	dilution	dilution	NOUN
aji-158	170	8	solution	solution	NOUN
aji-158	170	9	(	(	PUNCT
aji-158	170	10	nacl	nacl	NOUN
aji-158	170	11	10	10	NUM
aji-158	170	12	g	g	NOUN
aji-158	170	13	;	;	PUNCT
aji-158	170	14	kh2po4	kh2po4	NOUN
aji-158	170	15	0.72	0.72	NUM
aji-158	170	16	g	g	NOUN
aji-158	170	17	;	;	PUNCT
aji-158	170	18	na3po4	na3po4	NOUN
aji-158	170	19	2.86	2.86	NUM
aji-158	170	20	g	g	NOUN
aji-158	170	21	;	;	PUNCT
aji-158	170	22	methylparaben	methylparaben	NOUN
aji-158	170	23	1	1	NUM
aji-158	170	24	g	g	NOUN
aji-158	170	25	;	;	PUNCT
aji-158	170	26	propylparaben	propylparaben	PROPN
aji-158	170	27	0.5	0.5	NUM
aji-158	170	28	g	g	NOUN
aji-158	170	29	;	;	PUNCT
aji-158	170	30	glycerin	glycerin	PROPN
aji-158	170	31	400ml	400ml	PROPN
aji-158	170	32	;	;	PUNCT
aji-158	170	33	h2o	h2o	PROPN
aji-158	170	34	600ml	600ml	PROPN
aji-158	170	35	)	)	PUNCT
aji-158	170	36	to	to	ADP
aji-158	170	37	an	an	DET
aji-158	170	38	estimated	estimate	VERB
aji-158	170	39	protein	protein	NOUN
aji-158	170	40	concentration	concentration	NOUN
aji-158	170	41	of	of	ADP
aji-158	170	42	1	1	NUM
aji-158	170	43	mg	mg	NUM
aji-158	170	44	/	/	SYM
aji-158	170	45	ml	ml	NOUN
aji-158	170	46	and	and	CCONJ
aji-158	170	47	stored	store	VERB
aji-158	170	48	at	at	ADP
aji-158	170	49	4	4	NUM
aji-158	170	50	°	°	NOUN
aji-158	170	51	c	c	NOUN
aji-158	170	52	into	into	ADP
aji-158	170	53	amber	amber	PROPN
aji-158	170	54	opaque	opaque	ADJ
aji-158	170	55	glass	glass	NOUN
aji-158	170	56	vials	vial	NOUN
aji-158	170	57	.	.	PUNCT
aji-158	171	1	the	the	DET
aji-158	171	2	cocoa	cocoa	NOUN
aji-158	171	3	extract	extract	NOUN
aji-158	171	4	was	be	AUX
aji-158	171	5	used	use	VERB
aji-158	171	6	to	to	PART
aji-158	171	7	perform	perform	VERB
aji-158	171	8	allergic	allergic	ADJ
aji-158	171	9	skin	skin	NOUN
aji-158	171	10	tests	test	NOUN
aji-158	171	11	,	,	PUNCT
aji-158	171	12	ttp	ttp	X
aji-158	171	13	,	,	PUNCT
aji-158	171	14	and	and	CCONJ
aji-158	171	15	lait	lait	NOUN
aji-158	171	16	.	.	PUNCT
aji-158	172	1	all	all	DET
aji-158	172	2	relevant	relevant	ADJ
aji-158	172	3	and	and	CCONJ
aji-158	172	4	mandatory	mandatory	ADJ
aji-158	172	5	laboratory	laboratory	NOUN
aji-158	172	6	health	health	NOUN
aji-158	172	7	and	and	CCONJ
aji-158	172	8	safety	safety	NOUN
aji-158	172	9	measures	measure	NOUN
aji-158	172	10	have	have	AUX
aji-158	172	11	been	be	AUX
aji-158	172	12	complied	comply	VERB
aji-158	172	13	with	with	ADP
aji-158	172	14	during	during	ADP
aji-158	172	15	the	the	DET
aji-158	172	16	experiments	experiment	NOUN
aji-158	172	17	.	.	PUNCT
aji-158	173	1	2.2.2	2.2.2	NUM
aji-158	173	2	nickel	nickel	NOUN
aji-158	173	3	solution	solution	NOUN
aji-158	173	4	the	the	DET
aji-158	173	5	[	[	X
aji-158	173	6	niso4	niso4	PROPN
aji-158	173	7	(	(	PUNCT
aji-158	173	8	h2o)6	h2o)6	X
aji-158	173	9	]	]	PUNCT
aji-158	173	10	was	be	AUX
aji-158	173	11	acquired	acquire	VERB
aji-158	173	12	from	from	ADP
aji-158	173	13	labcenter	labcenter	PROPN
aji-158	173	14	campinas	campinas	PROPN
aji-158	173	15	.	.	PUNCT
aji-158	174	1	the	the	DET
aji-158	174	2	powder	powder	NOUN
aji-158	174	3	was	be	AUX
aji-158	174	4	weighed	weigh	VERB
aji-158	174	5	and	and	CCONJ
aji-158	174	6	diluted	dilute	VERB
aji-158	174	7	in	in	ADP
aji-158	174	8	a	a	DET
aji-158	174	9	buffer	buffer	NOUN
aji-158	174	10	solution	solution	NOUN
aji-158	175	1	[	[	X
aji-158	175	2	nacl	nacl	NOUN
aji-158	175	3	10	10	NUM
aji-158	175	4	g	g	NOUN
aji-158	175	5	;	;	PUNCT
aji-158	175	6	kh2po4	kh2po4	NOUN
aji-158	175	7	0,72	0,72	NUM
aji-158	175	8	g	g	NOUN
aji-158	175	9	;	;	PUNCT
aji-158	175	10	na3po4	na3po4	NOUN
aji-158	175	11	2,86	2,86	NUM
aji-158	175	12	g	g	NOUN
aji-158	175	13	;	;	PUNCT
aji-158	175	14	h2o	h2o	PROPN
aji-158	175	15	600ml	600ml	PROPN
aji-158	175	16	]	]	PUNCT
aji-158	175	17	to	to	PART
aji-158	175	18	achieve	achieve	VERB
aji-158	175	19	the	the	DET
aji-158	175	20	final	final	ADJ
aji-158	175	21	concentration	concentration	NOUN
aji-158	175	22	of	of	ADP
aji-158	175	23	1	1	NUM
aji-158	175	24	mg	mg	NUM
aji-158	175	25	/	/	SYM
aji-158	175	26	ml	ml	NOUN
aji-158	175	27	to	to	PART
aji-158	175	28	be	be	AUX
aji-158	175	29	employed	employ	VERB
aji-158	175	30	in	in	ADP
aji-158	175	31	the	the	DET
aji-158	175	32	lait	lait	NOUN
aji-158	175	33	,	,	PUNCT
aji-158	175	34	ttp	ttp	PROPN
aji-158	175	35	,	,	PUNCT
aji-158	175	36	and	and	CCONJ
aji-158	175	37	cutaneous	cutaneous	ADJ
aji-158	175	38	tests	test	NOUN
aji-158	175	39	.	.	PUNCT
aji-158	176	1	2.3	2.3	NUM
aji-158	176	2	lait	lait	NOUN
aji-158	176	3	:	:	PUNCT
aji-158	176	4	ex	ex	X
aji-158	176	5	vivo	vivo	ADJ
aji-158	176	6	investigation	investigation	NOUN
aji-158	176	7	:	:	PUNCT
aji-158	176	8	leukocyte	leukocyte	ADJ
aji-158	176	9	adherence	adherence	NOUN
aji-158	176	10	inhibition	inhibition	NOUN
aji-158	176	11	test	test	NOUN
aji-158	176	12	2.3.1	2.3.1	NUM
aji-158	176	13	lait	lait	NOUN
aji-158	176	14	:	:	PUNCT
aji-158	176	15	procedure	procedure	NOUN
aji-158	176	16	for	for	ADP
aji-158	176	17	allergen	allergen	NOUN
aji-158	176	18	ex	ex	PRON
aji-158	176	19	vivo	vivo	NOUN
aji-158	176	20	challenging	challenge	VERB
aji-158	176	21	we	we	PRON
aji-158	176	22	performed	perform	VERB
aji-158	176	23	the	the	DET
aji-158	176	24	lait	lait	NOUN
aji-158	176	25	as	as	ADP
aji-158	176	26	previously	previously	ADV
aji-158	176	27	described	describe	VERB
aji-158	176	28	(	(	PUNCT
aji-158	176	29	olivier	olivier	PROPN
aji-158	176	30	et	et	PROPN
aji-158	176	31	al	al	PROPN
aji-158	176	32	.	.	PROPN
aji-158	176	33	,	,	PUNCT
aji-158	176	34	2012	2012	NUM
aji-158	176	35	,	,	PUNCT
aji-158	176	36	olivier	olivier	PROPN
aji-158	176	37	et	et	PROPN
aji-158	176	38	al	al	PROPN
aji-158	176	39	.	.	PROPN
aji-158	176	40	,	,	PUNCT
aji-158	176	41	2014	2014	NUM
aji-158	176	42	,	,	PUNCT
aji-158	176	43	olivier	olivier	PROPN
aji-158	176	44	et	et	PROPN
aji-158	176	45	al	al	PROPN
aji-158	176	46	.	.	PROPN
aji-158	176	47	,	,	PUNCT
aji-158	176	48	2021b	2021b	NUM
aji-158	176	49	,	,	PUNCT
aji-158	176	50	olivier	olivier	PROPN
aji-158	176	51	et	et	PROPN
aji-158	176	52	al	al	PROPN
aji-158	176	53	.	.	PROPN
aji-158	176	54	,	,	PUNCT
aji-158	176	55	2021c	2021c	NUM
aji-158	176	56	,	,	PUNCT
aji-158	176	57	olivier	olivier	PROPN
aji-158	176	58	et	et	PROPN
aji-158	176	59	al	al	PROPN
aji-158	176	60	.	.	PROPN
aji-158	176	61	,	,	PUNCT
aji-158	176	62	2021e	2021e	NUM
aji-158	176	63	)	)	PUNCT
aji-158	176	64	.	.	PUNCT
aji-158	177	1	shortly	shortly	ADV
aji-158	177	2	,	,	PUNCT
aji-158	177	3	each	each	DET
aji-158	177	4	donor	donor	NOUN
aji-158	177	5	's	's	PART
aji-158	177	6	fresh	fresh	ADJ
aji-158	177	7	plasma	plasma	NOUN
aji-158	177	8	was	be	AUX
aji-158	177	9	divided	divide	VERB
aji-158	177	10	into	into	ADP
aji-158	177	11	two	two	NUM
aji-158	177	12	parts	part	NOUN
aji-158	177	13	and	and	CCONJ
aji-158	177	14	used	use	VERB
aji-158	177	15	in	in	ADP
aji-158	177	16	parallel	parallel	NOUN
aji-158	177	17	ex	ex	PRON
aji-158	177	18	vivo	vivo	ADJ
aji-158	177	19	challenging	challenge	VERB
aji-158	177	20	tests	test	NOUN
aji-158	177	21	with	with	ADP
aji-158	177	22	the	the	DET
aji-158	177	23	cocoa	cocoa	NOUN
aji-158	177	24	extract	extract	NOUN
aji-158	177	25	,	,	PUNCT
aji-158	177	26	the	the	DET
aji-158	177	27	nickel	nickel	NOUN
aji-158	177	28	solution	solution	NOUN
aji-158	177	29	,	,	PUNCT
aji-158	177	30	and	and	CCONJ
aji-158	177	31	the	the	DET
aji-158	177	32	unchallenged	unchallenged	ADJ
aji-158	177	33	plasma	plasma	NOUN
aji-158	177	34	(	(	PUNCT
aji-158	177	35	added	add	VERB
aji-158	177	36	with	with	ADP
aji-158	177	37	antigen	antigen	ADJ
aji-158	177	38	dilution	dilution	NOUN
aji-158	177	39	solution	solution	NOUN
aji-158	177	40	as	as	ADP
aji-158	177	41	a	a	DET
aji-158	177	42	control	control	NOUN
aji-158	177	43	)	)	PUNCT
aji-158	177	44	(	(	PUNCT
aji-158	177	45	olivier	olivier	PROPN
aji-158	177	46	et	et	PROPN
aji-158	177	47	al	al	PROPN
aji-158	177	48	.	.	PROPN
aji-158	177	49	,	,	PUNCT
aji-158	177	50	2022b	2022b	NUM
aji-158	177	51	,	,	PUNCT
aji-158	177	52	olivier	olivier	PROPN
aji-158	177	53	et	et	PROPN
aji-158	177	54	al	al	PROPN
aji-158	177	55	.	.	PROPN
aji-158	177	56	,	,	PUNCT
aji-158	177	57	2022a	2022a	NUM
aji-158	177	58	,	,	PUNCT
aji-158	177	59	olivier	olivier	PROPN
aji-158	177	60	et	et	PROPN
aji-158	177	61	al	al	PROPN
aji-158	177	62	.	.	PROPN
aji-158	177	63	,	,	PUNCT
aji-158	177	64	2022c	2022c	NUM
aji-158	177	65	,	,	PUNCT
aji-158	177	66	olivier	olivier	PROPN
aji-158	177	67	et	et	PROPN
aji-158	177	68	al	al	PROPN
aji-158	177	69	.	.	PROPN
aji-158	177	70	,	,	PUNCT
aji-158	177	71	2023f	2023f	NUM
aji-158	177	72	,	,	PUNCT
aji-158	177	73	olivier	olivier	PROPN
aji-158	177	74	et	et	PROPN
aji-158	177	75	al	al	PROPN
aji-158	177	76	.	.	PROPN
aji-158	177	77	,	,	PUNCT
aji-158	177	78	2023h	2023h	NUM
aji-158	177	79	)	)	PUNCT
aji-158	177	80	.	.	PUNCT
aji-158	178	1	we	we	PRON
aji-158	178	2	collected	collect	VERB
aji-158	178	3	plasma	plasma	NOUN
aji-158	178	4	with	with	ADP
aji-158	178	5	high	high	ADJ
aji-158	178	6	leukocyte	leukocyte	NOUN
aji-158	178	7	content	content	NOUN
aji-158	178	8	(	(	PUNCT
aji-158	178	9	buffy	buffy	PROPN
aji-158	178	10	coat	coat	PROPN
aji-158	178	11	)	)	PUNCT
aji-158	178	12	from	from	ADP
aji-158	178	13	the	the	DET
aji-158	178	14	heparinized	heparinize	VERB
aji-158	178	15	tube	tube	NOUN
aji-158	178	16	after	after	ADP
aji-158	178	17	one	one	NUM
aji-158	178	18	hour	hour	NOUN
aji-158	178	19	of	of	ADP
aji-158	178	20	sedimentation	sedimentation	NOUN
aji-158	178	21	at	at	ADP
aji-158	178	22	37	37	NUM
aji-158	178	23	°	°	NOUN
aji-158	178	24	c	c	NOUN
aji-158	178	25	.	.	PUNCT
aji-158	179	1	then	then	ADV
aji-158	179	2	,	,	PUNCT
aji-158	179	3	we	we	PRON
aji-158	179	4	distributed	distribute	VERB
aji-158	179	5	aliquots	aliquot	NOUN
aji-158	179	6	of	of	ADP
aji-158	179	7	100	100	NUM
aji-158	179	8	μl	μl	ADV
aji-158	179	9	into	into	ADP
aji-158	179	10	eppendorf	eppendorf	PROPN
aji-158	179	11	tubes	tube	NOUN
aji-158	179	12	with	with	ADP
aji-158	179	13	(	(	PUNCT
aji-158	179	14	or	or	CCONJ
aji-158	179	15	without	without	ADP
aji-158	179	16	)	)	PUNCT
aji-158	179	17	the	the	DET
aji-158	179	18	challenging	challenging	ADJ
aji-158	179	19	extract	extract	NOUN
aji-158	179	20	and	and	CCONJ
aji-158	179	21	kept	keep	VERB
aji-158	179	22	them	they	PRON
aji-158	179	23	under	under	ADP
aji-158	179	24	agitation	agitation	NOUN
aji-158	179	25	for	for	ADP
aji-158	179	26	30	30	NUM
aji-158	179	27	minutes	minute	NOUN
aji-158	179	28	(	(	PUNCT
aji-158	179	29	200	200	NUM
aji-158	179	30	rpm	rpm	NOUN
aji-158	179	31	at	at	ADP
aji-158	179	32	37	37	NUM
aji-158	179	33	°	°	NOUN
aji-158	179	34	c	c	NOUN
aji-158	179	35	)	)	PUNCT
aji-158	179	36	(	(	PUNCT
aji-158	179	37	olivier	olivier	PROPN
aji-158	179	38	et	et	PROPN
aji-158	179	39	al	al	PROPN
aji-158	179	40	.	.	PROPN
aji-158	179	41	,	,	PUNCT
aji-158	179	42	2023a	2023a	NUM
aji-158	179	43	,	,	PUNCT
aji-158	179	44	olivier	olivier	PROPN
aji-158	179	45	et	et	PROPN
aji-158	179	46	al	al	PROPN
aji-158	179	47	.	.	PROPN
aji-158	179	48	,	,	PUNCT
aji-158	179	49	2024e	2024e	NUM
aji-158	179	50	)	)	PUNCT
aji-158	179	51	.	.	PUNCT
aji-158	180	1	2.3.2	2.3.2	NUM
aji-158	180	2	lait	lait	NOUN
aji-158	180	3	:	:	PUNCT
aji-158	180	4	procedure	procedure	NOUN
aji-158	180	5	for	for	ADP
aji-158	180	6	adherence	adherence	NOUN
aji-158	180	7	assay	assay	VERB
aji-158	180	8	after	after	ADP
aji-158	180	9	incubation	incubation	NOUN
aji-158	180	10	,	,	PUNCT
aji-158	180	11	the	the	DET
aji-158	180	12	plasma	plasma	NOUN
aji-158	180	13	was	be	AUX
aji-158	180	14	allocated	allocate	VERB
aji-158	180	15	into	into	ADP
aji-158	180	16	a	a	DET
aji-158	180	17	standard	standard	ADJ
aji-158	180	18	neubauer	neubauer	PROPN
aji-158	180	19	hemocytometer	hemocytometer	PROPN
aji-158	180	20	counting	counting	PROPN
aji-158	180	21	chamber	chamber	NOUN
aji-158	180	22	with	with	ADP
aji-158	180	23	a	a	DET
aji-158	180	24	plain	plain	ADJ
aji-158	180	25	,	,	PUNCT
aji-158	180	26	non	non	ADJ
aji-158	180	27	-	-	ADJ
aji-158	180	28	metallic	metallic	ADJ
aji-158	180	29	glass	glass	NOUN
aji-158	180	30	surface	surface	NOUN
aji-158	180	31	and	and	CCONJ
aji-158	180	32	left	leave	VERB
aji-158	180	33	to	to	PART
aji-158	180	34	stand	stand	VERB
aji-158	180	35	for	for	ADP
aji-158	180	36	2	2	NUM
aji-158	180	37	hours	hour	NOUN
aji-158	180	38	at	at	ADP
aji-158	180	39	37	37	NUM
aji-158	180	40	°	°	SYM
aji-158	180	41	c	c	NOUN
aji-158	180	42	in	in	ADP
aji-158	180	43	the	the	DET
aji-158	180	44	humidified	humidified	ADJ
aji-158	180	45	atmosphere	atmosphere	NOUN
aji-158	180	46	of	of	ADP
aji-158	180	47	the	the	DET
aji-158	180	48	covered	cover	VERB
aji-158	180	49	water	water	NOUN
aji-158	180	50	bath	bath	NOUN
aji-158	180	51	to	to	PART
aji-158	180	52	allow	allow	VERB
aji-158	180	53	leukocytes	leukocyte	NOUN
aji-158	180	54	to	to	PART
aji-158	180	55	adhere	adhere	VERB
aji-158	180	56	to	to	ADP
aji-158	180	57	the	the	DET
aji-158	180	58	glass	glass	NOUN
aji-158	180	59	.	.	PUNCT
aji-158	181	1	next	next	ADV
aji-158	181	2	,	,	PUNCT
aji-158	181	3	we	we	PRON
aji-158	181	4	counted	count	VERB
aji-158	181	5	the	the	DET
aji-158	181	6	leukocytes	leukocyte	NOUN
aji-158	181	7	,	,	PUNCT
aji-158	181	8	removed	remove	VERB
aji-158	181	9	the	the	DET
aji-158	181	10	coverslip	coverslip	NOUN
aji-158	181	11	,	,	PUNCT
aji-158	181	12	and	and	CCONJ
aji-158	181	13	washed	wash	VERB
aji-158	181	14	the	the	DET
aji-158	181	15	chamber	chamber	NOUN
aji-158	181	16	by	by	ADP
aji-158	181	17	immersion	immersion	NOUN
aji-158	181	18	in	in	ADP
aji-158	181	19	a	a	DET
aji-158	181	20	beaker	beaker	NOUN
aji-158	181	21	with	with	ADP
aji-158	181	22	phosphate	phosphate	ADJ
aji-158	181	23	buffer	buffer	NOUN
aji-158	181	24	saline	saline	NOUN
aji-158	181	25	(	(	PUNCT
aji-158	181	26	pbs	pbs	PROPN
aji-158	181	27	)	)	PUNCT
aji-158	181	28	at	at	ADP
aji-158	181	29	37	37	NUM
aji-158	181	30	°	°	NOUN
aji-158	181	31	c	c	NOUN
aji-158	181	32	.	.	PUNCT
aji-158	182	1	then	then	ADV
aji-158	182	2	,	,	PUNCT
aji-158	182	3	we	we	PRON
aji-158	182	4	added	add	VERB
aji-158	182	5	a	a	DET
aji-158	182	6	drop	drop	NOUN
aji-158	182	7	of	of	ADP
aji-158	182	8	pbs	pbs	PROPN
aji-158	182	9	to	to	ADP
aji-158	182	10	the	the	DET
aji-158	182	11	hemocytometer	hemocytometer	NOUN
aji-158	182	12	's	's	PART
aji-158	182	13	chamber	chamber	NOUN
aji-158	182	14	and	and	CCONJ
aji-158	182	15	allocated	allocate	VERB
aji-158	182	16	a	a	DET
aji-158	182	17	clean	clean	ADJ
aji-158	182	18	coverslip	coverslip	NOUN
aji-158	182	19	over	over	ADP
aji-158	182	20	it	it	PRON
aji-158	182	21	.	.	PUNCT
aji-158	183	1	the	the	DET
aji-158	183	2	remaining	remain	VERB
aji-158	183	3	cells	cell	NOUN
aji-158	183	4	were	be	AUX
aji-158	183	5	counted	count	VERB
aji-158	183	6	in	in	ADP
aji-158	183	7	the	the	DET
aji-158	183	8	same	same	ADJ
aji-158	183	9	squares	square	NOUN
aji-158	183	10	as	as	SCONJ
aji-158	183	11	previously	previously	ADV
aji-158	183	12	examined	examine	VERB
aji-158	183	13	.	.	PUNCT
aji-158	184	1	2.3.3	2.3.3	NUM
aji-158	184	2	lait	lait	NOUN
aji-158	184	3	:	:	PUNCT
aji-158	184	4	procedure	procedure	NOUN
aji-158	184	5	for	for	ADP
aji-158	184	6	calculation	calculation	NOUN
aji-158	184	7	the	the	DET
aji-158	184	8	percentage	percentage	NOUN
aji-158	184	9	of	of	ADP
aji-158	184	10	leukocyte	leukocyte	NOUN
aji-158	184	11	adherence	adherence	NOUN
aji-158	184	12	(	(	PUNCT
aji-158	184	13	la	la	NOUN
aji-158	184	14	)	)	PUNCT
aji-158	184	15	of	of	ADP
aji-158	184	16	each	each	DET
aji-158	184	17	assay	assay	NOUN
aji-158	184	18	was	be	AUX
aji-158	184	19	estimated	estimate	VERB
aji-158	184	20	as	as	ADP
aji-158	184	21	:	:	PUNCT
aji-158	184	22	(	(	PUNCT
aji-158	184	23	the	the	DET
aji-158	184	24	number	number	NOUN
aji-158	184	25	of	of	ADP
aji-158	184	26	leukocytes	leukocyte	NOUN
aji-158	184	27	observed	observe	VERB
aji-158	184	28	on	on	ADP
aji-158	184	29	the	the	DET
aji-158	184	30	hemocytometry	hemocytometry	PROPN
aji-158	184	31	chamber	chamber	PROPN
aji-158	184	32	after	after	ADP
aji-158	184	33	washing	wash	VERB
aji-158	184	34	divided	divide	VERB
aji-158	184	35	by	by	ADP
aji-158	184	36	the	the	DET
aji-158	184	37	number	number	NOUN
aji-158	184	38	of	of	ADP
aji-158	184	39	leukocytes	leukocyte	NOUN
aji-158	184	40	observed	observe	VERB
aji-158	184	41	on	on	ADP
aji-158	184	42	the	the	DET
aji-158	184	43	hemocytometry	hemocytometry	PROPN
aji-158	184	44	chamber	chamber	PROPN
aji-158	184	45	before	before	ADP
aji-158	184	46	washing	washing	NOUN
aji-158	184	47	)	)	PUNCT
aji-158	184	48	and	and	CCONJ
aji-158	184	49	multiplied	multiply	VERB
aji-158	184	50	by	by	ADP
aji-158	184	51	100	100	NUM
aji-158	184	52	(	(	PUNCT
aji-158	184	53	%	%	NOUN
aji-158	184	54	)	)	PUNCT
aji-158	184	55	.	.	PUNCT
aji-158	185	1	the	the	DET
aji-158	185	2	leukocyte	leukocyte	NOUN
aji-158	185	3	adherence	adherence	NOUN
aji-158	185	4	ratio	ratio	NOUN
aji-158	185	5	(	(	PUNCT
aji-158	185	6	lar	lar	ADJ
aji-158	185	7	)	)	PUNCT
aji-158	185	8	was	be	AUX
aji-158	185	9	estimated	estimate	VERB
aji-158	185	10	based	base	VERB
aji-158	185	11	on	on	ADP
aji-158	185	12	the	the	DET
aji-158	185	13	ratio	ratio	NOUN
aji-158	185	14	between	between	ADP
aji-158	185	15	the	the	DET
aji-158	185	16	la	la	NOUN
aji-158	185	17	from	from	ADP
aji-158	185	18	the	the	DET
aji-158	185	19	antigen	antigen	NOUN
aji-158	185	20	-	-	PUNCT
aji-158	185	21	specific	specific	ADJ
aji-158	185	22	challenged	challenge	VERB
aji-158	185	23	plasma	plasma	NOUN
aji-158	185	24	and	and	CCONJ
aji-158	185	25	olivier	olivier	NOUN
aji-158	185	26	et	et	PROPN
aji-158	185	27	al	al	PROPN
aji-158	185	28	.	.	PROPN
aji-158	185	29	;	;	PUNCT
aji-158	186	1	asian	asian	PROPN
aji-158	186	2	j.	j.	PROPN
aji-158	186	3	immunol	immunol	PROPN
aji-158	186	4	.	.	PROPN
aji-158	186	5	,	,	PUNCT
aji-158	186	6	vol	vol	NOUN
aji-158	186	7	.	.	PROPN
aji-158	186	8	8	8	NUM
aji-158	186	9	,	,	PUNCT
aji-158	186	10	no	no	INTJ
aji-158	186	11	.	.	NOUN
aji-158	186	12	1	1	NUM
aji-158	186	13	,	,	PUNCT
aji-158	186	14	pp	pp	ADJ
aji-158	186	15	.	.	PUNCT
aji-158	187	1	35	35	NUM
aji-158	187	2	-	-	SYM
aji-158	187	3	49	49	NUM
aji-158	187	4	,	,	PUNCT
aji-158	187	5	2025	2025	NUM
aji-158	187	6	;	;	PUNCT
aji-158	187	7	article	article	NOUN
aji-158	187	8	no.aji.133582	no.aji.133582	PROPN
aji-158	187	9	39	39	NUM
aji-158	187	10	the	the	DET
aji-158	187	11	la	la	PROPN
aji-158	187	12	from	from	ADP
aji-158	187	13	the	the	DET
aji-158	187	14	unchallenged	unchallenged	ADJ
aji-158	187	15	control	control	NOUN
aji-158	187	16	plasma	plasma	NOUN
aji-158	187	17	:	:	PUNCT
aji-158	187	18	lar	lar	PROPN
aji-158	187	19	=	=	PUNCT
aji-158	187	20	la	la	PROPN
aji-158	187	21	of	of	ADP
aji-158	187	22	the	the	DET
aji-158	187	23	challenged	challenge	VERB
aji-158	187	24	sample	sample	NOUN
aji-158	187	25	divided	divide	VERB
aji-158	187	26	by	by	ADP
aji-158	187	27	la	la	PROPN
aji-158	187	28	of	of	ADP
aji-158	187	29	unchallenged	unchallenged	ADJ
aji-158	187	30	control	control	NOUN
aji-158	187	31	plasma	plasma	NOUN
aji-158	187	32	multiplied	multiply	VERB
aji-158	187	33	by	by	ADP
aji-158	187	34	100	100	NUM
aji-158	187	35	(	(	PUNCT
aji-158	187	36	%	%	NOUN
aji-158	187	37	)	)	PUNCT
aji-158	187	38	.	.	PUNCT
aji-158	188	1	to	to	PART
aji-158	188	2	further	far	ADV
aji-158	188	3	calculate	calculate	VERB
aji-158	188	4	the	the	DET
aji-158	188	5	leukocyte	leukocyte	NOUN
aji-158	188	6	adherence	adherence	NOUN
aji-158	188	7	inhibition	inhibition	NOUN
aji-158	188	8	(	(	PUNCT
aji-158	188	9	lai	lai	PROPN
aji-158	188	10	)	)	PUNCT
aji-158	188	11	,	,	PUNCT
aji-158	188	12	we	we	PRON
aji-158	188	13	subtracted	subtract	VERB
aji-158	188	14	the	the	DET
aji-158	188	15	lar	lar	NOUN
aji-158	188	16	from	from	ADP
aji-158	188	17	100	100	NUM
aji-158	188	18	(	(	PUNCT
aji-158	188	19	%	%	NOUN
aji-158	188	20	)	)	PUNCT
aji-158	188	21	.	.	PUNCT
aji-158	189	1	we	we	PRON
aji-158	189	2	employed	employ	VERB
aji-158	189	3	the	the	DET
aji-158	189	4	lai	lai	PROPN
aji-158	189	5	results	result	NOUN
aji-158	189	6	for	for	ADP
aji-158	189	7	the	the	DET
aji-158	189	8	cascade	cascade	NOUN
aji-158	189	9	distribution	distribution	NOUN
aji-158	189	10	chart	chart	NOUN
aji-158	189	11	and	and	CCONJ
aji-158	189	12	the	the	DET
aji-158	189	13	statistics	statistic	NOUN
aji-158	189	14	calculations	calculation	NOUN
aji-158	189	15	,	,	PUNCT
aji-158	189	16	both	both	PRON
aji-158	189	17	performed	perform	VERB
aji-158	189	18	with	with	ADP
aji-158	189	19	the	the	DET
aji-158	189	20	help	help	NOUN
aji-158	189	21	of	of	ADP
aji-158	189	22	the	the	DET
aji-158	189	23	microsoft	microsoft	PROPN
aji-158	189	24	excel	excel	PROPN
aji-158	189	25	®	®	NOUN
aji-158	189	26	statistical	statistical	ADJ
aji-158	189	27	package	package	NOUN
aji-158	189	28	.	.	PUNCT
aji-158	190	1	2.4	2.4	NUM
aji-158	190	2	ttp	ttp	NOUN
aji-158	190	3	:	:	PUNCT
aji-158	190	4	in	in	ADP
aji-158	190	5	vitro	vitro	X
aji-158	190	6	investigation	investigation	NOUN
aji-158	190	7	:	:	PUNCT
aji-158	190	8	tube	tube	NOUN
aji-158	190	9	titration	titration	NOUN
aji-158	190	10	of	of	ADP
aji-158	190	11	precipitins	precipitin	NOUN
aji-158	190	12	as	as	SCONJ
aji-158	190	13	previously	previously	ADV
aji-158	190	14	reported	report	VERB
aji-158	190	15	,	,	PUNCT
aji-158	190	16	the	the	DET
aji-158	190	17	semi	semi	ADJ
aji-158	190	18	-	-	ADJ
aji-158	190	19	quantitative	quantitative	ADJ
aji-158	190	20	ttp	ttp	NOUN
aji-158	190	21	against	against	ADP
aji-158	190	22	the	the	DET
aji-158	190	23	cocoa	cocoa	NOUN
aji-158	190	24	extract	extract	NOUN
aji-158	190	25	and	and	CCONJ
aji-158	190	26	the	the	DET
aji-158	190	27	nickel	nickel	NOUN
aji-158	190	28	solution	solution	NOUN
aji-158	190	29	was	be	AUX
aji-158	190	30	performed	perform	VERB
aji-158	190	31	in	in	ADP
aji-158	190	32	a	a	DET
aji-158	190	33	transparent	transparent	ADJ
aji-158	190	34	vitreous	vitreous	ADJ
aji-158	190	35	tube	tube	NOUN
aji-158	190	36	array	array	NOUN
aji-158	190	37	(	(	PUNCT
aji-158	190	38	olivier	olivier	PROPN
aji-158	190	39	et	et	PROPN
aji-158	190	40	al	al	PROPN
aji-158	190	41	.	.	PROPN
aji-158	190	42	2021f	2021f	NUM
aji-158	190	43	,	,	PUNCT
aji-158	190	44	olivier	olivier	PROPN
aji-158	190	45	et	et	PROPN
aji-158	190	46	al	al	PROPN
aji-158	190	47	.	.	PROPN
aji-158	190	48	2024	2024	NUM
aji-158	190	49	g	g	NOUN
aji-158	190	50	,	,	PUNCT
aji-158	190	51	olivier	olivier	PROPN
aji-158	190	52	et	et	PROPN
aji-158	190	53	al	al	PROPN
aji-158	190	54	.	.	PROPN
aji-158	190	55	2024d	2024d	NUM
aji-158	190	56	,	,	PUNCT
aji-158	190	57	olivier	olivier	PROPN
aji-158	190	58	et	et	PROPN
aji-158	190	59	al	al	PROPN
aji-158	190	60	.	.	PROPN
aji-158	190	61	2024b	2024b	NUM
aji-158	190	62	,	,	PUNCT
aji-158	190	63	olivier	olivier	PROPN
aji-158	190	64	et	et	PROPN
aji-158	190	65	al	al	PROPN
aji-158	190	66	.	.	PROPN
aji-158	190	67	2024a	2024a	NUM
aji-158	190	68	)	)	PUNCT
aji-158	190	69	.	.	PUNCT
aji-158	191	1	shortly	shortly	ADV
aji-158	191	2	,	,	PUNCT
aji-158	191	3	the	the	DET
aji-158	191	4	patient	patient	NOUN
aji-158	191	5	's	's	PART
aji-158	191	6	blood	blood	NOUN
aji-158	191	7	was	be	AUX
aji-158	191	8	collected	collect	VERB
aji-158	191	9	in	in	ADP
aji-158	191	10	a	a	DET
aji-158	191	11	clot	clot	NOUN
aji-158	191	12	-	-	PUNCT
aji-158	191	13	activator	activator	NOUN
aji-158	191	14	collecting	collect	VERB
aji-158	191	15	tube	tube	NOUN
aji-158	191	16	.	.	PUNCT
aji-158	192	1	after	after	ADP
aji-158	192	2	separation	separation	NOUN
aji-158	192	3	,	,	PUNCT
aji-158	192	4	the	the	DET
aji-158	192	5	serum	serum	NOUN
aji-158	192	6	was	be	AUX
aji-158	192	7	centrifugated	centrifugate	VERB
aji-158	192	8	at	at	ADP
aji-158	192	9	2,000	2,000	NUM
aji-158	192	10	rpm	rpm	NOUN
aji-158	192	11	for	for	ADP
aji-158	192	12	10	10	NUM
aji-158	192	13	minutes	minute	NOUN
aji-158	192	14	.	.	PUNCT
aji-158	193	1	each	each	DET
aji-158	193	2	allergen	allergen	NOUN
aji-158	193	3	extract	extract	NOUN
aji-158	193	4	was	be	AUX
aji-158	193	5	allocated	allocate	VERB
aji-158	193	6	in	in	ADP
aji-158	193	7	sets	set	NOUN
aji-158	193	8	of	of	ADP
aji-158	193	9	eleven	eleven	NUM
aji-158	193	10	glass	glass	NOUN
aji-158	193	11	tubes	tube	NOUN
aji-158	193	12	at	at	ADP
aji-158	193	13	progressive	progressive	ADJ
aji-158	193	14	duplicated	duplicate	VERB
aji-158	193	15	serum	serum	NOUN
aji-158	193	16	dilutions	dilution	NOUN
aji-158	193	17	.	.	PUNCT
aji-158	194	1	the	the	DET
aji-158	194	2	progressive	progressive	ADJ
aji-158	194	3	dilutions	dilution	NOUN
aji-158	194	4	were	be	AUX
aji-158	194	5	combined	combine	VERB
aji-158	194	6	with	with	ADP
aji-158	194	7	separated	separated	ADJ
aji-158	194	8	aliquots	aliquot	NOUN
aji-158	194	9	of	of	ADP
aji-158	194	10	15	15	NUM
aji-158	194	11	μl	μl	ADP
aji-158	194	12	of	of	ADP
aji-158	194	13	the	the	DET
aji-158	194	14	antigen	antigen	NOUN
aji-158	194	15	(	(	PUNCT
aji-158	194	16	cocoa	cocoa	NOUN
aji-158	194	17	extract	extract	NOUN
aji-158	194	18	or	or	CCONJ
aji-158	194	19	nickel	nickel	NOUN
aji-158	194	20	solution	solution	NOUN
aji-158	194	21	)	)	PUNCT
aji-158	194	22	with	with	ADP
aji-158	194	23	250	250	NUM
aji-158	194	24	μl	μl	ADP
aji-158	194	25	of	of	ADP
aji-158	194	26	the	the	DET
aji-158	194	27	patient	patient	NOUN
aji-158	194	28	's	's	PART
aji-158	194	29	serum	serum	NOUN
aji-158	194	30	,	,	PUNCT
aji-158	194	31	progressively	progressively	ADV
aji-158	194	32	diluted	dilute	VERB
aji-158	194	33	into	into	ADP
aji-158	194	34	physiological	physiological	ADJ
aji-158	194	35	saline	saline	NOUN
aji-158	194	36	solution	solution	NOUN
aji-158	194	37	(	(	PUNCT
aji-158	194	38	nacl	nacl	NOUN
aji-158	194	39	0,9	0,9	NUM
aji-158	194	40	%	%	NOUN
aji-158	194	41	)	)	PUNCT
aji-158	194	42	in	in	ADP
aji-158	194	43	the	the	DET
aji-158	194	44	dilution	dilution	NOUN
aji-158	194	45	ratios	ratio	NOUN
aji-158	194	46	of	of	ADP
aji-158	194	47	1:1	1:1	NUM
aji-158	194	48	;	;	PUNCT
aji-158	194	49	1:2	1:2	NUM
aji-158	194	50	;	;	PUNCT
aji-158	194	51	1:4	1:4	NUM
aji-158	194	52	;	;	PUNCT
aji-158	194	53	1:8	1:8	NUM
aji-158	194	54	;	;	PUNCT
aji-158	194	55	1:16	1:16	NUM
aji-158	194	56	;	;	PUNCT
aji-158	194	57	1:32	1:32	NUM
aji-158	194	58	;	;	PUNCT
aji-158	194	59	1:64	1:64	NUM
aji-158	194	60	;	;	PUNCT
aji-158	194	61	1:128	1:128	NUM
aji-158	194	62	;	;	PUNCT
aji-158	194	63	1:256	1:256	NUM
aji-158	194	64	;	;	PUNCT
aji-158	194	65	and	and	CCONJ
aji-158	194	66	1:512	1:512	NUM
aji-158	194	67	.	.	PUNCT
aji-158	195	1	one	one	NUM
aji-158	195	2	tube	tube	NOUN
aji-158	195	3	was	be	AUX
aji-158	195	4	a	a	DET
aji-158	195	5	blank	blank	ADJ
aji-158	195	6	control	control	NOUN
aji-158	195	7	done	do	VERB
aji-158	195	8	with	with	ADP
aji-158	195	9	the	the	DET
aji-158	195	10	distilled	distil	VERB
aji-158	195	11	water	water	NOUN
aji-158	195	12	and	and	CCONJ
aji-158	195	13	serum	serum	NOUN
aji-158	195	14	to	to	PART
aji-158	195	15	observe	observe	VERB
aji-158	195	16	occasional	occasional	ADJ
aji-158	195	17	spontaneous	spontaneous	ADJ
aji-158	195	18	precipitation	precipitation	NOUN
aji-158	195	19	(	(	PUNCT
aji-158	195	20	sia	sia	PROPN
aji-158	195	21	test	test	NOUN
aji-158	195	22	)	)	PUNCT
aji-158	195	23	.	.	PUNCT
aji-158	196	1	after	after	ADP
aji-158	196	2	24	24	NUM
aji-158	196	3	hours	hour	NOUN
aji-158	196	4	,	,	PUNCT
aji-158	196	5	the	the	DET
aji-158	196	6	tubes	tube	NOUN
aji-158	196	7	were	be	AUX
aji-158	196	8	examined	examine	VERB
aji-158	196	9	,	,	PUNCT
aji-158	196	10	and	and	CCONJ
aji-158	196	11	the	the	DET
aji-158	196	12	titers	titer	NOUN
aji-158	196	13	(	(	PUNCT
aji-158	196	14	the	the	DET
aji-158	196	15	highest	high	ADJ
aji-158	196	16	dilution	dilution	NOUN
aji-158	196	17	factor	factor	NOUN
aji-158	196	18	that	that	PRON
aji-158	196	19	yields	yield	VERB
aji-158	196	20	a	a	DET
aji-158	196	21	positive	positive	ADJ
aji-158	196	22	reading	reading	NOUN
aji-158	196	23	)	)	PUNCT
aji-158	196	24	were	be	AUX
aji-158	196	25	recorded	record	VERB
aji-158	196	26	(	(	PUNCT
aji-158	196	27	williams	williams	PROPN
aji-158	196	28	&	&	CCONJ
aji-158	196	29	chase	chase	PROPN
aji-158	196	30	,	,	PUNCT
aji-158	196	31	1971	1971	NUM
aji-158	196	32	)	)	PUNCT
aji-158	196	33	.	.	PUNCT
aji-158	197	1	3	3	X
aji-158	197	2	.	.	X
aji-158	197	3	results	result	NOUN
aji-158	197	4	as	as	ADP
aji-158	197	5	a	a	DET
aji-158	197	6	retrospective	retrospective	ADJ
aji-158	197	7	survey	survey	NOUN
aji-158	197	8	,	,	PUNCT
aji-158	197	9	there	there	PRON
aji-158	197	10	was	be	VERB
aji-158	197	11	no	no	DET
aji-158	197	12	research	research	NOUN
aji-158	197	13	protocol	protocol	NOUN
aji-158	197	14	;	;	PUNCT
aji-158	197	15	therefore	therefore	ADV
aji-158	197	16	,	,	PUNCT
aji-158	197	17	we	we	PRON
aji-158	197	18	report	report	VERB
aji-158	197	19	the	the	DET
aji-158	197	20	incidental	incidental	ADJ
aji-158	197	21	immune	immune	ADJ
aji-158	197	22	investigation	investigation	NOUN
aji-158	197	23	as	as	SCONJ
aji-158	197	24	registered	register	VERB
aji-158	197	25	in	in	ADP
aji-158	197	26	the	the	DET
aji-158	197	27	digital	digital	ADJ
aji-158	197	28	medical	medical	ADJ
aji-158	197	29	charts	chart	NOUN
aji-158	197	30	.	.	PUNCT
aji-158	198	1	the	the	DET
aji-158	198	2	ttp	ttp	NOUN
aji-158	198	3	for	for	ADP
aji-158	198	4	the	the	DET
aji-158	198	5	cocoa	cocoa	NOUN
aji-158	198	6	extract	extract	NOUN
aji-158	198	7	showed	show	VERB
aji-158	198	8	a	a	DET
aji-158	198	9	distribution	distribution	NOUN
aji-158	198	10	concentrated	concentrate	VERB
aji-158	198	11	on	on	ADP
aji-158	198	12	the	the	DET
aji-158	198	13	higher	high	ADJ
aji-158	198	14	dilutions	dilution	NOUN
aji-158	198	15	(	(	PUNCT
aji-158	198	16	fig	fig	NOUN
aji-158	198	17	.	.	PUNCT
aji-158	198	18	1	1	NUM
aji-158	198	19	)	)	PUNCT
aji-158	198	20	.	.	PUNCT
aji-158	199	1	there	there	PRON
aji-158	199	2	was	be	VERB
aji-158	199	3	one	one	NUM
aji-158	199	4	negative	negative	ADJ
aji-158	199	5	result	result	NOUN
aji-158	199	6	.	.	PUNCT
aji-158	200	1	the	the	DET
aji-158	200	2	mean	mean	NOUN
aji-158	200	3	was	be	AUX
aji-158	200	4	estimated	estimate	VERB
aji-158	200	5	at	at	ADP
aji-158	200	6	1:385	1:385	NUM
aji-158	200	7	;	;	PUNCT
aji-158	200	8	the	the	DET
aji-158	200	9	median	median	NOUN
aji-158	200	10	was	be	AUX
aji-158	200	11	1:512	1:512	NUM
aji-158	200	12	;	;	PUNCT
aji-158	200	13	the	the	DET
aji-158	200	14	standard	standard	ADJ
aji-158	200	15	deviation	deviation	NOUN
aji-158	200	16	was	be	AUX
aji-158	200	17	estimated	estimate	VERB
aji-158	200	18	at	at	ADP
aji-158	200	19	1:180	1:180	NUM
aji-158	200	20	;	;	PUNCT
aji-158	200	21	the	the	DET
aji-158	200	22	mode	mode	NOUN
aji-158	200	23	was	be	AUX
aji-158	200	24	1:512	1:512	NUM
aji-158	200	25	(	(	PUNCT
aji-158	200	26	appeared	appear	VERB
aji-158	200	27	65	65	NUM
aji-158	200	28	times	time	NOUN
aji-158	200	29	)	)	PUNCT
aji-158	200	30	.	.	PUNCT
aji-158	201	1	the	the	DET
aji-158	201	2	ttp	ttp	NOUN
aji-158	201	3	for	for	ADP
aji-158	201	4	the	the	DET
aji-158	201	5	nickel	nickel	NOUN
aji-158	201	6	showed	show	VERB
aji-158	201	7	a	a	DET
aji-158	201	8	distribution	distribution	NOUN
aji-158	201	9	concentrated	concentrate	VERB
aji-158	201	10	on	on	ADP
aji-158	201	11	the	the	DET
aji-158	201	12	higher	high	ADJ
aji-158	201	13	dilutions	dilution	NOUN
aji-158	201	14	(	(	PUNCT
aji-158	201	15	fig	fig	NOUN
aji-158	201	16	.	.	PUNCT
aji-158	202	1	2	2	NUM
aji-158	202	2	)	)	PUNCT
aji-158	202	3	.	.	PUNCT
aji-158	203	1	there	there	PRON
aji-158	203	2	was	be	VERB
aji-158	203	3	one	one	NUM
aji-158	203	4	negative	negative	ADJ
aji-158	203	5	result	result	NOUN
aji-158	203	6	.	.	PUNCT
aji-158	204	1	the	the	DET
aji-158	204	2	mean	mean	NOUN
aji-158	204	3	was	be	AUX
aji-158	204	4	estimated	estimate	VERB
aji-158	204	5	at	at	ADP
aji-158	204	6	1:309	1:309	NUM
aji-158	204	7	;	;	PUNCT
aji-158	204	8	the	the	DET
aji-158	204	9	median	median	NOUN
aji-158	204	10	was	be	AUX
aji-158	204	11	1:256	1:256	NUM
aji-158	204	12	;	;	PUNCT
aji-158	204	13	the	the	DET
aji-158	204	14	standard	standard	ADJ
aji-158	204	15	deviation	deviation	NOUN
aji-158	204	16	was	be	AUX
aji-158	204	17	estimated	estimate	VERB
aji-158	204	18	at	at	ADP
aji-158	204	19	1:199	1:199	NUM
aji-158	204	20	;	;	PUNCT
aji-158	204	21	the	the	DET
aji-158	204	22	mode	mode	NOUN
aji-158	204	23	was	be	AUX
aji-158	204	24	1:512	1:512	NUM
aji-158	204	25	(	(	PUNCT
aji-158	204	26	appeared	appear	VERB
aji-158	204	27	46	46	NUM
aji-158	204	28	times	time	NOUN
aji-158	204	29	)	)	PUNCT
aji-158	204	30	.	.	PUNCT
aji-158	205	1	the	the	DET
aji-158	205	2	lait	lait	NOUN
aji-158	205	3	for	for	ADP
aji-158	205	4	the	the	DET
aji-158	205	5	cocoa	cocoa	NOUN
aji-158	205	6	extract	extract	NOUN
aji-158	205	7	showed	show	VERB
aji-158	205	8	a	a	DET
aji-158	205	9	wide	wide	ADJ
aji-158	205	10	distribution	distribution	NOUN
aji-158	205	11	range	range	NOUN
aji-158	205	12	of	of	ADP
aji-158	205	13	results	result	NOUN
aji-158	205	14	.	.	PUNCT
aji-158	206	1	most	most	ADJ
aji-158	206	2	results	result	NOUN
aji-158	206	3	were	be	AUX
aji-158	206	4	concentrated	concentrate	VERB
aji-158	206	5	in	in	ADP
aji-158	206	6	the	the	DET
aji-158	206	7	higher	high	ADJ
aji-158	206	8	immunoreactive	immunoreactive	ADJ
aji-158	206	9	groups	group	NOUN
aji-158	206	10	.	.	PUNCT
aji-158	207	1	there	there	PRON
aji-158	207	2	were	be	VERB
aji-158	207	3	seven	seven	NUM
aji-158	207	4	negative	negative	ADJ
aji-158	207	5	results	result	NOUN
aji-158	207	6	.	.	PUNCT
aji-158	208	1	the	the	DET
aji-158	208	2	lai	lai	PROPN
aji-158	208	3	ranged	range	VERB
aji-158	208	4	from	from	ADP
aji-158	208	5	0	0	NUM
aji-158	208	6	%	%	NOUN
aji-158	208	7	to	to	PART
aji-158	208	8	98	98	NUM
aji-158	208	9	%	%	NOUN
aji-158	208	10	.	.	PUNCT
aji-158	209	1	the	the	DET
aji-158	209	2	mean	mean	NOUN
aji-158	209	3	was	be	AUX
aji-158	209	4	51.9	51.9	NUM
aji-158	209	5	%	%	NOUN
aji-158	209	6	;	;	PUNCT
aji-158	209	7	the	the	DET
aji-158	209	8	median	median	NOUN
aji-158	209	9	was	be	AUX
aji-158	209	10	56	56	NUM
aji-158	209	11	%	%	NOUN
aji-158	209	12	;	;	PUNCT
aji-158	209	13	the	the	DET
aji-158	209	14	standard	standard	ADJ
aji-158	209	15	deviation	deviation	NOUN
aji-158	209	16	was	be	AUX
aji-158	209	17	26.3	26.3	NUM
aji-158	209	18	%	%	NOUN
aji-158	209	19	;	;	PUNCT
aji-158	209	20	the	the	DET
aji-158	209	21	mode	mode	NOUN
aji-158	209	22	was	be	AUX
aji-158	209	23	0	0	NUM
aji-158	209	24	%	%	NOUN
aji-158	209	25	(	(	PUNCT
aji-158	209	26	appeared	appear	VERB
aji-158	209	27	seven	seven	NUM
aji-158	209	28	times	time	NOUN
aji-158	209	29	)	)	PUNCT
aji-158	209	30	.	.	PUNCT
aji-158	210	1	the	the	DET
aji-158	210	2	cascade	cascade	NOUN
aji-158	210	3	distribution	distribution	NOUN
aji-158	210	4	demonstrates	demonstrate	VERB
aji-158	210	5	a	a	DET
aji-158	210	6	wide	wide	ADJ
aji-158	210	7	range	range	NOUN
aji-158	210	8	of	of	ADP
aji-158	210	9	lai	lai	PROPN
aji-158	210	10	results	result	NOUN
aji-158	210	11	(	(	PUNCT
aji-158	210	12	fig	fig	NOUN
aji-158	210	13	.	.	PUNCT
aji-158	211	1	3	3	NUM
aji-158	211	2	)	)	PUNCT
aji-158	211	3	.	.	PUNCT
aji-158	212	1	some	some	DET
aji-158	212	2	patients	patient	NOUN
aji-158	212	3	showed	show	VERB
aji-158	212	4	low	low	ADJ
aji-158	212	5	or	or	CCONJ
aji-158	212	6	moderate	moderate	ADJ
aji-158	212	7	immunoreactivity	immunoreactivity	NOUN
aji-158	212	8	during	during	ADP
aji-158	212	9	the	the	DET
aji-158	212	10	ex	ex	ADJ
aji-158	212	11	vivo	vivo	NOUN
aji-158	212	12	challenge	challenge	NOUN
aji-158	212	13	test	test	NOUN
aji-158	212	14	.	.	PUNCT
aji-158	213	1	in	in	ADP
aji-158	213	2	contrast	contrast	NOUN
aji-158	213	3	,	,	PUNCT
aji-158	213	4	others	other	NOUN
aji-158	213	5	displayed	display	VERB
aji-158	213	6	strong	strong	ADJ
aji-158	213	7	immunoreactivity	immunoreactivity	NOUN
aji-158	213	8	,	,	PUNCT
aji-158	213	9	which	which	PRON
aji-158	213	10	supposedly	supposedly	ADV
aji-158	213	11	could	could	AUX
aji-158	213	12	reflect	reflect	VERB
aji-158	213	13	the	the	DET
aji-158	213	14	participation	participation	NOUN
aji-158	213	15	of	of	ADP
aji-158	213	16	cocoa	cocoa	NOUN
aji-158	213	17	allergens	allergen	NOUN
aji-158	213	18	in	in	ADP
aji-158	213	19	the	the	DET
aji-158	213	20	non	non	ADJ
aji-158	213	21	–	–	PUNCT
aji-158	213	22	ige	ige	ADJ
aji-158	213	23	-	-	PUNCT
aji-158	213	24	mediated	mediate	VERB
aji-158	213	25	hypersensitivity	hypersensitivity	NOUN
aji-158	213	26	condition	condition	NOUN
aji-158	213	27	of	of	ADP
aji-158	213	28	these	these	DET
aji-158	213	29	patients	patient	NOUN
aji-158	213	30	.	.	PUNCT
aji-158	214	1	fig	fig	NOUN
aji-158	214	2	.	.	PUNCT
aji-158	215	1	1	1	NUM
aji-158	215	2	.	.	X
aji-158	215	3	cascade	cascade	NOUN
aji-158	215	4	distribution	distribution	NOUN
aji-158	215	5	chart	chart	NOUN
aji-158	215	6	of	of	ADP
aji-158	215	7	the	the	DET
aji-158	215	8	tube	tube	NOUN
aji-158	215	9	titration	titration	NOUN
aji-158	215	10	of	of	ADP
aji-158	215	11	precipitins	precipitin	NOUN
aji-158	215	12	(	(	PUNCT
aji-158	215	13	x	x	NOUN
aji-158	215	14	-	-	ADJ
aji-158	215	15	axis	axis	ADJ
aji-158	215	16	%	%	NOUN
aji-158	215	17	)	)	PUNCT
aji-158	215	18	resulting	result	VERB
aji-158	215	19	from	from	ADP
aji-158	215	20	the	the	DET
aji-158	215	21	cocoa	cocoa	NOUN
aji-158	215	22	extract	extract	NOUN
aji-158	215	23	against	against	ADP
aji-158	215	24	the	the	DET
aji-158	215	25	serum	serum	NOUN
aji-158	215	26	of	of	ADP
aji-158	215	27	the	the	DET
aji-158	215	28	ttp	ttp	PROPN
aji-158	215	29	cohort	cohort	NOUN
aji-158	215	30	of	of	ADP
aji-158	215	31	100	100	NUM
aji-158	215	32	tests	test	NOUN
aji-158	215	33	/	/	SYM
aji-158	215	34	subjects	subject	NOUN
aji-158	215	35	(	(	PUNCT
aji-158	215	36	y	y	NOUN
aji-158	215	37	-	-	PUNCT
aji-158	215	38	axis	axis	NOUN
aji-158	215	39	)	)	PUNCT
aji-158	215	40	olivier	olivier	NOUN
aji-158	215	41	et	et	PROPN
aji-158	215	42	al	al	PROPN
aji-158	215	43	.	.	PROPN
aji-158	215	44	;	;	PUNCT
aji-158	215	45	asian	asian	PROPN
aji-158	215	46	j.	j.	PROPN
aji-158	215	47	immunol	immunol	PROPN
aji-158	215	48	.	.	PROPN
aji-158	215	49	,	,	PUNCT
aji-158	215	50	vol	vol	NOUN
aji-158	215	51	.	.	PROPN
aji-158	215	52	8	8	NUM
aji-158	215	53	,	,	PUNCT
aji-158	215	54	no	no	INTJ
aji-158	215	55	.	.	NOUN
aji-158	215	56	1	1	NUM
aji-158	215	57	,	,	PUNCT
aji-158	215	58	pp	pp	ADJ
aji-158	215	59	.	.	PUNCT
aji-158	216	1	35	35	NUM
aji-158	216	2	-	-	SYM
aji-158	216	3	49	49	NUM
aji-158	216	4	,	,	PUNCT
aji-158	216	5	2025	2025	NUM
aji-158	217	1	;	;	PUNCT
aji-158	217	2	article	article	NOUN
aji-158	217	3	no.aji.133582	no.aji.133582	PROPN
aji-158	217	4	40	40	NUM
aji-158	217	5	fig	fig	NOUN
aji-158	217	6	.	.	PUNCT
aji-158	218	1	2	2	NUM
aji-158	218	2	.	.	NOUN
aji-158	218	3	cascade	cascade	NOUN
aji-158	218	4	distribution	distribution	NOUN
aji-158	218	5	chart	chart	NOUN
aji-158	218	6	of	of	ADP
aji-158	218	7	the	the	DET
aji-158	218	8	tube	tube	NOUN
aji-158	218	9	titration	titration	NOUN
aji-158	218	10	of	of	ADP
aji-158	218	11	precipitins	precipitin	NOUN
aji-158	218	12	(	(	PUNCT
aji-158	218	13	x	x	NOUN
aji-158	218	14	-	-	ADJ
aji-158	218	15	axis	axis	ADJ
aji-158	218	16	%	%	NOUN
aji-158	218	17	)	)	PUNCT
aji-158	218	18	resulting	result	VERB
aji-158	218	19	from	from	ADP
aji-158	218	20	the	the	DET
aji-158	218	21	nickel	nickel	NOUN
aji-158	218	22	solution	solution	NOUN
aji-158	218	23	against	against	ADP
aji-158	218	24	the	the	DET
aji-158	218	25	serum	serum	NOUN
aji-158	218	26	of	of	ADP
aji-158	218	27	the	the	DET
aji-158	218	28	ttp	ttp	PROPN
aji-158	218	29	cohort	cohort	NOUN
aji-158	218	30	of	of	ADP
aji-158	218	31	100	100	NUM
aji-158	218	32	tests	test	NOUN
aji-158	218	33	/	/	SYM
aji-158	218	34	subjects	subject	NOUN
aji-158	218	35	(	(	PUNCT
aji-158	218	36	y	y	NOUN
aji-158	218	37	-	-	PUNCT
aji-158	218	38	axis	axis	NOUN
aji-158	218	39	)	)	PUNCT
aji-158	218	40	.	.	PUNCT
aji-158	219	1	fig	fig	NOUN
aji-158	219	2	.	.	PUNCT
aji-158	220	1	3	3	X
aji-158	220	2	.	.	NOUN
aji-158	220	3	cascade	cascade	NOUN
aji-158	220	4	distribution	distribution	NOUN
aji-158	220	5	chart	chart	NOUN
aji-158	220	6	of	of	ADP
aji-158	220	7	the	the	DET
aji-158	220	8	range	range	NOUN
aji-158	220	9	groups	group	NOUN
aji-158	220	10	of	of	ADP
aji-158	220	11	leukocyte	leukocyte	NOUN
aji-158	220	12	adherence	adherence	NOUN
aji-158	220	13	inhibition	inhibition	NOUN
aji-158	220	14	(	(	PUNCT
aji-158	220	15	lai	lai	NOUN
aji-158	220	16	)	)	PUNCT
aji-158	220	17	results	result	NOUN
aji-158	220	18	(	(	PUNCT
aji-158	220	19	x	x	NOUN
aji-158	220	20	-	-	ADJ
aji-158	220	21	axis	axis	ADJ
aji-158	220	22	%	%	NOUN
aji-158	220	23	)	)	PUNCT
aji-158	220	24	of	of	ADP
aji-158	220	25	the	the	DET
aji-158	220	26	ex	ex	X
aji-158	220	27	vivo	vivo	NOUN
aji-158	220	28	challenge	challenge	NOUN
aji-158	220	29	test	test	NOUN
aji-158	220	30	against	against	ADP
aji-158	220	31	cocoa	cocoa	NOUN
aji-158	220	32	extract	extract	NOUN
aji-158	220	33	monitored	monitor	VERB
aji-158	220	34	by	by	ADP
aji-158	220	35	the	the	DET
aji-158	220	36	leukocyte	leukocyte	NOUN
aji-158	220	37	adherence	adherence	NOUN
aji-158	220	38	inhibition	inhibition	NOUN
aji-158	220	39	test	test	NOUN
aji-158	220	40	(	(	PUNCT
aji-158	220	41	lait	lait	NOUN
aji-158	220	42	)	)	PUNCT
aji-158	220	43	,	,	PUNCT
aji-158	220	44	according	accord	VERB
aji-158	220	45	to	to	ADP
aji-158	220	46	the	the	DET
aji-158	220	47	respective	respective	ADJ
aji-158	220	48	number	number	NOUN
aji-158	220	49	of	of	ADP
aji-158	220	50	outcomes	outcome	NOUN
aji-158	220	51	over	over	ADP
aji-158	220	52	the	the	DET
aji-158	220	53	lait	lait	NOUN
aji-158	220	54	cohort	cohort	NOUN
aji-158	220	55	with	with	ADP
aji-158	220	56	100	100	NUM
aji-158	220	57	tests	test	NOUN
aji-158	220	58	/	/	SYM
aji-158	220	59	subjects	subject	NOUN
aji-158	220	60	(	(	PUNCT
aji-158	220	61	y	y	NOUN
aji-158	220	62	-	-	PUNCT
aji-158	220	63	axis	axis	NOUN
aji-158	220	64	)	)	PUNCT
aji-158	220	65	the	the	DET
aji-158	220	66	lait	lait	NOUN
aji-158	220	67	for	for	ADP
aji-158	220	68	nickel	nickel	NOUN
aji-158	220	69	solution	solution	NOUN
aji-158	220	70	showed	show	VERB
aji-158	220	71	a	a	DET
aji-158	220	72	wide	wide	ADJ
aji-158	220	73	distribution	distribution	NOUN
aji-158	220	74	range	range	NOUN
aji-158	220	75	of	of	ADP
aji-158	220	76	results	result	NOUN
aji-158	220	77	.	.	PUNCT
aji-158	221	1	most	most	ADJ
aji-158	221	2	results	result	NOUN
aji-158	221	3	were	be	AUX
aji-158	221	4	concentrated	concentrate	VERB
aji-158	221	5	in	in	ADP
aji-158	221	6	the	the	DET
aji-158	221	7	lower	low	ADJ
aji-158	221	8	and	and	CCONJ
aji-158	221	9	moderate	moderate	ADJ
aji-158	221	10	immunoreactive	immunoreactive	ADJ
aji-158	221	11	groups	group	NOUN
aji-158	221	12	.	.	PUNCT
aji-158	222	1	there	there	PRON
aji-158	222	2	were	be	VERB
aji-158	222	3	eighteen	eighteen	NUM
aji-158	222	4	negative	negative	ADJ
aji-158	222	5	results	result	NOUN
aji-158	222	6	.	.	PUNCT
aji-158	223	1	the	the	DET
aji-158	223	2	lai	lai	PROPN
aji-158	223	3	ranged	range	VERB
aji-158	223	4	from	from	ADP
aji-158	223	5	0	0	NUM
aji-158	223	6	%	%	NOUN
aji-158	223	7	to	to	PART
aji-158	223	8	89	89	NUM
aji-158	223	9	%	%	NOUN
aji-158	223	10	.	.	PUNCT
aji-158	224	1	the	the	DET
aji-158	224	2	mean	mean	NOUN
aji-158	224	3	was	be	AUX
aji-158	224	4	33	33	NUM
aji-158	224	5	%	%	NOUN
aji-158	224	6	;	;	PUNCT
aji-158	224	7	the	the	DET
aji-158	224	8	median	median	NOUN
aji-158	224	9	was	be	AUX
aji-158	224	10	33	33	NUM
aji-158	224	11	%	%	NOUN
aji-158	224	12	;	;	PUNCT
aji-158	224	13	the	the	DET
aji-158	224	14	standard	standard	ADJ
aji-158	224	15	deviation	deviation	NOUN
aji-158	224	16	was	be	AUX
aji-158	224	17	26,6	26,6	NUM
aji-158	224	18	%	%	NOUN
aji-158	224	19	;	;	PUNCT
aji-158	224	20	the	the	DET
aji-158	224	21	mode	mode	NOUN
aji-158	224	22	was	be	AUX
aji-158	224	23	0	0	NUM
aji-158	224	24	%	%	NOUN
aji-158	224	25	(	(	PUNCT
aji-158	224	26	appeared	appear	VERB
aji-158	224	27	eighteen	eighteen	NUM
aji-158	224	28	times	time	NOUN
aji-158	224	29	)	)	PUNCT
aji-158	224	30	.	.	PUNCT
aji-158	225	1	the	the	DET
aji-158	225	2	cascade	cascade	NOUN
aji-158	225	3	distribution	distribution	NOUN
aji-158	225	4	demonstrates	demonstrate	VERB
aji-158	225	5	a	a	DET
aji-158	225	6	wide	wide	ADJ
aji-158	225	7	range	range	NOUN
aji-158	225	8	of	of	ADP
aji-158	225	9	lai	lai	PROPN
aji-158	225	10	results	result	NOUN
aji-158	225	11	(	(	PUNCT
aji-158	225	12	fig	fig	NOUN
aji-158	225	13	.	.	PUNCT
aji-158	225	14	4	4	NUM
aji-158	225	15	)	)	PUNCT
aji-158	225	16	.	.	PUNCT
aji-158	226	1	some	some	DET
aji-158	226	2	patients	patient	NOUN
aji-158	226	3	showed	show	VERB
aji-158	226	4	low	low	ADJ
aji-158	226	5	or	or	CCONJ
aji-158	226	6	moderate	moderate	ADJ
aji-158	226	7	immunoreactivity	immunoreactivity	NOUN
aji-158	226	8	during	during	ADP
aji-158	226	9	the	the	DET
aji-158	226	10	ex	ex	ADJ
aji-158	226	11	vivo	vivo	NOUN
aji-158	226	12	challenge	challenge	NOUN
aji-158	226	13	test	test	NOUN
aji-158	226	14	.	.	PUNCT
aji-158	227	1	in	in	ADP
aji-158	227	2	contrast	contrast	NOUN
aji-158	227	3	,	,	PUNCT
aji-158	227	4	others	other	NOUN
aji-158	227	5	displayed	display	VERB
aji-158	227	6	strong	strong	ADJ
aji-158	227	7	immunoreactivity	immunoreactivity	NOUN
aji-158	227	8	,	,	PUNCT
aji-158	227	9	which	which	PRON
aji-158	227	10	could	could	AUX
aji-158	227	11	reflect	reflect	VERB
aji-158	227	12	the	the	DET
aji-158	227	13	participation	participation	NOUN
aji-158	227	14	of	of	ADP
aji-158	227	15	nickel	nickel	NOUN
aji-158	227	16	in	in	ADP
aji-158	227	17	the	the	DET
aji-158	227	18	non	non	ADJ
aji-158	227	19	–	–	PUNCT
aji-158	227	20	ige	ige	ADJ
aji-158	227	21	mediated	mediate	VERB
aji-158	227	22	hypersensitivity	hypersensitivity	NOUN
aji-158	227	23	condition	condition	NOUN
aji-158	227	24	of	of	ADP
aji-158	227	25	these	these	DET
aji-158	227	26	patients	patient	NOUN
aji-158	227	27	.	.	PUNCT
aji-158	228	1	olivier	olivier	PROPN
aji-158	228	2	et	et	PROPN
aji-158	228	3	al	al	PROPN
aji-158	228	4	.	.	PROPN
aji-158	228	5	;	;	PUNCT
aji-158	228	6	asian	asian	PROPN
aji-158	228	7	j.	j.	PROPN
aji-158	228	8	immunol	immunol	PROPN
aji-158	228	9	.	.	PROPN
aji-158	228	10	,	,	PUNCT
aji-158	228	11	vol	vol	NOUN
aji-158	228	12	.	.	PROPN
aji-158	228	13	8	8	NUM
aji-158	228	14	,	,	PUNCT
aji-158	228	15	no	no	INTJ
aji-158	228	16	.	.	NOUN
aji-158	228	17	1	1	NUM
aji-158	228	18	,	,	PUNCT
aji-158	228	19	pp	pp	ADJ
aji-158	228	20	.	.	PUNCT
aji-158	229	1	35	35	NUM
aji-158	229	2	-	-	SYM
aji-158	229	3	49	49	NUM
aji-158	229	4	,	,	PUNCT
aji-158	229	5	2025	2025	NUM
aji-158	229	6	;	;	PUNCT
aji-158	229	7	article	article	NOUN
aji-158	229	8	no.aji.133582	no.aji.133582	PROPN
aji-158	229	9	41	41	NUM
aji-158	229	10	the	the	DET
aji-158	229	11	pearson	pearson	NOUN
aji-158	229	12	correlation	correlation	NOUN
aji-158	229	13	indicated	indicate	VERB
aji-158	229	14	that	that	SCONJ
aji-158	229	15	there	there	PRON
aji-158	229	16	is	be	VERB
aji-158	229	17	a	a	DET
aji-158	229	18	significant	significant	ADJ
aji-158	229	19	medium	medium	ADJ
aji-158	229	20	positive	positive	ADJ
aji-158	229	21	relationship	relationship	NOUN
aji-158	229	22	between	between	ADP
aji-158	229	23	ttp	ttp	PROPN
aji-158	229	24	results	result	NOUN
aji-158	229	25	between	between	ADP
aji-158	229	26	cocoa	cocoa	NOUN
aji-158	229	27	(	(	PUNCT
aji-158	229	28	x	x	NOUN
aji-158	229	29	-	-	NOUN
aji-158	229	30	axis	axis	ADJ
aji-158	229	31	)	)	PUNCT
aji-158	229	32	and	and	CCONJ
aji-158	229	33	nickel	nickel	NOUN
aji-158	229	34	(	(	PUNCT
aji-158	229	35	y	y	NOUN
aji-158	229	36	-	-	PUNCT
aji-158	229	37	axis	axis	NOUN
aji-158	229	38	)	)	PUNCT
aji-158	229	39	,	,	PUNCT
aji-158	229	40	r(98	r(98	PROPN
aji-158	229	41	)	)	PUNCT
aji-158	230	1	=	=	PUNCT
aji-158	230	2	.335	.335	NUM
aji-158	230	3	;	;	PUNCT
aji-158	230	4	p	p	X
aji-158	230	5	<	<	X
aji-158	230	6	.001	.001	NUM
aji-158	230	7	;	;	PUNCT
aji-158	230	8	see	see	VERB
aji-158	230	9	fig	fig	NOUN
aji-158	230	10	.	.	PUNCT
aji-158	231	1	5	5	X
aji-158	231	2	.	.	PUNCT
aji-158	231	3	the	the	DET
aji-158	231	4	pearson	pearson	PROPN
aji-158	231	5	correlation	correlation	NOUN
aji-158	231	6	indicated	indicate	VERB
aji-158	231	7	that	that	SCONJ
aji-158	231	8	there	there	PRON
aji-158	231	9	is	be	VERB
aji-158	231	10	a	a	DET
aji-158	231	11	significant	significant	ADJ
aji-158	231	12	medium	medium	ADJ
aji-158	231	13	positive	positive	ADJ
aji-158	231	14	relationship	relationship	NOUN
aji-158	231	15	between	between	ADP
aji-158	231	16	lait	lait	NOUN
aji-158	231	17	results	result	NOUN
aji-158	231	18	between	between	ADP
aji-158	231	19	cocoa	cocoa	NOUN
aji-158	231	20	(	(	PUNCT
aji-158	231	21	x	x	NOUN
aji-158	231	22	-	-	NOUN
aji-158	231	23	axis	axis	ADJ
aji-158	231	24	)	)	PUNCT
aji-158	231	25	and	and	CCONJ
aji-158	231	26	nickel	nickel	NOUN
aji-158	231	27	(	(	PUNCT
aji-158	231	28	y	y	NOUN
aji-158	231	29	-	-	PUNCT
aji-158	231	30	axis	axis	NOUN
aji-158	231	31	)	)	PUNCT
aji-158	231	32	,	,	PUNCT
aji-158	231	33	r(98	r(98	PROPN
aji-158	231	34	)	)	PUNCT
aji-158	232	1	=	=	PUNCT
aji-158	232	2	.425	.425	NUM
aji-158	232	3	;	;	PUNCT
aji-158	232	4	p	p	X
aji-158	232	5	<	<	X
aji-158	232	6	.001	.001	NUM
aji-158	232	7	;	;	PUNCT
aji-158	232	8	see	see	VERB
aji-158	232	9	fig	fig	NOUN
aji-158	232	10	.	.	PUNCT
aji-158	233	1	6	6	NUM
aji-158	233	2	.	.	X
aji-158	233	3	fig	fig	NOUN
aji-158	233	4	.	.	PUNCT
aji-158	234	1	4	4	NUM
aji-158	234	2	.	.	NOUN
aji-158	234	3	cascade	cascade	NOUN
aji-158	234	4	distribution	distribution	NOUN
aji-158	234	5	chart	chart	NOUN
aji-158	234	6	of	of	ADP
aji-158	234	7	the	the	DET
aji-158	234	8	range	range	NOUN
aji-158	234	9	groups	group	NOUN
aji-158	234	10	of	of	ADP
aji-158	234	11	leukocyte	leukocyte	NOUN
aji-158	234	12	adherence	adherence	NOUN
aji-158	234	13	inhibition	inhibition	NOUN
aji-158	234	14	(	(	PUNCT
aji-158	234	15	lai	lai	NOUN
aji-158	234	16	)	)	PUNCT
aji-158	234	17	results	result	NOUN
aji-158	234	18	(	(	PUNCT
aji-158	234	19	x	x	NOUN
aji-158	234	20	-	-	ADJ
aji-158	234	21	axis	axis	ADJ
aji-158	234	22	%	%	NOUN
aji-158	234	23	)	)	PUNCT
aji-158	234	24	of	of	ADP
aji-158	234	25	ex	ex	X
aji-158	234	26	vivo	vivo	NOUN
aji-158	234	27	ex	ex	X
aji-158	234	28	vivo	vivo	NOUN
aji-158	234	29	challenge	challenge	NOUN
aji-158	234	30	test	test	NOUN
aji-158	234	31	against	against	ADP
aji-158	234	32	nickel	nickel	NOUN
aji-158	234	33	solution	solution	NOUN
aji-158	234	34	monitored	monitor	VERB
aji-158	234	35	by	by	ADP
aji-158	234	36	the	the	DET
aji-158	234	37	leukocyte	leukocyte	NOUN
aji-158	234	38	adherence	adherence	NOUN
aji-158	234	39	inhibition	inhibition	NOUN
aji-158	234	40	test	test	NOUN
aji-158	234	41	(	(	PUNCT
aji-158	234	42	lait	lait	NOUN
aji-158	234	43	)	)	PUNCT
aji-158	234	44	,	,	PUNCT
aji-158	234	45	according	accord	VERB
aji-158	234	46	to	to	ADP
aji-158	234	47	the	the	DET
aji-158	234	48	respective	respective	ADJ
aji-158	234	49	number	number	NOUN
aji-158	234	50	of	of	ADP
aji-158	234	51	outcomes	outcome	NOUN
aji-158	234	52	over	over	ADP
aji-158	234	53	the	the	DET
aji-158	234	54	lait	lait	NOUN
aji-158	234	55	cohort	cohort	NOUN
aji-158	234	56	with	with	ADP
aji-158	234	57	100	100	NUM
aji-158	234	58	tests	test	NOUN
aji-158	234	59	/	/	SYM
aji-158	234	60	subjects	subject	NOUN
aji-158	234	61	(	(	PUNCT
aji-158	234	62	y	y	NOUN
aji-158	234	63	-	-	PUNCT
aji-158	234	64	axis	axis	ADJ
aji-158	234	65	)	)	PUNCT
aji-158	234	66	fig	fig	NOUN
aji-158	234	67	.	.	PUNCT
aji-158	235	1	5	5	X
aji-158	235	2	.	.	X
aji-158	235	3	dispersion	dispersion	NOUN
aji-158	235	4	chart	chart	NOUN
aji-158	235	5	of	of	ADP
aji-158	235	6	the	the	DET
aji-158	235	7	leukocyte	leukocyte	NOUN
aji-158	235	8	adherence	adherence	NOUN
aji-158	235	9	inhibition	inhibition	NOUN
aji-158	235	10	(	(	PUNCT
aji-158	235	11	lai	lai	NOUN
aji-158	235	12	)	)	PUNCT
aji-158	235	13	results	result	NOUN
aji-158	235	14	of	of	ADP
aji-158	235	15	the	the	DET
aji-158	235	16	tube	tube	NOUN
aji-158	235	17	titration	titration	NOUN
aji-158	235	18	of	of	ADP
aji-158	235	19	precipitins	precipitin	NOUN
aji-158	235	20	against	against	ADP
aji-158	235	21	cocoa	cocoa	NOUN
aji-158	235	22	extract	extract	NOUN
aji-158	235	23	(	(	PUNCT
aji-158	235	24	x	x	NOUN
aji-158	235	25	-	-	ADJ
aji-158	235	26	axis	axis	ADJ
aji-158	235	27	%	%	NOUN
aji-158	235	28	)	)	PUNCT
aji-158	235	29	,	,	PUNCT
aji-158	235	30	plotted	plot	VERB
aji-158	235	31	against	against	ADP
aji-158	235	32	the	the	DET
aji-158	235	33	lai	lai	PROPN
aji-158	235	34	results	result	NOUN
aji-158	235	35	of	of	ADP
aji-158	235	36	the	the	DET
aji-158	235	37	tube	tube	NOUN
aji-158	235	38	titration	titration	NOUN
aji-158	235	39	of	of	ADP
aji-158	235	40	precipitins	precipitin	NOUN
aji-158	235	41	against	against	ADP
aji-158	235	42	nickel	nickel	NOUN
aji-158	235	43	solution	solution	NOUN
aji-158	235	44	(	(	PUNCT
aji-158	235	45	y	y	NOUN
aji-158	235	46	-	-	PUNCT
aji-158	235	47	axis	axis	NOUN
aji-158	235	48	%	%	NOUN
aji-158	235	49	)	)	PUNCT
aji-158	235	50	.	.	PUNCT
aji-158	236	1	olivier	olivier	PROPN
aji-158	236	2	et	et	PROPN
aji-158	236	3	al	al	PROPN
aji-158	236	4	.	.	PROPN
aji-158	236	5	;	;	PUNCT
aji-158	236	6	asian	asian	PROPN
aji-158	236	7	j.	j.	PROPN
aji-158	236	8	immunol	immunol	PROPN
aji-158	236	9	.	.	PROPN
aji-158	236	10	,	,	PUNCT
aji-158	236	11	vol	vol	NOUN
aji-158	236	12	.	.	PROPN
aji-158	236	13	8	8	NUM
aji-158	236	14	,	,	PUNCT
aji-158	236	15	no	no	INTJ
aji-158	236	16	.	.	NOUN
aji-158	236	17	1	1	NUM
aji-158	236	18	,	,	PUNCT
aji-158	236	19	pp	pp	ADJ
aji-158	236	20	.	.	PUNCT
aji-158	237	1	35	35	NUM
aji-158	237	2	-	-	SYM
aji-158	237	3	49	49	NUM
aji-158	237	4	,	,	PUNCT
aji-158	237	5	2025	2025	NUM
aji-158	237	6	;	;	PUNCT
aji-158	237	7	article	article	NOUN
aji-158	237	8	no.aji.133582	no.aji.133582	PROPN
aji-158	237	9	42	42	NUM
aji-158	237	10	fig	fig	NOUN
aji-158	237	11	.	.	PUNCT
aji-158	238	1	6	6	X
aji-158	238	2	.	.	X
aji-158	238	3	dispersion	dispersion	NOUN
aji-158	238	4	chart	chart	NOUN
aji-158	238	5	of	of	ADP
aji-158	238	6	the	the	DET
aji-158	238	7	leukocyte	leukocyte	NOUN
aji-158	238	8	adherence	adherence	NOUN
aji-158	238	9	inhibition	inhibition	NOUN
aji-158	238	10	(	(	PUNCT
aji-158	238	11	lai	lai	NOUN
aji-158	238	12	)	)	PUNCT
aji-158	238	13	results	result	NOUN
aji-158	238	14	of	of	ADP
aji-158	238	15	the	the	DET
aji-158	238	16	ex	ex	X
aji-158	238	17	vivo	vivo	NOUN
aji-158	238	18	challenge	challenge	NOUN
aji-158	238	19	test	test	NOUN
aji-158	238	20	against	against	ADP
aji-158	238	21	cocoa	cocoa	NOUN
aji-158	238	22	extract	extract	NOUN
aji-158	238	23	(	(	PUNCT
aji-158	238	24	x	x	NOUN
aji-158	238	25	-	-	ADJ
aji-158	238	26	axis	axis	ADJ
aji-158	238	27	%	%	NOUN
aji-158	238	28	)	)	PUNCT
aji-158	238	29	,	,	PUNCT
aji-158	238	30	plotted	plot	VERB
aji-158	238	31	against	against	ADP
aji-158	238	32	the	the	DET
aji-158	238	33	lai	lai	PROPN
aji-158	238	34	results	result	NOUN
aji-158	238	35	of	of	ADP
aji-158	238	36	the	the	DET
aji-158	238	37	ex	ex	X
aji-158	238	38	vivo	vivo	NOUN
aji-158	238	39	challenge	challenge	NOUN
aji-158	238	40	test	test	NOUN
aji-158	238	41	against	against	ADP
aji-158	238	42	nickel	nickel	NOUN
aji-158	238	43	solution	solution	NOUN
aji-158	238	44	(	(	PUNCT
aji-158	238	45	y	y	NOUN
aji-158	238	46	-	-	PUNCT
aji-158	238	47	axis	axis	NOUN
aji-158	238	48	%	%	NOUN
aji-158	238	49	)	)	PUNCT
aji-158	238	50	.	.	PUNCT
aji-158	239	1	4	4	X
aji-158	239	2	.	.	X
aji-158	239	3	discussion	discussion	NOUN
aji-158	239	4	cocoa	cocoa	NOUN
aji-158	239	5	polyphenols	polyphenol	NOUN
aji-158	239	6	have	have	VERB
aji-158	239	7	several	several	ADJ
aji-158	239	8	effects	effect	NOUN
aji-158	239	9	on	on	ADP
aji-158	239	10	innate	innate	ADJ
aji-158	239	11	inflammatory	inflammatory	ADJ
aji-158	239	12	response	response	NOUN
aji-158	239	13	and	and	CCONJ
aji-158	239	14	systemic	systemic	ADJ
aji-158	239	15	and	and	CCONJ
aji-158	239	16	intestinal	intestinal	ADJ
aji-158	239	17	adaptive	adaptive	ADJ
aji-158	239	18	immune	immune	ADJ
aji-158	239	19	systems	system	NOUN
aji-158	239	20	(	(	PUNCT
aji-158	239	21	pérez	pérez	NOUN
aji-158	239	22	-	-	PUNCT
aji-158	239	23	cano	cano	PROPN
aji-158	239	24	et	et	PROPN
aji-158	239	25	al	al	PROPN
aji-158	239	26	.	.	PROPN
aji-158	239	27	,	,	PUNCT
aji-158	239	28	2013	2013	NUM
aji-158	239	29	)	)	PUNCT
aji-158	239	30	.	.	PUNCT
aji-158	240	1	animal	animal	NOUN
aji-158	240	2	studies	study	NOUN
aji-158	240	3	have	have	AUX
aji-158	240	4	observed	observe	VERB
aji-158	240	5	that	that	SCONJ
aji-158	240	6	polyphenols	polyphenol	NOUN
aji-158	240	7	in	in	ADP
aji-158	240	8	cocoa	cocoa	NOUN
aji-158	240	9	extract	extract	NOUN
aji-158	240	10	prevent	prevent	VERB
aji-158	240	11	ige	ige	NOUN
aji-158	240	12	synthesis	synthesis	NOUN
aji-158	240	13	and	and	CCONJ
aji-158	240	14	can	can	AUX
aji-158	240	15	suppress	suppress	VERB
aji-158	240	16	the	the	DET
aji-158	240	17	development	development	NOUN
aji-158	240	18	of	of	ADP
aji-158	240	19	atopic	atopic	NOUN
aji-158	240	20	dermatitis	dermatitis	NOUN
aji-158	240	21	by	by	ADP
aji-158	240	22	downregulating	downregulate	VERB
aji-158	240	23	inflammatory	inflammatory	ADJ
aji-158	240	24	markers	marker	NOUN
aji-158	240	25	,	,	PUNCT
aji-158	240	26	inflammatory	inflammatory	ADJ
aji-158	240	27	chemokines	chemokine	NOUN
aji-158	240	28	,	,	PUNCT
aji-158	240	29	and	and	CCONJ
aji-158	240	30	cell	cell	NOUN
aji-158	240	31	infiltration	infiltration	NOUN
aji-158	240	32	into	into	ADP
aji-158	240	33	lesion	lesion	NOUN
aji-158	240	34	areas	area	NOUN
aji-158	240	35	,	,	PUNCT
aji-158	240	36	turning	turn	VERB
aji-158	240	37	this	this	DET
aji-158	240	38	food	food	NOUN
aji-158	240	39	a	a	DET
aji-158	240	40	potential	potential	ADJ
aji-158	240	41	therapy	therapy	NOUN
aji-158	240	42	for	for	ADP
aji-158	240	43	patients	patient	NOUN
aji-158	240	44	with	with	ADP
aji-158	240	45	skin	skin	NOUN
aji-158	240	46	diseases	disease	NOUN
aji-158	240	47	;	;	PUNCT
aji-158	240	48	however	however	ADV
aji-158	240	49	,	,	PUNCT
aji-158	240	50	these	these	DET
aji-158	240	51	preliminary	preliminary	ADJ
aji-158	240	52	data	datum	NOUN
aji-158	240	53	does	do	AUX
aji-158	240	54	not	not	PART
aji-158	240	55	justify	justify	VERB
aji-158	240	56	yet	yet	ADV
aji-158	240	57	its	its	PRON
aji-158	240	58	empirical	empirical	ADJ
aji-158	240	59	prescription	prescription	NOUN
aji-158	240	60	for	for	ADP
aji-158	240	61	the	the	DET
aji-158	240	62	treatment	treatment	NOUN
aji-158	240	63	of	of	ADP
aji-158	240	64	allergic	allergic	ADJ
aji-158	240	65	patients	patient	NOUN
aji-158	240	66	(	(	PUNCT
aji-158	240	67	kang	kang	PROPN
aji-158	240	68	et	et	PROPN
aji-158	240	69	al	al	PROPN
aji-158	240	70	.	.	PROPN
aji-158	240	71	,	,	PUNCT
aji-158	240	72	2017	2017	NUM
aji-158	240	73	;	;	PUNCT
aji-158	240	74	abril	abril	PROPN
aji-158	240	75	-	-	PUNCT
aji-158	240	76	gil	gil	PROPN
aji-158	240	77	et	et	PROPN
aji-158	240	78	al	al	PROPN
aji-158	240	79	.	.	PROPN
aji-158	240	80	,	,	PUNCT
aji-158	240	81	2012	2012	NUM
aji-158	240	82	)	)	PUNCT
aji-158	240	83	.	.	PUNCT
aji-158	241	1	despite	despite	SCONJ
aji-158	241	2	the	the	DET
aji-158	241	3	results	result	NOUN
aji-158	241	4	demonstrating	demonstrate	VERB
aji-158	241	5	a	a	DET
aji-158	241	6	positive	positive	ADJ
aji-158	241	7	correlation	correlation	NOUN
aji-158	241	8	between	between	ADP
aji-158	241	9	cocoa	cocoa	NOUN
aji-158	241	10	and	and	CCONJ
aji-158	241	11	nickel	nickel	NOUN
aji-158	241	12	immunoreactivity	immunoreactivity	NOUN
aji-158	241	13	,	,	PUNCT
aji-158	241	14	the	the	DET
aji-158	241	15	cocoa	cocoa	NOUN
aji-158	241	16	extract	extract	NOUN
aji-158	241	17	demonstrated	demonstrate	VERB
aji-158	241	18	significantly	significantly	ADV
aji-158	241	19	higher	high	ADJ
aji-158	241	20	immune	immune	ADJ
aji-158	241	21	responses	response	NOUN
aji-158	241	22	,	,	PUNCT
aji-158	241	23	suggesting	suggest	VERB
aji-158	241	24	that	that	SCONJ
aji-158	241	25	nickel	nickel	NOUN
aji-158	241	26	is	be	AUX
aji-158	241	27	not	not	PART
aji-158	241	28	the	the	DET
aji-158	241	29	only	only	ADJ
aji-158	241	30	active	active	ADJ
aji-158	241	31	allergen	allergen	NOUN
aji-158	241	32	in	in	ADP
aji-158	241	33	the	the	DET
aji-158	241	34	cocoa	cocoa	NOUN
aji-158	241	35	extract	extract	NOUN
aji-158	241	36	.	.	PUNCT
aji-158	242	1	this	this	DET
aji-158	242	2	infers	infer	NOUN
aji-158	242	3	that	that	PRON
aji-158	242	4	evaluating	evaluate	VERB
aji-158	242	5	one	one	NUM
aji-158	242	6	allergen	allergen	NOUN
aji-158	242	7	does	do	AUX
aji-158	242	8	not	not	PART
aji-158	242	9	eliminate	eliminate	VERB
aji-158	242	10	the	the	DET
aji-158	242	11	need	need	NOUN
aji-158	242	12	to	to	PART
aji-158	242	13	evaluate	evaluate	VERB
aji-158	242	14	the	the	DET
aji-158	242	15	other	other	ADJ
aji-158	242	16	.	.	PUNCT
aji-158	243	1	this	this	DET
aji-158	243	2	observation	observation	NOUN
aji-158	243	3	also	also	ADV
aji-158	243	4	demonstrates	demonstrate	VERB
aji-158	243	5	that	that	SCONJ
aji-158	243	6	cocoa	cocoa	NOUN
aji-158	243	7	polyphenols	polyphenol	NOUN
aji-158	243	8	do	do	AUX
aji-158	243	9	not	not	PART
aji-158	243	10	directly	directly	ADV
aji-158	243	11	suppress	suppress	VERB
aji-158	243	12	the	the	DET
aji-158	243	13	immunoreactivity	immunoreactivity	NOUN
aji-158	243	14	evaluated	evaluate	VERB
aji-158	243	15	by	by	ADP
aji-158	243	16	the	the	DET
aji-158	243	17	assays	assay	NOUN
aji-158	243	18	,	,	PUNCT
aji-158	243	19	leading	lead	VERB
aji-158	243	20	to	to	ADP
aji-158	243	21	more	more	ADJ
aji-158	243	22	studies	study	NOUN
aji-158	243	23	about	about	ADP
aji-158	243	24	their	their	PRON
aji-158	243	25	alleged	allege	VERB
aji-158	243	26	downregulation	downregulation	NOUN
aji-158	243	27	effects	effect	NOUN
aji-158	243	28	over	over	ADP
aji-158	243	29	inflammatory	inflammatory	ADJ
aji-158	243	30	chemokines	chemokine	NOUN
aji-158	243	31	and	and	CCONJ
aji-158	243	32	immune	immune	ADJ
aji-158	243	33	cells	cell	NOUN
aji-158	243	34	,	,	PUNCT
aji-158	243	35	as	as	SCONJ
aji-158	243	36	reported	report	VERB
aji-158	243	37	in	in	ADP
aji-158	243	38	animal	animal	NOUN
aji-158	243	39	studies	study	NOUN
aji-158	243	40	.	.	PUNCT
aji-158	244	1	endotyping	endotype	VERB
aji-158	244	2	cellular	cellular	ADJ
aji-158	244	3	and	and	CCONJ
aji-158	244	4	humoral	humoral	ADJ
aji-158	244	5	immunoreactivity	immunoreactivity	NOUN
aji-158	244	6	biomarkers	biomarker	NOUN
aji-158	244	7	against	against	ADP
aji-158	244	8	specific	specific	ADJ
aji-158	244	9	allergens	allergen	NOUN
aji-158	244	10	,	,	PUNCT
aji-158	244	11	haptens	hapten	NOUN
aji-158	244	12	,	,	PUNCT
aji-158	244	13	and	and	CCONJ
aji-158	244	14	their	their	PRON
aji-158	244	15	respective	respective	ADJ
aji-158	244	16	crossreactivities	crossreactivitie	NOUN
aji-158	244	17	are	be	AUX
aji-158	244	18	tools	tool	NOUN
aji-158	244	19	to	to	PART
aji-158	244	20	build	build	VERB
aji-158	244	21	effective	effective	ADJ
aji-158	244	22	strategies	strategy	NOUN
aji-158	244	23	to	to	PART
aji-158	244	24	personalize	personalize	VERB
aji-158	244	25	exclusion	exclusion	NOUN
aji-158	244	26	diets	diet	NOUN
aji-158	244	27	and	and	CCONJ
aji-158	244	28	desensitization	desensitization	NOUN
aji-158	244	29	treatments	treatment	NOUN
aji-158	244	30	for	for	ADP
aji-158	244	31	allergic	allergic	ADJ
aji-158	244	32	patients	patient	NOUN
aji-158	244	33	(	(	PUNCT
aji-158	244	34	agache	agache	NOUN
aji-158	244	35	&	&	CCONJ
aji-158	244	36	akdis	akdis	PROPN
aji-158	244	37	,	,	PUNCT
aji-158	244	38	2020	2020	NUM
aji-158	244	39	;	;	PUNCT
aji-158	244	40	khan	khan	PROPN
aji-158	244	41	,	,	PUNCT
aji-158	244	42	2016	2016	NUM
aji-158	244	43	)	)	PUNCT
aji-158	244	44	.	.	PUNCT
aji-158	245	1	due	due	ADP
aji-158	245	2	to	to	ADP
aji-158	245	3	the	the	DET
aji-158	245	4	facility	facility	NOUN
aji-158	245	5	's	's	PART
aji-158	245	6	ability	ability	NOUN
aji-158	245	7	to	to	PART
aji-158	245	8	diagnose	diagnose	VERB
aji-158	245	9	hypersensitivities	hypersensitivity	NOUN
aji-158	245	10	associated	associate	VERB
aji-158	245	11	with	with	ADP
aji-158	245	12	the	the	DET
aji-158	245	13	ige	ige	NOUN
aji-158	245	14	-	-	PUNCT
aji-158	245	15	mediated	mediate	VERB
aji-158	245	16	endotype	endotype	NOUN
aji-158	245	17	,	,	PUNCT
aji-158	245	18	there	there	PRON
aji-158	245	19	is	be	VERB
aji-158	245	20	a	a	DET
aji-158	245	21	tendentious	tendentious	ADJ
aji-158	245	22	bias	bias	NOUN
aji-158	245	23	among	among	ADP
aji-158	245	24	physicians	physician	NOUN
aji-158	245	25	to	to	PART
aji-158	245	26	just	just	ADV
aji-158	245	27	"	"	PUNCT
aji-158	245	28	ignore	ignore	VERB
aji-158	245	29	"	"	PUNCT
aji-158	245	30	the	the	DET
aji-158	245	31	non	non	ADJ
aji-158	245	32	-	-	ADJ
aji-158	245	33	ige	ige	ADJ
aji-158	245	34	-	-	PUNCT
aji-158	245	35	mediated	mediate	VERB
aji-158	245	36	mechanisms	mechanism	NOUN
aji-158	245	37	(	(	PUNCT
aji-158	245	38	zhang	zhang	X
aji-158	245	39	et	et	PROPN
aji-158	245	40	al	al	PROPN
aji-158	245	41	.	.	PROPN
aji-158	245	42	,	,	PUNCT
aji-158	245	43	2024	2024	NUM
aji-158	245	44	)	)	PUNCT
aji-158	245	45	.	.	PUNCT
aji-158	246	1	to	to	PART
aji-158	246	2	demonstrate	demonstrate	VERB
aji-158	246	3	a	a	DET
aji-158	246	4	non	non	ADJ
aji-158	246	5	–	–	PUNCT
aji-158	246	6	igemediated	igemediate	VERB
aji-158	246	7	allergic	allergic	ADJ
aji-158	246	8	endotype	endotype	NOUN
aji-158	246	9	,	,	PUNCT
aji-158	246	10	sometimes	sometimes	ADV
aji-158	246	11	it	it	PRON
aji-158	246	12	is	be	AUX
aji-158	246	13	necessary	necessary	ADJ
aji-158	246	14	to	to	PART
aji-158	246	15	employ	employ	VERB
aji-158	246	16	a	a	DET
aji-158	246	17	multi	multi	ADJ
aji-158	246	18	-	-	ADJ
aji-158	246	19	omics	omics	ADJ
aji-158	246	20	approach	approach	NOUN
aji-158	246	21	to	to	PART
aji-158	246	22	differentiate	differentiate	VERB
aji-158	246	23	the	the	DET
aji-158	246	24	variety	variety	NOUN
aji-158	246	25	of	of	ADP
aji-158	246	26	clinical	clinical	ADJ
aji-158	246	27	phenotypes	phenotype	NOUN
aji-158	246	28	and	and	CCONJ
aji-158	246	29	immune	immune	ADJ
aji-158	246	30	endotypes	endotype	NOUN
aji-158	246	31	(	(	PUNCT
aji-158	246	32	macowan	macowan	ADV
aji-158	246	33	et	et	PROPN
aji-158	246	34	al	al	PROPN
aji-158	246	35	.	.	PROPN
aji-158	246	36	,	,	PUNCT
aji-158	246	37	2025	2025	NUM
aji-158	246	38	;	;	PUNCT
aji-158	246	39	yoon	yoon	PROPN
aji-158	246	40	&	&	CCONJ
aji-158	246	41	bunyavanich	bunyavanich	PROPN
aji-158	246	42	,	,	PUNCT
aji-158	246	43	2025	2025	NUM
aji-158	246	44	)	)	PUNCT
aji-158	246	45	.	.	PUNCT
aji-158	247	1	the	the	DET
aji-158	247	2	substantial	substantial	ADJ
aji-158	247	3	number	number	NOUN
aji-158	247	4	of	of	ADP
aji-158	247	5	sources	source	NOUN
aji-158	247	6	for	for	ADP
aji-158	247	7	nickel	nickel	NOUN
aji-158	247	8	is	be	AUX
aji-158	247	9	a	a	DET
aji-158	247	10	confounding	confound	VERB
aji-158	247	11	factor	factor	NOUN
aji-158	247	12	when	when	SCONJ
aji-158	247	13	investigating	investigate	VERB
aji-158	247	14	clinical	clinical	ADJ
aji-158	247	15	hypersensitivity	hypersensitivity	NOUN
aji-158	247	16	against	against	ADP
aji-158	247	17	this	this	DET
aji-158	247	18	hapten	hapten	NOUN
aji-158	247	19	.	.	PUNCT
aji-158	248	1	initially	initially	ADV
aji-158	248	2	,	,	PUNCT
aji-158	248	3	it	it	PRON
aji-158	248	4	may	may	AUX
aji-158	248	5	appear	appear	VERB
aji-158	248	6	to	to	PART
aji-158	248	7	be	be	AUX
aji-158	248	8	a	a	DET
aji-158	248	9	polysensitization	polysensitization	NOUN
aji-158	248	10	picture	picture	NOUN
aji-158	248	11	since	since	SCONJ
aji-158	248	12	the	the	DET
aji-158	248	13	patients	patient	NOUN
aji-158	248	14	react	react	VERB
aji-158	248	15	to	to	ADP
aji-158	248	16	a	a	DET
aji-158	248	17	confounder	confounder	NOUN
aji-158	248	18	number	number	NOUN
aji-158	248	19	of	of	ADP
aji-158	248	20	unrelated	unrelated	ADJ
aji-158	248	21	sources	source	NOUN
aji-158	248	22	.	.	PUNCT
aji-158	249	1	the	the	DET
aji-158	249	2	patient	patient	NOUN
aji-158	249	3	may	may	AUX
aji-158	249	4	also	also	ADV
aji-158	249	5	present	present	VERB
aji-158	249	6	unrelated	unrelated	ADJ
aji-158	249	7	symptoms	symptom	NOUN
aji-158	249	8	,	,	PUNCT
aji-158	249	9	leading	lead	VERB
aji-158	249	10	to	to	ADP
aji-158	249	11	the	the	DET
aji-158	249	12	diagnosis	diagnosis	NOUN
aji-158	249	13	of	of	ADP
aji-158	249	14	several	several	ADJ
aji-158	249	15	allergic	allergic	ADJ
aji-158	249	16	phenotypes	phenotype	NOUN
aji-158	249	17	.	.	PUNCT
aji-158	250	1	until	until	ADP
aji-158	250	2	the	the	DET
aji-158	250	3	conclusion	conclusion	NOUN
aji-158	250	4	that	that	SCONJ
aji-158	250	5	all	all	DET
aji-158	250	6	phenotypes	phenotype	NOUN
aji-158	250	7	are	be	AUX
aji-158	250	8	produced	produce	VERB
aji-158	250	9	by	by	ADP
aji-158	250	10	only	only	ADV
aji-158	250	11	one	one	NUM
aji-158	250	12	endotype	endotype	NOUN
aji-158	250	13	mechanism	mechanism	NOUN
aji-158	250	14	elicited	elicit	VERB
aji-158	250	15	by	by	ADP
aji-158	250	16	only	only	ADV
aji-158	250	17	one	one	NUM
aji-158	250	18	allergen	allergen	NOUN
aji-158	250	19	,	,	PUNCT
aji-158	250	20	it	it	PRON
aji-158	250	21	is	be	AUX
aji-158	250	22	usually	usually	ADV
aji-158	250	23	a	a	DET
aji-158	250	24	long	long	ADJ
aji-158	250	25	journey	journey	NOUN
aji-158	250	26	requiring	require	VERB
aji-158	250	27	complex	complex	ADJ
aji-158	250	28	dietary	dietary	ADJ
aji-158	250	29	interventions	intervention	NOUN
aji-158	250	30	(	(	PUNCT
aji-158	250	31	mikajiri	mikajiri	X
aji-158	250	32	et	et	PROPN
aji-158	250	33	al	al	PROPN
aji-158	250	34	.	.	PROPN
aji-158	250	35	,	,	PUNCT
aji-158	250	36	2024	2024	NUM
aji-158	250	37	)	)	PUNCT
aji-158	250	38	.	.	PUNCT
aji-158	251	1	olivier	olivier	PROPN
aji-158	251	2	et	et	PROPN
aji-158	251	3	al	al	PROPN
aji-158	251	4	.	.	PROPN
aji-158	251	5	;	;	PUNCT
aji-158	251	6	asian	asian	PROPN
aji-158	251	7	j.	j.	PROPN
aji-158	251	8	immunol	immunol	PROPN
aji-158	251	9	.	.	PROPN
aji-158	251	10	,	,	PUNCT
aji-158	251	11	vol	vol	NOUN
aji-158	251	12	.	.	PROPN
aji-158	251	13	8	8	NUM
aji-158	251	14	,	,	PUNCT
aji-158	251	15	no	no	INTJ
aji-158	251	16	.	.	NOUN
aji-158	251	17	1	1	NUM
aji-158	251	18	,	,	PUNCT
aji-158	251	19	pp	pp	ADJ
aji-158	251	20	.	.	PUNCT
aji-158	252	1	35	35	NUM
aji-158	252	2	-	-	SYM
aji-158	252	3	49	49	NUM
aji-158	252	4	,	,	PUNCT
aji-158	252	5	2025	2025	NUM
aji-158	252	6	;	;	PUNCT
aji-158	252	7	article	article	NOUN
aji-158	252	8	no.aji.133582	no.aji.133582	NOUN
aji-158	252	9	43	43	NUM
aji-158	252	10	as	as	ADP
aji-158	252	11	a	a	DET
aji-158	252	12	hapten	hapten	NOUN
aji-158	252	13	,	,	PUNCT
aji-158	252	14	even	even	ADV
aji-158	252	15	in	in	ADP
aji-158	252	16	the	the	DET
aji-158	252	17	presence	presence	NOUN
aji-158	252	18	of	of	ADP
aji-158	252	19	an	an	DET
aji-158	252	20	igemediated	igemediate	VERB
aji-158	252	21	hypersensitivity	hypersensitivity	NOUN
aji-158	252	22	,	,	PUNCT
aji-158	252	23	it	it	PRON
aji-158	252	24	is	be	AUX
aji-158	252	25	almost	almost	ADV
aji-158	252	26	impossible	impossible	ADJ
aji-158	252	27	to	to	PART
aji-158	252	28	develop	develop	VERB
aji-158	252	29	a	a	DET
aji-158	252	30	specific	specific	ADJ
aji-158	252	31	ige	ige	NOUN
aji-158	252	32	-	-	PUNCT
aji-158	252	33	antibody	antibody	NOUN
aji-158	252	34	for	for	ADP
aji-158	252	35	a	a	DET
aji-158	252	36	commercial	commercial	ADJ
aji-158	252	37	immunoassay	immunoassay	NOUN
aji-158	252	38	against	against	ADP
aji-158	252	39	the	the	DET
aji-158	252	40	multitude	multitude	NOUN
aji-158	252	41	of	of	ADP
aji-158	252	42	carrier	carrier	NOUN
aji-158	252	43	-	-	PUNCT
aji-158	252	44	haptens	haptens	PROPN
aji-158	252	45	conjugates	conjugate	NOUN
aji-158	252	46	that	that	PRON
aji-158	252	47	may	may	AUX
aji-158	252	48	be	be	AUX
aji-158	252	49	produced	produce	VERB
aji-158	252	50	once	once	SCONJ
aji-158	252	51	nickel	nickel	NOUN
aji-158	252	52	gains	gain	VERB
aji-158	252	53	blood	blood	NOUN
aji-158	252	54	circulation	circulation	NOUN
aji-158	252	55	and	and	CCONJ
aji-158	252	56	conjugates	conjugate	NOUN
aji-158	252	57	with	with	ADP
aji-158	252	58	albumin	albumin	ADJ
aji-158	252	59	,	,	PUNCT
aji-158	252	60	nickeloplasmin	nickeloplasmin	NOUN
aji-158	252	61	,	,	PUNCT
aji-158	252	62	or	or	CCONJ
aji-158	252	63	another	another	DET
aji-158	252	64	serum	serum	NOUN
aji-158	252	65	protein	protein	NOUN
aji-158	252	66	(	(	PUNCT
aji-158	252	67	barceloux	barceloux	VERB
aji-158	252	68	,	,	PUNCT
aji-158	252	69	1999	1999	NUM
aji-158	252	70	)	)	PUNCT
aji-158	252	71	.	.	PUNCT
aji-158	253	1	the	the	DET
aji-158	253	2	best	good	ADJ
aji-158	253	3	strategy	strategy	NOUN
aji-158	253	4	is	be	AUX
aji-158	253	5	to	to	PART
aji-158	253	6	challenge	challenge	VERB
aji-158	253	7	the	the	DET
aji-158	253	8	patients	patient	NOUN
aji-158	253	9	'	'	PART
aji-158	253	10	living	live	VERB
aji-158	253	11	plasma	plasma	NOUN
aji-158	253	12	(	(	PUNCT
aji-158	253	13	ex	ex	X
aji-158	253	14	vivo	vivo	NOUN
aji-158	253	15	)	)	PUNCT
aji-158	253	16	or	or	CCONJ
aji-158	253	17	fresh	fresh	ADJ
aji-158	253	18	serum	serum	NOUN
aji-158	253	19	(	(	PUNCT
aji-158	253	20	in	in	ADP
aji-158	253	21	vitro	vitro	X
aji-158	253	22	)	)	PUNCT
aji-158	253	23	with	with	ADP
aji-158	253	24	nickel	nickel	NOUN
aji-158	253	25	solution	solution	NOUN
aji-158	253	26	and	and	CCONJ
aji-158	253	27	quantify	quantify	VERB
aji-158	253	28	the	the	DET
aji-158	253	29	resulting	result	VERB
aji-158	253	30	immunoreactivity	immunoreactivity	NOUN
aji-158	253	31	.	.	PUNCT
aji-158	254	1	the	the	DET
aji-158	254	2	correlation	correlation	NOUN
aji-158	254	3	and	and	CCONJ
aji-158	254	4	the	the	DET
aji-158	254	5	distribution	distribution	NOUN
aji-158	254	6	of	of	ADP
aji-158	254	7	simultaneous	simultaneous	ADJ
aji-158	254	8	positive	positive	ADJ
aji-158	254	9	specific	specific	ADJ
aji-158	254	10	ige	ige	NOUN
aji-158	254	11	against	against	ADP
aji-158	254	12	food	food	NOUN
aji-158	254	13	and	and	CCONJ
aji-158	254	14	inhalant	inhalant	NOUN
aji-158	254	15	allergens	allergen	NOUN
aji-158	254	16	is	be	AUX
aji-158	254	17	usually	usually	ADV
aji-158	254	18	weak	weak	ADJ
aji-158	254	19	.	.	PUNCT
aji-158	255	1	however	however	ADV
aji-158	255	2	,	,	PUNCT
aji-158	255	3	polysensitization	polysensitization	NOUN
aji-158	255	4	is	be	AUX
aji-158	255	5	more	more	ADJ
aji-158	255	6	of	of	ADP
aji-158	255	7	a	a	DET
aji-158	255	8	rule	rule	NOUN
aji-158	255	9	than	than	ADP
aji-158	255	10	an	an	DET
aji-158	255	11	exception	exception	NOUN
aji-158	255	12	(	(	PUNCT
aji-158	255	13	zhang	zhang	X
aji-158	255	14	et	et	PROPN
aji-158	255	15	al	al	PROPN
aji-158	255	16	.	.	PROPN
aji-158	255	17	,	,	PUNCT
aji-158	255	18	2025	2025	NUM
aji-158	255	19	;	;	PUNCT
aji-158	255	20	čelakovská	čelakovská	PROPN
aji-158	255	21	et	et	PROPN
aji-158	255	22	al	al	PROPN
aji-158	255	23	.	.	PROPN
aji-158	255	24	,	,	PUNCT
aji-158	255	25	2024	2024	NUM
aji-158	255	26	)	)	PUNCT
aji-158	255	27	.	.	PUNCT
aji-158	256	1	the	the	DET
aji-158	256	2	research	research	NOUN
aji-158	256	3	of	of	ADP
aji-158	256	4	precipitins	precipitin	NOUN
aji-158	256	5	is	be	AUX
aji-158	256	6	the	the	DET
aji-158	256	7	pioneering	pioneer	VERB
aji-158	256	8	laboratory	laboratory	NOUN
aji-158	256	9	exam	exam	NOUN
aji-158	256	10	upon	upon	SCONJ
aji-158	256	11	which	which	PRON
aji-158	256	12	the	the	DET
aji-158	256	13	bases	basis	NOUN
aji-158	256	14	of	of	ADP
aji-158	256	15	immunology	immunology	NOUN
aji-158	256	16	were	be	AUX
aji-158	256	17	constructed	construct	VERB
aji-158	256	18	(	(	PUNCT
aji-158	256	19	wells	well	NOUN
aji-158	256	20	,	,	PUNCT
aji-158	256	21	1911	1911	NUM
aji-158	256	22	)	)	PUNCT
aji-158	256	23	.	.	PUNCT
aji-158	257	1	precipitating	precipitate	VERB
aji-158	257	2	antibodies	antibody	NOUN
aji-158	257	3	testifies	testify	VERB
aji-158	257	4	a	a	DET
aji-158	257	5	humoral	humoral	ADJ
aji-158	257	6	immune	immune	ADJ
aji-158	257	7	response	response	NOUN
aji-158	257	8	against	against	ADP
aji-158	257	9	the	the	DET
aji-158	257	10	tested	test	VERB
aji-158	257	11	antigens	antigen	NOUN
aji-158	257	12	(	(	PUNCT
aji-158	257	13	gell	gell	NOUN
aji-158	257	14	et	et	NOUN
aji-158	257	15	al	al	PROPN
aji-158	257	16	.	.	PROPN
aji-158	257	17	,1946	,1946	PROPN
aji-158	257	18	)	)	PUNCT
aji-158	257	19	.	.	PUNCT
aji-158	258	1	before	before	ADP
aji-158	258	2	the	the	DET
aji-158	258	3	discovery	discovery	NOUN
aji-158	258	4	of	of	ADP
aji-158	258	5	ige	ige	PROPN
aji-158	258	6	,	,	PUNCT
aji-158	258	7	the	the	DET
aji-158	258	8	research	research	NOUN
aji-158	258	9	of	of	ADP
aji-158	258	10	precipitins	precipitin	NOUN
aji-158	258	11	was	be	AUX
aji-158	258	12	the	the	DET
aji-158	258	13	leading	lead	VERB
aji-158	258	14	way	way	NOUN
aji-158	258	15	to	to	PART
aji-158	258	16	realize	realize	VERB
aji-158	258	17	in	in	ADP
aji-158	258	18	vitro	vitro	X
aji-158	258	19	diagnosis	diagnosis	NOUN
aji-158	258	20	of	of	ADP
aji-158	258	21	immunoreactivity	immunoreactivity	NOUN
aji-158	258	22	against	against	ADP
aji-158	258	23	allergens	allergen	NOUN
aji-158	258	24	(	(	PUNCT
aji-158	258	25	augustin	augustin	PROPN
aji-158	258	26	&	&	CCONJ
aji-158	258	27	hayward	hayward	PROPN
aji-158	258	28	,	,	PUNCT
aji-158	258	29	1960	1960	NUM
aji-158	258	30	;	;	PUNCT
aji-158	258	31	augustin	augustin	PROPN
aji-158	258	32	et	et	PROPN
aji-158	258	33	al	al	PROPN
aji-158	258	34	.	.	PROPN
aji-158	258	35	,1960a	,1960a	PROPN
aji-158	258	36	;	;	PUNCT
aji-158	258	37	augustin	augustin	PROPN
aji-158	258	38	,	,	PUNCT
aji-158	258	39	1953	1953	NUM
aji-158	258	40	)	)	PUNCT
aji-158	258	41	.	.	PUNCT
aji-158	259	1	precipitins	precipitin	NOUN
aji-158	259	2	against	against	ADP
aji-158	259	3	food	food	NOUN
aji-158	259	4	proteins	protein	NOUN
aji-158	259	5	and	and	CCONJ
aji-158	259	6	circulating	circulating	ADJ
aji-158	259	7	immune	immune	ADJ
aji-158	259	8	complexes	complex	NOUN
aji-158	259	9	are	be	AUX
aji-158	259	10	strongly	strongly	ADV
aji-158	259	11	associated	associate	VERB
aji-158	259	12	with	with	ADP
aji-158	259	13	patients	patient	NOUN
aji-158	259	14	with	with	ADP
aji-158	259	15	selective	selective	ADJ
aji-158	259	16	iga	iga	PROPN
aji-158	259	17	deficiency	deficiency	NOUN
aji-158	259	18	since	since	SCONJ
aji-158	259	19	the	the	DET
aji-158	259	20	secretory	secretory	NOUN
aji-158	259	21	iga	iga	PROPN
aji-158	259	22	is	be	AUX
aji-158	259	23	one	one	NUM
aji-158	259	24	of	of	ADP
aji-158	259	25	the	the	DET
aji-158	259	26	main	main	ADJ
aji-158	259	27	participants	participant	NOUN
aji-158	259	28	of	of	ADP
aji-158	259	29	the	the	DET
aji-158	259	30	mechanism	mechanism	NOUN
aji-158	259	31	of	of	ADP
aji-158	259	32	immune	immune	ADJ
aji-158	259	33	exclusion	exclusion	NOUN
aji-158	259	34	promoted	promote	VERB
aji-158	259	35	into	into	ADP
aji-158	259	36	the	the	DET
aji-158	259	37	intestinal	intestinal	ADJ
aji-158	259	38	lumen	luman	NOUN
aji-158	259	39	to	to	PART
aji-158	259	40	prevent	prevent	VERB
aji-158	259	41	the	the	DET
aji-158	259	42	absorption	absorption	NOUN
aji-158	259	43	of	of	ADP
aji-158	259	44	undigested	undigested	ADJ
aji-158	259	45	proteins	protein	NOUN
aji-158	259	46	to	to	ADP
aji-158	259	47	blood	blood	NOUN
aji-158	259	48	circulation	circulation	NOUN
aji-158	259	49	(	(	PUNCT
aji-158	259	50	cunningham	cunningham	PROPN
aji-158	259	51	-	-	PUNCT
aji-158	259	52	rundles	rundle	NOUN
aji-158	259	53	et	et	PROPN
aji-158	259	54	al	al	PROPN
aji-158	259	55	.	.	PROPN
aji-158	259	56	,	,	PUNCT
aji-158	259	57	1978	1978	NUM
aji-158	259	58	)	)	PUNCT
aji-158	259	59	.	.	PUNCT
aji-158	260	1	primary	primary	ADJ
aji-158	260	2	selective	selective	ADJ
aji-158	260	3	immune	immune	ADJ
aji-158	260	4	deficiencies	deficiency	NOUN
aji-158	260	5	(	(	PUNCT
aji-158	260	6	such	such	ADJ
aji-158	260	7	as	as	ADP
aji-158	260	8	iga	iga	PROPN
aji-158	260	9	or	or	CCONJ
aji-158	260	10	ige	ige	PROPN
aji-158	260	11	)	)	PUNCT
aji-158	260	12	lead	lead	VERB
aji-158	260	13	to	to	ADP
aji-158	260	14	immune	immune	ADJ
aji-158	260	15	dysregulation	dysregulation	NOUN
aji-158	260	16	,	,	PUNCT
aji-158	260	17	a	a	DET
aji-158	260	18	concept	concept	NOUN
aji-158	260	19	that	that	PRON
aji-158	260	20	is	be	AUX
aji-158	260	21	evolving	evolve	VERB
aji-158	260	22	as	as	ADP
aji-158	260	23	specific	specific	ADJ
aji-158	260	24	endotypes	endotype	NOUN
aji-158	260	25	associated	associate	VERB
aji-158	260	26	with	with	ADP
aji-158	260	27	secondary	secondary	ADJ
aji-158	260	28	immunodeficiencies	immunodeficiency	NOUN
aji-158	260	29	raised	raise	VERB
aji-158	260	30	by	by	ADP
aji-158	260	31	the	the	DET
aji-158	260	32	inflammatory	inflammatory	ADJ
aji-158	260	33	conditions	condition	NOUN
aji-158	260	34	provided	provide	VERB
aji-158	260	35	by	by	ADP
aji-158	260	36	the	the	DET
aji-158	260	37	allergic	allergic	ADJ
aji-158	260	38	reactions	reaction	NOUN
aji-158	260	39	(	(	PUNCT
aji-158	260	40	henrickson	henrickson	NOUN
aji-158	260	41	,	,	PUNCT
aji-158	260	42	2025	2025	NUM
aji-158	260	43	;	;	PUNCT
aji-158	260	44	olivier	olivier	PROPN
aji-158	260	45	et	et	PROPN
aji-158	260	46	al	al	PROPN
aji-158	260	47	.	.	PROPN
aji-158	260	48	,	,	PUNCT
aji-158	260	49	2023	2023	NUM
aji-158	260	50	g	g	NOUN
aji-158	260	51	;	;	PUNCT
aji-158	260	52	sapartini	sapartini	NOUN
aji-158	260	53	et	et	PROPN
aji-158	260	54	al	al	PROPN
aji-158	260	55	.	.	PROPN
aji-158	260	56	,	,	PUNCT
aji-158	260	57	2025	2025	NUM
aji-158	260	58	)	)	PUNCT
aji-158	260	59	.	.	PUNCT
aji-158	261	1	the	the	DET
aji-158	261	2	lait	lait	NOUN
aji-158	261	3	was	be	AUX
aji-158	261	4	designed	design	VERB
aji-158	261	5	as	as	ADP
aji-158	261	6	an	an	DET
aji-158	261	7	ex	ex	X
aji-158	261	8	vivo	vivo	NOUN
aji-158	261	9	challenge	challenge	NOUN
aji-158	261	10	test	test	NOUN
aji-158	261	11	performed	perform	VERB
aji-158	261	12	with	with	ADP
aji-158	261	13	a	a	DET
aji-158	261	14	viable	viable	ADJ
aji-158	261	15	leukocyte	leukocyte	NOUN
aji-158	261	16	buffy	buffy	NOUN
aji-158	261	17	coat	coat	NOUN
aji-158	261	18	exploring	explore	VERB
aji-158	261	19	several	several	ADJ
aji-158	261	20	immune	immune	ADJ
aji-158	261	21	pathways	pathway	NOUN
aji-158	261	22	,	,	PUNCT
aji-158	261	23	resulting	result	VERB
aji-158	261	24	in	in	ADP
aji-158	261	25	a	a	DET
aji-158	261	26	final	final	ADJ
aji-158	261	27	result	result	NOUN
aji-158	261	28	quantified	quantify	VERB
aji-158	261	29	as	as	ADP
aji-158	261	30	the	the	DET
aji-158	261	31	allergen	allergen	NOUN
aji-158	261	32	-	-	PUNCT
aji-158	261	33	specific	specific	ADJ
aji-158	261	34	leukocyte	leukocyte	NOUN
aji-158	261	35	adherence	adherence	NOUN
aji-158	261	36	inhibition	inhibition	NOUN
aji-158	261	37	(	(	PUNCT
aji-158	261	38	olivier	olivier	PROPN
aji-158	261	39	et	et	PROPN
aji-158	261	40	al	al	PROPN
aji-158	261	41	.	.	PROPN
aji-158	261	42	2021a	2021a	NUM
aji-158	261	43	;	;	PUNCT
aji-158	261	44	thomson	thomson	PROPN
aji-158	261	45	,	,	PUNCT
aji-158	261	46	1982	1982	NUM
aji-158	261	47	;	;	PUNCT
aji-158	261	48	tong	tong	PROPN
aji-158	261	49	et	et	PROPN
aji-158	261	50	al	al	PROPN
aji-158	261	51	.	.	PROPN
aji-158	261	52	,	,	PUNCT
aji-158	261	53	1979	1979	NUM
aji-158	261	54	;	;	PUNCT
aji-158	261	55	fink	fink	PROPN
aji-158	261	56	et	et	PROPN
aji-158	261	57	al	al	PROPN
aji-158	261	58	.	.	PROPN
aji-158	261	59	,	,	PUNCT
aji-158	261	60	1987	1987	NUM
aji-158	261	61	;	;	PUNCT
aji-158	262	1	halliday	halliday	PROPN
aji-158	262	2	et	et	PROPN
aji-158	262	3	al	al	PROPN
aji-158	262	4	.	.	PROPN
aji-158	262	5	,1974	,1974	PUNCT
aji-158	262	6	)	)	PUNCT
aji-158	262	7	.	.	PUNCT
aji-158	263	1	the	the	DET
aji-158	263	2	comparative	comparative	ADJ
aji-158	263	3	results	result	NOUN
aji-158	263	4	obtained	obtain	VERB
aji-158	263	5	from	from	ADP
aji-158	263	6	the	the	DET
aji-158	263	7	tial	tial	ADJ
aji-158	263	8	cohort	cohort	NOUN
aji-158	263	9	demonstrated	demonstrate	VERB
aji-158	263	10	a	a	DET
aji-158	263	11	more	more	ADV
aji-158	263	12	significative	significative	ADJ
aji-158	263	13	immunoreactivity	immunoreactivity	NOUN
aji-158	263	14	from	from	ADP
aji-158	263	15	the	the	DET
aji-158	263	16	tests	test	NOUN
aji-158	263	17	performed	perform	VERB
aji-158	263	18	with	with	ADP
aji-158	263	19	cocoa	cocoa	NOUN
aji-158	263	20	extract	extract	NOUN
aji-158	263	21	than	than	ADP
aji-158	263	22	those	those	PRON
aji-158	263	23	obtained	obtain	VERB
aji-158	263	24	with	with	ADP
aji-158	263	25	the	the	DET
aji-158	263	26	nickel	nickel	NOUN
aji-158	263	27	solution	solution	NOUN
aji-158	263	28	.	.	PUNCT
aji-158	264	1	this	this	DET
aji-158	264	2	finding	find	VERB
aji-158	264	3	states	state	VERB
aji-158	264	4	that	that	SCONJ
aji-158	264	5	cocoas	cocoas	NOUN
aji-158	264	6	possess	possess	NOUN
aji-158	264	7	more	more	ADJ
aji-158	264	8	allergens	allergen	NOUN
aji-158	264	9	responsible	responsible	ADJ
aji-158	264	10	for	for	ADP
aji-158	264	11	cellular	cellular	ADJ
aji-158	264	12	immunoreactivity	immunoreactivity	NOUN
aji-158	264	13	besides	besides	SCONJ
aji-158	264	14	nickel	nickel	NOUN
aji-158	264	15	.	.	PUNCT
aji-158	265	1	this	this	PRON
aji-158	265	2	means	mean	VERB
aji-158	265	3	that	that	SCONJ
aji-158	265	4	if	if	SCONJ
aji-158	265	5	a	a	DET
aji-158	265	6	patient	patient	NOUN
aji-158	265	7	presents	present	VERB
aji-158	265	8	cellular	cellular	ADJ
aji-158	265	9	immunoreactivity	immunoreactivity	NOUN
aji-158	265	10	against	against	ADP
aji-158	265	11	cocoa	cocoa	NOUN
aji-158	265	12	,	,	PUNCT
aji-158	265	13	he	he	PRON
aji-158	265	14	/	/	SYM
aji-158	265	15	she	she	PRON
aji-158	265	16	will	will	AUX
aji-158	265	17	not	not	PART
aji-158	265	18	necessarily	necessarily	ADV
aji-158	265	19	present	present	VERB
aji-158	265	20	immunoreactivity	immunoreactivity	NOUN
aji-158	265	21	against	against	ADP
aji-158	265	22	nickel	nickel	NOUN
aji-158	265	23	;	;	PUNCT
aji-158	265	24	however	however	ADV
aji-158	265	25	,	,	PUNCT
aji-158	265	26	reciprocation	reciprocation	NOUN
aji-158	265	27	is	be	AUX
aji-158	265	28	less	less	ADV
aji-158	265	29	probable	probable	ADJ
aji-158	265	30	.	.	PUNCT
aji-158	266	1	this	this	DET
aji-158	266	2	preliminary	preliminary	ADJ
aji-158	266	3	retrospective	retrospective	ADJ
aji-158	266	4	survey	survey	NOUN
aji-158	266	5	demonstrated	demonstrate	VERB
aji-158	266	6	extensive	extensive	ADJ
aji-158	266	7	results	result	NOUN
aji-158	266	8	from	from	ADP
aji-158	266	9	the	the	DET
aji-158	266	10	ttp	ttp	NOUN
aji-158	266	11	and	and	CCONJ
aji-158	266	12	the	the	DET
aji-158	266	13	ex	ex	X
aji-158	266	14	vivo	vivo	NOUN
aji-158	266	15	challenge	challenge	NOUN
aji-158	266	16	test	test	NOUN
aji-158	266	17	monitored	monitor	VERB
aji-158	266	18	by	by	ADP
aji-158	266	19	lait	lait	NOUN
aji-158	266	20	against	against	ADP
aji-158	266	21	cocoa	cocoa	NOUN
aji-158	266	22	extract	extract	NOUN
aji-158	266	23	and	and	CCONJ
aji-158	266	24	nickel	nickel	NOUN
aji-158	266	25	solution	solution	NOUN
aji-158	266	26	in	in	ADP
aji-158	266	27	two	two	NUM
aji-158	266	28	cohorts	cohort	NOUN
aji-158	266	29	of	of	ADP
aji-158	266	30	patients	patient	NOUN
aji-158	266	31	with	with	ADP
aji-158	266	32	allergic	allergic	ADJ
aji-158	266	33	contact	contact	NOUN
aji-158	266	34	and	and	CCONJ
aji-158	266	35	atopic	atopic	NOUN
aji-158	266	36	dermatitis	dermatitis	NOUN
aji-158	266	37	.	.	PUNCT
aji-158	267	1	ttp	ttp	PROPN
aji-158	267	2	and	and	CCONJ
aji-158	267	3	lait	lait	NOUN
aji-158	267	4	are	be	AUX
aji-158	267	5	complementary	complementary	ADJ
aji-158	267	6	triage	triage	NOUN
aji-158	267	7	tests	test	NOUN
aji-158	267	8	used	use	VERB
aji-158	267	9	at	at	ADP
aji-158	267	10	our	our	PRON
aji-158	267	11	facilities	facility	NOUN
aji-158	267	12	to	to	PART
aji-158	267	13	select	select	VERB
aji-158	267	14	worthwhile	worthwhile	ADJ
aji-158	267	15	antigens	antigen	NOUN
aji-158	267	16	to	to	PART
aji-158	267	17	proceed	proceed	VERB
aji-158	267	18	with	with	ADP
aji-158	267	19	more	more	ADV
aji-158	267	20	laborious	laborious	ADJ
aji-158	267	21	in	in	ADP
aji-158	267	22	vivo	vivo	ADJ
aji-158	267	23	provocation	provocation	NOUN
aji-158	267	24	tests	test	NOUN
aji-158	267	25	when	when	SCONJ
aji-158	267	26	the	the	DET
aji-158	267	27	specific	specific	ADJ
aji-158	267	28	ige	ige	NOUN
aji-158	267	29	is	be	AUX
aji-158	267	30	undetectable	undetectable	ADJ
aji-158	267	31	.	.	PUNCT
aji-158	268	1	none	none	NOUN
aji-158	268	2	of	of	ADP
aji-158	268	3	our	our	PRON
aji-158	268	4	patients	patient	NOUN
aji-158	268	5	presented	present	VERB
aji-158	268	6	an	an	DET
aji-158	268	7	exclusive	exclusive	ADJ
aji-158	268	8	reaction	reaction	NOUN
aji-158	268	9	to	to	ADP
aji-158	268	10	these	these	DET
aji-158	268	11	allergens	allergen	NOUN
aji-158	268	12	.	.	PUNCT
aji-158	269	1	every	every	DET
aji-158	269	2	patient	patient	NOUN
aji-158	269	3	was	be	AUX
aji-158	269	4	simultaneously	simultaneously	ADV
aji-158	269	5	tested	test	VERB
aji-158	269	6	for	for	ADP
aji-158	269	7	several	several	ADJ
aji-158	269	8	chemical	chemical	ADJ
aji-158	269	9	and	and	CCONJ
aji-158	269	10	biological	biological	ADJ
aji-158	269	11	allergens	allergen	NOUN
aji-158	269	12	,	,	PUNCT
aji-158	269	13	demonstrating	demonstrate	VERB
aji-158	269	14	positive	positive	ADJ
aji-158	269	15	results	result	NOUN
aji-158	269	16	for	for	ADP
aji-158	269	17	some	some	PRON
aji-158	269	18	of	of	ADP
aji-158	269	19	them	they	PRON
aji-158	269	20	.	.	PUNCT
aji-158	270	1	5	5	X
aji-158	270	2	.	.	X
aji-158	270	3	limitations	limitation	NOUN
aji-158	270	4	this	this	DET
aji-158	270	5	study	study	NOUN
aji-158	270	6	is	be	AUX
aji-158	270	7	a	a	DET
aji-158	270	8	retrospective	retrospective	ADJ
aji-158	270	9	analysis	analysis	NOUN
aji-158	270	10	of	of	ADP
aji-158	270	11	data	datum	NOUN
aji-158	270	12	collected	collect	VERB
aji-158	270	13	over	over	ADP
aji-158	270	14	seven	seven	NUM
aji-158	270	15	years	year	NOUN
aji-158	270	16	.	.	PUNCT
aji-158	271	1	there	there	PRON
aji-158	271	2	was	be	VERB
aji-158	271	3	no	no	DET
aji-158	271	4	protocol	protocol	NOUN
aji-158	271	5	research	research	NOUN
aji-158	271	6	,	,	PUNCT
aji-158	271	7	and	and	CCONJ
aji-158	271	8	the	the	DET
aji-158	271	9	subject	subject	NOUN
aji-158	271	10	's	's	PART
aji-158	271	11	data	datum	NOUN
aji-158	271	12	was	be	AUX
aji-158	271	13	limited	limit	VERB
aji-158	271	14	to	to	ADP
aji-158	271	15	the	the	DET
aji-158	271	16	essentials	essential	NOUN
aji-158	271	17	available	available	ADJ
aji-158	271	18	on	on	ADP
aji-158	271	19	our	our	PRON
aji-158	271	20	electronic	electronic	ADJ
aji-158	271	21	sheets	sheet	NOUN
aji-158	271	22	.	.	PUNCT
aji-158	272	1	therefore	therefore	ADV
aji-158	272	2	,	,	PUNCT
aji-158	272	3	we	we	PRON
aji-158	272	4	could	could	AUX
aji-158	272	5	not	not	PART
aji-158	272	6	establish	establish	VERB
aji-158	272	7	a	a	DET
aji-158	272	8	cross	cross	NOUN
aji-158	272	9	-	-	NOUN
aji-158	272	10	comparison	comparison	NOUN
aji-158	272	11	between	between	ADP
aji-158	272	12	positive	positive	ADJ
aji-158	272	13	and	and	CCONJ
aji-158	272	14	negative	negative	ADJ
aji-158	272	15	controls	control	NOUN
aji-158	272	16	to	to	PART
aji-158	272	17	validate	validate	VERB
aji-158	272	18	the	the	DET
aji-158	272	19	results	result	NOUN
aji-158	272	20	.	.	PUNCT
aji-158	273	1	the	the	DET
aji-158	273	2	number	number	NOUN
aji-158	273	3	of	of	ADP
aji-158	273	4	subjects	subject	NOUN
aji-158	273	5	is	be	AUX
aji-158	273	6	appropriate	appropriate	ADJ
aji-158	273	7	for	for	ADP
aji-158	273	8	preliminary	preliminary	ADJ
aji-158	273	9	study	study	NOUN
aji-158	273	10	;	;	PUNCT
aji-158	273	11	however	however	ADV
aji-158	273	12	,	,	PUNCT
aji-158	273	13	future	future	ADJ
aji-158	273	14	studies	study	NOUN
aji-158	273	15	must	must	AUX
aji-158	273	16	be	be	AUX
aji-158	273	17	more	more	ADV
aji-158	273	18	comprehensive	comprehensive	ADJ
aji-158	273	19	.	.	PUNCT
aji-158	274	1	the	the	DET
aji-158	274	2	lack	lack	NOUN
aji-158	274	3	of	of	ADP
aji-158	274	4	a	a	DET
aji-158	274	5	prospective	prospective	ADJ
aji-158	274	6	research	research	NOUN
aji-158	274	7	protocol	protocol	NOUN
aji-158	274	8	implies	imply	VERB
aji-158	274	9	the	the	DET
aji-158	274	10	possibility	possibility	NOUN
aji-158	274	11	of	of	ADP
aji-158	274	12	a	a	DET
aji-158	274	13	bias	bias	NOUN
aji-158	274	14	produced	produce	VERB
aji-158	274	15	by	by	ADP
aji-158	274	16	the	the	DET
aji-158	274	17	physician	physician	NOUN
aji-158	274	18	's	's	PART
aji-158	274	19	point	point	NOUN
aji-158	274	20	of	of	ADP
aji-158	274	21	view	view	NOUN
aji-158	274	22	,	,	PUNCT
aji-158	274	23	which	which	PRON
aji-158	274	24	indicated	indicate	VERB
aji-158	274	25	the	the	DET
aji-158	274	26	exam	exam	NOUN
aji-158	274	27	was	be	AUX
aji-158	274	28	based	base	VERB
aji-158	274	29	on	on	ADP
aji-158	274	30	clinical	clinical	ADJ
aji-158	274	31	suspicion	suspicion	NOUN
aji-158	274	32	led	lead	VERB
aji-158	274	33	purely	purely	ADV
aji-158	274	34	by	by	ADP
aji-158	274	35	anamnesis	anamnesis	NOUN
aji-158	274	36	and	and	CCONJ
aji-158	274	37	physical	physical	ADJ
aji-158	274	38	examination	examination	NOUN
aji-158	274	39	.	.	PUNCT
aji-158	275	1	the	the	DET
aji-158	275	2	study	study	NOUN
aji-158	275	3	lost	lose	VERB
aji-158	275	4	many	many	ADJ
aji-158	275	5	of	of	ADP
aji-158	275	6	these	these	DET
aji-158	275	7	patients	patient	NOUN
aji-158	275	8	to	to	PART
aji-158	275	9	follow	follow	VERB
aji-158	275	10	-	-	PUNCT
aji-158	275	11	up	up	NOUN
aji-158	275	12	,	,	PUNCT
aji-158	275	13	so	so	ADV
aji-158	275	14	assuring	assure	VERB
aji-158	275	15	the	the	DET
aji-158	275	16	relationship	relationship	NOUN
aji-158	275	17	between	between	ADP
aji-158	275	18	the	the	DET
aji-158	275	19	immunoassay	immunoassay	ADJ
aji-158	275	20	results	result	NOUN
aji-158	275	21	and	and	CCONJ
aji-158	275	22	the	the	DET
aji-158	275	23	patient	patient	NOUN
aji-158	275	24	's	's	PART
aji-158	275	25	clinical	clinical	ADJ
aji-158	275	26	outcome	outcome	NOUN
aji-158	275	27	is	be	AUX
aji-158	275	28	not	not	PART
aji-158	275	29	possible	possible	ADJ
aji-158	275	30	yet	yet	ADV
aji-158	275	31	.	.	PUNCT
aji-158	276	1	the	the	DET
aji-158	276	2	two	two	NUM
aji-158	276	3	procedures	procedure	NOUN
aji-158	276	4	were	be	AUX
aji-158	276	5	not	not	PART
aji-158	276	6	compared	compare	VERB
aji-158	276	7	with	with	ADP
aji-158	276	8	paired	pair	VERB
aji-158	276	9	tests	test	NOUN
aji-158	276	10	because	because	SCONJ
aji-158	276	11	they	they	PRON
aji-158	276	12	were	be	AUX
aji-158	276	13	taken	take	VERB
aji-158	276	14	from	from	ADP
aji-158	276	15	distinct	distinct	ADJ
aji-158	276	16	groups	group	NOUN
aji-158	276	17	of	of	ADP
aji-158	276	18	patients	patient	NOUN
aji-158	276	19	.	.	PUNCT
aji-158	277	1	6	6	X
aji-158	277	2	.	.	X
aji-158	277	3	conclusion	conclusion	NOUN
aji-158	277	4	our	our	PRON
aji-158	277	5	preliminary	preliminary	ADJ
aji-158	277	6	results	result	NOUN
aji-158	277	7	show	show	VERB
aji-158	277	8	that	that	SCONJ
aji-158	277	9	the	the	DET
aji-158	277	10	lait	lait	NOUN
aji-158	277	11	and	and	CCONJ
aji-158	277	12	ttp	ttp	PROPN
aji-158	277	13	may	may	AUX
aji-158	277	14	differentiate	differentiate	VERB
aji-158	277	15	diverse	diverse	ADJ
aji-158	277	16	degrees	degree	NOUN
aji-158	277	17	of	of	ADP
aji-158	277	18	immunoreactivity	immunoreactivity	NOUN
aji-158	277	19	against	against	ADP
aji-158	277	20	cocoa	cocoa	NOUN
aji-158	277	21	extracts	extract	NOUN
aji-158	277	22	and	and	CCONJ
aji-158	277	23	nickel	nickel	NOUN
aji-158	277	24	solution	solution	NOUN
aji-158	277	25	in	in	ADP
aji-158	277	26	patients	patient	NOUN
aji-158	277	27	clinically	clinically	ADV
aji-158	277	28	diagnosed	diagnose	VERB
aji-158	277	29	with	with	ADP
aji-158	277	30	non	non	ADJ
aji-158	277	31	–	–	PUNCT
aji-158	277	32	ige	ige	ADJ
aji-158	277	33	-	-	PUNCT
aji-158	277	34	mediated	mediate	VERB
aji-158	277	35	atopic	atopic	NOUN
aji-158	277	36	and	and	CCONJ
aji-158	277	37	allergic	allergic	ADJ
aji-158	277	38	olivier	olivier	NOUN
aji-158	277	39	et	et	PROPN
aji-158	277	40	al	al	PROPN
aji-158	277	41	.	.	PROPN
aji-158	277	42	;	;	PUNCT
aji-158	277	43	asian	asian	PROPN
aji-158	277	44	j.	j.	PROPN
aji-158	277	45	immunol	immunol	PROPN
aji-158	277	46	.	.	PROPN
aji-158	277	47	,	,	PUNCT
aji-158	277	48	vol	vol	NOUN
aji-158	277	49	.	.	PROPN
aji-158	277	50	8	8	NUM
aji-158	277	51	,	,	PUNCT
aji-158	277	52	no	no	INTJ
aji-158	277	53	.	.	NOUN
aji-158	277	54	1	1	NUM
aji-158	277	55	,	,	PUNCT
aji-158	277	56	pp	pp	ADJ
aji-158	277	57	.	.	PUNCT
aji-158	278	1	35	35	NUM
aji-158	278	2	-	-	SYM
aji-158	278	3	49	49	NUM
aji-158	278	4	,	,	PUNCT
aji-158	278	5	2025	2025	NUM
aji-158	279	1	;	;	PUNCT
aji-158	279	2	article	article	NOUN
aji-158	279	3	no.aji.133582	no.aji.133582	NOUN
aji-158	279	4	44	44	NUM
aji-158	279	5	contact	contact	NOUN
aji-158	279	6	dermatitis	dermatitis	NOUN
aji-158	279	7	.	.	PUNCT
aji-158	280	1	tial	tial	PROPN
aji-158	280	2	and	and	CCONJ
aji-158	280	3	ttp	ttp	PROPN
aji-158	280	4	are	be	AUX
aji-158	280	5	inexpensive	inexpensive	ADJ
aji-158	280	6	,	,	PUNCT
aji-158	280	7	can	can	AUX
aji-158	280	8	be	be	AUX
aji-158	280	9	performed	perform	VERB
aji-158	280	10	with	with	ADP
aji-158	280	11	minimum	minimum	ADJ
aji-158	280	12	laboratory	laboratory	NOUN
aji-158	280	13	equipment	equipment	NOUN
aji-158	280	14	,	,	PUNCT
aji-158	280	15	and	and	CCONJ
aji-158	280	16	can	can	AUX
aji-158	280	17	be	be	AUX
aji-158	280	18	incorporated	incorporate	VERB
aji-158	280	19	into	into	ADP
aji-158	280	20	strategies	strategy	NOUN
aji-158	280	21	to	to	PART
aji-158	280	22	address	address	VERB
aji-158	280	23	health	health	NOUN
aji-158	280	24	disparities	disparity	NOUN
aji-158	280	25	in	in	ADP
aji-158	280	26	managing	manage	VERB
aji-158	280	27	allergies	allergy	NOUN
aji-158	280	28	(	(	PUNCT
aji-158	280	29	anagnostou	anagnostou	PROPN
aji-158	280	30	et	et	PROPN
aji-158	280	31	al	al	PROPN
aji-158	280	32	.	.	PROPN
aji-158	280	33	,	,	PUNCT
aji-158	280	34	2025	2025	NUM
aji-158	280	35	)	)	PUNCT
aji-158	280	36	.	.	PUNCT
aji-158	281	1	as	as	ADP
aji-158	281	2	a	a	DET
aji-158	281	3	preliminary	preliminary	ADJ
aji-158	281	4	report	report	NOUN
aji-158	281	5	,	,	PUNCT
aji-158	281	6	the	the	DET
aji-158	281	7	propaedeutic	propaedeutic	ADJ
aji-158	281	8	meaning	meaning	NOUN
aji-158	281	9	of	of	ADP
aji-158	281	10	the	the	DET
aji-158	281	11	presented	present	VERB
aji-158	281	12	results	result	NOUN
aji-158	281	13	and	and	CCONJ
aji-158	281	14	the	the	DET
aji-158	281	15	possibility	possibility	NOUN
aji-158	281	16	of	of	ADP
aji-158	281	17	interferents	interferent	NOUN
aji-158	281	18	must	must	AUX
aji-158	281	19	be	be	AUX
aji-158	281	20	yet	yet	ADV
aji-158	281	21	established	establish	VERB
aji-158	281	22	(	(	PUNCT
aji-158	281	23	anouar	anouar	NOUN
aji-158	281	24	,	,	PUNCT
aji-158	281	25	et	et	PROPN
aji-158	281	26	al	al	PROPN
aji-158	281	27	.	.	PROPN
aji-158	281	28	,	,	PUNCT
aji-158	281	29	2024	2024	NUM
aji-158	281	30	)	)	PUNCT
aji-158	281	31	.	.	PUNCT
aji-158	282	1	more	more	ADJ
aji-158	282	2	studies	study	NOUN
aji-158	282	3	focused	focus	VERB
aji-158	282	4	on	on	ADP
aji-158	282	5	the	the	DET
aji-158	282	6	qualityby	qualityby	ADJ
aji-158	282	7	-	-	PUNCT
aji-158	282	8	design	design	NOUN
aji-158	282	9	approach	approach	NOUN
aji-158	282	10	with	with	ADP
aji-158	282	11	prospective	prospective	ADJ
aji-158	282	12	larger	large	ADJ
aji-158	282	13	double	double	ADJ
aji-158	282	14	-	-	PUNCT
aji-158	282	15	blind	blind	ADJ
aji-158	282	16	cohorts	cohort	NOUN
aji-158	282	17	need	need	VERB
aji-158	282	18	to	to	PART
aji-158	282	19	evaluate	evaluate	VERB
aji-158	282	20	the	the	DET
aji-158	282	21	potential	potential	ADJ
aji-158	282	22	contribution	contribution	NOUN
aji-158	282	23	of	of	ADP
aji-158	282	24	lait	lait	NOUN
aji-158	282	25	and	and	CCONJ
aji-158	282	26	ttp	ttp	NOUN
aji-158	282	27	for	for	ADP
aji-158	282	28	endotyping	endotype	VERB
aji-158	282	29	cellular	cellular	ADJ
aji-158	282	30	and	and	CCONJ
aji-158	282	31	humoral	humoral	ADJ
aji-158	282	32	immunoreactivity	immunoreactivity	NOUN
aji-158	282	33	in	in	ADP
aji-158	282	34	patients	patient	NOUN
aji-158	282	35	suspected	suspect	VERB
aji-158	282	36	of	of	ADP
aji-158	282	37	hypersensitivity	hypersensitivity	NOUN
aji-158	282	38	against	against	ADP
aji-158	282	39	nickel	nickel	NOUN
aji-158	282	40	and	and	CCONJ
aji-158	282	41	nickelcontaining	nickelcontaine	VERB
aji-158	282	42	foods	food	NOUN
aji-158	282	43	(	(	PUNCT
aji-158	282	44	chiarentin	chiarentin	NOUN
aji-158	282	45	et	et	PROPN
aji-158	282	46	al	al	PROPN
aji-158	282	47	.	.	PROPN
aji-158	282	48	,	,	PUNCT
aji-158	282	49	2023	2023	NUM
aji-158	282	50	)	)	PUNCT
aji-158	282	51	.	.	PUNCT
aji-158	283	1	7	7	X
aji-158	283	2	.	.	X
aji-158	283	3	future	future	ADJ
aji-158	283	4	directions	direction	NOUN
aji-158	283	5	and	and	CCONJ
aji-158	283	6	recommendations	recommendation	NOUN
aji-158	283	7	for	for	ADP
aji-158	283	8	clinical	clinical	ADJ
aji-158	283	9	practice	practice	NOUN
aji-158	283	10	the	the	DET
aji-158	283	11	primary	primary	ADJ
aji-158	283	12	intended	intend	VERB
aji-158	283	13	use	use	NOUN
aji-158	283	14	of	of	ADP
aji-158	283	15	in	in	ADP
aji-158	283	16	vitro	vitro	X
aji-158	283	17	or	or	CCONJ
aji-158	283	18	ex	ex	PRON
aji-158	283	19	vivo	vivo	NOUN
aji-158	283	20	allergen	allergen	NOUN
aji-158	283	21	challenge	challenge	NOUN
aji-158	283	22	tests	test	NOUN
aji-158	283	23	is	be	AUX
aji-158	283	24	to	to	PART
aji-158	283	25	spare	spare	VERB
aji-158	283	26	the	the	DET
aji-158	283	27	patients	patient	NOUN
aji-158	283	28	from	from	ADP
aji-158	283	29	being	be	AUX
aji-158	283	30	submitted	submit	VERB
aji-158	283	31	to	to	ADP
aji-158	283	32	unnecessary	unnecessary	ADJ
aji-158	283	33	,	,	PUNCT
aji-158	283	34	exhaustive	exhaustive	ADJ
aji-158	283	35	,	,	PUNCT
aji-158	283	36	and	and	CCONJ
aji-158	283	37	dangerous	dangerous	ADJ
aji-158	283	38	in	in	ADP
aji-158	283	39	vivo	vivo	ADJ
aji-158	283	40	challenge	challenge	NOUN
aji-158	283	41	tests	test	NOUN
aji-158	283	42	.	.	PUNCT
aji-158	284	1	exploring	explore	VERB
aji-158	284	2	the	the	DET
aji-158	284	3	humoral	humoral	ADJ
aji-158	284	4	and	and	CCONJ
aji-158	284	5	the	the	DET
aji-158	284	6	cellular	cellular	ADJ
aji-158	284	7	arms	arm	NOUN
aji-158	284	8	of	of	ADP
aji-158	284	9	immune	immune	ADJ
aji-158	284	10	systems	system	NOUN
aji-158	284	11	,	,	PUNCT
aji-158	284	12	the	the	DET
aji-158	284	13	ttp	ttp	NOUN
aji-158	284	14	and	and	CCONJ
aji-158	284	15	tial	tial	NOUN
aji-158	284	16	alone	alone	ADV
aji-158	284	17	or	or	CCONJ
aji-158	284	18	combined	combine	VERB
aji-158	284	19	may	may	AUX
aji-158	284	20	represent	represent	VERB
aji-158	284	21	,	,	PUNCT
aji-158	284	22	in	in	ADP
aji-158	284	23	the	the	DET
aji-158	284	24	near	near	ADJ
aji-158	284	25	future	future	NOUN
aji-158	284	26	,	,	PUNCT
aji-158	284	27	a	a	DET
aji-158	284	28	tool	tool	NOUN
aji-158	284	29	for	for	ADP
aji-158	284	30	allergists	allergist	NOUN
aji-158	284	31	to	to	PART
aji-158	284	32	construct	construct	VERB
aji-158	284	33	an	an	DET
aji-158	284	34	etiologic	etiologic	ADJ
aji-158	284	35	diagnosis	diagnosis	NOUN
aji-158	284	36	from	from	ADP
aji-158	284	37	their	their	PRON
aji-158	284	38	patients	patient	NOUN
aji-158	284	39	,	,	PUNCT
aji-158	284	40	as	as	ADV
aji-158	284	41	well	well	ADV
aji-158	284	42	as	as	ADP
aji-158	284	43	determine	determine	VERB
aji-158	284	44	the	the	DET
aji-158	284	45	endotypes	endotype	NOUN
aji-158	284	46	(	(	PUNCT
aji-158	284	47	mechanisms	mechanism	NOUN
aji-158	284	48	)	)	PUNCT
aji-158	284	49	of	of	ADP
aji-158	284	50	hypersensitivity	hypersensitivity	NOUN
aji-158	284	51	,	,	PUNCT
aji-158	284	52	in	in	ADP
aji-158	284	53	order	order	NOUN
aji-158	284	54	to	to	PART
aji-158	284	55	choose	choose	VERB
aji-158	284	56	more	more	ADV
aji-158	284	57	convenient	convenient	ADJ
aji-158	284	58	and	and	CCONJ
aji-158	284	59	personalized	personalized	ADJ
aji-158	284	60	therapies	therapy	NOUN
aji-158	284	61	for	for	ADP
aji-158	284	62	them	they	PRON
aji-158	284	63	.	.	PUNCT
aji-158	285	1	adding	add	VERB
aji-158	285	2	data	datum	NOUN
aji-158	285	3	provided	provide	VERB
aji-158	285	4	by	by	ADP
aji-158	285	5	ttp	ttp	PROPN
aji-158	285	6	and	and	CCONJ
aji-158	285	7	tial	tial	NOUN
aji-158	285	8	may	may	AUX
aji-158	285	9	also	also	ADV
aji-158	285	10	contribute	contribute	VERB
aji-158	285	11	to	to	ADP
aji-158	285	12	streamlining	streamline	VERB
aji-158	285	13	biomedical	biomedical	ADJ
aji-158	285	14	research	research	NOUN
aji-158	285	15	and	and	CCONJ
aji-158	285	16	improving	improve	VERB
aji-158	285	17	tools	tool	NOUN
aji-158	285	18	such	such	ADJ
aji-158	285	19	as	as	ADP
aji-158	285	20	large	large	ADJ
aji-158	285	21	language	language	NOUN
aji-158	285	22	models	model	NOUN
aji-158	285	23	,	,	PUNCT
aji-158	285	24	usually	usually	ADV
aji-158	285	25	used	use	VERB
aji-158	285	26	by	by	ADP
aji-158	285	27	clinicians	clinician	NOUN
aji-158	285	28	as	as	ADP
aji-158	285	29	a	a	DET
aji-158	285	30	decision	decision	NOUN
aji-158	285	31	support	support	NOUN
aji-158	285	32	system	system	NOUN
aji-158	285	33	to	to	PART
aji-158	285	34	enhance	enhance	VERB
aji-158	285	35	diagnostic	diagnostic	ADJ
aji-158	285	36	accuracy	accuracy	NOUN
aji-158	285	37	(	(	PUNCT
aji-158	285	38	abers	aber	NOUN
aji-158	285	39	&	&	CCONJ
aji-158	285	40	mathias	mathias	PROPN
aji-158	285	41	,	,	PUNCT
aji-158	285	42	2025	2025	NUM
aji-158	285	43	)	)	PUNCT
aji-158	285	44	.	.	PUNCT
aji-158	286	1	consent	consent	NOUN
aji-158	286	2	it	it	PRON
aji-158	286	3	is	be	AUX
aji-158	286	4	not	not	PART
aji-158	286	5	applicable	applicable	ADJ
aji-158	286	6	.	.	PUNCT
aji-158	287	1	ethical	ethical	ADJ
aji-158	287	2	approvals	approval	NOUN
aji-158	287	3	as	as	ADP
aji-158	287	4	a	a	DET
aji-158	287	5	retrospective	retrospective	ADJ
aji-158	287	6	survey	survey	NOUN
aji-158	287	7	of	of	ADP
aji-158	287	8	results	result	NOUN
aji-158	287	9	recorded	record	VERB
aji-158	287	10	in	in	ADP
aji-158	287	11	cognito	cognito	PROPN
aji-158	287	12	,	,	PUNCT
aji-158	287	13	consent	consent	NOUN
aji-158	287	14	was	be	AUX
aji-158	287	15	given	give	VERB
aji-158	287	16	collectively	collectively	ADV
aji-158	287	17	by	by	ADP
aji-158	287	18	the	the	DET
aji-158	287	19	institution	institution	NOUN
aji-158	287	20	's	's	PART
aji-158	287	21	ethics	ethic	NOUN
aji-158	287	22	committee	committee	NOUN
aji-158	287	23	following	follow	VERB
aji-158	287	24	the	the	DET
aji-158	287	25	principles	principle	NOUN
aji-158	287	26	of	of	ADP
aji-158	287	27	the	the	DET
aji-158	287	28	declaration	declaration	NOUN
aji-158	287	29	of	of	ADP
aji-158	287	30	helsinki	helsinki	PROPN
aji-158	287	31	(	(	PUNCT
aji-158	287	32	wma	wma	PROPN
aji-158	287	33	,	,	PUNCT
aji-158	287	34	2013	2013	NUM
aji-158	287	35	)	)	PUNCT
aji-158	287	36	.	.	PUNCT
aji-158	288	1	disclaimer	disclaimer	NOUN
aji-158	288	2	(	(	PUNCT
aji-158	288	3	artificial	artificial	ADJ
aji-158	288	4	intelligence	intelligence	NOUN
aji-158	288	5	)	)	PUNCT
aji-158	288	6	authors	author	NOUN
aji-158	288	7	hereby	hereby	ADV
aji-158	288	8	declare	declare	VERB
aji-158	288	9	that	that	SCONJ
aji-158	288	10	no	no	DET
aji-158	288	11	generative	generative	NOUN
aji-158	288	12	ai	ai	VERB
aji-158	288	13	technologies	technology	NOUN
aji-158	288	14	such	such	ADJ
aji-158	288	15	as	as	ADP
aji-158	288	16	large	large	ADJ
aji-158	288	17	language	language	NOUN
aji-158	288	18	models	model	NOUN
aji-158	288	19	(	(	PUNCT
aji-158	288	20	chatgpt	chatgpt	NOUN
aji-158	288	21	,	,	PUNCT
aji-158	288	22	copilot	copilot	NOUN
aji-158	288	23	,	,	PUNCT
aji-158	288	24	etc	etc	X
aji-158	288	25	.	.	X
aji-158	288	26	)	)	PUNCT
aji-158	288	27	and	and	CCONJ
aji-158	288	28	text	text	NOUN
aji-158	288	29	-	-	PUNCT
aji-158	288	30	to	to	ADP
aji-158	288	31	-	-	PUNCT
aji-158	288	32	image	image	NOUN
aji-158	288	33	generators	generator	NOUN
aji-158	288	34	have	have	AUX
aji-158	288	35	been	be	AUX
aji-158	288	36	used	use	VERB
aji-158	288	37	during	during	ADP
aji-158	288	38	the	the	DET
aji-158	288	39	writing	writing	NOUN
aji-158	288	40	or	or	CCONJ
aji-158	288	41	editing	editing	NOUN
aji-158	288	42	of	of	ADP
aji-158	288	43	this	this	DET
aji-158	288	44	manuscript	manuscript	NOUN
aji-158	288	45	.	.	PUNCT
aji-158	289	1	acknowledgements	acknowledgement	VERB
aji-158	289	2	the	the	DET
aji-158	289	3	instituto	instituto	PROPN
aji-158	289	4	alergoimuno	alergoimuno	PROPN
aji-158	289	5	de	de	PROPN
aji-158	289	6	americana	americana	PROPN
aji-158	289	7	funded	fund	VERB
aji-158	289	8	this	this	DET
aji-158	289	9	work	work	NOUN
aji-158	289	10	.	.	PUNCT
aji-158	290	1	we	we	PRON
aji-158	290	2	want	want	VERB
aji-158	290	3	to	to	PART
aji-158	290	4	thank	thank	VERB
aji-158	290	5	the	the	DET
aji-158	290	6	laboratory	laboratory	NOUN
aji-158	290	7	technicians	technician	NOUN
aji-158	290	8	alessandra	alessandra	PROPN
aji-158	290	9	vieira	vieira	PROPN
aji-158	290	10	de	de	PROPN
aji-158	290	11	oliveira	oliveira	PROPN
aji-158	290	12	and	and	CCONJ
aji-158	290	13	luciana	luciana	PROPN
aji-158	290	14	sacilotto	sacilotto	PROPN
aji-158	290	15	carvalho	carvalho	PROPN
aji-158	290	16	for	for	ADP
aji-158	290	17	their	their	PRON
aji-158	290	18	help	help	NOUN
aji-158	290	19	with	with	ADP
aji-158	290	20	the	the	DET
aji-158	290	21	exams	exam	NOUN
aji-158	290	22	.	.	PUNCT
aji-158	291	1	competing	compete	VERB
aji-158	291	2	interests	interest	NOUN
aji-158	291	3	authors	author	NOUN
aji-158	291	4	have	have	AUX
aji-158	291	5	declared	declare	VERB
aji-158	291	6	that	that	SCONJ
aji-158	291	7	no	no	DET
aji-158	291	8	competing	compete	VERB
aji-158	291	9	interests	interest	NOUN
aji-158	291	10	exist	exist	VERB
aji-158	291	11	.	.	PUNCT
aji-158	292	1	references	reference	NOUN
aji-158	292	2	abeck	abeck	PROPN
aji-158	292	3	,	,	PUNCT
aji-158	292	4	d.	d.	PROPN
aji-158	292	5	,	,	PUNCT
aji-158	292	6	traenckner	traenckner	NOUN
aji-158	292	7	,	,	PUNCT
aji-158	292	8	i.	i.	PROPN
aji-158	292	9	,	,	PUNCT
aji-158	292	10	steinkraus	steinkraus	PROPN
aji-158	292	11	,	,	PUNCT
aji-158	292	12	v.	v.	PROPN
aji-158	292	13	,	,	PUNCT
aji-158	292	14	vieluf	vieluf	PROPN
aji-158	292	15	,	,	PUNCT
aji-158	292	16	d.	d.	PROPN
aji-158	292	17	,	,	PUNCT
aji-158	292	18	&	&	CCONJ
aji-158	292	19	ring	ring	PROPN
aji-158	292	20	,	,	PUNCT
aji-158	292	21	j.	j.	PROPN
aji-158	292	22	(	(	PUNCT
aji-158	292	23	1993	1993	NUM
aji-158	292	24	)	)	PUNCT
aji-158	292	25	.	.	PUNCT
aji-158	293	1	chronic	chronic	ADJ
aji-158	293	2	urticaria	urticaria	NOUN
aji-158	293	3	due	due	ADP
aji-158	293	4	to	to	ADP
aji-158	293	5	nickel	nickel	NOUN
aji-158	293	6	intake	intake	NOUN
aji-158	293	7	.	.	PUNCT
aji-158	294	1	acta	acta	PROPN
aji-158	294	2	dermatovenereologica	dermatovenereologica	PROPN
aji-158	294	3	,	,	PUNCT
aji-158	294	4	73(6	73(6	PROPN
aji-158	294	5	):	):	PUNCT
aji-158	294	6	438	438	NUM
aji-158	294	7	-	-	SYM
aji-158	294	8	439	439	NUM
aji-158	294	9	.	.	PUNCT
aji-158	295	1	abers	aber	NOUN
aji-158	295	2	,	,	PUNCT
aji-158	295	3	m.	m.	NOUN
aji-158	295	4	s.	s.	PROPN
aji-158	295	5	,	,	PUNCT
aji-158	295	6	&	&	CCONJ
aji-158	295	7	mathias	mathias	PROPN
aji-158	295	8	,	,	PUNCT
aji-158	295	9	r.	r.	PROPN
aji-158	295	10	a.	a.	PROPN
aji-158	295	11	(	(	PUNCT
aji-158	295	12	2025	2025	NUM
aji-158	295	13	)	)	PUNCT
aji-158	295	14	.	.	PUNCT
aji-158	296	1	novel	novel	ADJ
aji-158	296	2	applications	application	NOUN
aji-158	296	3	of	of	ADP
aji-158	296	4	large	large	ADJ
aji-158	296	5	language	language	NOUN
aji-158	296	6	models	model	NOUN
aji-158	296	7	in	in	ADP
aji-158	296	8	clinical	clinical	ADJ
aji-158	296	9	research	research	NOUN
aji-158	296	10	.	.	PUNCT
aji-158	297	1	journal	journal	PROPN
aji-158	297	2	of	of	ADP
aji-158	297	3	allergy	allergy	NOUN
aji-158	297	4	and	and	CCONJ
aji-158	297	5	clinical	clinical	ADJ
aji-158	297	6	immunology	immunology	NOUN
aji-158	297	7	,	,	PUNCT
aji-158	297	8	155(3	155(3	NUM
aji-158	297	9	)	)	PUNCT
aji-158	297	10	,	,	PUNCT
aji-158	297	11	813–814	813–814	NUM
aji-158	297	12	.	.	PUNCT
aji-158	298	1	abril	abril	PROPN
aji-158	298	2	-	-	PUNCT
aji-158	298	3	gil	gil	PROPN
aji-158	298	4	,	,	PUNCT
aji-158	298	5	m.	m.	NOUN
aji-158	298	6	,	,	PUNCT
aji-158	298	7	massot	massot	NOUN
aji-158	298	8	-	-	PUNCT
aji-158	298	9	cladera	cladera	NOUN
aji-158	298	10	,	,	PUNCT
aji-158	298	11	m.	m.	NOUN
aji-158	298	12	,	,	PUNCT
aji-158	298	13	pérez	pérez	NOUN
aji-158	298	14	-	-	PUNCT
aji-158	298	15	cano	cano	PROPN
aji-158	298	16	,	,	PUNCT
aji-158	298	17	f.	f.	PROPN
aji-158	298	18	j.	j.	PROPN
aji-158	298	19	,	,	PUNCT
aji-158	298	20	castellote	castellote	NOUN
aji-158	298	21	,	,	PUNCT
aji-158	298	22	c.	c.	NOUN
aji-158	298	23	,	,	PUNCT
aji-158	298	24	franch	franch	NOUN
aji-158	298	25	,	,	PUNCT
aji-158	298	26	a.	a.	NOUN
aji-158	298	27	,	,	PUNCT
aji-158	298	28	&	&	CCONJ
aji-158	298	29	castell	castell	PROPN
aji-158	298	30	,	,	PUNCT
aji-158	298	31	m.	m.	NOUN
aji-158	298	32	(	(	PUNCT
aji-158	298	33	2012	2012	NUM
aji-158	298	34	)	)	PUNCT
aji-158	298	35	.	.	PUNCT
aji-158	299	1	a	a	DET
aji-158	299	2	diet	diet	NOUN
aji-158	299	3	enriched	enrich	VERB
aji-158	299	4	with	with	ADP
aji-158	299	5	cocoa	cocoa	NOUN
aji-158	299	6	prevents	prevent	VERB
aji-158	299	7	ige	ige	PROPN
aji-158	299	8	synthesis	synthesis	NOUN
aji-158	299	9	in	in	ADP
aji-158	299	10	a	a	DET
aji-158	299	11	rat	rat	NOUN
aji-158	299	12	allergy	allergy	NOUN
aji-158	299	13	model	model	NOUN
aji-158	299	14	.	.	PUNCT
aji-158	300	1	pharmacology	pharmacology	NOUN
aji-158	300	2	research	research	NOUN
aji-158	300	3	,	,	PUNCT
aji-158	300	4	65(6	65(6	NUM
aji-158	300	5	):	):	PUNCT
aji-158	300	6	603	603	NUM
aji-158	300	7	-	-	SYM
aji-158	300	8	608	608	NUM
aji-158	300	9	.	.	PUNCT
aji-158	301	1	agache	agache	PROPN
aji-158	301	2	,	,	PUNCT
aji-158	301	3	i.	i.	PROPN
aji-158	301	4	,	,	PUNCT
aji-158	301	5	&	&	CCONJ
aji-158	301	6	akdis	akdis	PROPN
aji-158	301	7	,	,	PUNCT
aji-158	301	8	c.	c.	PROPN
aji-158	301	9	a.	a.	PROPN
aji-158	301	10	(	(	PUNCT
aji-158	301	11	2020	2020	NUM
aji-158	301	12	)	)	PUNCT
aji-158	301	13	.	.	PUNCT
aji-158	302	1	endotypes	endotype	NOUN
aji-158	302	2	of	of	ADP
aji-158	302	3	allergic	allergic	ADJ
aji-158	302	4	diseases	disease	NOUN
aji-158	302	5	and	and	CCONJ
aji-158	302	6	asthma	asthma	NOUN
aji-158	302	7	:	:	PUNCT
aji-158	302	8	an	an	DET
aji-158	302	9	important	important	ADJ
aji-158	302	10	step	step	NOUN
aji-158	302	11	in	in	ADP
aji-158	302	12	building	building	NOUN
aji-158	302	13	blocks	block	NOUN
aji-158	302	14	for	for	ADP
aji-158	302	15	the	the	DET
aji-158	302	16	future	future	NOUN
aji-158	302	17	of	of	ADP
aji-158	302	18	precision	precision	NOUN
aji-158	302	19	medicine	medicine	NOUN
aji-158	302	20	.	.	PUNCT
aji-158	303	1	allergology	allergology	NOUN
aji-158	303	2	international	international	PROPN
aji-158	303	3	,	,	PUNCT
aji-158	303	4	65(3	65(3	NUM
aji-158	303	5	):	):	PUNCT
aji-158	303	6	243	243	NUM
aji-158	303	7	-	-	SYM
aji-158	303	8	252	252	NUM
aji-158	303	9	.	.	PUNCT
aji-158	304	1	ahlström	ahlström	NOUN
aji-158	304	2	,	,	PUNCT
aji-158	304	3	m.	m.	NOUN
aji-158	304	4	g.	g.	PROPN
aji-158	304	5	,	,	PUNCT
aji-158	304	6	thyssen	thyssen	PROPN
aji-158	304	7	,	,	PUNCT
aji-158	304	8	j.	j.	PROPN
aji-158	304	9	p.	p.	PROPN
aji-158	304	10	,	,	PUNCT
aji-158	304	11	wennervaldt	wennervaldt	PROPN
aji-158	304	12	,	,	PUNCT
aji-158	304	13	m.	m.	NOUN
aji-158	304	14	,	,	PUNCT
aji-158	304	15	menné	menné	NOUN
aji-158	304	16	,	,	PUNCT
aji-158	304	17	t.	t.	PROPN
aji-158	304	18	,	,	PUNCT
aji-158	304	19	&	&	CCONJ
aji-158	304	20	johansen	johansen	PROPN
aji-158	304	21	,	,	PUNCT
aji-158	304	22	j.	j.	PROPN
aji-158	304	23	d.	d.	PROPN
aji-158	304	24	(	(	PUNCT
aji-158	304	25	2019	2019	NUM
aji-158	304	26	)	)	PUNCT
aji-158	304	27	.	.	PUNCT
aji-158	305	1	nickel	nickel	NOUN
aji-158	305	2	allergy	allergy	NOUN
aji-158	305	3	and	and	CCONJ
aji-158	305	4	allergic	allergic	ADJ
aji-158	305	5	contact	contact	NOUN
aji-158	305	6	dermatitis	dermatitis	PROPN
aji-158	305	7	:	:	PUNCT
aji-158	305	8	a	a	DET
aji-158	305	9	clinical	clinical	ADJ
aji-158	305	10	review	review	NOUN
aji-158	305	11	of	of	ADP
aji-158	305	12	immunology	immunology	NOUN
aji-158	305	13	,	,	PUNCT
aji-158	305	14	epidemiology	epidemiology	NOUN
aji-158	305	15	,	,	PUNCT
aji-158	305	16	exposure	exposure	NOUN
aji-158	305	17	,	,	PUNCT
aji-158	305	18	and	and	CCONJ
aji-158	305	19	treatment	treatment	NOUN
aji-158	305	20	.	.	PUNCT
aji-158	306	1	contact	contact	PROPN
aji-158	306	2	dermatitis	dermatitis	PROPN
aji-158	306	3	,	,	PUNCT
aji-158	306	4	81(4	81(4	NUM
aji-158	306	5	):	):	PUNCT
aji-158	306	6	227	227	NUM
aji-158	306	7	-	-	SYM
aji-158	306	8	241	241	NUM
aji-158	306	9	.	.	PUNCT
aji-158	307	1	akiba	akiba	PROPN
aji-158	307	2	,	,	PUNCT
aji-158	307	3	y.	y.	PROPN
aji-158	307	4	,	,	PUNCT
aji-158	307	5	takaoka	takaoka	NOUN
aji-158	307	6	,	,	PUNCT
aji-158	307	7	y.	y.	NOUN
aji-158	307	8	,	,	PUNCT
aji-158	307	9	eguch	eguch	ADJ
aji-158	307	10	,	,	PUNCT
aji-158	307	11	k.	k.	PROPN
aji-158	307	12	,	,	PUNCT
aji-158	307	13	akiba	akiba	PROPN
aji-158	307	14	,	,	PUNCT
aji-158	307	15	n.	n.	PROPN
aji-158	307	16	,	,	PUNCT
aji-158	307	17	ko	ko	PROPN
aji-158	307	18	,	,	PUNCT
aji-158	307	19	n.	n.	NOUN
aji-158	307	20	,	,	PUNCT
aji-158	307	21	&	&	CCONJ
aji-158	307	22	uoshima	uoshima	PROPN
aji-158	307	23	,	,	PUNCT
aji-158	307	24	k.	k.	PROPN
aji-158	307	25	(	(	PUNCT
aji-158	307	26	2025	2025	NUM
aji-158	307	27	)	)	PUNCT
aji-158	307	28	.	.	PUNCT
aji-158	308	1	metal	metal	NOUN
aji-158	308	2	allergy	allergy	NOUN
aji-158	308	3	as	as	ADP
aji-158	308	4	a	a	DET
aji-158	308	5	persistent	persistent	ADJ
aji-158	308	6	factor	factor	NOUN
aji-158	308	7	for	for	ADP
aji-158	308	8	psoriasis	psoriasis	NOUN
aji-158	308	9	.	.	PUNCT
aji-158	309	1	journal	journal	NOUN
aji-158	309	2	of	of	ADP
aji-158	309	3	prosthodontic	prosthodontic	ADJ
aji-158	309	4	research	research	NOUN
aji-158	309	5	.	.	PUNCT
aji-158	310	1	anagnostou	anagnostou	PROPN
aji-158	310	2	,	,	PUNCT
aji-158	310	3	a.	a.	PROPN
aji-158	310	4	,	,	PUNCT
aji-158	310	5	wang	wang	PROPN
aji-158	310	6	,	,	PUNCT
aji-158	310	7	j.	j.	PROPN
aji-158	310	8	,	,	PUNCT
aji-158	310	9	chinthrajah	chinthrajah	PROPN
aji-158	310	10	,	,	PUNCT
aji-158	310	11	s.	s.	PROPN
aji-158	310	12	,	,	PUNCT
aji-158	310	13	gupta	gupta	PROPN
aji-158	310	14	,	,	PUNCT
aji-158	310	15	r.	r.	PROPN
aji-158	310	16	,	,	PUNCT
aji-158	310	17	davis	davis	PROPN
aji-158	310	18	,	,	PUNCT
aji-158	310	19	c.	c.	PROPN
aji-158	310	20	m.	m.	PROPN
aji-158	310	21	,	,	PUNCT
aji-158	310	22	parrish	parrish	PROPN
aji-158	310	23	,	,	PUNCT
aji-158	310	24	c.	c.	PROPN
aji-158	310	25	,	,	PUNCT
aji-158	310	26	et	et	PROPN
aji-158	310	27	al	al	PROPN
aji-158	310	28	.	.	PROPN
aji-158	310	29	(	(	PUNCT
aji-158	310	30	2025	2025	NUM
aji-158	310	31	)	)	PUNCT
aji-158	310	32	.	.	PUNCT
aji-158	311	1	addressing	address	VERB
aji-158	311	2	health	health	NOUN
aji-158	311	3	disparities	disparity	NOUN
aji-158	311	4	in	in	ADP
aji-158	311	5	food	food	NOUN
aji-158	311	6	allergy	allergy	NOUN
aji-158	311	7	:	:	PUNCT
aji-158	311	8	a	a	DET
aji-158	311	9	position	position	NOUN
aji-158	311	10	statement	statement	NOUN
aji-158	311	11	of	of	ADP
aji-158	311	12	the	the	DET
aji-158	311	13	aaaai	aaaai	NOUN
aji-158	311	14	prior	prior	ADJ
aji-158	311	15	authorization	authorization	NOUN
aji-158	311	16	task	task	NOUN
aji-158	311	17	force	force	NOUN
aji-158	311	18	.	.	PUNCT
aji-158	312	1	journal	journal	PROPN
aji-158	312	2	of	of	ADP
aji-158	312	3	allergy	allergy	NOUN
aji-158	312	4	and	and	CCONJ
aji-158	312	5	clinical	clinical	ADJ
aji-158	312	6	immunology	immunology	NOUN
aji-158	312	7	,	,	PUNCT
aji-158	312	8	155(1	155(1	NUM
aji-158	312	9	):	):	PUNCT
aji-158	312	10	53	53	NUM
aji-158	312	11	-	-	SYM
aji-158	312	12	61	61	NUM
aji-158	312	13	.	.	PUNCT
aji-158	313	1	anouar	anouar	NOUN
aji-158	313	2	,	,	PUNCT
aji-158	313	3	s.	s.	PROPN
aji-158	313	4	,	,	PUNCT
aji-158	313	5	hazim	hazim	PROPN
aji-158	313	6	,	,	PUNCT
aji-158	313	7	r.	r.	PROPN
aji-158	313	8	,	,	PUNCT
aji-158	313	9	&	&	CCONJ
aji-158	313	10	brahim	brahim	PROPN
aji-158	313	11	,	,	PUNCT
aji-158	313	12	a.	a.	NOUN
aji-158	313	13	(	(	PUNCT
aji-158	313	14	2024	2024	NUM
aji-158	313	15	)	)	PUNCT
aji-158	313	16	.	.	PUNCT
aji-158	314	1	interferences	interference	NOUN
aji-158	314	2	in	in	ADP
aji-158	314	3	immunological	immunological	ADJ
aji-158	314	4	assays	assay	NOUN
aji-158	314	5	:	:	PUNCT
aji-158	314	6	causes	cause	NOUN
aji-158	314	7	,	,	PUNCT
aji-158	314	8	detection	detection	NOUN
aji-158	314	9	,	,	PUNCT
aji-158	314	10	and	and	CCONJ
aji-158	314	11	prevention	prevention	NOUN
aji-158	314	12	.	.	PUNCT
aji-158	315	1	asian	asian	ADJ
aji-158	315	2	journal	journal	NOUN
aji-158	315	3	of	of	ADP
aji-158	315	4	immunology	immunology	NOUN
aji-158	315	5	,	,	PUNCT
aji-158	315	6	7(1	7(1	NUM
aji-158	315	7	):	):	PUNCT
aji-158	315	8	71	71	NUM
aji-158	315	9	-	-	SYM
aji-158	315	10	78	78	NUM
aji-158	315	11	.	.	PUNCT
aji-158	316	1	olivier	olivier	PROPN
aji-158	316	2	et	et	PROPN
aji-158	316	3	al	al	PROPN
aji-158	316	4	.	.	PROPN
aji-158	316	5	;	;	PUNCT
aji-158	316	6	asian	asian	PROPN
aji-158	316	7	j.	j.	PROPN
aji-158	316	8	immunol	immunol	PROPN
aji-158	316	9	.	.	PROPN
aji-158	316	10	,	,	PUNCT
aji-158	316	11	vol	vol	NOUN
aji-158	316	12	.	.	PROPN
aji-158	316	13	8	8	NUM
aji-158	316	14	,	,	PUNCT
aji-158	316	15	no	no	INTJ
aji-158	316	16	.	.	NOUN
aji-158	316	17	1	1	NUM
aji-158	316	18	,	,	PUNCT
aji-158	316	19	pp	pp	ADJ
aji-158	316	20	.	.	PUNCT
aji-158	317	1	35	35	NUM
aji-158	317	2	-	-	SYM
aji-158	317	3	49	49	NUM
aji-158	317	4	,	,	PUNCT
aji-158	317	5	2025	2025	NUM
aji-158	317	6	;	;	PUNCT
aji-158	317	7	article	article	NOUN
aji-158	317	8	no.aji.133582	no.aji.133582	PROPN
aji-158	317	9	45	45	NUM
aji-158	317	10	antico	antico	NOUN
aji-158	317	11	,	,	PUNCT
aji-158	317	12	a.	a.	PROPN
aji-158	317	13	,	,	PUNCT
aji-158	317	14	&	&	CCONJ
aji-158	317	15	soana	soana	PROPN
aji-158	317	16	,	,	PUNCT
aji-158	317	17	r.	r.	PROPN
aji-158	317	18	(	(	PUNCT
aji-158	317	19	2015	2015	NUM
aji-158	317	20	)	)	PUNCT
aji-158	317	21	.	.	PUNCT
aji-158	318	1	nickel	nickel	NOUN
aji-158	318	2	sensitization	sensitization	NOUN
aji-158	318	3	and	and	CCONJ
aji-158	318	4	dietary	dietary	ADJ
aji-158	318	5	nickel	nickel	NOUN
aji-158	318	6	are	be	AUX
aji-158	318	7	a	a	DET
aji-158	318	8	substantial	substantial	ADJ
aji-158	318	9	cause	cause	NOUN
aji-158	318	10	of	of	ADP
aji-158	318	11	symptoms	symptom	NOUN
aji-158	318	12	provocation	provocation	VERB
aji-158	318	13	in	in	ADP
aji-158	318	14	patients	patient	NOUN
aji-158	318	15	with	with	ADP
aji-158	318	16	chronic	chronic	ADJ
aji-158	318	17	allergic	allergic	ADJ
aji-158	318	18	-	-	PUNCT
aji-158	318	19	like	like	ADJ
aji-158	318	20	dermatitis	dermatitis	NOUN
aji-158	318	21	syndromes	syndrome	NOUN
aji-158	318	22	.	.	PUNCT
aji-158	319	1	allergy	allergy	NOUN
aji-158	319	2	&	&	CCONJ
aji-158	319	3	rhinology	rhinology	PROPN
aji-158	319	4	(	(	PUNCT
aji-158	319	5	providence	providence	NOUN
aji-158	319	6	,	,	PUNCT
aji-158	319	7	r.i	r.i	PROPN
aji-158	319	8	.	.	PROPN
aji-158	319	9	)	)	PUNCT
aji-158	319	10	,	,	PUNCT
aji-158	319	11	6(1	6(1	NUM
aji-158	319	12	):	):	PUNCT
aji-158	319	13	56	56	NUM
aji-158	319	14	-	-	SYM
aji-158	319	15	63	63	NUM
aji-158	319	16	.	.	PUNCT
aji-158	319	17	augustin	augustin	PROPN
aji-158	319	18	,	,	PUNCT
aji-158	319	19	r.	r.	PROPN
aji-158	319	20	(	(	PUNCT
aji-158	319	21	1953	1953	NUM
aji-158	319	22	)	)	PUNCT
aji-158	319	23	.	.	PUNCT
aji-158	320	1	precipitins	precipitin	VERB
aji-158	320	2	to	to	PART
aji-158	320	3	grass	grass	VERB
aji-158	320	4	pollen	pollen	NOUN
aji-158	320	5	proteins	protein	NOUN
aji-158	320	6	.	.	PUNCT
aji-158	321	1	nature	nature	NOUN
aji-158	321	2	,	,	PUNCT
aji-158	321	3	172(4372	172(4372	NUM
aji-158	321	4	):	):	PUNCT
aji-158	321	5	307	307	NUM
aji-158	321	6	.	.	PUNCT
aji-158	322	1	augustin	augustin	PROPN
aji-158	322	2	,	,	PUNCT
aji-158	322	3	r.	r.	PROPN
aji-158	322	4	,	,	PUNCT
aji-158	322	5	&	&	CCONJ
aji-158	322	6	hayward	hayward	PROPN
aji-158	322	7	,	,	PUNCT
aji-158	322	8	b.	b.	PROPN
aji-158	322	9	j.	j.	PROPN
aji-158	322	10	(	(	PUNCT
aji-158	322	11	1960	1960	NUM
aji-158	322	12	)	)	PUNCT
aji-158	322	13	.	.	PUNCT
aji-158	323	1	human	human	ADJ
aji-158	323	2	reagins	reagin	NOUN
aji-158	323	3	to	to	PART
aji-158	323	4	grass	grass	VERB
aji-158	323	5	pollens	pollen	NOUN
aji-158	323	6	and	and	CCONJ
aji-158	323	7	moulds	mould	NOUN
aji-158	323	8	:	:	PUNCT
aji-158	323	9	their	their	PRON
aji-158	323	10	purification	purification	NOUN
aji-158	323	11	and	and	CCONJ
aji-158	323	12	physico	physico	NOUN
aji-158	323	13	-	-	PUNCT
aji-158	323	14	chemical	chemical	NOUN
aji-158	323	15	characterization	characterization	NOUN
aji-158	323	16	.	.	PUNCT
aji-158	324	1	immunology	immunology	NOUN
aji-158	324	2	,	,	PUNCT
aji-158	324	3	3(1	3(1	NUM
aji-158	324	4	):	):	PUNCT
aji-158	324	5	45	45	NUM
aji-158	324	6	-	-	SYM
aji-158	324	7	73	73	NUM
aji-158	324	8	.	.	PUNCT
aji-158	325	1	augustin	augustin	PROPN
aji-158	325	2	,	,	PUNCT
aji-158	325	3	r.	r.	PROPN
aji-158	325	4	,	,	PUNCT
aji-158	325	5	hayward	hayward	PROPN
aji-158	325	6	,	,	PUNCT
aji-158	325	7	b.	b.	PROPN
aji-158	325	8	j.	j.	PROPN
aji-158	325	9	,	,	PUNCT
aji-158	325	10	&	&	CCONJ
aji-158	325	11	longbottom	longbottom	PROPN
aji-158	325	12	,	,	PUNCT
aji-158	325	13	j.	j.	PROPN
aji-158	325	14	l.	l.	PROPN
aji-158	325	15	(	(	PUNCT
aji-158	325	16	1960a	1960a	NUM
aji-158	325	17	)	)	PUNCT
aji-158	325	18	.	.	PUNCT
aji-158	326	1	isolation	isolation	NOUN
aji-158	326	2	and	and	CCONJ
aji-158	326	3	physico	physico	NOUN
aji-158	326	4	-	-	PUNCT
aji-158	326	5	chemical	chemical	NOUN
aji-158	326	6	characterization	characterization	NOUN
aji-158	326	7	of	of	ADP
aji-158	326	8	reagins	reagin	NOUN
aji-158	326	9	,	,	PUNCT
aji-158	326	10	blocking	block	VERB
aji-158	326	11	antibodies	antibody	NOUN
aji-158	326	12	and	and	CCONJ
aji-158	326	13	precipitins	precipitin	VERB
aji-158	326	14	to	to	PART
aji-158	326	15	grass	grass	VERB
aji-158	326	16	pollens	pollen	NOUN
aji-158	326	17	.	.	PUNCT
aji-158	327	1	clinical	clinical	ADJ
aji-158	327	2	and	and	CCONJ
aji-158	327	3	experimental	experimental	ADJ
aji-158	327	4	allergy	allergy	NOUN
aji-158	327	5	(	(	PUNCT
aji-158	327	6	copenhagen	copenhagen	PROPN
aji-158	327	7	)	)	PUNCT
aji-158	327	8	,	,	PUNCT
aji-158	327	9	7	7	NUM
aji-158	327	10	:	:	SYM
aji-158	327	11	31	31	NUM
aji-158	327	12	-	-	SYM
aji-158	327	13	37	37	NUM
aji-158	327	14	.	.	PUNCT
aji-158	328	1	barceloux	barceloux	VERB
aji-158	328	2	,	,	PUNCT
aji-158	328	3	d.	d.	PROPN
aji-158	328	4	g.	g.	PROPN
aji-158	328	5	(	(	PUNCT
aji-158	328	6	1999	1999	NUM
aji-158	328	7	)	)	PUNCT
aji-158	328	8	.	.	PUNCT
aji-158	329	1	nickel	nickel	NOUN
aji-158	329	2	.	.	PUNCT
aji-158	329	3	journal	journal	PROPN
aji-158	329	4	of	of	ADP
aji-158	329	5	toxicology	toxicology	NOUN
aji-158	329	6	.	.	PUNCT
aji-158	330	1	clinical	clinical	ADJ
aji-158	330	2	toxicology	toxicology	NOUN
aji-158	330	3	,	,	PUNCT
aji-158	330	4	37(2	37(2	PRON
aji-158	330	5	):	):	PUNCT
aji-158	330	6	239258	239258	NUM
aji-158	330	7	.	.	PUNCT
aji-158	331	1	bradford	bradford	NOUN
aji-158	331	2	,	,	PUNCT
aji-158	331	3	m.	m.	NOUN
aji-158	331	4	m.	m.	NOUN
aji-158	331	5	(	(	PUNCT
aji-158	331	6	1976	1976	NUM
aji-158	331	7	)	)	PUNCT
aji-158	331	8	.	.	PUNCT
aji-158	332	1	a	a	DET
aji-158	332	2	rapid	rapid	ADJ
aji-158	332	3	and	and	CCONJ
aji-158	332	4	sensitive	sensitive	ADJ
aji-158	332	5	method	method	NOUN
aji-158	332	6	for	for	ADP
aji-158	332	7	the	the	DET
aji-158	332	8	quantitation	quantitation	NOUN
aji-158	332	9	of	of	ADP
aji-158	332	10	microgram	microgram	ADJ
aji-158	332	11	quantities	quantity	NOUN
aji-158	332	12	of	of	ADP
aji-158	332	13	protein	protein	NOUN
aji-158	332	14	utilizing	utilize	VERB
aji-158	332	15	the	the	DET
aji-158	332	16	principle	principle	NOUN
aji-158	332	17	of	of	ADP
aji-158	332	18	protein	protein	NOUN
aji-158	332	19	-	-	PUNCT
aji-158	332	20	dye	dye	NOUN
aji-158	332	21	binding	binding	NOUN
aji-158	332	22	.	.	PUNCT
aji-158	333	1	analitical	analitical	ADJ
aji-158	333	2	biochemical	biochemical	ADJ
aji-158	333	3	,	,	PUNCT
aji-158	333	4	72	72	NUM
aji-158	333	5	:	:	SYM
aji-158	333	6	248	248	NUM
aji-158	333	7	-	-	SYM
aji-158	333	8	254	254	NUM
aji-158	333	9	.	.	PUNCT
aji-158	334	1	čelakovská	čelakovská	PROPN
aji-158	334	2	,	,	PUNCT
aji-158	334	3	j.	j.	PROPN
aji-158	334	4	,	,	PUNCT
aji-158	334	5	čermákova	čermákova	PROPN
aji-158	334	6	,	,	PUNCT
aji-158	334	7	e.	e.	PROPN
aji-158	334	8	,	,	PUNCT
aji-158	334	9	andrýs	andrýs	PROPN
aji-158	334	10	,	,	PUNCT
aji-158	334	11	c.	c.	PROPN
aji-158	334	12	,	,	PUNCT
aji-158	334	13	boudkova	boudkova	NOUN
aji-158	334	14	,	,	PUNCT
aji-158	334	15	p.	p.	NOUN
aji-158	334	16	,	,	PUNCT
aji-158	334	17	&	&	CCONJ
aji-158	334	18	krejsek	krejsek	PROPN
aji-158	334	19	,	,	PUNCT
aji-158	334	20	j.	j.	PROPN
aji-158	334	21	(	(	PUNCT
aji-158	334	22	2024	2024	NUM
aji-158	334	23	)	)	PUNCT
aji-158	334	24	.	.	PUNCT
aji-158	335	1	sensitization	sensitization	NOUN
aji-158	335	2	to	to	ADP
aji-158	335	3	latex	latex	PROPN
aji-158	335	4	and	and	CCONJ
aji-158	335	5	food	food	NOUN
aji-158	335	6	allergens	allergen	NOUN
aji-158	335	7	in	in	ADP
aji-158	335	8	atopic	atopic	NOUN
aji-158	335	9	dermatitis	dermatitis	NOUN
aji-158	335	10	patients	patient	NOUN
aji-158	335	11	according	accord	VERB
aji-158	335	12	to	to	ADP
aji-158	335	13	alex2	alex2	PROPN
aji-158	335	14	allergy	allergy	PROPN
aji-158	335	15	xplorer	xplorer	PROPN
aji-158	335	16	test	test	PROPN
aji-158	335	17	.	.	PUNCT
aji-158	336	1	molecular	molecular	ADJ
aji-158	336	2	immunology	immunology	NOUN
aji-158	336	3	,	,	PUNCT
aji-158	336	4	175	175	NUM
aji-158	336	5	:	:	SYM
aji-158	336	6	89	89	NUM
aji-158	336	7	-	-	SYM
aji-158	336	8	102	102	NUM
aji-158	336	9	.	.	PUNCT
aji-158	337	1	chiarentin	chiarentin	PROPN
aji-158	337	2	,	,	PUNCT
aji-158	337	3	l.	l.	PROPN
aji-158	337	4	,	,	PUNCT
aji-158	337	5	gonçalves	gonçalves	PROPN
aji-158	337	6	,	,	PUNCT
aji-158	337	7	c.	c.	PROPN
aji-158	337	8	,	,	PUNCT
aji-158	337	9	augusto	augusto	NOUN
aji-158	337	10	,	,	PUNCT
aji-158	337	11	c.	c.	PROPN
aji-158	337	12	,	,	PUNCT
aji-158	337	13	miranda	miranda	PROPN
aji-158	337	14	,	,	PUNCT
aji-158	337	15	m.	m.	NOUN
aji-158	337	16	,	,	PUNCT
aji-158	337	17	cardoso	cardoso	PROPN
aji-158	337	18	,	,	PUNCT
aji-158	337	19	c.	c.	PROPN
aji-158	337	20	,	,	PUNCT
aji-158	337	21	&	&	CCONJ
aji-158	337	22	vitorino	vitorino	PROPN
aji-158	337	23	,	,	PUNCT
aji-158	337	24	c.	c.	PROPN
aji-158	337	25	(	(	PUNCT
aji-158	337	26	2023	2023	NUM
aji-158	337	27	)	)	PUNCT
aji-158	337	28	.	.	PUNCT
aji-158	338	1	drilling	drill	VERB
aji-158	338	2	into	into	ADP
aji-158	338	3	"	"	PUNCT
aji-158	338	4	quality	quality	NOUN
aji-158	338	5	by	by	ADP
aji-158	338	6	design	design	NOUN
aji-158	338	7	"	"	PUNCT
aji-158	338	8	approach	approach	NOUN
aji-158	338	9	for	for	ADP
aji-158	338	10	analytical	analytical	ADJ
aji-158	338	11	methods	method	NOUN
aji-158	338	12	.	.	PUNCT
aji-158	339	1	critical	critical	ADJ
aji-158	339	2	reviews	review	NOUN
aji-158	339	3	in	in	ADP
aji-158	339	4	analytical	analytical	ADJ
aji-158	339	5	chemistry	chemistry	NOUN
aji-158	339	6	:	:	PUNCT
aji-158	339	7	1	1	NUM
aji-158	339	8	-	-	SYM
aji-158	339	9	42	42	NUM
aji-158	339	10	.	.	PUNCT
aji-158	340	1	coca	coca	PROPN
aji-158	340	2	,	,	PUNCT
aji-158	340	3	a.	a.	PROPN
aji-158	340	4	f.	f.	PROPN
aji-158	340	5	(	(	PUNCT
aji-158	340	6	1922	1922	NUM
aji-158	340	7	)	)	PUNCT
aji-158	340	8	.	.	PUNCT
aji-158	341	1	studies	study	NOUN
aji-158	341	2	in	in	ADP
aji-158	341	3	specific	specific	ADJ
aji-158	341	4	hypersensitiveness	hypersensitiveness	NOUN
aji-158	341	5	v.	v.	ADP
aji-158	341	6	the	the	DET
aji-158	341	7	preparation	preparation	NOUN
aji-158	341	8	of	of	ADP
aji-158	341	9	fluid	fluid	ADJ
aji-158	341	10	extracts	extract	NOUN
aji-158	341	11	and	and	CCONJ
aji-158	341	12	solutions	solution	NOUN
aji-158	341	13	for	for	ADP
aji-158	341	14	use	use	NOUN
aji-158	341	15	in	in	ADP
aji-158	341	16	the	the	DET
aji-158	341	17	diagnosis	diagnosis	NOUN
aji-158	341	18	and	and	CCONJ
aji-158	341	19	treatment	treatment	NOUN
aji-158	341	20	of	of	ADP
aji-158	341	21	the	the	DET
aji-158	341	22	allergies	allergy	NOUN
aji-158	341	23	with	with	ADP
aji-158	341	24	notes	note	NOUN
aji-158	341	25	on	on	ADP
aji-158	341	26	the	the	DET
aji-158	341	27	collection	collection	NOUN
aji-158	341	28	of	of	ADP
aji-158	341	29	pollens	pollen	NOUN
aji-158	341	30	.	.	PUNCT
aji-158	342	1	the	the	DET
aji-158	342	2	journal	journal	NOUN
aji-158	342	3	of	of	ADP
aji-158	342	4	immunology	immunology	NOUN
aji-158	342	5	,	,	PUNCT
aji-158	342	6	7(2	7(2	NUM
aji-158	342	7	):	):	PUNCT
aji-158	342	8	163	163	NUM
aji-158	342	9	-	-	SYM
aji-158	342	10	178	178	NUM
aji-158	342	11	.	.	PUNCT
aji-158	343	1	cubadda	cubadda	PROPN
aji-158	343	2	,	,	PUNCT
aji-158	343	3	f.	f.	PROPN
aji-158	343	4	,	,	PUNCT
aji-158	343	5	iacoponi	iacoponi	PROPN
aji-158	343	6	,	,	PUNCT
aji-158	343	7	f.	f.	PROPN
aji-158	343	8	,	,	PUNCT
aji-158	343	9	ferraris	ferraris	PROPN
aji-158	343	10	,	,	PUNCT
aji-158	343	11	f.	f.	PROPN
aji-158	343	12	,	,	PUNCT
aji-158	343	13	d'amato	d'amato	PROPN
aji-158	343	14	,	,	PUNCT
aji-158	343	15	m.	m.	NOUN
aji-158	343	16	,	,	PUNCT
aji-158	343	17	aureli	aureli	INTJ
aji-158	343	18	,	,	PUNCT
aji-158	343	19	f.	f.	PROPN
aji-158	343	20	,	,	PUNCT
aji-158	343	21	raggi	raggi	NOUN
aji-158	343	22	,	,	PUNCT
aji-158	343	23	a.	a.	PROPN
aji-158	343	24	,	,	PUNCT
aji-158	343	25	et	et	PROPN
aji-158	343	26	al	al	PROPN
aji-158	343	27	.	.	PROPN
aji-158	343	28	(	(	PUNCT
aji-158	343	29	2020	2020	NUM
aji-158	343	30	)	)	PUNCT
aji-158	343	31	.	.	PUNCT
aji-158	344	1	dietary	dietary	ADJ
aji-158	344	2	exposure	exposure	NOUN
aji-158	344	3	of	of	ADP
aji-158	344	4	the	the	DET
aji-158	344	5	italian	italian	ADJ
aji-158	344	6	population	population	NOUN
aji-158	344	7	to	to	ADP
aji-158	344	8	nickel	nickel	NOUN
aji-158	344	9	:	:	PUNCT
aji-158	344	10	the	the	DET
aji-158	344	11	national	national	ADJ
aji-158	344	12	total	total	ADJ
aji-158	344	13	diet	diet	PROPN
aji-158	344	14	study	study	NOUN
aji-158	344	15	.	.	PUNCT
aji-158	345	1	food	food	NOUN
aji-158	345	2	and	and	CCONJ
aji-158	345	3	chemical	chemical	NOUN
aji-158	345	4	toxicology	toxicology	NOUN
aji-158	345	5	,	,	PUNCT
aji-158	345	6	146	146	NUM
aji-158	345	7	:	:	SYM
aji-158	345	8	111813	111813	NUM
aji-158	345	9	.	.	PUNCT
aji-158	346	1	cunningham	cunningham	PROPN
aji-158	346	2	-	-	PUNCT
aji-158	346	3	rundles	rundle	NOUN
aji-158	346	4	,	,	PUNCT
aji-158	346	5	c.	c.	PROPN
aji-158	346	6	,	,	PUNCT
aji-158	346	7	brandeis	brandeis	PROPN
aji-158	346	8	,	,	PUNCT
aji-158	346	9	w.	w.	PROPN
aji-158	346	10	e.	e.	PROPN
aji-158	346	11	,	,	PUNCT
aji-158	346	12	good	good	PROPN
aji-158	346	13	,	,	PUNCT
aji-158	346	14	r.	r.	PROPN
aji-158	346	15	a.	a.	PROPN
aji-158	346	16	,	,	PUNCT
aji-158	346	17	&	&	CCONJ
aji-158	346	18	day	day	PROPN
aji-158	346	19	,	,	PUNCT
aji-158	346	20	n.	n.	PROPN
aji-158	346	21	k.	k.	PROPN
aji-158	346	22	(	(	PUNCT
aji-158	346	23	1978	1978	NUM
aji-158	346	24	)	)	PUNCT
aji-158	346	25	.	.	PUNCT
aji-158	347	1	milk	milk	NOUN
aji-158	347	2	precipitins	precipitin	VERB
aji-158	347	3	,	,	PUNCT
aji-158	347	4	circulating	circulate	VERB
aji-158	347	5	immune	immune	ADJ
aji-158	347	6	complexes	complex	NOUN
aji-158	347	7	,	,	PUNCT
aji-158	347	8	and	and	CCONJ
aji-158	347	9	iga	iga	PROPN
aji-158	347	10	deficiency	deficiency	NOUN
aji-158	347	11	.	.	PUNCT
aji-158	348	1	proceedings	proceeding	NOUN
aji-158	348	2	of	of	ADP
aji-158	348	3	the	the	DET
aji-158	348	4	national	national	PROPN
aji-158	348	5	academy	academy	PROPN
aji-158	348	6	of	of	ADP
aji-158	348	7	sciences	sciences	PROPN
aji-158	348	8	of	of	ADP
aji-158	348	9	the	the	DET
aji-158	348	10	united	united	PROPN
aji-158	348	11	states	states	PROPN
aji-158	348	12	of	of	ADP
aji-158	348	13	america	america	PROPN
aji-158	348	14	,	,	PUNCT
aji-158	348	15	75(7	75(7	NUM
aji-158	348	16	):	):	PUNCT
aji-158	348	17	33873389	33873389	NUM
aji-158	348	18	.	.	PUNCT
aji-158	349	1	filatova	filatova	PROPN
aji-158	349	2	,	,	PUNCT
aji-158	349	3	d.	d.	PROPN
aji-158	349	4	,	,	PUNCT
aji-158	349	5	&	&	CCONJ
aji-158	349	6	cherpak	cherpak	PROPN
aji-158	349	7	,	,	PUNCT
aji-158	349	8	c.	c.	PROPN
aji-158	349	9	(	(	PUNCT
aji-158	349	10	2020	2020	NUM
aji-158	349	11	)	)	PUNCT
aji-158	349	12	.	.	PUNCT
aji-158	350	1	mechanisms	mechanism	NOUN
aji-158	350	2	of	of	ADP
aji-158	350	3	nickel	nickel	NOUN
aji-158	350	4	-	-	PUNCT
aji-158	350	5	induced	induce	VERB
aji-158	350	6	cell	cell	NOUN
aji-158	350	7	damage	damage	NOUN
aji-158	350	8	in	in	ADP
aji-158	350	9	allergic	allergic	ADJ
aji-158	350	10	contact	contact	NOUN
aji-158	350	11	dermatitis	dermatitis	NOUN
aji-158	350	12	and	and	CCONJ
aji-158	350	13	nutritional	nutritional	ADJ
aji-158	350	14	intervention	intervention	NOUN
aji-158	350	15	strategies	strategy	NOUN
aji-158	350	16	.	.	PUNCT
aji-158	351	1	endocrine	endocrine	PROPN
aji-158	351	2	metabolic	metabolic	PROPN
aji-158	351	3	&	&	CCONJ
aji-158	351	4	immune	immune	ADJ
aji-158	351	5	disorders	disorder	NOUN
aji-158	351	6	drug	drug	NOUN
aji-158	351	7	targets	target	NOUN
aji-158	351	8	,	,	PUNCT
aji-158	351	9	20(7	20(7	NUM
aji-158	351	10	):	):	PUNCT
aji-158	351	11	1010	1010	NUM
aji-158	351	12	-	-	SYM
aji-158	351	13	1014	1014	NUM
aji-158	351	14	.	.	PUNCT
aji-158	352	1	fink	fink	PROPN
aji-158	352	2	,	,	PUNCT
aji-158	352	3	a.	a.	PROPN
aji-158	352	4	,	,	PUNCT
aji-158	352	5	heller	heller	NOUN
aji-158	352	6	,	,	PUNCT
aji-158	352	7	l.	l.	PROPN
aji-158	352	8	,	,	PUNCT
aji-158	352	9	eliraz	eliraz	PROPN
aji-158	352	10	,	,	PUNCT
aji-158	352	11	a.	a.	NOUN
aji-158	352	12	,	,	PUNCT
aji-158	352	13	weisman	weisman	PROPN
aji-158	352	14	,	,	PUNCT
aji-158	352	15	z.	z.	PROPN
aji-158	352	16	,	,	PUNCT
aji-158	352	17	miskin	miskin	PROPN
aji-158	352	18	,	,	PUNCT
aji-158	352	19	a.	a.	NOUN
aji-158	352	20	,	,	PUNCT
aji-158	352	21	schlezinger	schlezinger	NOUN
aji-158	352	22	,	,	PUNCT
aji-158	352	23	et	et	PROPN
aji-158	352	24	al	al	PROPN
aji-158	352	25	.	.	PUNCT
aji-158	353	1	(	(	PUNCT
aji-158	353	2	1987	1987	NUM
aji-158	353	3	)	)	PUNCT
aji-158	353	4	.	.	PUNCT
aji-158	354	1	allergen	allergen	NOUN
aji-158	354	2	-	-	PUNCT
aji-158	354	3	specific	specific	ADJ
aji-158	354	4	leukocyte	leukocyte	NOUN
aji-158	354	5	adherence	adherence	NOUN
aji-158	354	6	inhibition	inhibition	NOUN
aji-158	354	7	(	(	PUNCT
aji-158	354	8	lai	lai	NOUN
aji-158	354	9	)	)	PUNCT
aji-158	354	10	assay	assay	VERB
aji-158	354	11	:	:	PUNCT
aji-158	354	12	sensitivity	sensitivity	NOUN
aji-158	354	13	,	,	PUNCT
aji-158	354	14	specificity	specificity	NOUN
aji-158	354	15	and	and	CCONJ
aji-158	354	16	mechanism	mechanism	NOUN
aji-158	354	17	.	.	PUNCT
aji-158	355	1	immunology	immunology	NOUN
aji-158	355	2	letters	letter	NOUN
aji-158	355	3	,	,	PUNCT
aji-158	355	4	16(1	16(1	NUM
aji-158	355	5	):	):	PUNCT
aji-158	355	6	65	65	NUM
aji-158	355	7	-	-	SYM
aji-158	355	8	70	70	NUM
aji-158	355	9	.	.	PUNCT
aji-158	356	1	frimpong	frimpong	PROPN
aji-158	356	2	,	,	PUNCT
aji-158	356	3	e.	e.	PROPN
aji-158	356	4	,	,	PUNCT
aji-158	356	5	ankapong	ankapong	PROPN
aji-158	356	6	,	,	PUNCT
aji-158	356	7	e.	e.	PROPN
aji-158	356	8	,	,	PUNCT
aji-158	356	9	boakye	boakye	PROPN
aji-158	356	10	,	,	PUNCT
aji-158	356	11	k.	k.	PROPN
aji-158	356	12	o.	o.	PROPN
aji-158	356	13	,	,	PUNCT
aji-158	356	14	ansah	ansah	PROPN
aji-158	356	15	,	,	PUNCT
aji-158	356	16	e.	e.	PROPN
aji-158	356	17	,	,	PUNCT
aji-158	356	18	gyamfi	gyamfi	PROPN
aji-158	356	19	,	,	PUNCT
aji-158	356	20	o.	o.	PROPN
aji-158	356	21	,	,	PUNCT
aji-158	356	22	barnes	barnes	PROPN
aji-158	356	23	,	,	PUNCT
aji-158	356	24	b.	b.	PROPN
aji-158	356	25	,	,	PUNCT
aji-158	356	26	et	et	PROPN
aji-158	356	27	al	al	PROPN
aji-158	356	28	.	.	PUNCT
aji-158	356	29	(	(	PUNCT
aji-158	356	30	2024	2024	NUM
aji-158	356	31	)	)	PUNCT
aji-158	356	32	.	.	PUNCT
aji-158	357	1	uptake	uptake	VERB
aji-158	357	2	and	and	CCONJ
aji-158	357	3	in	in	ADP
aji-158	357	4	-	-	PUNCT
aji-158	357	5	vitro	vitro	X
aji-158	357	6	bioaccessibility	bioaccessibility	NOUN
aji-158	357	7	of	of	ADP
aji-158	357	8	toxic	toxic	ADJ
aji-158	357	9	metals	metal	NOUN
aji-158	357	10	in	in	ADP
aji-158	357	11	cocoa	cocoa	NOUN
aji-158	357	12	beans	bean	NOUN
aji-158	357	13	:	:	PUNCT
aji-158	357	14	human	human	ADJ
aji-158	357	15	health	health	NOUN
aji-158	357	16	risks	risk	NOUN
aji-158	357	17	.	.	PUNCT
aji-158	358	1	environmental	environmental	ADJ
aji-158	358	2	geochemistry	geochemistry	NOUN
aji-158	358	3	and	and	CCONJ
aji-158	358	4	health	health	NOUN
aji-158	358	5	,	,	PUNCT
aji-158	358	6	47(2	47(2	PROPN
aji-158	358	7	):	):	PUNCT
aji-158	358	8	33	33	NUM
aji-158	358	9	.	.	PUNCT
aji-158	359	1	gell	gell	NOUN
aji-158	359	2	,	,	PUNCT
aji-158	359	3	p.	p.	NOUN
aji-158	359	4	g.	g.	PROPN
aji-158	359	5	h.	h.	PROPN
aji-158	359	6	,	,	PUNCT
aji-158	359	7	harington	harington	PROPN
aji-158	359	8	,	,	PUNCT
aji-158	359	9	c.	c.	PROPN
aji-158	359	10	r.	r.	PROPN
aji-158	359	11	,	,	PUNCT
aji-158	359	12	&	&	CCONJ
aji-158	359	13	rivers	river	NOUN
aji-158	359	14	,	,	PUNCT
aji-158	359	15	r.	r.	PROPN
aji-158	359	16	p.	p.	PROPN
aji-158	359	17	(	(	PUNCT
aji-158	359	18	1946	1946	NUM
aji-158	359	19	)	)	PUNCT
aji-158	359	20	.	.	PUNCT
aji-158	360	1	the	the	DET
aji-158	360	2	antigenic	antigenic	ADJ
aji-158	360	3	function	function	NOUN
aji-158	360	4	of	of	ADP
aji-158	360	5	simple	simple	ADJ
aji-158	360	6	chemical	chemical	NOUN
aji-158	360	7	compounds	compound	NOUN
aji-158	360	8	;	;	PUNCT
aji-158	360	9	production	production	NOUN
aji-158	360	10	of	of	ADP
aji-158	360	11	precipitins	precipitin	NOUN
aji-158	360	12	in	in	ADP
aji-158	360	13	rabbits	rabbit	NOUN
aji-158	360	14	.	.	PUNCT
aji-158	361	1	british	british	ADJ
aji-158	361	2	journal	journal	PROPN
aji-158	361	3	of	of	ADP
aji-158	361	4	experimental	experimental	ADJ
aji-158	361	5	pathology	pathology	NOUN
aji-158	361	6	,	,	PUNCT
aji-158	361	7	27(5	27(5	PROPN
aji-158	361	8	):	):	PUNCT
aji-158	361	9	267	267	NUM
aji-158	361	10	-	-	SYM
aji-158	361	11	286	286	NUM
aji-158	361	12	.	.	PUNCT
aji-158	362	1	gosset	gosset	NOUN
aji-158	362	2	-	-	PUNCT
aji-158	362	3	student	student	NOUN
aji-158	362	4	,	,	PUNCT
aji-158	362	5	w.	w.	PROPN
aji-158	362	6	s.	s.	PROPN
aji-158	362	7	(	(	PUNCT
aji-158	362	8	1908	1908	NUM
aji-158	362	9	)	)	PUNCT
aji-158	362	10	.	.	PUNCT
aji-158	363	1	the	the	DET
aji-158	363	2	probable	probable	ADJ
aji-158	363	3	error	error	NOUN
aji-158	363	4	of	of	ADP
aji-158	363	5	a	a	DET
aji-158	363	6	mean	mean	NOUN
aji-158	363	7	.	.	PUNCT
aji-158	364	1	biometrika	biometrika	NOUN
aji-158	364	2	,	,	PUNCT
aji-158	364	3	6(1	6(1	NUM
aji-158	364	4	):	):	PUNCT
aji-158	364	5	1	1	NUM
aji-158	364	6	-	-	SYM
aji-158	364	7	25	25	NUM
aji-158	364	8	.	.	PUNCT
aji-158	365	1	greco	greco	PROPN
aji-158	365	2	,	,	PUNCT
aji-158	365	3	n.	n.	PROPN
aji-158	365	4	,	,	PUNCT
aji-158	365	5	pisano	pisano	PROPN
aji-158	365	6	,	,	PUNCT
aji-158	365	7	a.	a.	NOUN
aji-158	365	8	,	,	PUNCT
aji-158	365	9	mezzatesta	mezzatesta	PROPN
aji-158	365	10	,	,	PUNCT
aji-158	365	11	l.	l.	PROPN
aji-158	365	12	,	,	PUNCT
aji-158	365	13	pettinelli	pettinelli	PROPN
aji-158	365	14	,	,	PUNCT
aji-158	365	15	m.	m.	NOUN
aji-158	365	16	,	,	PUNCT
aji-158	365	17	meacci	meacci	PROPN
aji-158	365	18	,	,	PUNCT
aji-158	365	19	a.	a.	PROPN
aji-158	365	20	,	,	PUNCT
aji-158	365	21	pignataro	pignataro	NOUN
aji-158	365	22	,	,	PUNCT
aji-158	365	23	m.	m.	NOUN
aji-158	365	24	g.	g.	PROPN
aji-158	365	25	,	,	PUNCT
aji-158	365	26	et	et	PROPN
aji-158	365	27	al	al	PROPN
aji-158	365	28	.	.	PROPN
aji-158	365	29	(	(	PUNCT
aji-158	365	30	2023	2023	NUM
aji-158	365	31	)	)	PUNCT
aji-158	365	32	.	.	PUNCT
aji-158	366	1	new	new	ADJ
aji-158	366	2	insights	insight	NOUN
aji-158	366	3	and	and	CCONJ
aji-158	366	4	evidence	evidence	NOUN
aji-158	366	5	on	on	ADP
aji-158	366	6	"	"	PUNCT
aji-158	366	7	food	food	NOUN
aji-158	366	8	intolerances	intolerance	NOUN
aji-158	366	9	"	"	PUNCT
aji-158	366	10	:	:	PUNCT
aji-158	366	11	non	non	ADJ
aji-158	366	12	-	-	ADJ
aji-158	366	13	celiac	celiac	ADJ
aji-158	366	14	gluten	gluten	VERB
aji-158	366	15	sensitivity	sensitivity	NOUN
aji-158	366	16	and	and	CCONJ
aji-158	366	17	nickel	nickel	NOUN
aji-158	366	18	allergic	allergic	ADJ
aji-158	366	19	contact	contact	NOUN
aji-158	366	20	mucositis	mucositis	PROPN
aji-158	366	21	.	.	PUNCT
aji-158	367	1	nutrients	nutrient	NOUN
aji-158	367	2	,	,	PUNCT
aji-158	367	3	15(10	15(10	NUM
aji-158	367	4	):	):	PUNCT
aji-158	367	5	2353	2353	NUM
aji-158	367	6	.	.	PUNCT
aji-158	368	1	halliday	halliday	PROPN
aji-158	368	2	,	,	PUNCT
aji-158	368	3	w.	w.	PROPN
aji-158	368	4	j.	j.	PROPN
aji-158	368	5	,	,	PUNCT
aji-158	368	6	maluish	maluish	PROPN
aji-158	368	7	,	,	PUNCT
aji-158	368	8	a.	a.	NOUN
aji-158	368	9	,	,	PUNCT
aji-158	368	10	&	&	CCONJ
aji-158	368	11	miller	miller	PROPN
aji-158	368	12	,	,	PUNCT
aji-158	368	13	s.	s.	PROPN
aji-158	368	14	(	(	PUNCT
aji-158	368	15	1974	1974	NUM
aji-158	368	16	)	)	PUNCT
aji-158	368	17	.	.	PUNCT
aji-158	369	1	blocking	block	VERB
aji-158	369	2	and	and	CCONJ
aji-158	369	3	unblocking	unblocking	NOUN
aji-158	369	4	of	of	ADP
aji-158	369	5	cell	cell	NOUN
aji-158	369	6	-	-	PUNCT
aji-158	369	7	mediated	mediate	VERB
aji-158	369	8	anti	anti	ADJ
aji-158	369	9	-	-	ADJ
aji-158	369	10	tumor	tumor	ADJ
aji-158	369	11	immunity	immunity	NOUN
aji-158	369	12	in	in	ADP
aji-158	369	13	mice	mouse	NOUN
aji-158	369	14	,	,	PUNCT
aji-158	369	15	as	as	SCONJ
aji-158	369	16	detected	detect	VERB
aji-158	369	17	by	by	ADP
aji-158	369	18	the	the	DET
aji-158	369	19	leucocyte	leucocyte	PROPN
aji-158	369	20	adherence	adherence	NOUN
aji-158	369	21	inhibition	inhibition	NOUN
aji-158	369	22	test	test	NOUN
aji-158	369	23	.	.	PUNCT
aji-158	370	1	cellular	cellular	ADJ
aji-158	370	2	immunology	immunology	NOUN
aji-158	370	3	,	,	PUNCT
aji-158	370	4	10(3	10(3	NUM
aji-158	370	5	):	):	PUNCT
aji-158	370	6	467	467	NUM
aji-158	370	7	-	-	SYM
aji-158	370	8	475	475	NUM
aji-158	370	9	.	.	PUNCT
aji-158	371	1	henrickson	henrickson	PROPN
aji-158	371	2	,	,	PUNCT
aji-158	371	3	s.	s.	PROPN
aji-158	371	4	e.	e.	PROPN
aji-158	371	5	(	(	PUNCT
aji-158	371	6	2025	2025	NUM
aji-158	371	7	)	)	PUNCT
aji-158	371	8	.	.	PUNCT
aji-158	372	1	evolution	evolution	NOUN
aji-158	372	2	of	of	ADP
aji-158	372	3	the	the	DET
aji-158	372	4	concept	concept	NOUN
aji-158	372	5	of	of	ADP
aji-158	372	6	immune	immune	ADJ
aji-158	372	7	dysregulation	dysregulation	NOUN
aji-158	372	8	and	and	CCONJ
aji-158	372	9	current	current	ADJ
aji-158	372	10	classification	classification	NOUN
aji-158	372	11	.	.	PUNCT
aji-158	373	1	journal	journal	PROPN
aji-158	373	2	of	of	ADP
aji-158	373	3	allergy	allergy	PROPN
aji-158	373	4	and	and	CCONJ
aji-158	373	5	clinical	clinical	ADJ
aji-158	373	6	immunology	immunology	NOUN
aji-158	373	7	,	,	PUNCT
aji-158	373	8	155(1	155(1	NUM
aji-158	373	9	):	):	PUNCT
aji-158	373	10	89	89	NUM
aji-158	373	11	-	-	SYM
aji-158	373	12	91	91	NUM
aji-158	373	13	.	.	PUNCT
aji-158	374	1	isufi	isufi	ADJ
aji-158	374	2	,	,	PUNCT
aji-158	374	3	d.	d.	PROPN
aji-158	374	4	,	,	PUNCT
aji-158	374	5	jensen	jensen	PROPN
aji-158	374	6	,	,	PUNCT
aji-158	374	7	m.	m.	PROPN
aji-158	374	8	b.	b.	PROPN
aji-158	374	9	,	,	PUNCT
aji-158	374	10	kursawe	kursawe	PROPN
aji-158	374	11	larsen	larsen	PROPN
aji-158	374	12	,	,	PUNCT
aji-158	374	13	c.	c.	PROPN
aji-158	374	14	,	,	PUNCT
aji-158	374	15	alinaghi	alinaghi	PROPN
aji-158	374	16	,	,	PUNCT
aji-158	374	17	f.	f.	PROPN
aji-158	374	18	,	,	PUNCT
aji-158	374	19	schwensen	schwensen	PROPN
aji-158	374	20	,	,	PUNCT
aji-158	374	21	j.	j.	PROPN
aji-158	374	22	f.	f.	PROPN
aji-158	374	23	b.	b.	PROPN
aji-158	374	24	,	,	PUNCT
aji-158	374	25	&	&	CCONJ
aji-158	374	26	johansen	johansen	PROPN
aji-158	374	27	,	,	PUNCT
aji-158	374	28	j.	j.	PROPN
aji-158	374	29	d.	d.	PROPN
aji-158	374	30	(	(	PUNCT
aji-158	374	31	2025	2025	NUM
aji-158	374	32	)	)	PUNCT
aji-158	374	33	.	.	PUNCT
aji-158	375	1	allergens	allergen	NOUN
aji-158	375	2	responsible	responsible	ADJ
aji-158	375	3	for	for	ADP
aji-158	375	4	contact	contact	NOUN
aji-158	375	5	allergy	allergy	NOUN
aji-158	375	6	in	in	ADP
aji-158	375	7	children	child	NOUN
aji-158	375	8	from	from	ADP
aji-158	375	9	2010	2010	NUM
aji-158	375	10	to	to	ADP
aji-158	375	11	2024	2024	NUM
aji-158	375	12	:	:	PUNCT
aji-158	375	13	a	a	DET
aji-158	375	14	systematic	systematic	ADJ
aji-158	375	15	review	review	NOUN
aji-158	375	16	and	and	CCONJ
aji-158	375	17	meta	meta	ADJ
aji-158	375	18	-	-	PUNCT
aji-158	375	19	analysis	analysis	NOUN
aji-158	375	20	.	.	PUNCT
aji-158	376	1	contact	contact	NOUN
aji-158	376	2	dermatitis	dermatitis	PROPN
aji-158	376	3	.	.	PUNCT
aji-158	377	1	kang	kang	PROPN
aji-158	377	2	,	,	PUNCT
aji-158	377	3	h.	h.	PROPN
aji-158	377	4	,	,	PUNCT
aji-158	377	5	lee	lee	PROPN
aji-158	377	6	,	,	PUNCT
aji-158	377	7	c.	c.	PROPN
aji-158	377	8	h.	h.	PROPN
aji-158	377	9	,	,	PUNCT
aji-158	377	10	kim	kim	PROPN
aji-158	377	11	,	,	PUNCT
aji-158	377	12	j.	j.	PROPN
aji-158	377	13	r.	r.	PROPN
aji-158	377	14	,	,	PUNCT
aji-158	377	15	kwon	kwon	PROPN
aji-158	377	16	,	,	PUNCT
aji-158	377	17	j.	j.	PROPN
aji-158	377	18	y.	y.	PROPN
aji-158	377	19	,	,	PUNCT
aji-158	377	20	son	son	NOUN
aji-158	377	21	,	,	PUNCT
aji-158	377	22	m.	m.	NOUN
aji-158	377	23	j.	j.	PROPN
aji-158	377	24	,	,	PUNCT
aji-158	377	25	kim	kim	PROPN
aji-158	377	26	,	,	PUNCT
aji-158	377	27	j.	j.	PROPN
aji-158	377	28	e.	e.	PROPN
aji-158	377	29	,	,	PUNCT
aji-158	377	30	et	et	PROPN
aji-158	377	31	al	al	PROPN
aji-158	377	32	.	.	PUNCT
aji-158	378	1	(	(	PUNCT
aji-158	378	2	2017	2017	NUM
aji-158	378	3	)	)	PUNCT
aji-158	378	4	.	.	PUNCT
aji-158	379	1	theobroma	theobroma	NOUN
aji-158	379	2	cacao	cacao	NOUN
aji-158	379	3	extract	extract	NOUN
aji-158	379	4	attenuates	attenuate	VERB
aji-158	379	5	the	the	DET
aji-158	379	6	development	development	NOUN
aji-158	379	7	of	of	ADP
aji-158	379	8	dermatophagoides	dermatophagoide	NOUN
aji-158	379	9	farinae	farinae	ADV
aji-158	379	10	-	-	PUNCT
aji-158	379	11	induced	induce	VERB
aji-158	379	12	atopic	atopic	NOUN
aji-158	379	13	dermatitis	dermatitis	NOUN
aji-158	379	14	-	-	PUNCT
aji-158	379	15	like	like	ADJ
aji-158	379	16	symptoms	symptom	NOUN
aji-158	379	17	in	in	ADP
aji-158	379	18	nc	nc	PROPN
aji-158	379	19	/	/	SYM
aji-158	379	20	nga	nga	NOUN
aji-158	379	21	mice	mouse	NOUN
aji-158	379	22	.	.	PUNCT
aji-158	380	1	food	food	NOUN
aji-158	380	2	chemistry	chemistry	NOUN
aji-158	380	3	,	,	PUNCT
aji-158	380	4	216	216	NUM
aji-158	380	5	:	:	SYM
aji-158	380	6	19	19	NUM
aji-158	380	7	-	-	SYM
aji-158	380	8	26	26	NUM
aji-158	380	9	.	.	PUNCT
aji-158	381	1	khan	khan	PROPN
aji-158	381	2	,	,	PUNCT
aji-158	381	3	m.	m.	NOUN
aji-158	381	4	m.	m.	NOUN
aji-158	381	5	(	(	PUNCT
aji-158	381	6	2016	2016	NUM
aji-158	381	7	)	)	PUNCT
aji-158	381	8	.	.	PUNCT
aji-158	382	1	allergic	allergic	ADJ
aji-158	382	2	disease	disease	NOUN
aji-158	382	3	.	.	PUNCT
aji-158	383	1	in	in	ADP
aji-158	383	2	m.	m.	PROPN
aji-158	383	3	m.	m.	PROPN
aji-158	383	4	khan	khan	PROPN
aji-158	383	5	(	(	PUNCT
aji-158	383	6	ed	ed	NOUN
aji-158	383	7	.	.	PUNCT
aji-158	383	8	)	)	PUNCT
aji-158	383	9	,	,	PUNCT
aji-158	383	10	immunopharmacology	immunopharmacology	NOUN
aji-158	383	11	:	:	PUNCT
aji-158	383	12	197225	197225	NUM
aji-158	383	13	.	.	PUNCT
aji-158	384	1	cham	cham	PROPN
aji-158	384	2	:	:	PUNCT
aji-158	384	3	springer	springer	NOUN
aji-158	384	4	international	international	ADJ
aji-158	384	5	publishing	publishing	NOUN
aji-158	384	6	.	.	PUNCT
aji-158	385	1	olivier	olivier	PROPN
aji-158	385	2	et	et	PROPN
aji-158	385	3	al	al	PROPN
aji-158	385	4	.	.	PROPN
aji-158	385	5	;	;	PUNCT
aji-158	385	6	asian	asian	PROPN
aji-158	385	7	j.	j.	PROPN
aji-158	385	8	immunol	immunol	PROPN
aji-158	385	9	.	.	PROPN
aji-158	385	10	,	,	PUNCT
aji-158	385	11	vol	vol	NOUN
aji-158	385	12	.	.	PROPN
aji-158	385	13	8	8	NUM
aji-158	385	14	,	,	PUNCT
aji-158	385	15	no	no	INTJ
aji-158	385	16	.	.	NOUN
aji-158	385	17	1	1	NUM
aji-158	385	18	,	,	PUNCT
aji-158	385	19	pp	pp	ADJ
aji-158	385	20	.	.	PUNCT
aji-158	386	1	35	35	NUM
aji-158	386	2	-	-	SYM
aji-158	386	3	49	49	NUM
aji-158	386	4	,	,	PUNCT
aji-158	386	5	2025	2025	NUM
aji-158	386	6	;	;	PUNCT
aji-158	386	7	article	article	NOUN
aji-158	386	8	no.aji.133582	no.aji.133582	PROPN
aji-158	386	9	46	46	NUM
aji-158	386	10	kuratsuji	kuratsuji	PROPN
aji-158	386	11	,	,	PUNCT
aji-158	386	12	t.	t.	PROPN
aji-158	386	13	(	(	PUNCT
aji-158	386	14	1981	1981	NUM
aji-158	386	15	)	)	PUNCT
aji-158	386	16	.	.	PUNCT
aji-158	387	1	studies	study	NOUN
aji-158	387	2	on	on	ADP
aji-158	387	3	leukocyte	leukocyte	ADJ
aji-158	387	4	adherence	adherence	NOUN
aji-158	387	5	inhibition	inhibition	NOUN
aji-158	387	6	test	test	NOUN
aji-158	387	7	.	.	PUNCT
aji-158	388	1	part	part	PROPN
aji-158	388	2	ii	ii	PROPN
aji-158	388	3	.	.	PUNCT
aji-158	389	1	clinical	clinical	ADJ
aji-158	389	2	applications	application	NOUN
aji-158	389	3	of	of	ADP
aji-158	389	4	lai	lai	PROPN
aji-158	389	5	test	test	PROPN
aji-158	389	6	to	to	PART
aji-158	389	7	detect	detect	VERB
aji-158	389	8	delayed	delay	VERB
aji-158	389	9	type	type	NOUN
aji-158	389	10	hypersensitivity	hypersensitivity	NOUN
aji-158	389	11	in	in	ADP
aji-158	389	12	infants	infant	NOUN
aji-158	389	13	and	and	CCONJ
aji-158	389	14	children	child	NOUN
aji-158	389	15	.	.	PUNCT
aji-158	390	1	keio	keio	PROPN
aji-158	390	2	journal	journal	PROPN
aji-158	390	3	of	of	ADP
aji-158	390	4	medicine	medicine	NOUN
aji-158	390	5	,	,	PUNCT
aji-158	390	6	30(2	30(2	NUM
aji-158	390	7	):	):	PUNCT
aji-158	390	8	65	65	NUM
aji-158	390	9	-	-	SYM
aji-158	390	10	69	69	NUM
aji-158	390	11	.	.	PUNCT
aji-158	391	1	lopes	lopes	PROPN
aji-158	391	2	,	,	PUNCT
aji-158	391	3	j.	j.	PROPN
aji-158	391	4	p.	p.	PROPN
aji-158	391	5	,	,	PUNCT
aji-158	391	6	kattan	kattan	PROPN
aji-158	391	7	,	,	PUNCT
aji-158	391	8	j.	j.	PROPN
aji-158	391	9	,	,	PUNCT
aji-158	391	10	doppelt	doppelt	PROPN
aji-158	391	11	,	,	PUNCT
aji-158	391	12	a.	a.	NOUN
aji-158	391	13	,	,	PUNCT
aji-158	391	14	nowakwęgrzyn	nowakwęgrzyn	PROPN
aji-158	391	15	,	,	PUNCT
aji-158	391	16	a.	a.	NOUN
aji-158	391	17	,	,	PUNCT
aji-158	391	18	&	&	CCONJ
aji-158	391	19	bunyavanich	bunyavanich	PROPN
aji-158	391	20	,	,	PUNCT
aji-158	391	21	s.	s.	PROPN
aji-158	391	22	(	(	PUNCT
aji-158	391	23	2019	2019	NUM
aji-158	391	24	)	)	PUNCT
aji-158	391	25	.	.	PUNCT
aji-158	392	1	not	not	PART
aji-158	392	2	so	so	ADV
aji-158	392	3	sweet	sweet	ADJ
aji-158	392	4	:	:	PUNCT
aji-158	392	5	true	true	ADJ
aji-158	392	6	chocolate	chocolate	NOUN
aji-158	392	7	and	and	CCONJ
aji-158	392	8	cocoa	cocoa	NOUN
aji-158	392	9	allergy	allergy	NOUN
aji-158	392	10	.	.	PUNCT
aji-158	393	1	the	the	DET
aji-158	393	2	journal	journal	PROPN
aji-158	393	3	of	of	ADP
aji-158	393	4	allergy	allergy	NOUN
aji-158	393	5	and	and	CCONJ
aji-158	393	6	clinical	clinical	ADJ
aji-158	393	7	immunology	immunology	NOUN
aji-158	393	8	:	:	PUNCT
aji-158	393	9	in	in	ADP
aji-158	393	10	practice	practice	NOUN
aji-158	393	11	,	,	PUNCT
aji-158	393	12	7(8	7(8	NUM
aji-158	393	13	):	):	PUNCT
aji-158	393	14	2868	2868	NUM
aji-158	393	15	-	-	SYM
aji-158	393	16	2871	2871	NUM
aji-158	393	17	.	.	PUNCT
aji-158	394	1	macowan	macowan	ADJ
aji-158	394	2	,	,	PUNCT
aji-158	394	3	m.	m.	NOUN
aji-158	394	4	,	,	PUNCT
aji-158	394	5	pattaroni	pattaroni	NOUN
aji-158	394	6	,	,	PUNCT
aji-158	394	7	c.	c.	PROPN
aji-158	394	8	,	,	PUNCT
aji-158	394	9	bonner	bonner	PROPN
aji-158	394	10	,	,	PUNCT
aji-158	394	11	k.	k.	PROPN
aji-158	394	12	,	,	PUNCT
aji-158	394	13	chatzis	chatzis	PROPN
aji-158	394	14	,	,	PUNCT
aji-158	394	15	r.	r.	PROPN
aji-158	394	16	,	,	PUNCT
aji-158	394	17	daunt	daunt	PROPN
aji-158	394	18	,	,	PUNCT
aji-158	394	19	c.	c.	PROPN
aji-158	394	20	,	,	PUNCT
aji-158	394	21	gore	gore	PROPN
aji-158	394	22	,	,	PUNCT
aji-158	394	23	m.	m.	NOUN
aji-158	394	24	,	,	PUNCT
aji-158	394	25	et	et	PROPN
aji-158	394	26	al	al	PROPN
aji-158	394	27	.	.	PROPN
aji-158	394	28	(	(	PUNCT
aji-158	394	29	2025	2025	NUM
aji-158	394	30	)	)	PUNCT
aji-158	394	31	.	.	PUNCT
aji-158	395	1	deep	deep	ADJ
aji-158	395	2	multiomic	multiomic	ADJ
aji-158	395	3	profiling	profiling	NOUN
aji-158	395	4	reveals	reveal	VERB
aji-158	395	5	molecular	molecular	ADJ
aji-158	395	6	signatures	signature	NOUN
aji-158	395	7	that	that	PRON
aji-158	395	8	underpin	underpin	VERB
aji-158	395	9	preschool	preschool	ADJ
aji-158	395	10	wheeze	wheeze	NOUN
aji-158	395	11	and	and	CCONJ
aji-158	395	12	asthma	asthma	NOUN
aji-158	395	13	.	.	PUNCT
aji-158	396	1	journal	journal	PROPN
aji-158	396	2	of	of	ADP
aji-158	396	3	allergy	allergy	PROPN
aji-158	396	4	and	and	CCONJ
aji-158	396	5	clinical	clinical	ADJ
aji-158	396	6	immunology	immunology	NOUN
aji-158	396	7	,	,	PUNCT
aji-158	396	8	155(1	155(1	NUM
aji-158	396	9	):	):	PUNCT
aji-158	396	10	94	94	NUM
aji-158	396	11	-	-	SYM
aji-158	396	12	106	106	NUM
aji-158	396	13	.	.	PUNCT
aji-158	397	1	menezes	menezes	PROPN
aji-158	397	2	,	,	PUNCT
aji-158	397	3	s.	s.	PROPN
aji-158	397	4	p.	p.	PROPN
aji-158	397	5	,	,	PUNCT
aji-158	397	6	dos	dos	PROPN
aji-158	397	7	santos	santos	PROPN
aji-158	397	8	,	,	PUNCT
aji-158	397	9	j.	j.	PROPN
aji-158	397	10	l.	l.	PROPN
aji-158	397	11	,	,	PUNCT
aji-158	397	12	cardoso	cardoso	PROPN
aji-158	397	13	,	,	PUNCT
aji-158	397	14	t.	t.	PROPN
aji-158	397	15	h.	h.	PROPN
aji-158	397	16	s.	s.	PROPN
aji-158	397	17	,	,	PUNCT
aji-158	397	18	pirovani	pirovani	PROPN
aji-158	397	19	,	,	PUNCT
aji-158	397	20	c.	c.	PROPN
aji-158	397	21	p.	p.	PROPN
aji-158	397	22	,	,	PUNCT
aji-158	397	23	micheli	micheli	PROPN
aji-158	397	24	,	,	PUNCT
aji-158	397	25	f.	f.	PROPN
aji-158	397	26	,	,	PUNCT
aji-158	397	27	noronha	noronha	PROPN
aji-158	397	28	,	,	PUNCT
aji-158	397	29	f.	f.	PROPN
aji-158	397	30	s.	s.	PROPN
aji-158	397	31	m.	m.	PROPN
aji-158	397	32	,	,	PUNCT
aji-158	397	33	et	et	PROPN
aji-158	397	34	al	al	PROPN
aji-158	397	35	.	.	PUNCT
aji-158	397	36	(	(	PUNCT
aji-158	397	37	2012	2012	NUM
aji-158	397	38	)	)	PUNCT
aji-158	397	39	.	.	PUNCT
aji-158	398	1	evaluation	evaluation	NOUN
aji-158	398	2	of	of	ADP
aji-158	398	3	the	the	DET
aji-158	398	4	allergenicity	allergenicity	NOUN
aji-158	398	5	potential	potential	NOUN
aji-158	398	6	of	of	ADP
aji-158	398	7	tcpr-10	tcpr-10	ADJ
aji-158	398	8	protein	protein	NOUN
aji-158	398	9	from	from	ADP
aji-158	398	10	theobroma	theobroma	NOUN
aji-158	398	11	cacao	cacao	NOUN
aji-158	398	12	.	.	PUNCT
aji-158	399	1	plos	plos	PROPN
aji-158	399	2	one	one	NUM
aji-158	399	3	,	,	PUNCT
aji-158	399	4	7(6	7(6	NUM
aji-158	399	5	):	):	PUNCT
aji-158	399	6	e37969	e37969	ADJ
aji-158	399	7	.	.	PUNCT
aji-158	400	1	mikajiri	mikajiri	PROPN
aji-158	400	2	,	,	PUNCT
aji-158	400	3	r.	r.	PROPN
aji-158	400	4	,	,	PUNCT
aji-158	400	5	fukunaga	fukunaga	PROPN
aji-158	400	6	,	,	PUNCT
aji-158	400	7	a.	a.	PROPN
aji-158	400	8	,	,	PUNCT
aji-158	400	9	miyoshi	miyoshi	PROPN
aji-158	400	10	,	,	PUNCT
aji-158	400	11	m.	m.	NOUN
aji-158	400	12	,	,	PUNCT
aji-158	400	13	maeshige	maeshige	ADJ
aji-158	400	14	,	,	PUNCT
aji-158	400	15	n.	n.	NOUN
aji-158	400	16	,	,	PUNCT
aji-158	400	17	washio	washio	PROPN
aji-158	400	18	,	,	PUNCT
aji-158	400	19	k.	k.	PROPN
aji-158	400	20	,	,	PUNCT
aji-158	400	21	masaki	masaki	PROPN
aji-158	400	22	,	,	PUNCT
aji-158	400	23	t.	t.	PROPN
aji-158	400	24	,	,	PUNCT
aji-158	400	25	etal	etal	NOUN
aji-158	400	26	.	.	PUNCT
aji-158	401	1	(	(	PUNCT
aji-158	401	2	2024	2024	NUM
aji-158	401	3	)	)	PUNCT
aji-158	401	4	.	.	PUNCT
aji-158	402	1	dietary	dietary	ADJ
aji-158	402	2	intervention	intervention	NOUN
aji-158	402	3	for	for	ADP
aji-158	402	4	control	control	NOUN
aji-158	402	5	of	of	ADP
aji-158	402	6	clinical	clinical	ADJ
aji-158	402	7	symptom	symptom	NOUN
aji-158	402	8	in	in	ADP
aji-158	402	9	patients	patient	NOUN
aji-158	402	10	with	with	ADP
aji-158	402	11	systemic	systemic	ADJ
aji-158	402	12	metal	metal	NOUN
aji-158	402	13	allergy	allergy	NOUN
aji-158	402	14	:	:	PUNCT
aji-158	402	15	a	a	DET
aji-158	402	16	single	single	ADJ
aji-158	402	17	center	center	NOUN
aji-158	402	18	randomized	randomize	VERB
aji-158	402	19	controlled	control	VERB
aji-158	402	20	clinical	clinical	ADJ
aji-158	402	21	study	study	NOUN
aji-158	402	22	.	.	PUNCT
aji-158	403	1	the	the	DET
aji-158	403	2	kobe	kobe	PROPN
aji-158	403	3	journal	journal	PROPN
aji-158	403	4	of	of	ADP
aji-158	403	5	medical	medical	ADJ
aji-158	403	6	sciences	sciences	PROPN
aji-158	403	7	,	,	PUNCT
aji-158	403	8	69(4	69(4	NUM
aji-158	403	9	):	):	PUNCT
aji-158	403	10	e129	e129	PROPN
aji-158	403	11	-	-	PUNCT
aji-158	403	12	e143	e143	PROPN
aji-158	403	13	.	.	PUNCT
aji-158	403	14	morris	morris	PROPN
aji-158	403	15	,	,	PUNCT
aji-158	403	16	d.	d.	PROPN
aji-158	403	17	l.	l.	PROPN
aji-158	403	18	(	(	PUNCT
aji-158	403	19	1998	1998	NUM
aji-158	403	20	)	)	PUNCT
aji-158	403	21	.	.	PUNCT
aji-158	404	1	intradermal	intradermal	ADJ
aji-158	404	2	testing	testing	NOUN
aji-158	404	3	and	and	CCONJ
aji-158	404	4	sublingual	sublingual	ADJ
aji-158	404	5	desensitization	desensitization	NOUN
aji-158	404	6	for	for	ADP
aji-158	404	7	nickel	nickel	NOUN
aji-158	404	8	.	.	PUNCT
aji-158	405	1	cutis	cutis	NOUN
aji-158	405	2	,	,	PUNCT
aji-158	405	3	61(3	61(3	NUM
aji-158	405	4	):	):	PUNCT
aji-158	405	5	129	129	NUM
aji-158	405	6	-	-	SYM
aji-158	405	7	132	132	NUM
aji-158	405	8	.	.	PUNCT
aji-158	406	1	mostafa	mostafa	PROPN
aji-158	406	2	,	,	PUNCT
aji-158	406	3	m.	m.	PROPN
aji-158	406	4	r.	r.	PROPN
aji-158	406	5	,	,	PUNCT
aji-158	406	6	mohamed	mohamed	PROPN
aji-158	406	7	,	,	PUNCT
aji-158	406	8	g.	g.	PROPN
aji-158	406	9	g.	g.	PROPN
aji-158	406	10	,	,	PUNCT
aji-158	406	11	&	&	CCONJ
aji-158	406	12	fouad	fouad	PROPN
aji-158	406	13	,	,	PUNCT
aji-158	406	14	o.	o.	NOUN
aji-158	406	15	a.	a.	NOUN
aji-158	406	16	(	(	PUNCT
aji-158	406	17	2024	2024	NUM
aji-158	406	18	)	)	PUNCT
aji-158	406	19	.	.	PUNCT
aji-158	407	1	electrochemical	electrochemical	ADJ
aji-158	407	2	and	and	CCONJ
aji-158	407	3	statistical	statistical	ADJ
aji-158	407	4	study	study	NOUN
aji-158	407	5	of	of	ADP
aji-158	407	6	nickel	nickel	NOUN
aji-158	407	7	ion	ion	NOUN
aji-158	407	8	assessment	assessment	NOUN
aji-158	407	9	in	in	ADP
aji-158	407	10	daily	daily	ADJ
aji-158	407	11	children	child	NOUN
aji-158	407	12	intake	intake	NOUN
aji-158	407	13	samples	sample	NOUN
aji-158	407	14	relying	rely	VERB
aji-158	407	15	on	on	ADP
aji-158	407	16	magnesium	magnesium	NOUN
aji-158	407	17	aluminate	aluminate	NOUN
aji-158	407	18	spinel	spinel	NOUN
aji-158	407	19	nanoparticles	nanoparticle	NOUN
aji-158	407	20	.	.	PUNCT
aji-158	408	1	scientific	scientific	ADJ
aji-158	408	2	reports	report	NOUN
aji-158	408	3	,	,	PUNCT
aji-158	408	4	14(1	14(1	NUM
aji-158	408	5	):	):	PUNCT
aji-158	408	6	16424	16424	NUM
aji-158	408	7	.	.	PUNCT
aji-158	409	1	nijhawan	nijhawan	PROPN
aji-158	409	2	,	,	PUNCT
aji-158	409	3	r.	r.	PROPN
aji-158	409	4	i.	i.	PROPN
aji-158	409	5	,	,	PUNCT
aji-158	409	6	molenda	molenda	ADV
aji-158	409	7	,	,	PUNCT
aji-158	409	8	m.	m.	NOUN
aji-158	409	9	,	,	PUNCT
aji-158	409	10	zirwas	zirwas	PROPN
aji-158	409	11	,	,	PUNCT
aji-158	409	12	m.	m.	PROPN
aji-158	409	13	j.	j.	PROPN
aji-158	409	14	,	,	PUNCT
aji-158	409	15	&	&	CCONJ
aji-158	409	16	jacob	jacob	PROPN
aji-158	409	17	,	,	PUNCT
aji-158	409	18	s.	s.	PROPN
aji-158	409	19	e.	e.	PROPN
aji-158	409	20	(	(	PUNCT
aji-158	409	21	2009	2009	NUM
aji-158	409	22	)	)	PUNCT
aji-158	409	23	.	.	PUNCT
aji-158	410	1	systemic	systemic	ADJ
aji-158	410	2	contact	contact	NOUN
aji-158	410	3	dermatitis	dermatitis	NOUN
aji-158	410	4	.	.	PUNCT
aji-158	411	1	dermatologic	dermatologic	ADJ
aji-158	411	2	clinics	clinic	NOUN
aji-158	411	3	,	,	PUNCT
aji-158	411	4	27(3	27(3	NUM
aji-158	411	5	):	):	PUNCT
aji-158	411	6	355	355	NUM
aji-158	411	7	-	-	SYM
aji-158	411	8	364	364	NUM
aji-158	411	9	,	,	PUNCT
aji-158	411	10	vii	vii	PROPN
aji-158	411	11	.	.	PUNCT
aji-158	412	1	nin	nin	PROPN
aji-158	412	2	-	-	PUNCT
aji-158	412	3	valencia	valencia	PROPN
aji-158	412	4	,	,	PUNCT
aji-158	412	5	a.	a.	PROPN
aji-158	412	6	,	,	PUNCT
aji-158	412	7	retes	rete	NOUN
aji-158	412	8	,	,	PUNCT
aji-158	412	9	l.	l.	PROPN
aji-158	412	10	s.	s.	PROPN
aji-158	412	11	,	,	PUNCT
aji-158	412	12	bartolomé	bartolomé	NOUN
aji-158	412	13	-	-	PUNCT
aji-158	412	14	zavala	zavala	NOUN
aji-158	412	15	,	,	PUNCT
aji-158	412	16	b.	b.	PROPN
aji-158	412	17	,	,	PUNCT
aji-158	412	18	perdomo	perdomo	NOUN
aji-158	412	19	-	-	PUNCT
aji-158	412	20	gutiérrez	gutiérrez	NOUN
aji-158	412	21	,	,	PUNCT
aji-158	412	22	g.	g.	PROPN
aji-158	412	23	,	,	PUNCT
aji-158	412	24	&	&	CCONJ
aji-158	412	25	bigorra	bigorra	PROPN
aji-158	412	26	,	,	PUNCT
aji-158	412	27	t.	t.	PROPN
aji-158	412	28	(	(	PUNCT
aji-158	412	29	2024	2024	NUM
aji-158	412	30	)	)	PUNCT
aji-158	412	31	.	.	PUNCT
aji-158	413	1	allergy	allergy	NOUN
aji-158	413	2	to	to	ADP
aji-158	413	3	theobroma	theobroma	NOUN
aji-158	413	4	cacao	cacao	NOUN
aji-158	413	5	.	.	PUNCT
aji-158	414	1	clinical	clinical	ADJ
aji-158	414	2	case	case	NOUN
aji-158	414	3	reports	report	NOUN
aji-158	414	4	,	,	PUNCT
aji-158	414	5	12(6	12(6	NUM
aji-158	414	6	):	):	PUNCT
aji-158	414	7	e8803	e8803	NOUN
aji-158	414	8	.	.	PUNCT
aji-158	415	1	olivier	olivier	PROPN
aji-158	415	2	,	,	PUNCT
aji-158	415	3	c.	c.	PROPN
aji-158	415	4	e.	e.	PROPN
aji-158	415	5	,	,	PUNCT
aji-158	415	6	argentão	argentão	PROPN
aji-158	415	7	,	,	PUNCT
aji-158	415	8	d.	d.	PROPN
aji-158	415	9	g.	g.	PROPN
aji-158	415	10	p.	p.	PROPN
aji-158	415	11	,	,	PUNCT
aji-158	415	12	santos	santos	PROPN
aji-158	415	13	,	,	PUNCT
aji-158	415	14	r.	r.	PROPN
aji-158	415	15	a.	a.	PROPN
aji-158	415	16	p.	p.	PROPN
aji-158	415	17	g.	g.	PROPN
aji-158	415	18	,	,	PUNCT
aji-158	415	19	silva	silva	PROPN
aji-158	415	20	,	,	PUNCT
aji-158	415	21	m.	m.	NOUN
aji-158	415	22	d.	d.	PROPN
aji-158	415	23	,	,	PUNCT
aji-158	415	24	lima	lima	PROPN
aji-158	415	25	,	,	PUNCT
aji-158	415	26	r.	r.	PROPN
aji-158	415	27	p.	p.	PROPN
aji-158	415	28	s.	s.	PROPN
aji-158	415	29	,	,	PUNCT
aji-158	415	30	&	&	CCONJ
aji-158	415	31	zollner	zollner	PROPN
aji-158	415	32	,	,	PUNCT
aji-158	415	33	r.	r.	PROPN
aji-158	415	34	l.	l.	PROPN
aji-158	415	35	(	(	PUNCT
aji-158	415	36	2013	2013	NUM
aji-158	415	37	)	)	PUNCT
aji-158	415	38	.	.	PUNCT
aji-158	416	1	skin	skin	NOUN
aji-158	416	2	scrape	scrape	PROPN
aji-158	416	3	test	test	NOUN
aji-158	416	4	:	:	PUNCT
aji-158	416	5	an	an	DET
aji-158	416	6	inexpensive	inexpensive	ADJ
aji-158	416	7	and	and	CCONJ
aji-158	416	8	painless	painless	ADJ
aji-158	416	9	skin	skin	NOUN
aji-158	416	10	test	test	NOUN
aji-158	416	11	for	for	ADP
aji-158	416	12	recognition	recognition	NOUN
aji-158	416	13	of	of	ADP
aji-158	416	14	immediate	immediate	ADJ
aji-158	416	15	hypersensitivity	hypersensitivity	NOUN
aji-158	416	16	in	in	ADP
aji-158	416	17	children	child	NOUN
aji-158	416	18	and	and	CCONJ
aji-158	416	19	adults	adult	NOUN
aji-158	416	20	.	.	PUNCT
aji-158	417	1	the	the	DET
aji-158	417	2	open	open	ADJ
aji-158	417	3	allergy	allergy	NOUN
aji-158	417	4	journal	journal	NOUN
aji-158	417	5	,	,	PUNCT
aji-158	417	6	6	6	NUM
aji-158	417	7	:	:	SYM
aji-158	417	8	9	9	NUM
aji-158	417	9	-	-	SYM
aji-158	417	10	17	17	NUM
aji-158	417	11	.	.	PUNCT
aji-158	418	1	olivier	olivier	PROPN
aji-158	418	2	,	,	PUNCT
aji-158	418	3	c.	c.	PROPN
aji-158	418	4	e.	e.	PROPN
aji-158	418	5	,	,	PUNCT
aji-158	418	6	lima	lima	PROPN
aji-158	418	7	,	,	PUNCT
aji-158	418	8	r.	r.	PROPN
aji-158	418	9	p.	p.	PROPN
aji-158	418	10	d.	d.	PROPN
aji-158	418	11	s.	s.	PROPN
aji-158	418	12	,	,	PUNCT
aji-158	418	13	pinto	pinto	PROPN
aji-158	418	14	,	,	PUNCT
aji-158	418	15	d.	d.	PROPN
aji-158	418	16	g.	g.	PROPN
aji-158	418	17	,	,	PUNCT
aji-158	418	18	&	&	CCONJ
aji-158	418	19	santos	santos	PROPN
aji-158	418	20	,	,	PUNCT
aji-158	419	1	r.	r.	PROPN
aji-158	419	2	a.	a.	PROPN
aji-158	419	3	p.	p.	PROPN
aji-158	419	4	g.	g.	PROPN
aji-158	419	5	d.	d.	PROPN
aji-158	419	6	(	(	PUNCT
aji-158	419	7	2021a	2021a	NUM
aji-158	419	8	)	)	PUNCT
aji-158	419	9	.	.	PUNCT
aji-158	420	1	the	the	DET
aji-158	420	2	plasma	plasma	NOUN
aji-158	420	3	preincubation	preincubation	NOUN
aji-158	420	4	with	with	ADP
aji-158	420	5	papain	papain	NOUN
aji-158	420	6	before	before	SCONJ
aji-158	420	7	the	the	DET
aji-158	420	8	assay	assay	NOUN
aji-158	420	9	suggests	suggest	VERB
aji-158	420	10	that	that	SCONJ
aji-158	420	11	a	a	DET
aji-158	420	12	gell	gell	NOUN
aji-158	420	13	and	and	CCONJ
aji-158	420	14	coombs	coombs	PROPN
aji-158	420	15	type	type	PROPN
aji-158	420	16	ii	ii	PROPN
aji-158	420	17	reaction	reaction	NOUN
aji-158	420	18	is	be	AUX
aji-158	420	19	been	be	AUX
aji-158	420	20	demonstrated	demonstrate	VERB
aji-158	420	21	by	by	ADP
aji-158	420	22	the	the	DET
aji-158	420	23	leukocyte	leukocyte	NOUN
aji-158	420	24	adherence	adherence	NOUN
aji-158	420	25	inhibition	inhibition	NOUN
aji-158	420	26	test	test	NOUN
aji-158	420	27	.	.	PUNCT
aji-158	421	1	biomedical	biomedical	ADJ
aji-158	421	2	journal	journal	PROPN
aji-158	421	3	of	of	ADP
aji-158	421	4	scientific	scientific	PROPN
aji-158	421	5	&	&	CCONJ
aji-158	421	6	technical	technical	ADJ
aji-158	421	7	research	research	PROPN
aji-158	421	8	,	,	PUNCT
aji-158	421	9	36(3	36(3	NUM
aji-158	421	10	):	):	PUNCT
aji-158	421	11	28647	28647	NUM
aji-158	421	12	28655	28655	NUM
aji-158	421	13	.	.	PUNCT
aji-158	422	1	olivier	olivier	PROPN
aji-158	422	2	,	,	PUNCT
aji-158	422	3	c.	c.	PROPN
aji-158	422	4	e.	e.	PROPN
aji-158	422	5	,	,	PUNCT
aji-158	422	6	lima	lima	PROPN
aji-158	422	7	,	,	PUNCT
aji-158	422	8	r.	r.	PROPN
aji-158	422	9	p.	p.	PROPN
aji-158	422	10	s.	s.	PROPN
aji-158	422	11	,	,	PUNCT
aji-158	422	12	pinto	pinto	NOUN
aji-158	422	13	,	,	PUNCT
aji-158	422	14	d.	d.	PROPN
aji-158	422	15	g.	g.	PROPN
aji-158	422	16	,	,	PUNCT
aji-158	422	17	santos	santos	PROPN
aji-158	422	18	,	,	PUNCT
aji-158	422	19	r.	r.	PROPN
aji-158	422	20	a.	a.	PROPN
aji-158	422	21	p.	p.	PROPN
aji-158	422	22	g.	g.	PROPN
aji-158	422	23	,	,	PUNCT
aji-158	422	24	silva	silva	PROPN
aji-158	422	25	,	,	PUNCT
aji-158	422	26	g.	g.	PROPN
aji-158	422	27	k.	k.	PROPN
aji-158	422	28	m.	m.	PROPN
aji-158	422	29	,	,	PUNCT
aji-158	422	30	lorena	lorena	PROPN
aji-158	422	31	,	,	PUNCT
aji-158	422	32	s.	s.	PROPN
aji-158	422	33	l.	l.	PROPN
aji-158	422	34	s.	s.	PROPN
aji-158	422	35	,	,	PUNCT
aji-158	422	36	et	et	PROPN
aji-158	422	37	al	al	PROPN
aji-158	422	38	.	.	PUNCT
aji-158	422	39	(	(	PUNCT
aji-158	422	40	2012	2012	NUM
aji-158	422	41	)	)	PUNCT
aji-158	422	42	.	.	PUNCT
aji-158	423	1	in	in	ADP
aji-158	423	2	search	search	NOUN
aji-158	423	3	of	of	ADP
aji-158	423	4	a	a	DET
aji-158	423	5	tolerance	tolerance	NOUN
aji-158	423	6	-	-	PUNCT
aji-158	423	7	induction	induction	NOUN
aji-158	423	8	strategy	strategy	NOUN
aji-158	423	9	for	for	ADP
aji-158	423	10	cow	cow	NOUN
aji-158	423	11	's	's	PART
aji-158	423	12	milk	milk	NOUN
aji-158	423	13	allergies	allergy	NOUN
aji-158	423	14	:	:	PUNCT
aji-158	423	15	significant	significant	ADJ
aji-158	423	16	reduction	reduction	NOUN
aji-158	423	17	of	of	ADP
aji-158	423	18	betalactoglobulin	betalactoglobulin	ADJ
aji-158	423	19	allergenicity	allergenicity	NOUN
aji-158	423	20	via	via	ADP
aji-158	423	21	transglutaminase	transglutaminase	NOUN
aji-158	423	22	/	/	SYM
aji-158	423	23	cysteine	cysteine	NOUN
aji-158	423	24	polymerization	polymerization	NOUN
aji-158	423	25	.	.	PUNCT
aji-158	424	1	clinics	clinic	NOUN
aji-158	424	2	,	,	PUNCT
aji-158	424	3	67(10	67(10	NUM
aji-158	424	4	):	):	PUNCT
aji-158	424	5	1171	1171	NUM
aji-158	424	6	-	-	SYM
aji-158	424	7	1179	1179	NUM
aji-158	424	8	.	.	PUNCT
aji-158	425	1	olivier	olivier	PROPN
aji-158	425	2	,	,	PUNCT
aji-158	425	3	c.	c.	PROPN
aji-158	425	4	e.	e.	PROPN
aji-158	425	5	,	,	PUNCT
aji-158	425	6	pinto	pinto	PROPN
aji-158	425	7	,	,	PUNCT
aji-158	425	8	d.	d.	PROPN
aji-158	425	9	g.	g.	PROPN
aji-158	425	10	,	,	PUNCT
aji-158	425	11	lima	lima	PROPN
aji-158	425	12	,	,	PUNCT
aji-158	425	13	r.	r.	PROPN
aji-158	425	14	p.	p.	PROPN
aji-158	425	15	s.	s.	PROPN
aji-158	425	16	,	,	PUNCT
aji-158	425	17	silva	silva	PROPN
aji-158	425	18	,	,	PUNCT
aji-158	425	19	m.	m.	PROPN
aji-158	425	20	d.	d.	PROPN
aji-158	425	21	d.	d.	PROPN
aji-158	425	22	,	,	PUNCT
aji-158	425	23	santos	santos	PROPN
aji-158	425	24	,	,	PUNCT
aji-158	425	25	r.	r.	PROPN
aji-158	425	26	a.	a.	PROPN
aji-158	425	27	p.	p.	PROPN
aji-158	425	28	g.	g.	PROPN
aji-158	425	29	,	,	PUNCT
aji-158	425	30	teixeira	teixeira	PROPN
aji-158	425	31	,	,	PUNCT
aji-158	425	32	a.	a.	NOUN
aji-158	425	33	p.	p.	NOUN
aji-158	425	34	m.	m.	NOUN
aji-158	425	35	,	,	PUNCT
aji-158	425	36	et	et	PROPN
aji-158	425	37	al	al	PROPN
aji-158	425	38	.	.	PROPN
aji-158	425	39	(	(	PUNCT
aji-158	425	40	2021b	2021b	NUM
aji-158	425	41	)	)	PUNCT
aji-158	425	42	.	.	PUNCT
aji-158	426	1	assessment	assessment	NOUN
aji-158	426	2	of	of	ADP
aji-158	426	3	immunoreactivity	immunoreactivity	NOUN
aji-158	426	4	against	against	ADP
aji-158	426	5	therapeutic	therapeutic	ADJ
aji-158	426	6	options	option	NOUN
aji-158	426	7	employing	employ	VERB
aji-158	426	8	the	the	DET
aji-158	426	9	leukocyte	leukocyte	NOUN
aji-158	426	10	adherence	adherence	NOUN
aji-158	426	11	inhibition	inhibition	NOUN
aji-158	426	12	test	test	NOUN
aji-158	426	13	as	as	ADP
aji-158	426	14	a	a	DET
aji-158	426	15	tool	tool	NOUN
aji-158	426	16	for	for	ADP
aji-158	426	17	precision	precision	NOUN
aji-158	426	18	medicine	medicine	NOUN
aji-158	426	19	.	.	PUNCT
aji-158	427	1	european	european	ADJ
aji-158	427	2	journal	journal	PROPN
aji-158	427	3	of	of	ADP
aji-158	427	4	clinical	clinical	ADJ
aji-158	427	5	medicine	medicine	NOUN
aji-158	427	6	,	,	PUNCT
aji-158	427	7	2(3	2(3	NUM
aji-158	427	8	):	):	PUNCT
aji-158	427	9	40	40	NUM
aji-158	427	10	-	-	SYM
aji-158	427	11	45	45	NUM
aji-158	427	12	.	.	PUNCT
aji-158	428	1	olivier	olivier	PROPN
aji-158	428	2	,	,	PUNCT
aji-158	428	3	c.	c.	PROPN
aji-158	428	4	e.	e.	PROPN
aji-158	428	5	,	,	PUNCT
aji-158	428	6	pinto	pinto	PROPN
aji-158	428	7	,	,	PUNCT
aji-158	428	8	d.	d.	PROPN
aji-158	428	9	g.	g.	PROPN
aji-158	428	10	,	,	PUNCT
aji-158	428	11	santos	santos	PROPN
aji-158	428	12	,	,	PUNCT
aji-158	428	13	r.	r.	PROPN
aji-158	428	14	a.	a.	PROPN
aji-158	428	15	p.	p.	PROPN
aji-158	428	16	g.	g.	PROPN
aji-158	428	17	,	,	PUNCT
aji-158	428	18	&	&	CCONJ
aji-158	428	19	lima	lima	PROPN
aji-158	428	20	,	,	PUNCT
aji-158	428	21	r.	r.	PROPN
aji-158	428	22	p.	p.	PROPN
aji-158	428	23	s.	s.	PROPN
aji-158	428	24	(	(	PUNCT
aji-158	428	25	2021c	2021c	NUM
aji-158	428	26	)	)	PUNCT
aji-158	428	27	.	.	PUNCT
aji-158	429	1	dextran	dextran	PROPN
aji-158	429	2	's	's	PART
aji-158	429	3	interference	interference	NOUN
aji-158	429	4	over	over	ADP
aji-158	429	5	the	the	DET
aji-158	429	6	leukocyte	leukocyte	NOUN
aji-158	429	7	adherence	adherence	NOUN
aji-158	429	8	inhibition	inhibition	NOUN
aji-158	429	9	test	test	NOUN
aji-158	429	10	.	.	PUNCT
aji-158	430	1	academia	academia	PROPN
aji-158	430	2	letter	letter	PROPN
aji-158	430	3	,	,	PUNCT
aji-158	430	4	article	article	NOUN
aji-158	430	5	(	(	PUNCT
aji-158	430	6	number	number	NOUN
aji-158	430	7	):	):	PUNCT
aji-158	430	8	3792	3792	NUM
aji-158	430	9	.	.	PUNCT
aji-158	431	1	olivier	olivier	PROPN
aji-158	431	2	,	,	PUNCT
aji-158	431	3	c.	c.	PROPN
aji-158	431	4	e.	e.	PROPN
aji-158	431	5	,	,	PUNCT
aji-158	431	6	pinto	pinto	PROPN
aji-158	431	7	,	,	PUNCT
aji-158	431	8	d.	d.	PROPN
aji-158	431	9	g.	g.	PROPN
aji-158	431	10	,	,	PUNCT
aji-158	431	11	teixeira	teixeira	PROPN
aji-158	431	12	,	,	PUNCT
aji-158	431	13	a.	a.	NOUN
aji-158	431	14	p.	p.	NOUN
aji-158	431	15	m.	m.	NOUN
aji-158	431	16	,	,	PUNCT
aji-158	431	17	miguel	miguel	PROPN
aji-158	431	18	,	,	PUNCT
aji-158	431	19	c.	c.	PROPN
aji-158	431	20	s.	s.	PROPN
aji-158	431	21	,	,	PUNCT
aji-158	431	22	santos	santos	PROPN
aji-158	431	23	,	,	PUNCT
aji-158	431	24	r.	r.	PROPN
aji-158	431	25	a.	a.	PROPN
aji-158	431	26	p.	p.	PROPN
aji-158	431	27	g.	g.	PROPN
aji-158	431	28	,	,	PUNCT
aji-158	431	29	rocha	rocha	PROPN
aji-158	431	30	,	,	PUNCT
aji-158	431	31	n.	n.	PROPN
aji-158	431	32	s.	s.	PROPN
aji-158	431	33	,	,	PUNCT
aji-158	431	34	et	et	PROPN
aji-158	431	35	-	-	PUNCT
aji-158	431	36	al	al	PROPN
aji-158	431	37	.	.	PUNCT
aji-158	431	38	(	(	PUNCT
aji-158	431	39	2025	2025	NUM
aji-158	431	40	)	)	PUNCT
aji-158	431	41	.	.	PUNCT
aji-158	432	1	endotyping	endotype	VERB
aji-158	432	2	cellular	cellular	ADJ
aji-158	432	3	and	and	CCONJ
aji-158	432	4	humoral	humoral	ADJ
aji-158	432	5	immunoreactivity	immunoreactivity	NOUN
aji-158	432	6	against	against	ADP
aji-158	432	7	pollen	pollen	NOUN
aji-158	432	8	and	and	CCONJ
aji-158	432	9	citrus	citrus	NOUN
aji-158	432	10	fruits	fruit	NOUN
aji-158	432	11	in	in	ADP
aji-158	432	12	patients	patient	NOUN
aji-158	432	13	with	with	ADP
aji-158	432	14	non	non	ADJ
aji-158	432	15	ige	ige	PROPN
aji-158	432	16	mediated	mediate	VERB
aji-158	432	17	rhinoconjunctivitis	rhinoconjunctivitis	NOUN
aji-158	432	18	.	.	PUNCT
aji-158	433	1	asian	asian	ADJ
aji-158	433	2	journal	journal	PROPN
aji-158	433	3	of	of	ADP
aji-158	433	4	immunology	immunology	NOUN
aji-158	433	5	,	,	PUNCT
aji-158	433	6	8(1	8(1	NOUN
aji-158	433	7	):	):	PUNCT
aji-158	433	8	8	8	NUM
aji-158	433	9	-	-	SYM
aji-158	433	10	25	25	NUM
aji-158	433	11	.	.	PUNCT
aji-158	434	1	olivier	olivier	PROPN
aji-158	434	2	,	,	PUNCT
aji-158	434	3	c.	c.	PROPN
aji-158	434	4	e.	e.	PROPN
aji-158	434	5	,	,	PUNCT
aji-158	434	6	pinto	pinto	PROPN
aji-158	434	7	,	,	PUNCT
aji-158	434	8	d.	d.	PROPN
aji-158	434	9	g.	g.	PROPN
aji-158	434	10	,	,	PUNCT
aji-158	434	11	teixeira	teixeira	PROPN
aji-158	434	12	,	,	PUNCT
aji-158	434	13	a.	a.	NOUN
aji-158	434	14	p.	p.	NOUN
aji-158	434	15	m.	m.	NOUN
aji-158	434	16	,	,	PUNCT
aji-158	434	17	miguel	miguel	PROPN
aji-158	434	18	,	,	PUNCT
aji-158	434	19	c.	c.	PROPN
aji-158	434	20	s.	s.	PROPN
aji-158	434	21	,	,	PUNCT
aji-158	434	22	santos	santos	PROPN
aji-158	434	23	,	,	PUNCT
aji-158	434	24	r.	r.	PROPN
aji-158	434	25	a.	a.	PROPN
aji-158	434	26	p.	p.	PROPN
aji-158	434	27	g.	g.	PROPN
aji-158	434	28	,	,	PUNCT
aji-158	434	29	santana	santana	PROPN
aji-158	434	30	,	,	PUNCT
aji-158	434	31	j.	j.	PROPN
aji-158	434	32	l.	l.	PROPN
aji-158	434	33	s.	s.	PROPN
aji-158	434	34	et	et	PROPN
aji-158	434	35	al	al	PROPN
aji-158	434	36	.	.	PROPN
aji-158	434	37	(	(	PUNCT
aji-158	434	38	2024a	2024a	NUM
aji-158	434	39	)	)	PUNCT
aji-158	434	40	.	.	PUNCT
aji-158	435	1	cellular	cellular	ADJ
aji-158	435	2	and	and	CCONJ
aji-158	435	3	humoral	humoral	ADJ
aji-158	435	4	immunoreactivity	immunoreactivity	NOUN
aji-158	435	5	against	against	ADP
aji-158	435	6	hen	hen	NOUN
aji-158	435	7	's	's	PART
aji-158	435	8	egg	egg	NOUN
aji-158	435	9	white	white	NOUN
aji-158	435	10	:	:	PUNCT
aji-158	435	11	relevance	relevance	NOUN
aji-158	435	12	in	in	ADP
aji-158	435	13	allergic	allergic	ADJ
aji-158	435	14	patients	patient	NOUN
aji-158	435	15	.	.	PUNCT
aji-158	436	1	asian	asian	ADJ
aji-158	436	2	journal	journal	NOUN
aji-158	436	3	of	of	ADP
aji-158	436	4	immunology	immunology	NOUN
aji-158	436	5	,	,	PUNCT
aji-158	436	6	7(1	7(1	NUM
aji-158	436	7	):	):	PUNCT
aji-158	436	8	274	274	NUM
aji-158	436	9	-	-	SYM
aji-158	436	10	284	284	NUM
aji-158	436	11	.	.	PUNCT
aji-158	437	1	olivier	olivier	PROPN
aji-158	437	2	,	,	PUNCT
aji-158	437	3	c.	c.	PROPN
aji-158	437	4	e.	e.	PROPN
aji-158	437	5	,	,	PUNCT
aji-158	437	6	pinto	pinto	PROPN
aji-158	437	7	,	,	PUNCT
aji-158	437	8	d.	d.	PROPN
aji-158	437	9	g.	g.	PROPN
aji-158	437	10	,	,	PUNCT
aji-158	437	11	teixeira	teixeira	PROPN
aji-158	437	12	,	,	PUNCT
aji-158	437	13	a.	a.	NOUN
aji-158	437	14	p.	p.	NOUN
aji-158	437	15	m.	m.	NOUN
aji-158	437	16	,	,	PUNCT
aji-158	437	17	miguel	miguel	PROPN
aji-158	437	18	,	,	PUNCT
aji-158	437	19	c.	c.	PROPN
aji-158	437	20	s.	s.	PROPN
aji-158	437	21	,	,	PUNCT
aji-158	437	22	santos	santos	PROPN
aji-158	437	23	,	,	PUNCT
aji-158	437	24	r.	r.	PROPN
aji-158	437	25	a.	a.	PROPN
aji-158	437	26	p.	p.	PROPN
aji-158	437	27	g.	g.	PROPN
aji-158	437	28	,	,	PUNCT
aji-158	437	29	santana	santana	PROPN
aji-158	437	30	,	,	PUNCT
aji-158	437	31	j.	j.	PROPN
aji-158	437	32	l.	l.	PROPN
aji-158	437	33	s.	s.	PROPN
aji-158	437	34	,	,	PUNCT
aji-158	437	35	et	et	PROPN
aji-158	437	36	al	al	PROPN
aji-158	437	37	.	.	PROPN
aji-158	437	38	(	(	PUNCT
aji-158	437	39	2024b	2024b	NUM
aji-158	437	40	)	)	PUNCT
aji-158	437	41	.	.	PUNCT
aji-158	438	1	endotyping	endotype	VERB
aji-158	438	2	cellular	cellular	ADJ
aji-158	438	3	and	and	CCONJ
aji-158	438	4	humoral	humoral	ADJ
aji-158	438	5	immunoreactivity	immunoreactivity	NOUN
aji-158	438	6	against	against	ADP
aji-158	438	7	allium	allium	NOUN
aji-158	438	8	spices	spice	NOUN
aji-158	438	9	and	and	CCONJ
aji-158	438	10	sulfites	sulfite	NOUN
aji-158	438	11	preservatives	preservative	NOUN
aji-158	438	12	in	in	ADP
aji-158	438	13	allergic	allergic	ADJ
aji-158	438	14	patients	patient	NOUN
aji-158	438	15	.	.	PUNCT
aji-158	439	1	a	a	DET
aji-158	439	2	retrospective	retrospective	ADJ
aji-158	439	3	study	study	NOUN
aji-158	439	4	.	.	PUNCT
aji-158	440	1	asian	asian	ADJ
aji-158	440	2	journal	journal	NOUN
aji-158	440	3	of	of	ADP
aji-158	440	4	immunology	immunology	NOUN
aji-158	440	5	,	,	PUNCT
aji-158	440	6	7(1	7(1	NUM
aji-158	440	7	)	)	PUNCT
aji-158	440	8	.	.	PUNCT
aji-158	441	1	olivier	olivier	PROPN
aji-158	441	2	,	,	PUNCT
aji-158	441	3	c.	c.	PROPN
aji-158	441	4	e.	e.	PROPN
aji-158	441	5	,	,	PUNCT
aji-158	441	6	pinto	pinto	PROPN
aji-158	441	7	,	,	PUNCT
aji-158	441	8	d.	d.	PROPN
aji-158	441	9	g.	g.	PROPN
aji-158	441	10	,	,	PUNCT
aji-158	441	11	teixeira	teixeira	PROPN
aji-158	441	12	,	,	PUNCT
aji-158	441	13	a.	a.	NOUN
aji-158	441	14	p.	p.	NOUN
aji-158	441	15	m.	m.	NOUN
aji-158	441	16	,	,	PUNCT
aji-158	441	17	santana	santana	PROPN
aji-158	441	18	,	,	PUNCT
aji-158	441	19	j.	j.	PROPN
aji-158	441	20	l.	l.	PROPN
aji-158	441	21	s.	s.	PROPN
aji-158	441	22	,	,	PUNCT
aji-158	441	23	santos	santos	PROPN
aji-158	441	24	,	,	PUNCT
aji-158	441	25	r.	r.	PROPN
aji-158	441	26	a.	a.	PROPN
aji-158	441	27	p.	p.	PROPN
aji-158	441	28	g.	g.	PROPN
aji-158	441	29	,	,	PUNCT
aji-158	441	30	&	&	CCONJ
aji-158	441	31	lima	lima	PROPN
aji-158	441	32	,	,	PUNCT
aji-158	441	33	r.	r.	PROPN
aji-158	441	34	p.	p.	PROPN
aji-158	441	35	s.	s.	PROPN
aji-158	441	36	(	(	PUNCT
aji-158	441	37	2021d	2021d	NUM
aji-158	441	38	)	)	PUNCT
aji-158	441	39	.	.	PUNCT
aji-158	442	1	self	self	NOUN
aji-158	442	2	-	-	PUNCT
aji-158	442	3	imposed	impose	VERB
aji-158	442	4	food	food	NOUN
aji-158	442	5	restriction	restriction	NOUN
aji-158	442	6	and	and	CCONJ
aji-158	442	7	oral	oral	ADJ
aji-158	442	8	food	food	NOUN
aji-158	442	9	challenges	challenge	NOUN
aji-158	442	10	are	be	AUX
aji-158	442	11	correlated	correlate	VERB
aji-158	442	12	with	with	ADP
aji-158	442	13	precipitin	precipitin	PROPN
aji-158	442	14	's	's	PART
aji-158	442	15	accuracy	accuracy	NOUN
aji-158	442	16	in	in	ADP
aji-158	442	17	the	the	DET
aji-158	442	18	olivier	olivier	NOUN
aji-158	442	19	et	et	PROPN
aji-158	442	20	al	al	PROPN
aji-158	442	21	.	.	PROPN
aji-158	442	22	;	;	PUNCT
aji-158	443	1	asian	asian	PROPN
aji-158	443	2	j.	j.	PROPN
aji-158	443	3	immunol	immunol	PROPN
aji-158	443	4	.	.	PROPN
aji-158	443	5	,	,	PUNCT
aji-158	443	6	vol	vol	NOUN
aji-158	443	7	.	.	PROPN
aji-158	443	8	8	8	NUM
aji-158	443	9	,	,	PUNCT
aji-158	443	10	no	no	INTJ
aji-158	443	11	.	.	NOUN
aji-158	443	12	1	1	NUM
aji-158	443	13	,	,	PUNCT
aji-158	443	14	pp	pp	ADJ
aji-158	443	15	.	.	PUNCT
aji-158	444	1	35	35	NUM
aji-158	444	2	-	-	SYM
aji-158	444	3	49	49	NUM
aji-158	444	4	,	,	PUNCT
aji-158	444	5	2025	2025	NUM
aji-158	444	6	;	;	PUNCT
aji-158	444	7	article	article	NOUN
aji-158	444	8	no.aji.133582	no.aji.133582	NOUN
aji-158	444	9	47	47	NUM
aji-158	444	10	diagnosis	diagnosis	NOUN
aji-158	444	11	of	of	ADP
aji-158	444	12	non	non	ADJ
aji-158	444	13	-	-	ADJ
aji-158	444	14	ige	ige	ADJ
aji-158	444	15	-	-	PUNCT
aji-158	444	16	mediated	mediate	VERB
aji-158	444	17	foodrelated	foodrelated	ADJ
aji-158	444	18	adulthood	adulthood	NOUN
aji-158	444	19	acute	acute	NOUN
aji-158	444	20	episodes	episode	NOUN
aji-158	444	21	of	of	ADP
aji-158	444	22	urticaria	urticaria	PROPN
aji-158	444	23	.	.	PUNCT
aji-158	445	1	journal	journal	PROPN
aji-158	445	2	of	of	ADP
aji-158	445	3	allergy	allergy	PROPN
aji-158	445	4	&	&	CCONJ
aji-158	445	5	therapy	therapy	NOUN
aji-158	445	6	,	,	PUNCT
aji-158	445	7	12(8	12(8	NUM
aji-158	445	8	):	):	PUNCT
aji-158	445	9	1	1	NUM
aji-158	445	10	-	-	SYM
aji-158	445	11	8	8	NUM
aji-158	445	12	.	.	PUNCT
aji-158	446	1	olivier	olivier	PROPN
aji-158	446	2	,	,	PUNCT
aji-158	446	3	c.	c.	PROPN
aji-158	446	4	e.	e.	PROPN
aji-158	446	5	,	,	PUNCT
aji-158	446	6	pinto	pinto	PROPN
aji-158	446	7	,	,	PUNCT
aji-158	446	8	d.	d.	PROPN
aji-158	446	9	g.	g.	PROPN
aji-158	446	10	,	,	PUNCT
aji-158	446	11	teixeira	teixeira	PROPN
aji-158	446	12	,	,	PUNCT
aji-158	446	13	a.	a.	NOUN
aji-158	446	14	p.	p.	NOUN
aji-158	446	15	m.	m.	NOUN
aji-158	446	16	,	,	PUNCT
aji-158	446	17	santana	santana	PROPN
aji-158	446	18	,	,	PUNCT
aji-158	446	19	j.	j.	PROPN
aji-158	446	20	l.	l.	PROPN
aji-158	446	21	s.	s.	PROPN
aji-158	446	22	,	,	PUNCT
aji-158	446	23	santos	santos	PROPN
aji-158	446	24	,	,	PUNCT
aji-158	446	25	r.	r.	PROPN
aji-158	446	26	a.	a.	PROPN
aji-158	446	27	p.	p.	PROPN
aji-158	446	28	g.	g.	PROPN
aji-158	446	29	,	,	PUNCT
aji-158	446	30	&	&	CCONJ
aji-158	446	31	lima	lima	PROPN
aji-158	446	32	,	,	PUNCT
aji-158	446	33	r.	r.	PROPN
aji-158	446	34	p.	p.	PROPN
aji-158	446	35	s.	s.	PROPN
aji-158	446	36	(	(	PUNCT
aji-158	446	37	2023a	2023a	NUM
aji-158	446	38	)	)	PUNCT
aji-158	446	39	.	.	PUNCT
aji-158	447	1	contribution	contribution	NOUN
aji-158	447	2	of	of	ADP
aji-158	447	3	the	the	DET
aji-158	447	4	leukocyte	leukocyte	NOUN
aji-158	447	5	adherence	adherence	NOUN
aji-158	447	6	inhibition	inhibition	NOUN
aji-158	447	7	test	test	NOUN
aji-158	447	8	to	to	ADP
aji-158	447	9	the	the	DET
aji-158	447	10	diagnosis	diagnosis	NOUN
aji-158	447	11	of	of	ADP
aji-158	447	12	immunoreactivity	immunoreactivity	NOUN
aji-158	447	13	against	against	ADP
aji-158	447	14	cobalt	cobalt	NOUN
aji-158	447	15	.	.	PUNCT
aji-158	448	1	asian	asian	ADJ
aji-158	448	2	journal	journal	NOUN
aji-158	448	3	of	of	ADP
aji-158	448	4	immunology	immunology	NOUN
aji-158	448	5	,	,	PUNCT
aji-158	448	6	6(1	6(1	NUM
aji-158	448	7	):	):	PUNCT
aji-158	448	8	174	174	NUM
aji-158	448	9	-	-	SYM
aji-158	448	10	184	184	NUM
aji-158	448	11	.	.	PUNCT
aji-158	449	1	olivier	olivier	PROPN
aji-158	449	2	,	,	PUNCT
aji-158	449	3	c.	c.	PROPN
aji-158	449	4	e.	e.	PROPN
aji-158	449	5	,	,	PUNCT
aji-158	449	6	pinto	pinto	PROPN
aji-158	449	7	,	,	PUNCT
aji-158	449	8	d.	d.	PROPN
aji-158	449	9	g.	g.	PROPN
aji-158	449	10	,	,	PUNCT
aji-158	449	11	teixeira	teixeira	PROPN
aji-158	449	12	,	,	PUNCT
aji-158	449	13	a.	a.	NOUN
aji-158	449	14	p.	p.	NOUN
aji-158	449	15	m.	m.	NOUN
aji-158	449	16	,	,	PUNCT
aji-158	449	17	santana	santana	PROPN
aji-158	449	18	,	,	PUNCT
aji-158	449	19	j.	j.	PROPN
aji-158	449	20	l.	l.	PROPN
aji-158	449	21	s.	s.	PROPN
aji-158	449	22	,	,	PUNCT
aji-158	449	23	santos	santos	PROPN
aji-158	449	24	,	,	PUNCT
aji-158	449	25	r.	r.	PROPN
aji-158	449	26	a.	a.	PROPN
aji-158	449	27	p.	p.	PROPN
aji-158	449	28	g.	g.	PROPN
aji-158	449	29	,	,	PUNCT
aji-158	449	30	&	&	CCONJ
aji-158	449	31	lima	lima	PROPN
aji-158	449	32	,	,	PUNCT
aji-158	449	33	r.	r.	PROPN
aji-158	449	34	p.	p.	PROPN
aji-158	449	35	s.	s.	PROPN
aji-158	449	36	(	(	PUNCT
aji-158	449	37	2023b	2023b	NUM
aji-158	449	38	)	)	PUNCT
aji-158	449	39	.	.	PUNCT
aji-158	450	1	contribution	contribution	NOUN
aji-158	450	2	of	of	ADP
aji-158	450	3	the	the	DET
aji-158	450	4	leukocyte	leukocyte	NOUN
aji-158	450	5	adherence	adherence	NOUN
aji-158	450	6	inhibition	inhibition	NOUN
aji-158	450	7	test	test	NOUN
aji-158	450	8	to	to	ADP
aji-158	450	9	the	the	DET
aji-158	450	10	diagnosis	diagnosis	NOUN
aji-158	450	11	of	of	ADP
aji-158	450	12	innate	innate	ADJ
aji-158	450	13	non	non	ADJ
aji-158	450	14	–	–	PUNCT
aji-158	450	15	ige	ige	ADJ
aji-158	450	16	-	-	PUNCT
aji-158	450	17	mediated	mediate	VERB
aji-158	450	18	immunoreactivity	immunoreactivity	NOUN
aji-158	450	19	against	against	ADP
aji-158	450	20	saccharomyces	saccharomyce	NOUN
aji-158	450	21	cerevisiae	cerevisiae	NOUN
aji-158	450	22	.	.	PUNCT
aji-158	451	1	asian	asian	ADJ
aji-158	451	2	journal	journal	NOUN
aji-158	451	3	of	of	ADP
aji-158	451	4	immunology	immunology	NOUN
aji-158	451	5	,	,	PUNCT
aji-158	451	6	6(1	6(1	NUM
aji-158	451	7	):	):	PUNCT
aji-158	451	8	234	234	NUM
aji-158	451	9	-	-	SYM
aji-158	451	10	241	241	NUM
aji-158	451	11	.	.	PUNCT
aji-158	452	1	olivier	olivier	PROPN
aji-158	452	2	,	,	PUNCT
aji-158	452	3	c.	c.	PROPN
aji-158	452	4	e.	e.	PROPN
aji-158	452	5	,	,	PUNCT
aji-158	452	6	pinto	pinto	PROPN
aji-158	452	7	,	,	PUNCT
aji-158	452	8	d.	d.	PROPN
aji-158	452	9	g.	g.	PROPN
aji-158	452	10	,	,	PUNCT
aji-158	452	11	teixeira	teixeira	PROPN
aji-158	452	12	,	,	PUNCT
aji-158	452	13	a.	a.	NOUN
aji-158	452	14	p.	p.	NOUN
aji-158	452	15	m.	m.	NOUN
aji-158	452	16	,	,	PUNCT
aji-158	452	17	santana	santana	PROPN
aji-158	452	18	,	,	PUNCT
aji-158	452	19	j.	j.	PROPN
aji-158	452	20	l.	l.	PROPN
aji-158	452	21	s.	s.	PROPN
aji-158	452	22	,	,	PUNCT
aji-158	452	23	santos	santos	PROPN
aji-158	452	24	,	,	PUNCT
aji-158	452	25	r.	r.	PROPN
aji-158	452	26	a.	a.	PROPN
aji-158	452	27	p.	p.	PROPN
aji-158	452	28	g.	g.	PROPN
aji-158	452	29	,	,	PUNCT
aji-158	452	30	&	&	CCONJ
aji-158	452	31	lima	lima	PROPN
aji-158	452	32	,	,	PUNCT
aji-158	452	33	r.	r.	PROPN
aji-158	452	34	p.	p.	PROPN
aji-158	452	35	s.	s.	PROPN
aji-158	452	36	(	(	PUNCT
aji-158	452	37	2023c	2023c	NUM
aji-158	452	38	)	)	PUNCT
aji-158	452	39	.	.	PUNCT
aji-158	453	1	contributions	contribution	NOUN
aji-158	453	2	of	of	ADP
aji-158	453	3	the	the	DET
aji-158	453	4	leukocyte	leukocyte	NOUN
aji-158	453	5	adherence	adherence	NOUN
aji-158	453	6	inhibition	inhibition	NOUN
aji-158	453	7	test	test	NOUN
aji-158	453	8	to	to	ADP
aji-158	453	9	the	the	DET
aji-158	453	10	diagnosis	diagnosis	NOUN
aji-158	453	11	of	of	ADP
aji-158	453	12	hypersensitivity	hypersensitivity	NOUN
aji-158	453	13	reactions	reaction	NOUN
aji-158	453	14	produced	produce	VERB
aji-158	453	15	by	by	ADP
aji-158	453	16	nickel	nickel	NOUN
aji-158	453	17	.	.	PUNCT
aji-158	454	1	asian	asian	ADJ
aji-158	454	2	journal	journal	NOUN
aji-158	454	3	of	of	ADP
aji-158	454	4	immunology	immunology	NOUN
aji-158	454	5	,	,	PUNCT
aji-158	454	6	6(1	6(1	NUM
aji-158	454	7	):	):	PUNCT
aji-158	454	8	120128	120128	NUM
aji-158	454	9	.	.	PUNCT
aji-158	455	1	olivier	olivier	PROPN
aji-158	455	2	,	,	PUNCT
aji-158	455	3	c.	c.	PROPN
aji-158	455	4	e.	e.	PROPN
aji-158	455	5	,	,	PUNCT
aji-158	455	6	pinto	pinto	PROPN
aji-158	455	7	,	,	PUNCT
aji-158	455	8	d.	d.	PROPN
aji-158	455	9	g.	g.	PROPN
aji-158	455	10	,	,	PUNCT
aji-158	455	11	teixeira	teixeira	PROPN
aji-158	455	12	,	,	PUNCT
aji-158	455	13	a.	a.	NOUN
aji-158	455	14	p.	p.	NOUN
aji-158	455	15	m.	m.	NOUN
aji-158	455	16	,	,	PUNCT
aji-158	455	17	santana	santana	PROPN
aji-158	455	18	,	,	PUNCT
aji-158	455	19	j.	j.	PROPN
aji-158	455	20	l.	l.	PROPN
aji-158	455	21	s.	s.	PROPN
aji-158	455	22	,	,	PUNCT
aji-158	455	23	santos	santos	PROPN
aji-158	455	24	,	,	PUNCT
aji-158	455	25	r.	r.	PROPN
aji-158	455	26	a.	a.	PROPN
aji-158	455	27	p.	p.	PROPN
aji-158	455	28	g.	g.	PROPN
aji-158	455	29	,	,	PUNCT
aji-158	455	30	&	&	CCONJ
aji-158	455	31	lima	lima	PROPN
aji-158	455	32	,	,	PUNCT
aji-158	455	33	r.	r.	PROPN
aji-158	455	34	p.	p.	PROPN
aji-158	455	35	s.	s.	PROPN
aji-158	455	36	(	(	PUNCT
aji-158	455	37	2024c	2024c	NUM
aji-158	455	38	)	)	PUNCT
aji-158	455	39	.	.	PUNCT
aji-158	456	1	contribution	contribution	NOUN
aji-158	456	2	of	of	ADP
aji-158	456	3	leukocyte	leukocyte	NOUN
aji-158	456	4	adherence	adherence	NOUN
aji-158	456	5	inhibition	inhibition	NOUN
aji-158	456	6	test	test	NOUN
aji-158	456	7	in	in	ADP
aji-158	456	8	the	the	DET
aji-158	456	9	evaluation	evaluation	NOUN
aji-158	456	10	of	of	ADP
aji-158	456	11	non	non	ADJ
aji-158	456	12	–	–	PUNCT
aji-158	456	13	ige	ige	ADJ
aji-158	456	14	-	-	PUNCT
aji-158	456	15	mediated	mediate	VERB
aji-158	456	16	immunoreactivity	immunoreactivity	NOUN
aji-158	456	17	against	against	ADP
aji-158	456	18	peanut	peanut	NOUN
aji-158	456	19	proteins	protein	NOUN
aji-158	456	20	in	in	ADP
aji-158	456	21	children	child	NOUN
aji-158	456	22	and	and	CCONJ
aji-158	456	23	adults	adult	NOUN
aji-158	456	24	with	with	ADP
aji-158	456	25	atopic	atopic	NOUN
aji-158	456	26	dermatitis	dermatitis	NOUN
aji-158	456	27	.	.	PUNCT
aji-158	457	1	asian	asian	ADJ
aji-158	457	2	journal	journal	NOUN
aji-158	457	3	of	of	ADP
aji-158	457	4	immunology	immunology	NOUN
aji-158	457	5	,	,	PUNCT
aji-158	457	6	7(1	7(1	NUM
aji-158	457	7	):	):	PUNCT
aji-158	457	8	55	55	NUM
aji-158	457	9	-	-	SYM
aji-158	457	10	62	62	NUM
aji-158	457	11	.	.	PUNCT
aji-158	458	1	olivier	olivier	PROPN
aji-158	458	2	,	,	PUNCT
aji-158	458	3	c.	c.	PROPN
aji-158	458	4	e.	e.	PROPN
aji-158	458	5	,	,	PUNCT
aji-158	458	6	pinto	pinto	PROPN
aji-158	458	7	,	,	PUNCT
aji-158	458	8	d.	d.	PROPN
aji-158	458	9	g.	g.	PROPN
aji-158	458	10	,	,	PUNCT
aji-158	458	11	teixeira	teixeira	PROPN
aji-158	458	12	,	,	PUNCT
aji-158	458	13	a.	a.	NOUN
aji-158	458	14	p.	p.	NOUN
aji-158	458	15	m.	m.	NOUN
aji-158	458	16	,	,	PUNCT
aji-158	458	17	santana	santana	PROPN
aji-158	458	18	,	,	PUNCT
aji-158	458	19	j.	j.	PROPN
aji-158	458	20	l.	l.	PROPN
aji-158	458	21	s.	s.	PROPN
aji-158	458	22	,	,	PUNCT
aji-158	458	23	santos	santos	PROPN
aji-158	458	24	,	,	PUNCT
aji-158	458	25	r.	r.	PROPN
aji-158	458	26	a.	a.	PROPN
aji-158	458	27	p.	p.	PROPN
aji-158	458	28	g.	g.	PROPN
aji-158	458	29	,	,	PUNCT
aji-158	458	30	&	&	CCONJ
aji-158	458	31	lima	lima	PROPN
aji-158	458	32	,	,	PUNCT
aji-158	458	33	r.	r.	PROPN
aji-158	458	34	p.	p.	PROPN
aji-158	458	35	s.	s.	PROPN
aji-158	458	36	(	(	PUNCT
aji-158	458	37	2024d	2024d	NUM
aji-158	458	38	)	)	PUNCT
aji-158	458	39	.	.	PUNCT
aji-158	459	1	endotyping	endotype	VERB
aji-158	459	2	cellular	cellular	ADJ
aji-158	459	3	and	and	CCONJ
aji-158	459	4	humoral	humoral	ADJ
aji-158	459	5	immunoreactivity	immunoreactivity	NOUN
aji-158	459	6	against	against	ADP
aji-158	459	7	aluminum	aluminum	NOUN
aji-158	459	8	in	in	ADP
aji-158	459	9	allergic	allergic	ADJ
aji-158	459	10	patients	patient	NOUN
aji-158	459	11	:	:	PUNCT
aji-158	459	12	a	a	DET
aji-158	459	13	retrospective	retrospective	ADJ
aji-158	459	14	study	study	NOUN
aji-158	459	15	.	.	PUNCT
aji-158	460	1	asian	asian	ADJ
aji-158	460	2	journal	journal	NOUN
aji-158	460	3	of	of	ADP
aji-158	460	4	immunology	immunology	NOUN
aji-158	460	5	,	,	PUNCT
aji-158	460	6	7(1	7(1	NUM
aji-158	460	7	):	):	PUNCT
aji-158	460	8	149	149	NUM
aji-158	460	9	-	-	SYM
aji-158	460	10	158	158	NUM
aji-158	460	11	.	.	PUNCT
aji-158	461	1	olivier	olivier	PROPN
aji-158	461	2	,	,	PUNCT
aji-158	461	3	c.	c.	PROPN
aji-158	461	4	e.	e.	PROPN
aji-158	461	5	,	,	PUNCT
aji-158	461	6	pinto	pinto	PROPN
aji-158	461	7	,	,	PUNCT
aji-158	461	8	d.	d.	PROPN
aji-158	461	9	g.	g.	PROPN
aji-158	461	10	,	,	PUNCT
aji-158	461	11	teixeira	teixeira	PROPN
aji-158	461	12	,	,	PUNCT
aji-158	461	13	a.	a.	NOUN
aji-158	461	14	p.	p.	NOUN
aji-158	461	15	m.	m.	NOUN
aji-158	461	16	,	,	PUNCT
aji-158	461	17	santana	santana	PROPN
aji-158	461	18	,	,	PUNCT
aji-158	461	19	j.	j.	PROPN
aji-158	461	20	l.	l.	PROPN
aji-158	461	21	s.	s.	PROPN
aji-158	461	22	,	,	PUNCT
aji-158	461	23	santos	santos	PROPN
aji-158	461	24	,	,	PUNCT
aji-158	461	25	r.	r.	PROPN
aji-158	461	26	a.	a.	PROPN
aji-158	461	27	p.	p.	PROPN
aji-158	461	28	g.	g.	PROPN
aji-158	461	29	,	,	PUNCT
aji-158	461	30	&	&	CCONJ
aji-158	461	31	lima	lima	PROPN
aji-158	461	32	,	,	PUNCT
aji-158	461	33	r.	r.	PROPN
aji-158	461	34	p.	p.	PROPN
aji-158	461	35	s.	s.	PROPN
aji-158	461	36	(	(	PUNCT
aji-158	461	37	2024e	2024e	NUM
aji-158	461	38	)	)	PUNCT
aji-158	461	39	.	.	PUNCT
aji-158	462	1	exploring	explore	VERB
aji-158	462	2	the	the	DET
aji-158	462	3	role	role	NOUN
aji-158	462	4	of	of	ADP
aji-158	462	5	leukocyte	leukocyte	NOUN
aji-158	462	6	adherence	adherence	NOUN
aji-158	462	7	inhibition	inhibition	NOUN
aji-158	462	8	test	test	NOUN
aji-158	462	9	in	in	ADP
aji-158	462	10	assessing	assess	VERB
aji-158	462	11	non	non	ADJ
aji-158	462	12	-	-	ADJ
aji-158	462	13	ige	ige	ADJ
aji-158	462	14	mediated	mediate	VERB
aji-158	462	15	immunoreactivity	immunoreactivity	NOUN
aji-158	462	16	to	to	ADP
aji-158	462	17	benzoic	benzoic	NOUN
aji-158	462	18	acid	acid	NOUN
aji-158	462	19	in	in	ADP
aji-158	462	20	allergic	allergic	ADJ
aji-158	462	21	patients	patient	NOUN
aji-158	462	22	.	.	PUNCT
aji-158	463	1	asian	asian	ADJ
aji-158	463	2	journal	journal	NOUN
aji-158	463	3	of	of	ADP
aji-158	463	4	immunology	immunology	NOUN
aji-158	463	5	,	,	PUNCT
aji-158	463	6	7(1	7(1	NUM
aji-158	463	7	):	):	PUNCT
aji-158	463	8	63	63	NUM
aji-158	463	9	-	-	SYM
aji-158	463	10	70	70	NUM
aji-158	463	11	.	.	PUNCT
aji-158	464	1	olivier	olivier	PROPN
aji-158	464	2	,	,	PUNCT
aji-158	464	3	c.	c.	PROPN
aji-158	464	4	e.	e.	PROPN
aji-158	464	5	,	,	PUNCT
aji-158	464	6	pinto	pinto	PROPN
aji-158	464	7	,	,	PUNCT
aji-158	464	8	d.	d.	PROPN
aji-158	464	9	g.	g.	PROPN
aji-158	464	10	,	,	PUNCT
aji-158	464	11	teixeira	teixeira	PROPN
aji-158	464	12	,	,	PUNCT
aji-158	464	13	a.	a.	NOUN
aji-158	464	14	p.	p.	NOUN
aji-158	464	15	m.	m.	NOUN
aji-158	464	16	,	,	PUNCT
aji-158	464	17	santana	santana	PROPN
aji-158	464	18	,	,	PUNCT
aji-158	464	19	j.	j.	PROPN
aji-158	464	20	l.	l.	PROPN
aji-158	464	21	s.	s.	PROPN
aji-158	464	22	,	,	PUNCT
aji-158	464	23	santos	santos	PROPN
aji-158	464	24	,	,	PUNCT
aji-158	464	25	r.	r.	PROPN
aji-158	464	26	a.	a.	PROPN
aji-158	464	27	p.	p.	PROPN
aji-158	464	28	g.	g.	PROPN
aji-158	464	29	,	,	PUNCT
aji-158	464	30	lima	lima	PROPN
aji-158	464	31	,	,	PUNCT
aji-158	464	32	r.	r.	PROPN
aji-158	464	33	p.	p.	PROPN
aji-158	464	34	s.	s.	PROPN
aji-158	464	35	,	,	PUNCT
aji-158	464	36	et	et	PROPN
aji-158	464	37	al	al	PROPN
aji-158	464	38	.	.	PROPN
aji-158	464	39	(	(	PUNCT
aji-158	464	40	2023d	2023d	NUM
aji-158	464	41	)	)	PUNCT
aji-158	464	42	.	.	PUNCT
aji-158	465	1	contribution	contribution	NOUN
aji-158	465	2	of	of	ADP
aji-158	465	3	the	the	DET
aji-158	465	4	leukocyte	leukocyte	NOUN
aji-158	465	5	adherence	adherence	NOUN
aji-158	465	6	inhibition	inhibition	NOUN
aji-158	465	7	test	test	NOUN
aji-158	465	8	to	to	ADP
aji-158	465	9	the	the	DET
aji-158	465	10	diagnosis	diagnosis	NOUN
aji-158	465	11	of	of	ADP
aji-158	465	12	innate	innate	ADJ
aji-158	465	13	non	non	ADJ
aji-158	465	14	–	–	PUNCT
aji-158	465	15	igemediated	igemediate	VERB
aji-158	465	16	immunoreactivity	immunoreactivity	NOUN
aji-158	465	17	against	against	ADP
aji-158	465	18	alternaria	alternaria	PROPN
aji-158	465	19	alternata	alternata	PROPN
aji-158	465	20	.	.	PUNCT
aji-158	466	1	asian	asian	ADJ
aji-158	466	2	journal	journal	NOUN
aji-158	466	3	of	of	ADP
aji-158	466	4	immunology	immunology	NOUN
aji-158	466	5	,	,	PUNCT
aji-158	466	6	6(1	6(1	NUM
aji-158	466	7	):	):	PUNCT
aji-158	466	8	243	243	NUM
aji-158	466	9	-	-	SYM
aji-158	466	10	251	251	NUM
aji-158	466	11	.	.	PUNCT
aji-158	467	1	olivier	olivier	PROPN
aji-158	467	2	,	,	PUNCT
aji-158	467	3	c.	c.	PROPN
aji-158	467	4	e.	e.	PROPN
aji-158	467	5	,	,	PUNCT
aji-158	467	6	pinto	pinto	PROPN
aji-158	467	7	,	,	PUNCT
aji-158	467	8	d.	d.	PROPN
aji-158	467	9	g.	g.	PROPN
aji-158	467	10	,	,	PUNCT
aji-158	467	11	teixeira	teixeira	PROPN
aji-158	467	12	,	,	PUNCT
aji-158	467	13	a.	a.	NOUN
aji-158	467	14	p.	p.	NOUN
aji-158	467	15	m.	m.	NOUN
aji-158	467	16	,	,	PUNCT
aji-158	467	17	santana	santana	PROPN
aji-158	467	18	,	,	PUNCT
aji-158	467	19	j.	j.	PROPN
aji-158	467	20	l.	l.	PROPN
aji-158	467	21	s.	s.	PROPN
aji-158	467	22	,	,	PUNCT
aji-158	467	23	santos	santos	PROPN
aji-158	467	24	,	,	PUNCT
aji-158	467	25	r.	r.	PROPN
aji-158	467	26	a.	a.	PROPN
aji-158	467	27	p.	p.	PROPN
aji-158	467	28	g.	g.	PROPN
aji-158	467	29	,	,	PUNCT
aji-158	467	30	lima	lima	PROPN
aji-158	467	31	,	,	PUNCT
aji-158	467	32	r.	r.	PROPN
aji-158	467	33	p.	p.	PROPN
aji-158	467	34	s.	s.	PROPN
aji-158	467	35	,	,	PUNCT
aji-158	467	36	et	et	PROPN
aji-158	467	37	al	al	PROPN
aji-158	467	38	.	.	PROPN
aji-158	467	39	(	(	PUNCT
aji-158	467	40	2023e	2023e	NUM
aji-158	467	41	)	)	PUNCT
aji-158	467	42	.	.	PUNCT
aji-158	468	1	contribution	contribution	NOUN
aji-158	468	2	of	of	ADP
aji-158	468	3	the	the	DET
aji-158	468	4	leukocyte	leukocyte	NOUN
aji-158	468	5	adherence	adherence	NOUN
aji-158	468	6	inhibition	inhibition	NOUN
aji-158	468	7	test	test	NOUN
aji-158	468	8	to	to	ADP
aji-158	468	9	the	the	DET
aji-158	468	10	diagnosis	diagnosis	NOUN
aji-158	468	11	of	of	ADP
aji-158	468	12	non	non	ADJ
aji-158	468	13	–	–	PUNCT
aji-158	468	14	ige	ige	ADJ
aji-158	468	15	-	-	PUNCT
aji-158	468	16	mediated	mediate	VERB
aji-158	468	17	immunoreactivity	immunoreactivity	NOUN
aji-158	468	18	against	against	ADP
aji-158	468	19	candida	candida	NOUN
aji-158	468	20	albicans	albican	NOUN
aji-158	468	21	in	in	ADP
aji-158	468	22	patients	patient	NOUN
aji-158	468	23	with	with	ADP
aji-158	468	24	atopic	atopic	NOUN
aji-158	468	25	dermatitis	dermatitis	NOUN
aji-158	468	26	.	.	PUNCT
aji-158	469	1	asian	asian	ADJ
aji-158	469	2	journal	journal	NOUN
aji-158	469	3	of	of	ADP
aji-158	469	4	immunology	immunology	NOUN
aji-158	469	5	,	,	PUNCT
aji-158	469	6	6(1	6(1	NUM
aji-158	469	7	):	):	PUNCT
aji-158	469	8	268	268	NUM
aji-158	469	9	-	-	SYM
aji-158	469	10	276	276	NUM
aji-158	469	11	.	.	PUNCT
aji-158	470	1	olivier	olivier	PROPN
aji-158	470	2	,	,	PUNCT
aji-158	470	3	c.	c.	PROPN
aji-158	470	4	e.	e.	PROPN
aji-158	470	5	,	,	PUNCT
aji-158	470	6	pinto	pinto	PROPN
aji-158	470	7	,	,	PUNCT
aji-158	470	8	d.	d.	PROPN
aji-158	470	9	g.	g.	PROPN
aji-158	470	10	,	,	PUNCT
aji-158	470	11	teixeira	teixeira	PROPN
aji-158	470	12	,	,	PUNCT
aji-158	470	13	a.	a.	NOUN
aji-158	470	14	p.	p.	NOUN
aji-158	470	15	m.	m.	NOUN
aji-158	470	16	,	,	PUNCT
aji-158	470	17	santana	santana	PROPN
aji-158	470	18	,	,	PUNCT
aji-158	470	19	j.	j.	PROPN
aji-158	470	20	l.	l.	PROPN
aji-158	470	21	s.	s.	PROPN
aji-158	470	22	,	,	PUNCT
aji-158	470	23	santos	santos	PROPN
aji-158	470	24	,	,	PUNCT
aji-158	470	25	r.	r.	PROPN
aji-158	470	26	a.	a.	PROPN
aji-158	470	27	p.	p.	PROPN
aji-158	470	28	g.	g.	PROPN
aji-158	470	29	,	,	PUNCT
aji-158	470	30	lima	lima	PROPN
aji-158	470	31	,	,	PUNCT
aji-158	470	32	r.	r.	PROPN
aji-158	470	33	p.	p.	PROPN
aji-158	470	34	s.	s.	PROPN
aji-158	470	35	,	,	PUNCT
aji-158	470	36	et	et	PROPN
aji-158	470	37	al	al	PROPN
aji-158	470	38	.	.	PROPN
aji-158	470	39	(	(	PUNCT
aji-158	470	40	2023f	2023f	NUM
aji-158	470	41	)	)	PUNCT
aji-158	470	42	.	.	PUNCT
aji-158	471	1	evaluating	evaluate	VERB
aji-158	471	2	non	non	ADJ
aji-158	471	3	-	-	ADJ
aji-158	471	4	ige	ige	ADJ
aji-158	471	5	-	-	PUNCT
aji-158	471	6	mediated	mediate	VERB
aji-158	471	7	allergens	allergen	NOUN
aji-158	471	8	'	'	PART
aji-158	471	9	immunoreactivity	immunoreactivity	NOUN
aji-158	471	10	in	in	ADP
aji-158	471	11	patients	patient	NOUN
aji-158	471	12	with	with	ADP
aji-158	471	13	"	"	PUNCT
aji-158	471	14	intrinsic	intrinsic	ADJ
aji-158	471	15	"	"	PUNCT
aji-158	471	16	persistent	persistent	ADJ
aji-158	471	17	rhinitis	rhinitis	NOUN
aji-158	471	18	with	with	ADP
aji-158	471	19	help	help	NOUN
aji-158	471	20	of	of	ADP
aji-158	471	21	the	the	DET
aji-158	471	22	leukocyte	leukocyte	NOUN
aji-158	471	23	adherence	adherence	NOUN
aji-158	471	24	inhibition	inhibition	NOUN
aji-158	471	25	test	test	NOUN
aji-158	471	26	.	.	PUNCT
aji-158	472	1	european	european	ADJ
aji-158	472	2	journal	journal	PROPN
aji-158	472	3	of	of	ADP
aji-158	472	4	medical	medical	ADJ
aji-158	472	5	and	and	CCONJ
aji-158	472	6	health	health	NOUN
aji-158	472	7	sciences	science	NOUN
aji-158	472	8	,	,	PUNCT
aji-158	472	9	5(1	5(1	NUM
aji-158	472	10	):	):	PUNCT
aji-158	472	11	17	17	NUM
aji-158	472	12	-	-	SYM
aji-158	472	13	22	22	NUM
aji-158	472	14	.	.	PUNCT
aji-158	473	1	olivier	olivier	PROPN
aji-158	473	2	,	,	PUNCT
aji-158	473	3	c.	c.	PROPN
aji-158	473	4	e.	e.	PROPN
aji-158	473	5	,	,	PUNCT
aji-158	473	6	pinto	pinto	PROPN
aji-158	473	7	,	,	PUNCT
aji-158	473	8	d.	d.	PROPN
aji-158	473	9	g.	g.	PROPN
aji-158	473	10	,	,	PUNCT
aji-158	473	11	teixeira	teixeira	PROPN
aji-158	473	12	,	,	PUNCT
aji-158	473	13	a.	a.	NOUN
aji-158	473	14	p.	p.	NOUN
aji-158	473	15	m.	m.	NOUN
aji-158	473	16	,	,	PUNCT
aji-158	473	17	santana	santana	PROPN
aji-158	473	18	,	,	PUNCT
aji-158	473	19	j.	j.	PROPN
aji-158	473	20	l.	l.	PROPN
aji-158	473	21	s.	s.	PROPN
aji-158	473	22	,	,	PUNCT
aji-158	473	23	santos	santos	PROPN
aji-158	473	24	,	,	PUNCT
aji-158	473	25	r.	r.	PROPN
aji-158	473	26	a.	a.	PROPN
aji-158	473	27	p.	p.	PROPN
aji-158	473	28	g.	g.	PROPN
aji-158	473	29	,	,	PUNCT
aji-158	473	30	lima	lima	PROPN
aji-158	473	31	,	,	PUNCT
aji-158	473	32	r.	r.	PROPN
aji-158	473	33	p.	p.	PROPN
aji-158	473	34	s.	s.	PROPN
aji-158	473	35	,	,	PUNCT
aji-158	473	36	et	et	PROPN
aji-158	473	37	al	al	PROPN
aji-158	473	38	.	.	PUNCT
aji-158	474	1	(	(	PUNCT
aji-158	474	2	2023	2023	NUM
aji-158	474	3	g	g	NOUN
aji-158	474	4	)	)	PUNCT
aji-158	474	5	.	.	PUNCT
aji-158	475	1	far	far	ADV
aji-158	475	2	beyond	beyond	ADP
aji-158	475	3	the	the	DET
aji-158	475	4	ige	ige	NOUN
aji-158	475	5	:	:	PUNCT
aji-158	475	6	insights	insight	NOUN
aji-158	475	7	into	into	ADP
aji-158	475	8	the	the	DET
aji-158	475	9	clinical	clinical	ADJ
aji-158	475	10	profile	profile	NOUN
aji-158	475	11	of	of	ADP
aji-158	475	12	allergic	allergic	ADJ
aji-158	475	13	patients	patient	NOUN
aji-158	475	14	with	with	ADP
aji-158	475	15	selective	selective	ADJ
aji-158	475	16	ige	ige	NOUN
aji-158	475	17	deficiency	deficiency	NOUN
aji-158	475	18	,	,	PUNCT
aji-158	475	19	urticarial	urticarial	ADJ
aji-158	475	20	vasculitis	vasculitis	NOUN
aji-158	475	21	,	,	PUNCT
aji-158	475	22	allergic	allergic	ADJ
aji-158	475	23	pharyngitis	pharyngitis	NOUN
aji-158	475	24	,	,	PUNCT
aji-158	475	25	and	and	CCONJ
aji-158	475	26	perennial	perennial	ADJ
aji-158	475	27	allergic	allergic	ADJ
aji-158	475	28	conjunctivitis	conjunctivitis	NOUN
aji-158	475	29	.	.	PUNCT
aji-158	475	30	,	,	PUNCT
aji-158	475	31	7(1	7(1	NUM
aji-158	475	32	)	)	PUNCT
aji-158	475	33	,	,	PUNCT
aji-158	475	34	35–45	35–45	NUM
aji-158	475	35	.	.	PUNCT
aji-158	475	36	asian	asian	ADJ
aji-158	475	37	journal	journal	NOUN
aji-158	475	38	of	of	ADP
aji-158	475	39	immunology	immunology	NOUN
aji-158	475	40	,	,	PUNCT
aji-158	475	41	7(1	7(1	NUM
aji-158	475	42	):	):	PUNCT
aji-158	475	43	35	35	NUM
aji-158	475	44	-	-	SYM
aji-158	475	45	45	45	NUM
aji-158	475	46	.	.	PUNCT
aji-158	476	1	olivier	olivier	PROPN
aji-158	476	2	,	,	PUNCT
aji-158	476	3	c.	c.	PROPN
aji-158	476	4	e.	e.	PROPN
aji-158	476	5	,	,	PUNCT
aji-158	476	6	pinto	pinto	PROPN
aji-158	476	7	,	,	PUNCT
aji-158	476	8	d.	d.	PROPN
aji-158	476	9	g.	g.	PROPN
aji-158	476	10	,	,	PUNCT
aji-158	476	11	teixeira	teixeira	PROPN
aji-158	476	12	,	,	PUNCT
aji-158	476	13	a.	a.	NOUN
aji-158	476	14	p.	p.	NOUN
aji-158	476	15	m.	m.	NOUN
aji-158	476	16	,	,	PUNCT
aji-158	476	17	santana	santana	PROPN
aji-158	476	18	,	,	PUNCT
aji-158	476	19	j.	j.	PROPN
aji-158	476	20	l.	l.	PROPN
aji-158	476	21	s.	s.	PROPN
aji-158	476	22	,	,	PUNCT
aji-158	476	23	santos	santos	PROPN
aji-158	476	24	,	,	PUNCT
aji-158	476	25	r.	r.	PROPN
aji-158	476	26	a.	a.	PROPN
aji-158	476	27	p.	p.	PROPN
aji-158	476	28	g.	g.	PROPN
aji-158	476	29	,	,	PUNCT
aji-158	476	30	lima	lima	PROPN
aji-158	476	31	,	,	PUNCT
aji-158	476	32	r.	r.	PROPN
aji-158	476	33	p.	p.	PROPN
aji-158	476	34	s.	s.	PROPN
aji-158	476	35	,	,	PUNCT
aji-158	476	36	et	et	PROPN
aji-158	476	37	al	al	PROPN
aji-158	476	38	.	.	PROPN
aji-158	476	39	(	(	PUNCT
aji-158	476	40	2024f	2024f	NUM
aji-158	476	41	)	)	PUNCT
aji-158	476	42	.	.	PUNCT
aji-158	477	1	contribution	contribution	NOUN
aji-158	477	2	of	of	ADP
aji-158	477	3	the	the	DET
aji-158	477	4	leukocyte	leukocyte	NOUN
aji-158	477	5	adherence	adherence	NOUN
aji-158	477	6	inhibition	inhibition	NOUN
aji-158	477	7	test	test	NOUN
aji-158	477	8	in	in	ADP
aji-158	477	9	diagnosing	diagnose	VERB
aji-158	477	10	non	non	ADJ
aji-158	477	11	–	–	PUNCT
aji-158	477	12	ige	ige	ADJ
aji-158	477	13	-	-	PUNCT
aji-158	477	14	mediated	mediate	VERB
aji-158	477	15	immunoreactivity	immunoreactivity	NOUN
aji-158	477	16	against	against	ADP
aji-158	477	17	aspergillus	aspergillus	NOUN
aji-158	477	18	fumigatus	fumigatus	NOUN
aji-158	477	19	in	in	ADP
aji-158	477	20	patients	patient	NOUN
aji-158	477	21	with	with	ADP
aji-158	477	22	allergic	allergic	ADJ
aji-158	477	23	rhinitis	rhinitis	NOUN
aji-158	477	24	and	and	CCONJ
aji-158	477	25	asthma	asthma	NOUN
aji-158	477	26	.	.	PUNCT
aji-158	478	1	asian	asian	ADJ
aji-158	478	2	journal	journal	NOUN
aji-158	478	3	of	of	ADP
aji-158	478	4	immunology	immunology	NOUN
aji-158	478	5	,	,	PUNCT
aji-158	478	6	7(1	7(1	NUM
aji-158	478	7	):	):	PUNCT
aji-158	478	8	12	12	NUM
aji-158	478	9	-	-	SYM
aji-158	478	10	20	20	NUM
aji-158	478	11	.	.	PUNCT
aji-158	479	1	olivier	olivier	PROPN
aji-158	479	2	,	,	PUNCT
aji-158	479	3	c.	c.	PROPN
aji-158	479	4	e.	e.	PROPN
aji-158	479	5	,	,	PUNCT
aji-158	479	6	pinto	pinto	PROPN
aji-158	479	7	,	,	PUNCT
aji-158	479	8	d.	d.	PROPN
aji-158	479	9	g.	g.	PROPN
aji-158	479	10	,	,	PUNCT
aji-158	479	11	teixeira	teixeira	PROPN
aji-158	479	12	,	,	PUNCT
aji-158	479	13	a.	a.	NOUN
aji-158	479	14	p.	p.	NOUN
aji-158	479	15	m.	m.	NOUN
aji-158	479	16	,	,	PUNCT
aji-158	479	17	santana	santana	PROPN
aji-158	479	18	,	,	PUNCT
aji-158	479	19	j.	j.	PROPN
aji-158	479	20	l.	l.	PROPN
aji-158	479	21	s.	s.	PROPN
aji-158	479	22	,	,	PUNCT
aji-158	479	23	santos	santos	PROPN
aji-158	479	24	,	,	PUNCT
aji-158	479	25	r.	r.	PROPN
aji-158	479	26	a.	a.	PROPN
aji-158	479	27	p.	p.	PROPN
aji-158	479	28	g.	g.	PROPN
aji-158	479	29	,	,	PUNCT
aji-158	479	30	lima	lima	PROPN
aji-158	479	31	,	,	PUNCT
aji-158	479	32	r.	r.	PROPN
aji-158	479	33	p.	p.	PROPN
aji-158	479	34	s.	s.	PROPN
aji-158	479	35	,	,	PUNCT
aji-158	479	36	et	et	PROPN
aji-158	479	37	al	al	PROPN
aji-158	479	38	.	.	PUNCT
aji-158	480	1	(	(	PUNCT
aji-158	480	2	2024	2024	NUM
aji-158	480	3	g	g	NOUN
aji-158	480	4	)	)	PUNCT
aji-158	480	5	.	.	PUNCT
aji-158	481	1	endotyping	endotype	VERB
aji-158	481	2	non	non	ADJ
aji-158	481	3	-	-	ADJ
aji-158	481	4	ige	ige	ADJ
aji-158	481	5	-	-	PUNCT
aji-158	481	6	mediated	mediate	VERB
aji-158	481	7	immunoreactivity	immunoreactivity	NOUN
aji-158	481	8	to	to	ADP
aji-158	481	9	dermatophagoides	dermatophagoide	NOUN
aji-158	481	10	farinae	farinae	NOUN
aji-158	481	11	:	:	PUNCT
aji-158	481	12	implications	implication	NOUN
aji-158	481	13	for	for	ADP
aji-158	481	14	allergic	allergic	ADJ
aji-158	481	15	patients	patient	NOUN
aji-158	481	16	.	.	PUNCT
aji-158	482	1	asian	asian	ADJ
aji-158	482	2	journal	journal	NOUN
aji-158	482	3	of	of	ADP
aji-158	482	4	immunology	immunology	NOUN
aji-158	482	5	,	,	PUNCT
aji-158	482	6	7(1	7(1	NUM
aji-158	482	7	):	):	PUNCT
aji-158	482	8	90	90	NUM
aji-158	482	9	-	-	SYM
aji-158	482	10	99	99	NUM
aji-158	482	11	.	.	PUNCT
aji-158	483	1	olivier	olivier	PROPN
aji-158	483	2	,	,	PUNCT
aji-158	483	3	c.	c.	PROPN
aji-158	483	4	e.	e.	PROPN
aji-158	483	5	,	,	PUNCT
aji-158	483	6	pinto	pinto	PROPN
aji-158	483	7	,	,	PUNCT
aji-158	483	8	d.	d.	PROPN
aji-158	483	9	g.	g.	PROPN
aji-158	483	10	,	,	PUNCT
aji-158	483	11	teixeira	teixeira	PROPN
aji-158	483	12	,	,	PUNCT
aji-158	483	13	a.	a.	NOUN
aji-158	483	14	p.	p.	NOUN
aji-158	483	15	m.	m.	NOUN
aji-158	483	16	,	,	PUNCT
aji-158	483	17	santana	santana	PROPN
aji-158	483	18	,	,	PUNCT
aji-158	483	19	j.	j.	PROPN
aji-158	483	20	l.	l.	PROPN
aji-158	483	21	s.	s.	PROPN
aji-158	483	22	,	,	PUNCT
aji-158	483	23	santos	santos	PROPN
aji-158	483	24	,	,	PUNCT
aji-158	484	1	r.	r.	PROPN
aji-158	484	2	a.	a.	PROPN
aji-158	484	3	p.	p.	PROPN
aji-158	484	4	g.	g.	PROPN
aji-158	485	1	s.	s.	PROPN
aji-158	485	2	,	,	PUNCT
aji-158	485	3	&	&	CCONJ
aji-158	485	4	lima	lima	PROPN
aji-158	485	5	,	,	PUNCT
aji-158	485	6	r.	r.	PROPN
aji-158	485	7	p.	p.	PROPN
aji-158	485	8	s.	s.	PROPN
aji-158	485	9	(	(	PUNCT
aji-158	485	10	2021e	2021e	NUM
aji-158	485	11	)	)	PUNCT
aji-158	485	12	.	.	PUNCT
aji-158	486	1	immunoreactivity	immunoreactivity	NOUN
aji-158	486	2	against	against	ADP
aji-158	486	3	dermatophagoides	dermatophagoide	NOUN
aji-158	486	4	pteronyssinus	pteronyssinus	NOUN
aji-158	486	5	assessed	assess	VERB
aji-158	486	6	by	by	ADP
aji-158	486	7	the	the	DET
aji-158	486	8	leukocyte	leukocyte	NOUN
aji-158	486	9	adherence	adherence	NOUN
aji-158	486	10	inhibition	inhibition	NOUN
aji-158	486	11	test	test	NOUN
aji-158	486	12	in	in	ADP
aji-158	486	13	patients	patient	NOUN
aji-158	486	14	with	with	ADP
aji-158	486	15	intrinsic	intrinsic	ADJ
aji-158	486	16	atopic	atopic	NOUN
aji-158	486	17	dermatitis	dermatitis	NOUN
aji-158	486	18	and	and	CCONJ
aji-158	486	19	correlated	correlate	VERB
aji-158	486	20	"	"	PUNCT
aji-158	486	21	intrinsic	intrinsic	ADJ
aji-158	486	22	"	"	PUNCT
aji-158	486	23	non	non	ADJ
aji-158	486	24	–	–	PUNCT
aji-158	486	25	ige	ige	ADJ
aji-158	486	26	-	-	PUNCT
aji-158	486	27	mediated	mediate	VERB
aji-158	486	28	allergic	allergic	ADJ
aji-158	486	29	conditions	condition	NOUN
aji-158	486	30	.	.	PUNCT
aji-158	487	1	european	european	ADJ
aji-158	487	2	journal	journal	PROPN
aji-158	487	3	of	of	ADP
aji-158	487	4	clinical	clinical	ADJ
aji-158	487	5	medicine	medicine	NOUN
aji-158	487	6	,	,	PUNCT
aji-158	487	7	2(6	2(6	NUM
aji-158	487	8	):	):	PUNCT
aji-158	487	9	45	45	NUM
aji-158	487	10	-	-	SYM
aji-158	487	11	50	50	NUM
aji-158	487	12	.	.	PUNCT
aji-158	488	1	olivier	olivier	NOUN
aji-158	488	2	,	,	PUNCT
aji-158	488	3	c.	c.	PROPN
aji-158	488	4	e.	e.	PROPN
aji-158	488	5	,	,	PUNCT
aji-158	488	6	pinto	pinto	PROPN
aji-158	488	7	,	,	PUNCT
aji-158	488	8	d.	d.	PROPN
aji-158	488	9	g.	g.	PROPN
aji-158	488	10	,	,	PUNCT
aji-158	488	11	teixeira	teixeira	PROPN
aji-158	488	12	,	,	PUNCT
aji-158	488	13	a.	a.	NOUN
aji-158	488	14	p.	p.	NOUN
aji-158	488	15	m.	m.	NOUN
aji-158	488	16	,	,	PUNCT
aji-158	488	17	santana	santana	PROPN
aji-158	488	18	,	,	PUNCT
aji-158	488	19	j.	j.	PROPN
aji-158	488	20	l.	l.	PROPN
aji-158	488	21	s.	s.	PROPN
aji-158	488	22	,	,	PUNCT
aji-158	488	23	santos	santos	PROPN
aji-158	488	24	,	,	PUNCT
aji-158	489	1	r.	r.	PROPN
aji-158	489	2	a.	a.	PROPN
aji-158	489	3	p.	p.	PROPN
aji-158	489	4	g.	g.	PROPN
aji-158	490	1	s.	s.	PROPN
aji-158	490	2	,	,	PUNCT
aji-158	490	3	&	&	CCONJ
aji-158	490	4	lima	lima	PROPN
aji-158	490	5	,	,	PUNCT
aji-158	490	6	r.	r.	PROPN
aji-158	490	7	p.	p.	PROPN
aji-158	490	8	s.	s.	PROPN
aji-158	490	9	(	(	PUNCT
aji-158	490	10	2021f	2021f	NUM
aji-158	490	11	)	)	PUNCT
aji-158	490	12	.	.	PUNCT
aji-158	491	1	intrinsic	intrinsic	ADJ
aji-158	491	2	atopic	atopic	NOUN
aji-158	491	3	olivier	olivier	NOUN
aji-158	491	4	et	et	PROPN
aji-158	491	5	al	al	PROPN
aji-158	491	6	.	.	PROPN
aji-158	491	7	;	;	PUNCT
aji-158	491	8	asian	asian	PROPN
aji-158	491	9	j.	j.	PROPN
aji-158	491	10	immunol	immunol	PROPN
aji-158	491	11	.	.	PROPN
aji-158	491	12	,	,	PUNCT
aji-158	491	13	vol	vol	NOUN
aji-158	491	14	.	.	PROPN
aji-158	491	15	8	8	NUM
aji-158	491	16	,	,	PUNCT
aji-158	491	17	no	no	INTJ
aji-158	491	18	.	.	NOUN
aji-158	491	19	1	1	NUM
aji-158	491	20	,	,	PUNCT
aji-158	491	21	pp	pp	ADJ
aji-158	491	22	.	.	PUNCT
aji-158	492	1	35	35	NUM
aji-158	492	2	-	-	SYM
aji-158	492	3	49	49	NUM
aji-158	492	4	,	,	PUNCT
aji-158	492	5	2025	2025	NUM
aji-158	492	6	;	;	PUNCT
aji-158	492	7	article	article	NOUN
aji-158	492	8	no.aji.133582	no.aji.133582	PROPN
aji-158	492	9	48	48	NUM
aji-158	492	10	dermatitis	dermatitis	NOUN
aji-158	492	11	:	:	PUNCT
aji-158	492	12	titration	titration	NOUN
aji-158	492	13	of	of	ADP
aji-158	492	14	precipitins	precipitin	NOUN
aji-158	492	15	in	in	ADP
aji-158	492	16	the	the	DET
aji-158	492	17	screening	screening	NOUN
aji-158	492	18	of	of	ADP
aji-158	492	19	food	food	NOUN
aji-158	492	20	allergens	allergen	NOUN
aji-158	492	21	for	for	ADP
aji-158	492	22	prescription	prescription	NOUN
aji-158	492	23	of	of	ADP
aji-158	492	24	elimination	elimination	NOUN
aji-158	492	25	diets	diet	NOUN
aji-158	492	26	and	and	CCONJ
aji-158	492	27	desensitization	desensitization	NOUN
aji-158	492	28	strategies	strategy	NOUN
aji-158	492	29	.	.	PUNCT
aji-158	493	1	european	european	ADJ
aji-158	493	2	journal	journal	PROPN
aji-158	493	3	of	of	ADP
aji-158	493	4	clinical	clinical	ADJ
aji-158	493	5	medicine	medicine	NOUN
aji-158	493	6	,	,	PUNCT
aji-158	493	7	2(6	2(6	NUM
aji-158	493	8	):	):	PUNCT
aji-158	493	9	1	1	NUM
aji-158	493	10	-	-	SYM
aji-158	493	11	9	9	NUM
aji-158	493	12	.	.	PUNCT
aji-158	494	1	olivier	olivier	PROPN
aji-158	494	2	,	,	PUNCT
aji-158	494	3	c.	c.	PROPN
aji-158	494	4	e.	e.	PROPN
aji-158	494	5	,	,	PUNCT
aji-158	494	6	pinto	pinto	PROPN
aji-158	494	7	,	,	PUNCT
aji-158	494	8	d.	d.	PROPN
aji-158	494	9	g.	g.	PROPN
aji-158	494	10	,	,	PUNCT
aji-158	494	11	teixeira	teixeira	PROPN
aji-158	494	12	,	,	PUNCT
aji-158	494	13	a.	a.	NOUN
aji-158	494	14	p.	p.	NOUN
aji-158	494	15	m.	m.	NOUN
aji-158	494	16	,	,	PUNCT
aji-158	494	17	santana	santana	PROPN
aji-158	494	18	,	,	PUNCT
aji-158	494	19	j.	j.	PROPN
aji-158	494	20	l.	l.	PROPN
aji-158	494	21	s.	s.	PROPN
aji-158	494	22	,	,	PUNCT
aji-158	494	23	santos	santos	PROPN
aji-158	494	24	,	,	PUNCT
aji-158	495	1	r.	r.	PROPN
aji-158	495	2	a.	a.	PROPN
aji-158	495	3	p.	p.	PROPN
aji-158	495	4	g.	g.	PROPN
aji-158	496	1	s.	s.	PROPN
aji-158	496	2	,	,	PUNCT
aji-158	496	3	&	&	CCONJ
aji-158	496	4	lima	lima	PROPN
aji-158	496	5	,	,	PUNCT
aji-158	496	6	r.	r.	PROPN
aji-158	496	7	p.	p.	PROPN
aji-158	496	8	s.	s.	PROPN
aji-158	496	9	(	(	PUNCT
aji-158	496	10	2022a	2022a	NUM
aji-158	496	11	)	)	PUNCT
aji-158	496	12	.	.	PUNCT
aji-158	497	1	contribution	contribution	NOUN
aji-158	497	2	of	of	ADP
aji-158	497	3	the	the	DET
aji-158	497	4	leukocyte	leukocyte	NOUN
aji-158	497	5	adherence	adherence	NOUN
aji-158	497	6	inhibition	inhibition	NOUN
aji-158	497	7	test	test	NOUN
aji-158	497	8	for	for	ADP
aji-158	497	9	the	the	DET
aji-158	497	10	evaluation	evaluation	NOUN
aji-158	497	11	of	of	ADP
aji-158	497	12	immunoreactivity	immunoreactivity	NOUN
aji-158	497	13	against	against	ADP
aji-158	497	14	gluten	gluten	ADJ
aji-158	497	15	extracts	extract	NOUN
aji-158	497	16	in	in	ADP
aji-158	497	17	non	non	ADJ
aji-158	497	18	—	—	PUNCT
aji-158	497	19	ige	ige	ADJ
aji-158	497	20	-	-	PUNCT
aji-158	497	21	mediated	mediate	VERB
aji-158	497	22	/	/	SYM
aji-158	497	23	non	non	ADJ
aji-158	497	24	-	-	ADJ
aji-158	497	25	autoimmune	autoimmune	ADJ
aji-158	497	26	gluten	gluten	NOUN
aji-158	497	27	-	-	PUNCT
aji-158	497	28	related	relate	VERB
aji-158	497	29	disorders	disorder	NOUN
aji-158	497	30	.	.	PUNCT
aji-158	498	1	european	european	ADJ
aji-158	498	2	journal	journal	PROPN
aji-158	498	3	of	of	ADP
aji-158	498	4	clinical	clinical	ADJ
aji-158	498	5	medicine	medicine	NOUN
aji-158	498	6	,	,	PUNCT
aji-158	498	7	3(2	3(2	NUM
aji-158	498	8	):	):	PUNCT
aji-158	498	9	1	1	NUM
aji-158	498	10	-	-	SYM
aji-158	498	11	7	7	NUM
aji-158	498	12	.	.	PUNCT
aji-158	499	1	olivier	olivier	PROPN
aji-158	499	2	,	,	PUNCT
aji-158	499	3	c.	c.	PROPN
aji-158	499	4	e.	e.	PROPN
aji-158	499	5	,	,	PUNCT
aji-158	499	6	pinto	pinto	PROPN
aji-158	499	7	,	,	PUNCT
aji-158	499	8	d.	d.	PROPN
aji-158	499	9	g.	g.	PROPN
aji-158	499	10	,	,	PUNCT
aji-158	499	11	teixeira	teixeira	PROPN
aji-158	499	12	,	,	PUNCT
aji-158	499	13	a.	a.	NOUN
aji-158	499	14	p.	p.	NOUN
aji-158	499	15	m.	m.	NOUN
aji-158	499	16	,	,	PUNCT
aji-158	499	17	santana	santana	PROPN
aji-158	499	18	,	,	PUNCT
aji-158	499	19	j.	j.	PROPN
aji-158	499	20	l.	l.	PROPN
aji-158	499	21	s.	s.	PROPN
aji-158	499	22	,	,	PUNCT
aji-158	499	23	santos	santos	PROPN
aji-158	499	24	,	,	PUNCT
aji-158	500	1	r.	r.	PROPN
aji-158	500	2	a.	a.	PROPN
aji-158	500	3	p.	p.	PROPN
aji-158	500	4	g.	g.	PROPN
aji-158	501	1	s.	s.	PROPN
aji-158	501	2	,	,	PUNCT
aji-158	501	3	&	&	CCONJ
aji-158	501	4	lima	lima	PROPN
aji-158	501	5	,	,	PUNCT
aji-158	501	6	r.	r.	PROPN
aji-158	501	7	p.	p.	PROPN
aji-158	501	8	s.	s.	PROPN
aji-158	501	9	(	(	PUNCT
aji-158	501	10	2022b	2022b	NUM
aji-158	501	11	)	)	PUNCT
aji-158	501	12	.	.	PUNCT
aji-158	502	1	contribution	contribution	NOUN
aji-158	502	2	of	of	ADP
aji-158	502	3	the	the	DET
aji-158	502	4	leukocyte	leukocyte	NOUN
aji-158	502	5	adherence	adherence	NOUN
aji-158	502	6	inhibition	inhibition	NOUN
aji-158	502	7	test	test	NOUN
aji-158	502	8	to	to	ADP
aji-158	502	9	the	the	DET
aji-158	502	10	evaluation	evaluation	NOUN
aji-158	502	11	of	of	ADP
aji-158	502	12	cellular	cellular	ADJ
aji-158	502	13	immunoreactivity	immunoreactivity	NOUN
aji-158	502	14	against	against	ADP
aji-158	502	15	latex	latex	NOUN
aji-158	502	16	extracts	extract	NOUN
aji-158	502	17	for	for	ADP
aji-158	502	18	non	non	ADJ
aji-158	502	19	—	—	ADJ
aji-158	502	20	igemediated	igemediate	VERB
aji-158	502	21	latex	latex	NOUN
aji-158	502	22	-	-	PUNCT
aji-158	502	23	fruit	fruit	NOUN
aji-158	502	24	-	-	PUNCT
aji-158	502	25	pollen	pollen	NOUN
aji-158	502	26	syndrome	syndrome	NOUN
aji-158	502	27	in	in	ADP
aji-158	502	28	allergic	allergic	ADJ
aji-158	502	29	candidates	candidate	NOUN
aji-158	502	30	to	to	PART
aji-158	502	31	exclusion	exclusion	VERB
aji-158	502	32	diets	diet	NOUN
aji-158	502	33	and	and	CCONJ
aji-158	502	34	allergic	allergic	ADJ
aji-158	502	35	desensitization	desensitization	NOUN
aji-158	502	36	.	.	PUNCT
aji-158	503	1	european	european	ADJ
aji-158	503	2	journal	journal	PROPN
aji-158	503	3	of	of	ADP
aji-158	503	4	clinical	clinical	ADJ
aji-158	503	5	medicine	medicine	NOUN
aji-158	503	6	,	,	PUNCT
aji-158	503	7	3(1	3(1	NUM
aji-158	503	8	):	):	PUNCT
aji-158	503	9	11	11	NUM
aji-158	503	10	-	-	SYM
aji-158	503	11	17	17	NUM
aji-158	503	12	.	.	PUNCT
aji-158	504	1	olivier	olivier	PROPN
aji-158	504	2	,	,	PUNCT
aji-158	504	3	c.	c.	PROPN
aji-158	504	4	e.	e.	PROPN
aji-158	504	5	,	,	PUNCT
aji-158	504	6	pinto	pinto	PROPN
aji-158	504	7	,	,	PUNCT
aji-158	504	8	d.	d.	PROPN
aji-158	504	9	g.	g.	PROPN
aji-158	504	10	,	,	PUNCT
aji-158	504	11	teixeira	teixeira	PROPN
aji-158	504	12	,	,	PUNCT
aji-158	504	13	a.	a.	NOUN
aji-158	504	14	p.	p.	NOUN
aji-158	504	15	m.	m.	NOUN
aji-158	504	16	,	,	PUNCT
aji-158	504	17	santana	santana	PROPN
aji-158	504	18	,	,	PUNCT
aji-158	504	19	j.	j.	PROPN
aji-158	504	20	l.	l.	PROPN
aji-158	504	21	s.	s.	PROPN
aji-158	504	22	,	,	PUNCT
aji-158	504	23	santos	santos	PROPN
aji-158	504	24	,	,	PUNCT
aji-158	505	1	r.	r.	PROPN
aji-158	505	2	a.	a.	PROPN
aji-158	505	3	p.	p.	PROPN
aji-158	505	4	g.	g.	PROPN
aji-158	506	1	s.	s.	PROPN
aji-158	506	2	,	,	PUNCT
aji-158	506	3	&	&	CCONJ
aji-158	506	4	lima	lima	PROPN
aji-158	506	5	,	,	PUNCT
aji-158	506	6	r.	r.	PROPN
aji-158	506	7	p.	p.	PROPN
aji-158	506	8	s.	s.	PROPN
aji-158	506	9	(	(	PUNCT
aji-158	506	10	2022c	2022c	NUM
aji-158	506	11	)	)	PUNCT
aji-158	506	12	.	.	PUNCT
aji-158	507	1	leukocyte	leukocyte	NOUN
aji-158	507	2	adherence	adherence	NOUN
aji-158	507	3	inhibition	inhibition	NOUN
aji-158	507	4	test	test	NOUN
aji-158	507	5	to	to	ADP
aji-158	507	6	the	the	DET
aji-158	507	7	assessment	assessment	NOUN
aji-158	507	8	of	of	ADP
aji-158	507	9	immunoreactivity	immunoreactivity	NOUN
aji-158	507	10	against	against	ADP
aji-158	507	11	cow	cow	NOUN
aji-158	507	12	's	's	PART
aji-158	507	13	milk	milk	NOUN
aji-158	507	14	proteins	protein	NOUN
aji-158	507	15	in	in	ADP
aji-158	507	16	non	non	ADJ
aji-158	507	17	—	—	PUNCT
aji-158	507	18	ige	ige	ADJ
aji-158	507	19	-	-	PUNCT
aji-158	507	20	mediated	mediate	VERB
aji-158	507	21	gastrointestinal	gastrointestinal	ADJ
aji-158	507	22	food	food	NOUN
aji-158	507	23	allergy	allergy	NOUN
aji-158	507	24	.	.	PUNCT
aji-158	508	1	european	european	PROPN
aji-158	508	2	journal	journal	PROPN
aji-158	508	3	of	of	ADP
aji-158	508	4	clinical	clinical	ADJ
aji-158	508	5	medicine	medicine	NOUN
aji-158	508	6	,	,	PUNCT
aji-158	508	7	3(2	3(2	NUM
aji-158	508	8	):	):	PUNCT
aji-158	508	9	38	38	NUM
aji-158	508	10	-	-	SYM
aji-158	508	11	43	43	NUM
aji-158	508	12	.	.	PUNCT
aji-158	509	1	olivier	olivier	PROPN
aji-158	509	2	,	,	PUNCT
aji-158	509	3	c.	c.	PROPN
aji-158	509	4	e.	e.	PROPN
aji-158	509	5	,	,	PUNCT
aji-158	509	6	pinto	pinto	PROPN
aji-158	509	7	,	,	PUNCT
aji-158	509	8	d.	d.	PROPN
aji-158	509	9	g.	g.	PROPN
aji-158	509	10	,	,	PUNCT
aji-158	509	11	teixeira	teixeira	PROPN
aji-158	509	12	,	,	PUNCT
aji-158	509	13	a.	a.	NOUN
aji-158	509	14	p.	p.	NOUN
aji-158	509	15	m.	m.	NOUN
aji-158	509	16	,	,	PUNCT
aji-158	509	17	santana	santana	PROPN
aji-158	509	18	,	,	PUNCT
aji-158	509	19	j.	j.	PROPN
aji-158	509	20	l.	l.	PROPN
aji-158	509	21	s.	s.	PROPN
aji-158	509	22	,	,	PUNCT
aji-158	509	23	santos	santos	PROPN
aji-158	509	24	,	,	PUNCT
aji-158	510	1	r.	r.	PROPN
aji-158	510	2	a.	a.	PROPN
aji-158	510	3	p.	p.	PROPN
aji-158	510	4	g.	g.	PROPN
aji-158	510	5	s.	s.	PROPN
aji-158	510	6	,	,	PUNCT
aji-158	510	7	lima	lima	PROPN
aji-158	510	8	,	,	PUNCT
aji-158	510	9	r.	r.	PROPN
aji-158	510	10	p.	p.	PROPN
aji-158	510	11	s.	s.	PROPN
aji-158	510	12	,	,	PUNCT
aji-158	510	13	et	et	PROPN
aji-158	510	14	al	al	PROPN
aji-158	510	15	.	.	PROPN
aji-158	510	16	(	(	PUNCT
aji-158	510	17	2023h	2023h	NUM
aji-158	510	18	)	)	PUNCT
aji-158	510	19	.	.	PUNCT
aji-158	511	1	evaluating	evaluate	VERB
aji-158	511	2	non	non	ADJ
aji-158	511	3	-	-	ADJ
aji-158	511	4	ige	ige	ADJ
aji-158	511	5	-	-	PUNCT
aji-158	511	6	mediated	mediate	VERB
aji-158	511	7	allergens	allergen	NOUN
aji-158	511	8	'	'	PART
aji-158	511	9	immunoreactivity	immunoreactivity	NOUN
aji-158	511	10	in	in	ADP
aji-158	511	11	patients	patient	NOUN
aji-158	511	12	formerly	formerly	ADV
aji-158	511	13	classified	classify	VERB
aji-158	511	14	as	as	ADP
aji-158	511	15	"	"	PUNCT
aji-158	511	16	intrinsic	intrinsic	ADJ
aji-158	511	17	"	"	PUNCT
aji-158	511	18	asthmatics	asthmatic	NOUN
aji-158	511	19	with	with	ADP
aji-158	511	20	help	help	NOUN
aji-158	511	21	of	of	ADP
aji-158	511	22	the	the	DET
aji-158	511	23	leukocyte	leukocyte	NOUN
aji-158	511	24	adherence	adherence	NOUN
aji-158	511	25	inhibition	inhibition	NOUN
aji-158	511	26	test	test	NOUN
aji-158	511	27	.	.	PUNCT
aji-158	512	1	european	european	ADJ
aji-158	512	2	journal	journal	PROPN
aji-158	512	3	of	of	ADP
aji-158	512	4	clinical	clinical	ADJ
aji-158	512	5	medicine	medicine	NOUN
aji-158	512	6	,	,	PUNCT
aji-158	512	7	4(2	4(2	NUM
aji-158	512	8	):	):	PUNCT
aji-158	512	9	1	1	NUM
aji-158	512	10	-	-	SYM
aji-158	512	11	7	7	NUM
aji-158	512	12	.	.	PUNCT
aji-158	513	1	olivier	olivier	PROPN
aji-158	513	2	,	,	PUNCT
aji-158	513	3	c.	c.	PROPN
aji-158	513	4	e.	e.	PROPN
aji-158	513	5	,	,	PUNCT
aji-158	513	6	santos	santos	PROPN
aji-158	513	7	,	,	PUNCT
aji-158	513	8	r.	r.	PROPN
aji-158	513	9	a.	a.	PROPN
aji-158	513	10	p.	p.	PROPN
aji-158	513	11	g.	g.	PROPN
aji-158	513	12	,	,	PUNCT
aji-158	513	13	lima	lima	PROPN
aji-158	513	14	,	,	PUNCT
aji-158	513	15	r.	r.	PROPN
aji-158	513	16	p.	p.	PROPN
aji-158	513	17	s.	s.	PROPN
aji-158	513	18	,	,	PUNCT
aji-158	513	19	argentão	argentão	PROPN
aji-158	513	20	,	,	PUNCT
aji-158	513	21	d.	d.	PROPN
aji-158	513	22	g.	g.	PROPN
aji-158	513	23	p.	p.	PROPN
aji-158	513	24	,	,	PUNCT
aji-158	513	25	silva	silva	PROPN
aji-158	513	26	,	,	PUNCT
aji-158	513	27	g.	g.	PROPN
aji-158	513	28	k.	k.	PROPN
aji-158	513	29	m.	m.	PROPN
aji-158	513	30	,	,	PUNCT
aji-158	513	31	&	&	CCONJ
aji-158	513	32	silva	silva	PROPN
aji-158	513	33	,	,	PUNCT
aji-158	513	34	m.	m.	PROPN
aji-158	513	35	d.	d.	PROPN
aji-158	513	36	(	(	PUNCT
aji-158	513	37	2014	2014	NUM
aji-158	513	38	)	)	PUNCT
aji-158	513	39	.	.	PUNCT
aji-158	514	1	a	a	DET
aji-158	514	2	novel	novel	ADJ
aji-158	514	3	utility	utility	NOUN
aji-158	514	4	for	for	ADP
aji-158	514	5	an	an	DET
aji-158	514	6	old	old	ADJ
aji-158	514	7	method	method	NOUN
aji-158	514	8	:	:	PUNCT
aji-158	514	9	the	the	DET
aji-158	514	10	leukocyte	leukocyte	NOUN
aji-158	514	11	adherence	adherence	NOUN
aji-158	514	12	inhibition	inhibition	NOUN
aji-158	514	13	test	test	NOUN
aji-158	514	14	is	be	AUX
aji-158	514	15	an	an	DET
aji-158	514	16	easy	easy	ADJ
aji-158	514	17	way	way	NOUN
aji-158	514	18	to	to	PART
aji-158	514	19	detect	detect	VERB
aji-158	514	20	the	the	DET
aji-158	514	21	immunoreactive	immunoreactive	ADJ
aji-158	514	22	interference	interference	NOUN
aji-158	514	23	of	of	ADP
aji-158	514	24	the	the	DET
aji-158	514	25	collection	collection	NOUN
aji-158	514	26	tube	tube	NOUN
aji-158	514	27	anticoagulant	anticoagulant	NOUN
aji-158	514	28	on	on	ADP
aji-158	514	29	cellular	cellular	ADJ
aji-158	514	30	immunoassays	immunoassay	NOUN
aji-158	514	31	.	.	PUNCT
aji-158	515	1	journal	journal	NOUN
aji-158	515	2	of	of	ADP
aji-158	515	3	cell	cell	NOUN
aji-158	515	4	adhesion	adhesion	NOUN
aji-158	515	5	,	,	PUNCT
aji-158	515	6	article	article	NOUN
aji-158	515	7	i	i	PROPN
aji-158	515	8	d	d	PROPN
aji-158	515	9	860427(http://dx.doi.org/10.1155/2014/860	860427(http://dx.doi.org/10.1155/2014/860	PROPN
aji-158	515	10	427	427	NUM
aji-158	515	11	):	):	PUNCT
aji-158	515	12	1	1	NUM
aji-158	515	13	-	-	SYM
aji-158	515	14	6	6	NUM
aji-158	515	15	.	.	PUNCT
aji-158	515	16	pérez	pérez	NOUN
aji-158	515	17	-	-	PUNCT
aji-158	515	18	cano	cano	PROPN
aji-158	515	19	,	,	PUNCT
aji-158	515	20	f.	f.	PROPN
aji-158	515	21	j.	j.	PROPN
aji-158	515	22	,	,	PUNCT
aji-158	515	23	massot	massot	NOUN
aji-158	515	24	-	-	PUNCT
aji-158	515	25	cladera	cladera	NOUN
aji-158	515	26	,	,	PUNCT
aji-158	515	27	m.	m.	NOUN
aji-158	515	28	,	,	PUNCT
aji-158	515	29	franch	franch	NOUN
aji-158	515	30	,	,	PUNCT
aji-158	515	31	à	à	X
aji-158	515	32	.	.	PROPN
aji-158	515	33	,	,	PUNCT
aji-158	515	34	castellote	castellote	NOUN
aji-158	515	35	,	,	PUNCT
aji-158	515	36	c.	c.	PROPN
aji-158	515	37	,	,	PUNCT
aji-158	515	38	&	&	CCONJ
aji-158	515	39	castell	castell	PROPN
aji-158	515	40	,	,	PUNCT
aji-158	515	41	m.	m.	NOUN
aji-158	515	42	(	(	PUNCT
aji-158	515	43	2013	2013	NUM
aji-158	515	44	)	)	PUNCT
aji-158	515	45	.	.	PUNCT
aji-158	516	1	the	the	DET
aji-158	516	2	effects	effect	NOUN
aji-158	516	3	of	of	ADP
aji-158	516	4	cocoa	cocoa	NOUN
aji-158	516	5	on	on	ADP
aji-158	516	6	the	the	DET
aji-158	516	7	immune	immune	ADJ
aji-158	516	8	system	system	NOUN
aji-158	516	9	.	.	PUNCT
aji-158	517	1	frontiers	frontier	NOUN
aji-158	517	2	in	in	ADP
aji-158	517	3	pharmacology	pharmacology	NOUN
aji-158	517	4	,	,	PUNCT
aji-158	517	5	4:4:71	4:4:71	PROPN
aji-158	517	6	.	.	PUNCT
aji-158	517	7	pilolli	pilolli	PROPN
aji-158	517	8	,	,	PUNCT
aji-158	517	9	r.	r.	PROPN
aji-158	517	10	,	,	PUNCT
aji-158	517	11	lamonaca	lamonaca	PROPN
aji-158	517	12	,	,	PUNCT
aji-158	517	13	a.	a.	NOUN
aji-158	517	14	,	,	PUNCT
aji-158	517	15	nitride	nitride	PROPN
aji-158	517	16	,	,	PUNCT
aji-158	517	17	c.	c.	PROPN
aji-158	517	18	,	,	PUNCT
aji-158	517	19	de	de	PROPN
aji-158	517	20	angelis	angelis	PROPN
aji-158	517	21	,	,	PUNCT
aji-158	517	22	e.	e.	PROPN
aji-158	517	23	,	,	PUNCT
aji-158	517	24	van	van	PROPN
aji-158	517	25	poucke	poucke	PROPN
aji-158	517	26	,	,	PUNCT
aji-158	517	27	c.	c.	PROPN
aji-158	517	28	,	,	PUNCT
aji-158	517	29	gillard	gillard	PROPN
aji-158	517	30	,	,	PUNCT
aji-158	517	31	n.	n.	PROPN
aji-158	517	32	,	,	PUNCT
aji-158	517	33	et	et	PROPN
aji-158	517	34	al	al	PROPN
aji-158	517	35	.	.	PUNCT
aji-158	517	36	(	(	PUNCT
aji-158	517	37	2024	2024	NUM
aji-158	517	38	)	)	PUNCT
aji-158	517	39	.	.	PUNCT
aji-158	518	1	in	in	ADP
aji-158	518	2	-	-	PUNCT
aji-158	518	3	house	house	NOUN
aji-158	518	4	validation	validation	NOUN
aji-158	518	5	of	of	ADP
aji-158	518	6	an	an	DET
aji-158	518	7	lc	lc	NOUN
aji-158	518	8	-	-	PUNCT
aji-158	518	9	ms	ms	NOUN
aji-158	518	10	method	method	NOUN
aji-158	518	11	for	for	ADP
aji-158	518	12	the	the	DET
aji-158	518	13	multiplexed	multiplexed	ADJ
aji-158	518	14	quantitative	quantitative	ADJ
aji-158	518	15	determination	determination	NOUN
aji-158	518	16	of	of	ADP
aji-158	518	17	total	total	ADJ
aji-158	518	18	allergenic	allergenic	ADJ
aji-158	518	19	food	food	NOUN
aji-158	518	20	in	in	ADP
aji-158	518	21	chocolate	chocolate	NOUN
aji-158	518	22	.	.	PUNCT
aji-158	519	1	analytical	analytical	ADJ
aji-158	519	2	and	and	CCONJ
aji-158	519	3	bioanalytical	bioanalytical	ADJ
aji-158	519	4	chemistry	chemistry	NOUN
aji-158	519	5	,	,	PUNCT
aji-158	519	6	416(3	416(3	NUM
aji-158	519	7	):	):	PUNCT
aji-158	519	8	809	809	NUM
aji-158	519	9	-	-	SYM
aji-158	519	10	825	825	NUM
aji-158	519	11	.	.	PUNCT
aji-158	520	1	ricciardi	ricciardi	PROPN
aji-158	520	2	,	,	PUNCT
aji-158	520	3	l.	l.	PROPN
aji-158	520	4	,	,	PUNCT
aji-158	520	5	arena	arena	NOUN
aji-158	520	6	,	,	PUNCT
aji-158	520	7	a.	a.	NOUN
aji-158	520	8	,	,	PUNCT
aji-158	520	9	arena	arena	NOUN
aji-158	520	10	,	,	PUNCT
aji-158	520	11	e.	e.	PROPN
aji-158	520	12	,	,	PUNCT
aji-158	520	13	zambito	zambito	PROPN
aji-158	520	14	,	,	PUNCT
aji-158	520	15	m.	m.	NOUN
aji-158	520	16	,	,	PUNCT
aji-158	520	17	ingrassia	ingrassia	PROPN
aji-158	520	18	,	,	PUNCT
aji-158	520	19	a.	a.	PROPN
aji-158	520	20	,	,	PUNCT
aji-158	520	21	valenti	valenti	PROPN
aji-158	520	22	,	,	PUNCT
aji-158	520	23	g.	g.	PROPN
aji-158	520	24	,	,	PUNCT
aji-158	520	25	et	et	PROPN
aji-158	520	26	al	al	PROPN
aji-158	520	27	.	.	PUNCT
aji-158	520	28	(	(	PUNCT
aji-158	520	29	2014	2014	NUM
aji-158	520	30	)	)	PUNCT
aji-158	520	31	.	.	PUNCT
aji-158	521	1	systemic	systemic	ADJ
aji-158	521	2	nickel	nickel	NOUN
aji-158	521	3	allergy	allergy	NOUN
aji-158	521	4	syndrome	syndrome	NOUN
aji-158	521	5	:	:	PUNCT
aji-158	521	6	epidemiological	epidemiological	ADJ
aji-158	521	7	data	datum	NOUN
aji-158	521	8	from	from	ADP
aji-158	521	9	four	four	NUM
aji-158	521	10	italian	italian	ADJ
aji-158	521	11	allergy	allergy	NOUN
aji-158	521	12	units	unit	NOUN
aji-158	521	13	.	.	PUNCT
aji-158	522	1	international	international	ADJ
aji-158	522	2	journal	journal	PROPN
aji-158	522	3	immunopathology	immunopathology	NOUN
aji-158	522	4	and	and	CCONJ
aji-158	522	5	pharmacology	pharmacology	NOUN
aji-158	522	6	,	,	PUNCT
aji-158	522	7	27(1	27(1	NUM
aji-158	522	8	):	):	PUNCT
aji-158	522	9	131	131	NUM
aji-158	522	10	-	-	SYM
aji-158	522	11	136	136	NUM
aji-158	522	12	.	.	PUNCT
aji-158	523	1	ricciardi	ricciardi	NOUN
aji-158	523	2	,	,	PUNCT
aji-158	523	3	l.	l.	PROPN
aji-158	523	4	,	,	PUNCT
aji-158	523	5	carni	carni	PROPN
aji-158	523	6	,	,	PUNCT
aji-158	523	7	a.	a.	NOUN
aji-158	523	8	,	,	PUNCT
aji-158	523	9	loschiavo	loschiavo	NOUN
aji-158	523	10	,	,	PUNCT
aji-158	523	11	g.	g.	PROPN
aji-158	523	12	,	,	PUNCT
aji-158	523	13	gangemi	gangemi	PROPN
aji-158	523	14	,	,	PUNCT
aji-158	523	15	s.	s.	PROPN
aji-158	523	16	,	,	PUNCT
aji-158	523	17	tigano	tigano	NOUN
aji-158	523	18	,	,	PUNCT
aji-158	523	19	v.	v.	PROPN
aji-158	523	20	,	,	PUNCT
aji-158	523	21	arena	arena	NOUN
aji-158	523	22	,	,	PUNCT
aji-158	523	23	e.	e.	PROPN
aji-158	523	24	,	,	PUNCT
aji-158	523	25	et	et	PROPN
aji-158	523	26	al	al	PROPN
aji-158	523	27	.	.	PROPN
aji-158	524	1	(	(	PUNCT
aji-158	524	2	2013	2013	NUM
aji-158	524	3	)	)	PUNCT
aji-158	524	4	.	.	PUNCT
aji-158	525	1	systemic	systemic	ADJ
aji-158	525	2	nickel	nickel	NOUN
aji-158	525	3	allergy	allergy	NOUN
aji-158	525	4	:	:	PUNCT
aji-158	525	5	oral	oral	ADJ
aji-158	525	6	desensitization	desensitization	NOUN
aji-158	525	7	and	and	CCONJ
aji-158	525	8	possible	possible	ADJ
aji-158	525	9	role	role	NOUN
aji-158	525	10	of	of	ADP
aji-158	525	11	cytokines	cytokine	NOUN
aji-158	525	12	interleukins	interleukin	VERB
aji-158	525	13	2	2	NUM
aji-158	525	14	and	and	CCONJ
aji-158	525	15	10	10	NUM
aji-158	525	16	.	.	PUNCT
aji-158	526	1	international	international	ADJ
aji-158	526	2	journal	journal	PROPN
aji-158	526	3	immunopathology	immunopathology	NOUN
aji-158	526	4	and	and	CCONJ
aji-158	526	5	pharmacology	pharmacology	NOUN
aji-158	526	6	,	,	PUNCT
aji-158	526	7	26(1	26(1	NUM
aji-158	526	8	):	):	PUNCT
aji-158	526	9	251	251	NUM
aji-158	526	10	-	-	SYM
aji-158	526	11	257	257	NUM
aji-158	526	12	.	.	PUNCT
aji-158	527	1	roediger	roedig	ADJ
aji-158	527	2	,	,	PUNCT
aji-158	527	3	b.	b.	PROPN
aji-158	527	4	,	,	PUNCT
aji-158	527	5	&	&	CCONJ
aji-158	527	6	weninger	weninger	PROPN
aji-158	527	7	,	,	PUNCT
aji-158	527	8	w.	w.	PROPN
aji-158	527	9	(	(	PUNCT
aji-158	527	10	2011	2011	NUM
aji-158	527	11	)	)	PUNCT
aji-158	527	12	.	.	PUNCT
aji-158	528	1	how	how	SCONJ
aji-158	528	2	nickel	nickel	NOUN
aji-158	528	3	turns	turn	VERB
aji-158	528	4	on	on	ADP
aji-158	528	5	innate	innate	ADJ
aji-158	528	6	immune	immune	ADJ
aji-158	528	7	cells	cell	NOUN
aji-158	528	8	.	.	PUNCT
aji-158	529	1	immunology	immunology	NOUN
aji-158	529	2	and	and	CCONJ
aji-158	529	3	cell	cell	NOUN
aji-158	529	4	biology	biology	NOUN
aji-158	529	5	,	,	PUNCT
aji-158	529	6	89(1	89(1	NUM
aji-158	529	7	):	):	PUNCT
aji-158	529	8	1	1	NUM
aji-158	529	9	-	-	SYM
aji-158	529	10	2	2	NUM
aji-158	529	11	.	.	PUNCT
aji-158	529	12	sapartini	sapartini	NOUN
aji-158	529	13	,	,	PUNCT
aji-158	529	14	g.	g.	PROPN
aji-158	529	15	,	,	PUNCT
aji-158	529	16	wong	wong	PROPN
aji-158	529	17	,	,	PUNCT
aji-158	529	18	g.	g.	PROPN
aji-158	529	19	w.	w.	PROPN
aji-158	529	20	k.	k.	PROPN
aji-158	529	21	,	,	PUNCT
aji-158	529	22	indrati	indrati	PROPN
aji-158	529	23	,	,	PUNCT
aji-158	529	24	a.	a.	PROPN
aji-158	529	25	r.	r.	PROPN
aji-158	529	26	,	,	PUNCT
aji-158	529	27	kartasasmita	kartasasmita	PROPN
aji-158	529	28	,	,	PUNCT
aji-158	529	29	c.	c.	PROPN
aji-158	529	30	b.	b.	PROPN
aji-158	529	31	,	,	PUNCT
aji-158	529	32	&	&	CCONJ
aji-158	529	33	setiabudiawan	setiabudiawan	PROPN
aji-158	529	34	,	,	PUNCT
aji-158	529	35	b.	b.	PROPN
aji-158	529	36	(	(	PUNCT
aji-158	529	37	2025	2025	NUM
aji-158	529	38	)	)	PUNCT
aji-158	529	39	.	.	PUNCT
aji-158	530	1	asthma	asthma	PROPN
aji-158	530	2	risk	risk	VERB
aji-158	530	3	prevalence	prevalence	NOUN
aji-158	530	4	and	and	CCONJ
aji-158	530	5	associated	associated	ADJ
aji-158	530	6	factors	factor	NOUN
aji-158	530	7	in	in	ADP
aji-158	530	8	stunted	stunted	ADJ
aji-158	530	9	children	child	NOUN
aji-158	530	10	:	:	PUNCT
aji-158	530	11	a	a	DET
aji-158	530	12	study	study	NOUN
aji-158	530	13	using	use	VERB
aji-158	530	14	asthma	asthma	PROPN
aji-158	530	15	predictive	predictive	PROPN
aji-158	530	16	index	index	PROPN
aji-158	530	17	.	.	PUNCT
aji-158	531	1	medicina	medicina	PROPN
aji-158	531	2	(	(	PUNCT
aji-158	531	3	mdpi	mdpi	PROPN
aji-158	531	4	)	)	PUNCT
aji-158	531	5	,	,	PUNCT
aji-158	531	6	61(1	61(1	NOUN
aji-158	531	7	):	):	PUNCT
aji-158	531	8	140	140	NUM
aji-158	531	9	.	.	PUNCT
aji-158	532	1	schmidt	schmidt	PROPN
aji-158	532	2	,	,	PUNCT
aji-158	532	3	m.	m.	NOUN
aji-158	532	4	,	,	PUNCT
aji-158	532	5	raghavan	raghavan	PROPN
aji-158	532	6	,	,	PUNCT
aji-158	532	7	b.	b.	PROPN
aji-158	532	8	,	,	PUNCT
aji-158	532	9	müller	müller	PROPN
aji-158	532	10	,	,	PUNCT
aji-158	532	11	v.	v.	PROPN
aji-158	532	12	,	,	PUNCT
aji-158	532	13	vogl	vogl	NOUN
aji-158	532	14	,	,	PUNCT
aji-158	532	15	t.	t.	PROPN
aji-158	532	16	,	,	PUNCT
aji-158	532	17	fejer	fejer	PROPN
aji-158	532	18	,	,	PUNCT
aji-158	532	19	g.	g.	PROPN
aji-158	532	20	,	,	PUNCT
aji-158	532	21	tchaptchet	tchaptchet	PROPN
aji-158	532	22	,	,	PUNCT
aji-158	532	23	s.	s.	PROPN
aji-158	532	24	,	,	PUNCT
aji-158	532	25	et	et	PROPN
aji-158	532	26	al	al	PROPN
aji-158	532	27	.	.	PUNCT
aji-158	532	28	(	(	PUNCT
aji-158	532	29	2010	2010	NUM
aji-158	532	30	)	)	PUNCT
aji-158	532	31	.	.	PUNCT
aji-158	533	1	crucial	crucial	ADJ
aji-158	533	2	role	role	NOUN
aji-158	533	3	for	for	ADP
aji-158	533	4	human	human	ADJ
aji-158	533	5	toll	toll	NOUN
aji-158	533	6	-	-	PUNCT
aji-158	533	7	like	like	ADJ
aji-158	533	8	receptor	receptor	NOUN
aji-158	533	9	4	4	NUM
aji-158	533	10	in	in	ADP
aji-158	533	11	the	the	DET
aji-158	533	12	development	development	NOUN
aji-158	533	13	of	of	ADP
aji-158	533	14	contact	contact	NOUN
aji-158	533	15	allergy	allergy	NOUN
aji-158	533	16	to	to	ADP
aji-158	533	17	nickel	nickel	NOUN
aji-158	533	18	.	.	PUNCT
aji-158	534	1	nature	nature	NOUN
aji-158	534	2	immunology	immunology	NOUN
aji-158	534	3	,	,	PUNCT
aji-158	534	4	11(9	11(9	NUM
aji-158	534	5	):	):	PUNCT
aji-158	534	6	814819	814819	NUM
aji-158	534	7	.	.	PUNCT
aji-158	535	1	schäfer	schäfer	NOUN
aji-158	535	2	,	,	PUNCT
aji-158	535	3	t.	t.	PROPN
aji-158	535	4	,	,	PUNCT
aji-158	535	5	böhler	böhler	PROPN
aji-158	535	6	,	,	PUNCT
aji-158	535	7	e.	e.	PROPN
aji-158	535	8	,	,	PUNCT
aji-158	535	9	ruhdorfer	ruhdorfer	VERB
aji-158	535	10	,	,	PUNCT
aji-158	535	11	s.	s.	PROPN
aji-158	535	12	,	,	PUNCT
aji-158	535	13	weigl	weigl	PROPN
aji-158	535	14	,	,	PUNCT
aji-158	535	15	l.	l.	PROPN
aji-158	535	16	,	,	PUNCT
aji-158	535	17	wessner	wessner	PROPN
aji-158	535	18	,	,	PUNCT
aji-158	535	19	d.	d.	PROPN
aji-158	535	20	,	,	PUNCT
aji-158	535	21	filipiak	filipiak	PROPN
aji-158	535	22	,	,	PUNCT
aji-158	535	23	b.	b.	PROPN
aji-158	535	24	,	,	PUNCT
aji-158	535	25	et	et	PROPN
aji-158	535	26	al	al	PROPN
aji-158	535	27	.	.	PUNCT
aji-158	535	28	(	(	PUNCT
aji-158	535	29	2001	2001	NUM
aji-158	535	30	)	)	PUNCT
aji-158	535	31	.	.	PUNCT
aji-158	536	1	epidemiology	epidemiology	NOUN
aji-158	536	2	of	of	ADP
aji-158	536	3	contact	contact	NOUN
aji-158	536	4	allergy	allergy	NOUN
aji-158	536	5	in	in	ADP
aji-158	536	6	adults	adult	NOUN
aji-158	536	7	.	.	PUNCT
aji-158	537	1	allergy	allergy	NOUN
aji-158	537	2	,	,	PUNCT
aji-158	537	3	56(12	56(12	NUM
aji-158	537	4	):	):	PUNCT
aji-158	537	5	1192	1192	NUM
aji-158	537	6	-	-	SYM
aji-158	537	7	1196	1196	NUM
aji-158	537	8	.	.	PUNCT
aji-158	538	1	sharma	sharma	PROPN
aji-158	538	2	,	,	PUNCT
aji-158	538	3	a.	a.	PROPN
aji-158	538	4	d.	d.	PROPN
aji-158	538	5	(	(	PUNCT
aji-158	538	6	2013	2013	NUM
aji-158	538	7	)	)	PUNCT
aji-158	538	8	.	.	PUNCT
aji-158	539	1	low	low	ADJ
aji-158	539	2	nickel	nickel	NOUN
aji-158	539	3	diet	diet	NOUN
aji-158	539	4	in	in	ADP
aji-158	539	5	dermatology	dermatology	NOUN
aji-158	539	6	.	.	PUNCT
aji-158	540	1	indian	indian	PROPN
aji-158	540	2	journal	journal	PROPN
aji-158	540	3	of	of	ADP
aji-158	540	4	dermatology	dermatology	NOUN
aji-158	540	5	,	,	PUNCT
aji-158	540	6	58(3	58(3	NUM
aji-158	540	7	):	):	PUNCT
aji-158	540	8	240	240	NUM
aji-158	540	9	.	.	PUNCT
aji-158	541	1	sloan	sloan	PROPN
aji-158	541	2	,	,	PUNCT
aji-158	541	3	a.	a.	PROPN
aji-158	541	4	e.	e.	PROPN
aji-158	541	5	,	,	PUNCT
aji-158	541	6	&	&	CCONJ
aji-158	541	7	powers	power	NOUN
aji-158	541	8	,	,	PUNCT
aji-158	541	9	m.	m.	PROPN
aji-158	541	10	e.	e.	PROPN
aji-158	541	11	(	(	PUNCT
aji-158	541	12	1986	1986	NUM
aji-158	541	13	)	)	PUNCT
aji-158	541	14	.	.	PUNCT
aji-158	542	1	a	a	DET
aji-158	542	2	perspective	perspective	NOUN
aji-158	542	3	on	on	ADP
aji-158	542	4	popular	popular	ADJ
aji-158	542	5	perceptions	perception	NOUN
aji-158	542	6	of	of	ADP
aji-158	542	7	adverse	adverse	ADJ
aji-158	542	8	reactions	reaction	NOUN
aji-158	542	9	to	to	ADP
aji-158	542	10	foods	food	NOUN
aji-158	542	11	.	.	PUNCT
aji-158	543	1	the	the	DET
aji-158	543	2	journal	journal	NOUN
aji-158	543	3	of	of	ADP
aji-158	543	4	allergy	allergy	NOUN
aji-158	543	5	and	and	CCONJ
aji-158	543	6	clinical	clinical	ADJ
aji-158	543	7	immunology	immunology	NOUN
aji-158	543	8	,	,	PUNCT
aji-158	543	9	78(1	78(1	X
aji-158	543	10	pt	pt	X
aji-158	543	11	2	2	NUM
aji-158	543	12	):	):	PUNCT
aji-158	543	13	127	127	NUM
aji-158	543	14	-	-	SYM
aji-158	543	15	133	133	NUM
aji-158	543	16	.	.	PUNCT
aji-158	544	1	thomson	thomson	PROPN
aji-158	544	2	,	,	PUNCT
aji-158	544	3	d.	d.	PROPN
aji-158	544	4	m.	m.	PROPN
aji-158	545	1	p.	p.	PROPN
aji-158	545	2	1982	1982	NUM
aji-158	545	3	.	.	PUNCT
aji-158	546	1	assessment	assessment	NOUN
aji-158	546	2	of	of	ADP
aji-158	546	3	immune	immune	ADJ
aji-158	546	4	status	status	NOUN
aji-158	546	5	by	by	ADP
aji-158	546	6	the	the	DET
aji-158	546	7	leukocyte	leukocyte	NOUN
aji-158	546	8	adherence	adherence	NOUN
aji-158	546	9	inhibition	inhibition	NOUN
aji-158	546	10	test	test	NOUN
aji-158	546	11	.	.	PUNCT
aji-158	547	1	new	new	PROPN
aji-158	547	2	york	york	PROPN
aji-158	547	3	:	:	PUNCT
aji-158	547	4	academic	academic	ADJ
aji-158	547	5	press	press	NOUN
aji-158	547	6	.	.	PUNCT
aji-158	548	1	tong	tong	PROPN
aji-158	548	2	,	,	PUNCT
aji-158	548	3	a.	a.	PROPN
aji-158	548	4	w.	w.	PROPN
aji-158	548	5	,	,	PUNCT
aji-158	548	6	burger	burger	NOUN
aji-158	548	7	,	,	PUNCT
aji-158	548	8	d.	d.	PROPN
aji-158	548	9	r.	r.	PROPN
aji-158	548	10	,	,	PUNCT
aji-158	548	11	finke	finke	PROPN
aji-158	548	12	,	,	PUNCT
aji-158	548	13	p.	p.	PROPN
aji-158	548	14	,	,	PUNCT
aji-158	548	15	barney	barney	PROPN
aji-158	548	16	,	,	PUNCT
aji-158	548	17	c.	c.	PROPN
aji-158	548	18	,	,	PUNCT
aji-158	548	19	vandenbark	vandenbark	PROPN
aji-158	548	20	,	,	PUNCT
aji-158	548	21	a.	a.	NOUN
aji-158	548	22	a.	a.	PROPN
aji-158	548	23	,	,	PUNCT
aji-158	548	24	&	&	CCONJ
aji-158	548	25	vetto	vetto	PROPN
aji-158	548	26	,	,	PUNCT
aji-158	548	27	r.	r.	PROPN
aji-158	548	28	m.	m.	PROPN
aji-158	548	29	(	(	PUNCT
aji-158	548	30	1979	1979	NUM
aji-158	548	31	)	)	PUNCT
aji-158	548	32	.	.	PUNCT
aji-158	549	1	assessment	assessment	NOUN
aji-158	549	2	of	of	ADP
aji-158	549	3	the	the	DET
aji-158	549	4	mechanism	mechanism	NOUN
aji-158	549	5	of	of	ADP
aji-158	549	6	the	the	DET
aji-158	549	7	leukocyte	leukocyte	NOUN
aji-158	549	8	adherence	adherence	NOUN
aji-158	549	9	inhibition	inhibition	NOUN
aji-158	549	10	test	test	NOUN
aji-158	549	11	.	.	PUNCT
aji-158	550	1	cancer	cancer	NOUN
aji-158	550	2	research	research	NOUN
aji-158	550	3	,	,	PUNCT
aji-158	550	4	39(2	39(2	NUM
aji-158	550	5	pt	pt	NOUN
aji-158	550	6	2	2	NUM
aji-158	550	7	):	):	PUNCT
aji-158	550	8	597	597	NUM
aji-158	550	9	-	-	SYM
aji-158	550	10	603	603	NUM
aji-158	550	11	.	.	PUNCT
aji-158	551	1	olivier	olivier	PROPN
aji-158	551	2	et	et	PROPN
aji-158	551	3	al	al	PROPN
aji-158	551	4	.	.	PROPN
aji-158	551	5	;	;	PUNCT
aji-158	551	6	asian	asian	PROPN
aji-158	551	7	j.	j.	PROPN
aji-158	551	8	immunol	immunol	PROPN
aji-158	551	9	.	.	PROPN
aji-158	551	10	,	,	PUNCT
aji-158	551	11	vol	vol	NOUN
aji-158	551	12	.	.	PROPN
aji-158	551	13	8	8	NUM
aji-158	551	14	,	,	PUNCT
aji-158	551	15	no	no	INTJ
aji-158	551	16	.	.	NOUN
aji-158	551	17	1	1	NUM
aji-158	551	18	,	,	PUNCT
aji-158	551	19	pp	pp	ADJ
aji-158	551	20	.	.	PUNCT
aji-158	552	1	35	35	NUM
aji-158	552	2	-	-	SYM
aji-158	552	3	49	49	NUM
aji-158	552	4	,	,	PUNCT
aji-158	552	5	2025	2025	NUM
aji-158	552	6	;	;	PUNCT
aji-158	552	7	article	article	NOUN
aji-158	552	8	no.aji.133582	no.aji.133582	PROPN
aji-158	552	9	49	49	NUM
aji-158	552	10	veien	veien	NOUN
aji-158	552	11	,	,	PUNCT
aji-158	552	12	n.	n.	PROPN
aji-158	552	13	k.	k.	PROPN
aji-158	552	14	(	(	PUNCT
aji-158	552	15	2011	2011	NUM
aji-158	552	16	)	)	PUNCT
aji-158	552	17	.	.	PUNCT
aji-158	553	1	systemic	systemic	ADJ
aji-158	553	2	contact	contact	NOUN
aji-158	553	3	dermatitis	dermatitis	PROPN
aji-158	553	4	.	.	PUNCT
aji-158	554	1	international	international	ADJ
aji-158	554	2	journal	journal	PROPN
aji-158	554	3	of	of	ADP
aji-158	554	4	dermatology	dermatology	NOUN
aji-158	554	5	,	,	PUNCT
aji-158	554	6	50(12	50(12	NUM
aji-158	554	7	):	):	PUNCT
aji-158	554	8	1445	1445	NUM
aji-158	554	9	-	-	SYM
aji-158	554	10	1456	1456	NUM
aji-158	554	11	.	.	PUNCT
aji-158	555	1	veien	veien	PROPN
aji-158	555	2	,	,	PUNCT
aji-158	555	3	n.	n.	PROPN
aji-158	555	4	k.	k.	PROPN
aji-158	555	5	,	,	PUNCT
aji-158	555	6	&	&	CCONJ
aji-158	555	7	menné	menné	NOUN
aji-158	555	8	,	,	PUNCT
aji-158	555	9	t.	t.	PROPN
aji-158	555	10	(	(	PUNCT
aji-158	555	11	1990	1990	NUM
aji-158	555	12	)	)	PUNCT
aji-158	555	13	.	.	PUNCT
aji-158	556	1	nickel	nickel	NOUN
aji-158	556	2	contact	contact	NOUN
aji-158	556	3	allergy	allergy	NOUN
aji-158	556	4	and	and	CCONJ
aji-158	556	5	a	a	DET
aji-158	556	6	nickel	nickel	NOUN
aji-158	556	7	-	-	PUNCT
aji-158	556	8	restricted	restrict	VERB
aji-158	556	9	diet	diet	NOUN
aji-158	556	10	.	.	PUNCT
aji-158	557	1	seminars	seminar	NOUN
aji-158	557	2	in	in	ADP
aji-158	557	3	dermatology	dermatology	NOUN
aji-158	557	4	,	,	PUNCT
aji-158	557	5	9(3	9(3	NUM
aji-158	557	6	):	):	PUNCT
aji-158	557	7	197	197	NUM
aji-158	557	8	-	-	SYM
aji-158	557	9	205	205	NUM
aji-158	557	10	.	.	PUNCT
aji-158	558	1	veien	veien	PROPN
aji-158	558	2	,	,	PUNCT
aji-158	558	3	n.	n.	PROPN
aji-158	558	4	k.	k.	PROPN
aji-158	558	5	,	,	PUNCT
aji-158	558	6	hattel	hattel	PROPN
aji-158	558	7	,	,	PUNCT
aji-158	558	8	t.	t.	PROPN
aji-158	558	9	,	,	PUNCT
aji-158	558	10	justesen	justesen	PROPN
aji-158	558	11	,	,	PUNCT
aji-158	558	12	o.	o.	PROPN
aji-158	558	13	,	,	PUNCT
aji-158	558	14	&	&	CCONJ
aji-158	558	15	nørholm	nørholm	PROPN
aji-158	558	16	,	,	PUNCT
aji-158	558	17	a.	a.	NOUN
aji-158	558	18	(	(	PUNCT
aji-158	558	19	1985	1985	NUM
aji-158	558	20	)	)	PUNCT
aji-158	558	21	.	.	PUNCT
aji-158	559	1	dietary	dietary	ADJ
aji-158	559	2	treatment	treatment	NOUN
aji-158	559	3	of	of	ADP
aji-158	559	4	nickel	nickel	NOUN
aji-158	559	5	dermatitis	dermatitis	NOUN
aji-158	559	6	.	.	PUNCT
aji-158	560	1	acta	acta	PROPN
aji-158	560	2	dermato	dermato	PROPN
aji-158	560	3	-	-	PUNCT
aji-158	560	4	venereologica	venereologica	NOUN
aji-158	560	5	,	,	PUNCT
aji-158	560	6	65(2	65(2	NUM
aji-158	560	7	):	):	PUNCT
aji-158	560	8	138	138	NUM
aji-158	560	9	-	-	SYM
aji-158	560	10	142	142	NUM
aji-158	560	11	.	.	PUNCT
aji-158	561	1	veien	veien	PROPN
aji-158	561	2	,	,	PUNCT
aji-158	561	3	n.	n.	PROPN
aji-158	561	4	k.	k.	PROPN
aji-158	561	5	,	,	PUNCT
aji-158	561	6	hattel	hattel	PROPN
aji-158	561	7	,	,	PUNCT
aji-158	561	8	t.	t.	PROPN
aji-158	561	9	,	,	PUNCT
aji-158	561	10	justesen	justesen	PROPN
aji-158	561	11	,	,	PUNCT
aji-158	561	12	o.	o.	PROPN
aji-158	561	13	,	,	PUNCT
aji-158	561	14	&	&	CCONJ
aji-158	561	15	nørholm	nørholm	PROPN
aji-158	561	16	,	,	PUNCT
aji-158	561	17	a.	a.	NOUN
aji-158	561	18	(	(	PUNCT
aji-158	561	19	1987	1987	NUM
aji-158	561	20	)	)	PUNCT
aji-158	561	21	.	.	PUNCT
aji-158	562	1	oral	oral	ADJ
aji-158	562	2	challenge	challenge	NOUN
aji-158	562	3	with	with	ADP
aji-158	562	4	nickel	nickel	NOUN
aji-158	562	5	and	and	CCONJ
aji-158	562	6	cobalt	cobalt	NOUN
aji-158	562	7	in	in	ADP
aji-158	562	8	patients	patient	NOUN
aji-158	562	9	with	with	ADP
aji-158	562	10	positive	positive	ADJ
aji-158	562	11	patch	patch	NOUN
aji-158	562	12	tests	test	NOUN
aji-158	562	13	to	to	ADP
aji-158	562	14	nickel	nickel	NOUN
aji-158	562	15	and/or	and/or	CCONJ
aji-158	562	16	cobalt	cobalt	NOUN
aji-158	562	17	.	.	PUNCT
aji-158	563	1	acta	acta	PROPN
aji-158	563	2	dermatovenereologica	dermatovenereologica	PROPN
aji-158	563	3	,	,	PUNCT
aji-158	563	4	67(4	67(4	NUM
aji-158	563	5	):	):	PUNCT
aji-158	563	6	321	321	NUM
aji-158	563	7	-	-	SYM
aji-158	563	8	325	325	NUM
aji-158	563	9	.	.	PUNCT
aji-158	564	1	wells	wells	PROPN
aji-158	564	2	,	,	PUNCT
aji-158	564	3	h.	h.	PROPN
aji-158	564	4	g.	g.	PROPN
aji-158	564	5	(	(	PUNCT
aji-158	564	6	1911	1911	NUM
aji-158	564	7	)	)	PUNCT
aji-158	564	8	.	.	PUNCT
aji-158	565	1	studies	study	NOUN
aji-158	565	2	on	on	ADP
aji-158	565	3	the	the	DET
aji-158	565	4	chemistry	chemistry	NOUN
aji-158	565	5	of	of	ADP
aji-158	565	6	anaphylaxis	anaphylaxis	ADJ
aji-158	565	7	(	(	PUNCT
aji-158	565	8	iii	iii	NOUN
aji-158	565	9	)	)	PUNCT
aji-158	565	10	.	.	PUNCT
aji-158	566	1	experiments	experiment	NOUN
aji-158	566	2	with	with	ADP
aji-158	566	3	isolated	isolated	ADJ
aji-158	566	4	proteins	protein	NOUN
aji-158	566	5	,	,	PUNCT
aji-158	566	6	especially	especially	ADV
aji-158	566	7	those	those	PRON
aji-158	566	8	of	of	ADP
aji-158	566	9	the	the	DET
aji-158	566	10	hen	hen	NOUN
aji-158	566	11	's	's	PART
aji-158	566	12	egg	egg	NOUN
aji-158	566	13	.	.	PUNCT
aji-158	567	1	journal	journal	PROPN
aji-158	567	2	of	of	ADP
aji-158	567	3	infectious	infectious	ADJ
aji-158	567	4	diseases	disease	NOUN
aji-158	567	5	,	,	PUNCT
aji-158	567	6	9	9	NUM
aji-158	567	7	:	:	SYM
aji-158	567	8	147	147	NUM
aji-158	567	9	-	-	SYM
aji-158	567	10	171	171	NUM
aji-158	567	11	.	.	PUNCT
aji-158	568	1	williams	williams	PROPN
aji-158	568	2	,	,	PUNCT
aji-158	568	3	c.	c.	PROPN
aji-158	568	4	a.	a.	PROPN
aji-158	568	5	,	,	PUNCT
aji-158	568	6	&	&	CCONJ
aji-158	568	7	chase	chase	PROPN
aji-158	568	8	,	,	PUNCT
aji-158	568	9	m.	m.	NOUN
aji-158	568	10	w.	w.	PROPN
aji-158	568	11	(	(	PUNCT
aji-158	568	12	1971	1971	NUM
aji-158	568	13	)	)	PUNCT
aji-158	568	14	.	.	PUNCT
aji-158	569	1	chapter	chapter	NOUN
aji-158	569	2	13	13	NUM
aji-158	569	3	precipitation	precipitation	NOUN
aji-158	569	4	reactions	reaction	NOUN
aji-158	569	5	,	,	PUNCT
aji-158	569	6	reactions	reaction	NOUN
aji-158	569	7	of	of	ADP
aji-158	569	8	antibodies	antibody	NOUN
aji-158	569	9	with	with	ADP
aji-158	569	10	soluble	soluble	ADJ
aji-158	569	11	antigens	antigen	NOUN
aji-158	569	12	,	,	PUNCT
aji-158	569	13	vol	vol	NOUN
aji-158	569	14	.	.	PUNCT
aji-158	570	1	3	3	NUM
aji-158	570	2	:	:	SYM
aji-158	570	3	1	1	NUM
aji-158	570	4	-	-	SYM
aji-158	570	5	102	102	NUM
aji-158	570	6	:	:	PUNCT
aji-158	570	7	academic	academic	ADJ
aji-158	570	8	press	press	NOUN
aji-158	570	9	.	.	PUNCT
aji-158	571	1	wma	wma	PROPN
aji-158	571	2	.	.	PUNCT
aji-158	572	1	(	(	PUNCT
aji-158	572	2	2013	2013	NUM
aji-158	572	3	)	)	PUNCT
aji-158	572	4	.	.	PUNCT
aji-158	573	1	world	world	PROPN
aji-158	573	2	medical	medical	PROPN
aji-158	573	3	association	association	PROPN
aji-158	573	4	declaration	declaration	PROPN
aji-158	573	5	of	of	ADP
aji-158	573	6	helsinki	helsinki	PROPN
aji-158	573	7	:	:	PUNCT
aji-158	573	8	ethical	ethical	ADJ
aji-158	573	9	principles	principle	NOUN
aji-158	573	10	for	for	ADP
aji-158	573	11	medical	medical	ADJ
aji-158	573	12	research	research	NOUN
aji-158	573	13	involving	involve	VERB
aji-158	573	14	human	human	ADJ
aji-158	573	15	subjects	subject	NOUN
aji-158	573	16	.	.	PUNCT
aji-158	574	1	journal	journal	PROPN
aji-158	574	2	of	of	ADP
aji-158	574	3	allergy	allergy	PROPN
aji-158	574	4	and	and	CCONJ
aji-158	574	5	clinical	clinical	ADJ
aji-158	574	6	immunology	immunology	NOUN
aji-158	574	7	,	,	PUNCT
aji-158	574	8	310(20	310(20	NUM
aji-158	574	9	):	):	PUNCT
aji-158	574	10	2191	2191	NUM
aji-158	574	11	-	-	SYM
aji-158	574	12	2194	2194	NUM
aji-158	574	13	.	.	PUNCT
aji-158	575	1	yoon	yoon	PROPN
aji-158	575	2	,	,	PUNCT
aji-158	575	3	y.	y.	PROPN
aji-158	575	4	,	,	PUNCT
aji-158	575	5	&	&	CCONJ
aji-158	575	6	bunyavanich	bunyavanich	PROPN
aji-158	575	7	,	,	PUNCT
aji-158	575	8	s.	s.	PROPN
aji-158	575	9	(	(	PUNCT
aji-158	575	10	2025	2025	NUM
aji-158	575	11	)	)	PUNCT
aji-158	575	12	.	.	PUNCT
aji-158	576	1	multi	multi	ADJ
aji-158	576	2	-	-	ADJ
aji-158	576	3	omic	omic	ADJ
aji-158	576	4	approaches	approach	NOUN
aji-158	576	5	for	for	ADP
aji-158	576	6	endotype	endotype	NOUN
aji-158	576	7	discovery	discovery	NOUN
aji-158	576	8	in	in	ADP
aji-158	576	9	allergy	allergy	NOUN
aji-158	576	10	/	/	SYM
aji-158	576	11	immunology	immunology	NOUN
aji-158	576	12	.	.	PUNCT
aji-158	577	1	journal	journal	PROPN
aji-158	577	2	of	of	ADP
aji-158	577	3	allergy	allergy	NOUN
aji-158	577	4	and	and	CCONJ
aji-158	577	5	clinical	clinical	ADJ
aji-158	577	6	immunology	immunology	NOUN
aji-158	577	7	.	.	PUNCT
aji-158	578	1	dec	dec	PROPN
aji-158	578	2	31	31	NUM
aji-158	578	3	:	:	PUNCT
aji-158	578	4	s00916749(24)02473	s00916749(24)02473	NOUN
aji-158	578	5	-	-	SYM
aji-158	578	6	4	4	NUM
aji-158	578	7	.	.	PUNCT
aji-158	579	1	zhang	zhang	PROPN
aji-158	579	2	,	,	PUNCT
aji-158	579	3	j.	j.	PROPN
aji-158	579	4	,	,	PUNCT
aji-158	579	5	tang	tang	PROPN
aji-158	579	6	,	,	PUNCT
aji-158	579	7	y.	y.	PROPN
aji-158	579	8	,	,	PUNCT
aji-158	579	9	yang	yang	PROPN
aji-158	579	10	,	,	PUNCT
aji-158	579	11	d.	d.	PROPN
aji-158	579	12	,	,	PUNCT
aji-158	579	13	&	&	CCONJ
aji-158	579	14	yu	yu	PROPN
aji-158	579	15	,	,	PUNCT
aji-158	579	16	j.	j.	PROPN
aji-158	579	17	(	(	PUNCT
aji-158	579	18	2025	2025	NUM
aji-158	579	19	)	)	PUNCT
aji-158	579	20	.	.	PUNCT
aji-158	580	1	investigating	investigate	VERB
aji-158	580	2	allergen	allergen	NOUN
aji-158	580	3	-	-	PUNCT
aji-158	580	4	specific	specific	ADJ
aji-158	580	5	ige	ige	NOUN
aji-158	580	6	distribution	distribution	NOUN
aji-158	580	7	and	and	CCONJ
aji-158	580	8	correlations	correlation	NOUN
aji-158	580	9	in	in	ADP
aji-158	580	10	chronic	chronic	ADJ
aji-158	580	11	urticaria	urticaria	NOUN
aji-158	580	12	:	:	PUNCT
aji-158	580	13	a	a	DET
aji-158	580	14	retrospective	retrospective	ADJ
aji-158	580	15	study	study	NOUN
aji-158	580	16	in	in	ADP
aji-158	580	17	shanghai	shanghai	PROPN
aji-158	580	18	,	,	PUNCT
aji-158	580	19	china	china	PROPN
aji-158	580	20	.	.	PUNCT
aji-158	581	1	european	european	PROPN
aji-158	581	2	journal	journal	PROPN
aji-158	581	3	of	of	ADP
aji-158	581	4	medical	medical	ADJ
aji-158	581	5	research	research	NOUN
aji-158	581	6	,	,	PUNCT
aji-158	581	7	30(1	30(1	NUM
aji-158	581	8	):	):	PUNCT
aji-158	581	9	182	182	NUM
aji-158	581	10	.	.	X
aji-158	582	1	zhang	zhang	PROPN
aji-158	582	2	,	,	PUNCT
aji-158	582	3	s.	s.	PROPN
aji-158	582	4	,	,	PUNCT
aji-158	582	5	zhang	zhang	PROPN
aji-158	582	6	,	,	PUNCT
aji-158	582	7	x.	x.	PROPN
aji-158	582	8	,	,	PUNCT
aji-158	582	9	wei	wei	PROPN
aji-158	582	10	,	,	PUNCT
aji-158	582	11	c.	c.	PROPN
aji-158	582	12	,	,	PUNCT
aji-158	582	13	zhang	zhang	PROPN
aji-158	582	14	,	,	PUNCT
aji-158	582	15	l.	l.	PROPN
aji-158	582	16	,	,	PUNCT
aji-158	582	17	&	&	CCONJ
aji-158	582	18	li	li	PROPN
aji-158	582	19	,	,	PUNCT
aji-158	582	20	z.	z.	PROPN
aji-158	582	21	(	(	PUNCT
aji-158	582	22	2024	2024	NUM
aji-158	582	23	)	)	PUNCT
aji-158	582	24	.	.	PUNCT
aji-158	583	1	causality	causality	NOUN
aji-158	583	2	between	between	ADP
aji-158	583	3	91	91	NUM
aji-158	583	4	circulating	circulate	VERB
aji-158	583	5	inflammatory	inflammatory	ADJ
aji-158	583	6	proteins	protein	NOUN
aji-158	583	7	and	and	CCONJ
aji-158	583	8	various	various	ADJ
aji-158	583	9	asthma	asthma	NOUN
aji-158	583	10	phenotypes	phenotype	NOUN
aji-158	583	11	:	:	PUNCT
aji-158	583	12	a	a	DET
aji-158	583	13	mendelian	mendelian	ADJ
aji-158	583	14	randomization	randomization	NOUN
aji-158	583	15	study	study	NOUN
aji-158	583	16	.	.	PUNCT
aji-158	584	1	immunotargets	immunotarget	NOUN
aji-158	584	2	and	and	CCONJ
aji-158	584	3	therapy	therapy	NOUN
aji-158	584	4	,	,	PUNCT
aji-158	584	5	13	13	NUM
aji-158	584	6	:	:	SYM
aji-158	584	7	617	617	NUM
aji-158	584	8	-	-	SYM
aji-158	584	9	629	629	NUM
aji-158	584	10	.	.	PUNCT
aji-158	585	1	disclaimer	disclaimer	ADJ
aji-158	585	2	/	/	SYM
aji-158	585	3	publisher	publisher	NOUN
aji-158	585	4	’s	’s	PART
aji-158	585	5	note	note	NOUN
aji-158	585	6	:	:	PUNCT
aji-158	585	7	the	the	DET
aji-158	585	8	statements	statement	NOUN
aji-158	585	9	,	,	PUNCT
aji-158	585	10	opinions	opinion	NOUN
aji-158	585	11	and	and	CCONJ
aji-158	585	12	data	datum	NOUN
aji-158	585	13	contained	contain	VERB
aji-158	585	14	in	in	ADP
aji-158	585	15	all	all	DET
aji-158	585	16	publications	publication	NOUN
aji-158	585	17	are	be	AUX
aji-158	585	18	solely	solely	ADV
aji-158	585	19	those	those	PRON
aji-158	585	20	of	of	ADP
aji-158	585	21	the	the	DET
aji-158	585	22	individual	individual	ADJ
aji-158	585	23	author(s	author(s	PROPN
aji-158	585	24	)	)	PUNCT
aji-158	585	25	and	and	CCONJ
aji-158	585	26	contributor(s	contributor(s	NOUN
aji-158	585	27	)	)	PUNCT
aji-158	585	28	and	and	CCONJ
aji-158	585	29	not	not	PART
aji-158	585	30	of	of	ADP
aji-158	585	31	the	the	DET
aji-158	585	32	publisher	publisher	NOUN
aji-158	585	33	and/or	and/or	CCONJ
aji-158	585	34	the	the	DET
aji-158	585	35	editor(s	editor(s	NOUN
aji-158	585	36	)	)	PUNCT
aji-158	585	37	.	.	PUNCT
aji-158	586	1	this	this	DET
aji-158	586	2	publisher	publisher	NOUN
aji-158	586	3	and/or	and/or	CCONJ
aji-158	586	4	the	the	DET
aji-158	586	5	editor(s	editor(s	NOUN
aji-158	586	6	)	)	PUNCT
aji-158	586	7	disclaim	disclaim	VERB
aji-158	586	8	responsibility	responsibility	NOUN
aji-158	586	9	for	for	ADP
aji-158	586	10	any	any	DET
aji-158	586	11	injury	injury	NOUN
aji-158	586	12	to	to	ADP
aji-158	586	13	people	people	NOUN
aji-158	586	14	or	or	CCONJ
aji-158	586	15	property	property	NOUN
aji-158	586	16	resulting	result	VERB
aji-158	586	17	from	from	ADP
aji-158	586	18	any	any	DET
aji-158	586	19	ideas	idea	NOUN
aji-158	586	20	,	,	PUNCT
aji-158	586	21	methods	method	NOUN
aji-158	586	22	,	,	PUNCT
aji-158	586	23	instructions	instruction	NOUN
aji-158	586	24	or	or	CCONJ
aji-158	586	25	products	product	NOUN
aji-158	586	26	referred	refer	VERB
aji-158	586	27	to	to	ADP
aji-158	586	28	in	in	ADP
aji-158	586	29	the	the	DET
aji-158	586	30	content	content	NOUN
aji-158	586	31	.	.	PUNCT
aji-158	587	1	_	_	PUNCT
aji-158	588	1	_	_	PUNCT
aji-158	589	1	_	_	PUNCT
aji-158	590	1	_	_	PUNCT
aji-158	591	1	_	_	PUNCT
aji-158	592	1	_	_	PUNCT
aji-158	593	1	_	_	PUNCT
aji-158	594	1	_	_	PUNCT
aji-158	595	1	_	_	PUNCT
aji-158	596	1	_	_	PUNCT
aji-158	597	1	_	_	PUNCT
aji-158	598	1	_	_	PUNCT
aji-158	599	1	_	_	PUNCT
aji-158	600	1	_	_	PUNCT
aji-158	601	1	_	_	PUNCT
aji-158	602	1	_	_	PUNCT
aji-158	603	1	_	_	PUNCT
aji-158	604	1	_	_	PUNCT
aji-158	605	1	_	_	PUNCT
aji-158	606	1	_	_	PUNCT
aji-158	607	1	_	_	PUNCT
aji-158	608	1	_	_	PUNCT
aji-158	609	1	_	_	PUNCT
aji-158	610	1	_	_	PUNCT
aji-158	611	1	_	_	PUNCT
aji-158	612	1	_	_	PUNCT
aji-158	613	1	_	_	PUNCT
aji-158	614	1	_	_	PUNCT
aji-158	615	1	_	_	PUNCT
aji-158	616	1	_	_	PUNCT
aji-158	617	1	_	_	PUNCT
aji-158	618	1	_	_	PUNCT
aji-158	619	1	_	_	PUNCT
aji-158	620	1	_	_	PUNCT
aji-158	621	1	_	_	PUNCT
aji-158	622	1	_	_	PUNCT
aji-158	623	1	_	_	PUNCT
aji-158	624	1	_	_	PUNCT
aji-158	625	1	_	_	PUNCT
aji-158	626	1	_	_	PUNCT
aji-158	627	1	_	_	PUNCT
aji-158	628	1	_	_	PUNCT
aji-158	629	1	_	_	PUNCT
aji-158	630	1	_	_	PUNCT
aji-158	631	1	_	_	PUNCT
aji-158	632	1	_	_	PUNCT
aji-158	633	1	_	_	PUNCT
aji-158	634	1	_	_	PUNCT
aji-158	635	1	_	_	PUNCT
aji-158	636	1	_	_	PUNCT
aji-158	637	1	_	_	PUNCT
aji-158	638	1	_	_	PUNCT
aji-158	639	1	_	_	PUNCT
aji-158	640	1	_	_	PUNCT
aji-158	641	1	_	_	PUNCT
aji-158	642	1	_	_	PUNCT
aji-158	643	1	_	_	PUNCT
aji-158	644	1	_	_	PUNCT
aji-158	645	1	_	_	PUNCT
aji-158	646	1	_	_	PUNCT
aji-158	647	1	_	_	PUNCT
aji-158	648	1	_	_	PUNCT
aji-158	649	1	_	_	PUNCT
aji-158	650	1	_	_	PUNCT
aji-158	651	1	_	_	PUNCT
aji-158	652	1	_	_	PUNCT
aji-158	653	1	_	_	PUNCT
aji-158	654	1	_	_	PUNCT
aji-158	655	1	_	_	PUNCT
aji-158	656	1	_	_	PUNCT
aji-158	657	1	_	_	PUNCT
aji-158	658	1	_	_	PUNCT
aji-158	659	1	_	_	PUNCT
aji-158	660	1	_	_	PUNCT
aji-158	661	1	_	_	PUNCT
aji-158	662	1	_	_	PUNCT
aji-158	663	1	_	_	PUNCT
aji-158	664	1	_	_	PUNCT
aji-158	665	1	_	_	PUNCT
aji-158	666	1	_	_	PUNCT
aji-158	667	1	_	_	PUNCT
aji-158	668	1	©	©	PRON
aji-158	668	2	copyright	copyright	NOUN
aji-158	668	3	(	(	PUNCT
aji-158	668	4	2025	2025	NUM
aji-158	668	5	):	):	PUNCT
aji-158	668	6	author(s	author(s	NOUN
aji-158	668	7	)	)	PUNCT
aji-158	668	8	.	.	PUNCT
aji-158	669	1	the	the	DET
aji-158	669	2	licensee	licensee	NOUN
aji-158	669	3	is	be	AUX
aji-158	669	4	the	the	DET
aji-158	669	5	journal	journal	PROPN
aji-158	669	6	publisher	publisher	NOUN
aji-158	669	7	.	.	PUNCT
aji-158	670	1	this	this	PRON
aji-158	670	2	is	be	AUX
aji-158	670	3	an	an	DET
aji-158	670	4	open	open	ADJ
aji-158	670	5	access	access	NOUN
aji-158	670	6	article	article	NOUN
aji-158	670	7	distributed	distribute	VERB
aji-158	670	8	under	under	ADP
aji-158	670	9	the	the	DET
aji-158	670	10	terms	term	NOUN
aji-158	670	11	of	of	ADP
aji-158	670	12	the	the	DET
aji-158	670	13	creative	creative	ADJ
aji-158	670	14	commons	common	NOUN
aji-158	670	15	attribution	attribution	NOUN
aji-158	670	16	license	license	NOUN
aji-158	670	17	(	(	PUNCT
aji-158	670	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-158	670	19	)	)	PUNCT
aji-158	670	20	,	,	PUNCT
aji-158	670	21	which	which	PRON
aji-158	670	22	permits	permit	VERB
aji-158	670	23	unrestricted	unrestricted	ADJ
aji-158	670	24	use	use	NOUN
aji-158	670	25	,	,	PUNCT
aji-158	670	26	distribution	distribution	NOUN
aji-158	670	27	,	,	PUNCT
aji-158	670	28	and	and	CCONJ
aji-158	670	29	reproduction	reproduction	NOUN
aji-158	670	30	in	in	ADP
aji-158	670	31	any	any	DET
aji-158	670	32	medium	medium	NOUN
aji-158	670	33	,	,	PUNCT
aji-158	670	34	provided	provide	VERB
aji-158	670	35	the	the	DET
aji-158	670	36	original	original	ADJ
aji-158	670	37	work	work	NOUN
aji-158	670	38	is	be	AUX
aji-158	670	39	properly	properly	ADV
aji-158	670	40	cited	cite	VERB
aji-158	670	41	.	.	PUNCT
aji-158	671	1	peer	peer	NOUN
aji-158	671	2	-	-	PUNCT
aji-158	671	3	review	review	NOUN
aji-158	671	4	history	history	NOUN
aji-158	671	5	:	:	PUNCT
aji-158	671	6	the	the	DET
aji-158	671	7	peer	peer	NOUN
aji-158	671	8	review	review	NOUN
aji-158	671	9	history	history	NOUN
aji-158	671	10	for	for	ADP
aji-158	671	11	this	this	DET
aji-158	671	12	paper	paper	NOUN
aji-158	671	13	can	can	AUX
aji-158	671	14	be	be	AUX
aji-158	671	15	accessed	access	VERB
aji-158	671	16	here	here	ADV
aji-158	671	17	:	:	PUNCT
aji-158	671	18	https://pr.sdiarticle5.com/review-history/133582	https://pr.sdiarticle5.com/review-history/133582	X
aji-158	671	19	https://pr.sdiarticle5.com/review-history/133582	https://pr.sdiarticle5.com/review-history/133582	NUM